company,disease_class,compound,mw,clogp,arom,hba,hbd,rtb,psa,bpka,apka
AAIPHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C15 Hemic and Lymphatic Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C10 Nervous System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C04 Neoplasms,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C14 Cardiovascular Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C12 Male Urogenital Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C17 Skin and Connective Tissue Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C08 Respiratory Tract Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C06 Digestive System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C05 Musculoskeletal Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AAIPHARMA LLC,C20 Immune System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ABBVIE ENDOCRINE INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEUPROLIDE ACETATE,1209.42,,,,,,,,
ABBVIE ENDOCRINE INC,C14 Cardiovascular Diseases,LEUPROLIDE ACETATE,1209.42,,,,,,,,
ABBVIE ENDOCRINE INC,C12 Male Urogenital Diseases,LEUPROLIDE ACETATE,1209.42,,,,,,,,
ABBVIE ENDOCRINE INC,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ABBVIE ENDOCRINE INC,C10 Nervous System Diseases,LEUPROLIDE ACETATE,1209.42,,,,,,,,
ABBVIE ENDOCRINE INC,C18 Nutritional and Metabolic Diseases,LEUPROLIDE ACETATE,1209.42,,,,,,,,
ABBVIE ENDOCRINE INC,C19 Endocrine System Diseases,LEUPROLIDE ACETATE,1209.42,,,,,,,,
ABBVIE ENDOCRINE INC,C04 Neoplasms,LEUPROLIDE ACETATE,1209.42,,,,,,,,
ABBVIE ENDOCRINE INC,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ABBVIE ENDOCRINE INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ABBVIE ENDOCRINE INC,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ABBVIE ENDOCRINE INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ABBVIE ENDOCRINE INC,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ABBVIE ENDOCRINE INC,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ABBVIE INC,C06 Digestive System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C10 Nervous System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
ABBVIE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
ABBVIE INC,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C14 Cardiovascular Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ABBVIE INC,C04 Neoplasms,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
ABBVIE INC,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,C14 Cardiovascular Diseases,TRANDOLAPRIL,430.55,1.95,1,5,2,9,95.94,5.21,3.8
ABBVIE INC,C01 Infections,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABBVIE INC,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,C08 Respiratory Tract Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABBVIE INC,C06 Digestive System Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABBVIE INC,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C01 Infections,LOPINAVIR,628.81,4.69,3,5,4,15,120,,13.39
ABBVIE INC,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C18 Nutritional and Metabolic Diseases,LOPINAVIR,628.81,4.69,3,5,4,15,120,,13.39
ABBVIE INC,G08 Reproductive and Urinary Physiological Phenomena,LOPINAVIR,628.81,4.69,3,5,4,15,120,,13.39
ABBVIE INC,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C18 Nutritional and Metabolic Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ABBVIE INC,C01 Infections,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
ABBVIE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ABBVIE INC,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C14 Cardiovascular Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
ABBVIE INC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C04 Neoplasms,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C18 Nutritional and Metabolic Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
ABBVIE INC,C06 Digestive System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
ABBVIE INC,C08 Respiratory Tract Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C11 Eye Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,C18 Nutritional and Metabolic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,G08 Reproductive and Urinary Physiological Phenomena,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
ABBVIE INC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C14 Cardiovascular Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,C12 Male Urogenital Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,C17 Skin and Connective Tissue Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,C05 Musculoskeletal Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C08 Respiratory Tract Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
ABBVIE INC,C12 Male Urogenital Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
ABBVIE INC,"C23 Pathological Conditions, Signs and Symptoms",DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABBVIE INC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,"C23 Pathological Conditions, Signs and Symptoms",CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,C19 Endocrine System Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
ABBVIE INC,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,C18 Nutritional and Metabolic Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
ABBVIE INC,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,C01 Infections,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C04 Neoplasms,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
ABBVIE INC,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ABBVIE INC,C12 Male Urogenital Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
ABBVIE INC,C15 Hemic and Lymphatic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,C20 Immune System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C05 Musculoskeletal Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABBVIE INC,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,F03 Mental Disorders,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
ABBVIE INC,C01 Infections,DASABUVIR SODIUM,493.59,3.42,4,6,2,5,110.26,,9.09
ABBVIE INC,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C10 Nervous System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,C10 Nervous System Diseases,TRIMETHADIONE,143.14,0.5,0,3,0,0,46.61,,
ABBVIE INC,C05 Musculoskeletal Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
ABBVIE INC,C19 Endocrine System Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
ABBVIE INC,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C04 Neoplasms,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
ABBVIE INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
ABBVIE INC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ABBVIE INC,C26 Wounds and Injuries,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,C25 Chemically-Induced Disorders,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABBVIE INC,C10 Nervous System Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABBVIE INC,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,C15 Hemic and Lymphatic Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABBVIE INC,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C07 Stomatognathic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
ABBVIE INC,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ABBVIE INC,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ABBVIE INC,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
ABBVIE INC,F03 Mental Disorders,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABBVIE INC,F01 Behavior and Behavior Mechanisms,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
ABHAI LLC,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ABHAI LLC,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ABHAI LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ABHAI LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ABHAI LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ABHAI LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ABHAI LLC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ABHAI LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ABHAI LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ABHAI LLC,C10 Nervous System Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
ABHAI LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ABHAI LLC,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ABHAI LLC,"C23 Pathological Conditions, Signs and Symptoms",DESMOPRESSIN ACETATE,1069.24,,,,,,,,
ABHAI LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ABHAI LLC,C12 Male Urogenital Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
ABHAI LLC,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ABHAI LLC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
ABHAI LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ABHAI LLC,C14 Cardiovascular Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
ABHAI LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ABHAI LLC,C04 Neoplasms,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ABHAI LLC,C05 Musculoskeletal Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ABHAI LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C20 Immune System Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ABHAI LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ABHAI LLC,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
ABHAI LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ABHAI LLC,C17 Skin and Connective Tissue Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ABHAI LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C12 Male Urogenital Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ABHAI LLC,C01 Infections,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ABHAI LLC,C14 Cardiovascular Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ABHAI LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
ABHAI LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ABHAI LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
ABHAI LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ABHAI LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ABHAI LLC,C11 Eye Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ACCORD HEALTHCARE INC,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ACCORD HEALTHCARE INC,C11 Eye Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
ACCORD HEALTHCARE INC,C04 Neoplasms,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ACCORD HEALTHCARE INC,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
ACCORD HEALTHCARE INC,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ACCORD HEALTHCARE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ACCORD HEALTHCARE INC,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
ACCORD HEALTHCARE INC,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
ACCORD HEALTHCARE INC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
ACCORD HEALTHCARE INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
ACCORD HEALTHCARE INC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
ACCORD HEALTHCARE INC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ACCORD HEALTHCARE INC,C11 Eye Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ACCORD HEALTHCARE INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
ACCORD HEALTHCARE INC,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ACCORD HEALTHCARE INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ACCORD HEALTHCARE INC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
ACCORD HEALTHCARE INC,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACCORD HEALTHCARE INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACCORD HEALTHCARE INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACCORD HEALTHCARE INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACCORD HEALTHCARE INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACCORD HEALTHCARE INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ACCORD HEALTHCARE INC,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ACCORD HEALTHCARE INC,C20 Immune System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACCORD HEALTHCARE INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ACCORD HEALTHCARE INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACCORD HEALTHCARE INC,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ACCORD HEALTHCARE INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACCORD HEALTHCARE INC,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
ACCORD HEALTHCARE INC,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C25 Chemically-Induced Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
ACCORD HEALTHCARE INC,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,F03 Mental Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
ACCORD HEALTHCARE INC,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
ACCORD HEALTHCARE INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACCORD HEALTHCARE INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACCORD HEALTHCARE INC,F03 Mental Disorders,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
ACCORD HEALTHCARE INC,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACCORD HEALTHCARE INC,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACCORD HEALTHCARE INC,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACCORD HEALTHCARE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
ACCORD HEALTHCARE INC,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
ACCORD HEALTHCARE INC,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
ACCORD HEALTHCARE INC,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ACCORD HEALTHCARE INC,F01 Behavior and Behavior Mechanisms,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ACCORD HEALTHCARE INC,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACCORD HEALTHCARE INC,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACCORD HEALTHCARE INC,F03 Mental Disorders,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
ACCORD HEALTHCARE INC,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACCORD HEALTHCARE INC,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACCORD HEALTHCARE INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACCORD HEALTHCARE INC,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
ACCORD HEALTHCARE INC,C19 Endocrine System Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
ACCORD HEALTHCARE INC,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACCORD HEALTHCARE INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ACCORD HEALTHCARE INC,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ACCORD HEALTHCARE INC,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ACCORD HEALTHCARE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ACCORD HEALTHCARE INC,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACCORD HEALTHCARE INC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACCORD HEALTHCARE INC,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
ACCORD HEALTHCARE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ACCORD HEALTHCARE INC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACCORD HEALTHCARE INC,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ACCORD HEALTHCARE INC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ACCORD HEALTHCARE INC,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ACCORD HEALTHCARE INC,F03 Mental Disorders,LURASIDONE HYDROCHLORIDE,492.69,4.56,2,6,0,5,56.75,8.5,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACCORD HEALTHCARE INC,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ACCORD HEALTHCARE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACCORD HEALTHCARE INC,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,PRASUGREL HYDROCHLORIDE,373.45,4.31,2,5,0,5,46.61,5.12,
ACCORD HEALTHCARE INC,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ACCORD HEALTHCARE INC,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
ACCORD HEALTHCARE INC,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
ACCORD HEALTHCARE INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
ACCORD HEALTHCARE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ACCORD HEALTHCARE INC,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
ACCORD HEALTHCARE INC,C20 Immune System Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
ACCORD HEALTHCARE INC,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
ACCORD HEALTHCARE INC,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
ACCORD HEALTHCARE INC,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,C20 Immune System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
ACCORD HEALTHCARE INC,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
ACCORD HEALTHCARE INC,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
ACCORD HEALTHCARE INC,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
ACCORD HEALTHCARE INC,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
ACCORD HEALTHCARE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ACCORD HEALTHCARE INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C04 Neoplasms,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ACCORD HEALTHCARE INC,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
ACCORD HEALTHCARE INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ACCORD HEALTHCARE INC,C12 Male Urogenital Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ACCORD HEALTHCARE INC,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ACCORD HEALTHCARE INC,C11 Eye Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ACCORD HEALTHCARE INC,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ACCORD HEALTHCARE INC,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
ACCORD HEALTHCARE INC,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ACCORD HEALTHCARE INC,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
ACCORD HEALTHCARE INC,C04 Neoplasms,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
ACCORD HEALTHCARE INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ACCORD HEALTHCARE INC,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ACCORD HEALTHCARE INC,C19 Endocrine System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ACCORD HEALTHCARE INC,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ACCORD HEALTHCARE INC,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
ACCORD HEALTHCARE INC,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ACCORD HEALTHCARE INC,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ACCORD HEALTHCARE INC,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
ACELLA PHARMACEUTICALS LLC,C01 Infections,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
ACELLA PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACELLA PHARMACEUTICALS LLC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACELLA PHARMACEUTICALS LLC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACELLA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACELLA PHARMACEUTICALS LLC,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACELLA PHARMACEUTICALS LLC,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACELLA PHARMACEUTICALS LLC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
ACELLA PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
ACELLA PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACELLA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
ACELLA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
ACELLA PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
ACELLA PHARMACEUTICALS LLC,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACELLA PHARMACEUTICALS LLC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
ACELLA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACELLA PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACELLA PHARMACEUTICALS LLC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
ACELLA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACELLA PHARMACEUTICALS LLC,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACELLA PHARMACEUTICALS LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACELLA PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
ACELLA PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACELLA PHARMACEUTICALS LLC,C01 Infections,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
ACI HEALTHCARE LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ACI HEALTHCARE LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACI HEALTHCARE LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACI HEALTHCARE LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACI HEALTHCARE LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ACI HEALTHCARE LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ACI HEALTHCARE LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACI HEALTHCARE LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACI HEALTHCARE LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ACI HEALTHCARE LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACI HEALTHCARE LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACI HEALTHCARE LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ACP NIMBLE BUYER INC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
ACP NIMBLE BUYER INC,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
ACP NIMBLE BUYER INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACP NIMBLE BUYER INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACP NIMBLE BUYER INC,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
ACP NIMBLE BUYER INC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACP NIMBLE BUYER INC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
ACP NIMBLE BUYER INC,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
ACP NIMBLE BUYER INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
ACP NIMBLE BUYER INC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACP NIMBLE BUYER INC,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
ACP NIMBLE BUYER INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACP NIMBLE BUYER INC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
ACP NIMBLE BUYER INC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACP NIMBLE BUYER INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACP NIMBLE BUYER INC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACP NIMBLE BUYER INC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
ACTAVIS ELIZABETH LLC,C19 Endocrine System Diseases,PROPYLTHIOURACIL,170.24,1.2,1,2,2,2,48.65,,8.09
ACTAVIS ELIZABETH LLC,C11 Eye Diseases,PROPYLTHIOURACIL,170.24,1.2,1,2,2,2,48.65,,8.09
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS ELIZABETH LLC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ACTAVIS ELIZABETH LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACTAVIS ELIZABETH LLC,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ACTAVIS ELIZABETH LLC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACTAVIS ELIZABETH LLC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ACTAVIS ELIZABETH LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACTAVIS ELIZABETH LLC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ACTAVIS ELIZABETH LLC,C04 Neoplasms,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
ACTAVIS ELIZABETH LLC,C01 Infections,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
ACTAVIS ELIZABETH LLC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
ACTAVIS ELIZABETH LLC,C15 Hemic and Lymphatic Diseases,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
ACTAVIS ELIZABETH LLC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C01 Infections,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ACTAVIS ELIZABETH LLC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ACTAVIS ELIZABETH LLC,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACTAVIS ELIZABETH LLC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS ELIZABETH LLC,F01 Behavior and Behavior Mechanisms,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ACTAVIS ELIZABETH LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ACTAVIS ELIZABETH LLC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
ACTAVIS ELIZABETH LLC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ACTAVIS ELIZABETH LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
ACTAVIS ELIZABETH LLC,F01 Behavior and Behavior Mechanisms,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,FLUVOXAMINE MALEATE,318.34,2.8,1,4,1,9,56.84,8.86,
ACTAVIS ELIZABETH LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ACTAVIS ELIZABETH LLC,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACTAVIS ELIZABETH LLC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS ELIZABETH LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ACTAVIS ELIZABETH LLC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
ACTAVIS ELIZABETH LLC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
ACTAVIS ELIZABETH LLC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
ACTAVIS ELIZABETH LLC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACTAVIS ELIZABETH LLC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ACTAVIS ELIZABETH LLC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ACTAVIS ELIZABETH LLC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ACTAVIS ELIZABETH LLC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACTAVIS ELIZABETH LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS ELIZABETH LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACTAVIS ELIZABETH LLC,C01 Infections,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
ACTAVIS ELIZABETH LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS ELIZABETH LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
ACTAVIS ELIZABETH LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS ELIZABETH LLC,C20 Immune System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
ACTAVIS ELIZABETH LLC,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
ACTAVIS ELIZABETH LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS ELIZABETH LLC,C04 Neoplasms,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
ACTAVIS ELIZABETH LLC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,QUINIDINE SULFATE,324.42,2.51,2,4,1,4,45.59,9.05,13.89
ACTAVIS ELIZABETH LLC,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ACTAVIS ELIZABETH LLC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ACTAVIS ELIZABETH LLC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS ELIZABETH LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,QUINIDINE SULFATE,324.42,2.51,2,4,1,4,45.59,9.05,13.89
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS ELIZABETH LLC,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS ELIZABETH LLC,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS ELIZABETH LLC,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
ACTAVIS ELIZABETH LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS ELIZABETH LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS ELIZABETH LLC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS ELIZABETH LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS ELIZABETH LLC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS ELIZABETH LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS ELIZABETH LLC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
ACTAVIS ELIZABETH LLC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ACTAVIS ELIZABETH LLC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ACTAVIS ELIZABETH LLC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
ACTAVIS ELIZABETH LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS ELIZABETH LLC,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
ACTAVIS ELIZABETH LLC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS ELIZABETH LLC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ACTAVIS ELIZABETH LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
ACTAVIS ELIZABETH LLC,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
ACTAVIS ELIZABETH LLC,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
ACTAVIS ELIZABETH LLC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS ELIZABETH LLC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
ACTAVIS LABORATORIES FL INC,C11 Eye Diseases,VALGANCICLOVIR HYDROCHLORIDE,354.37,-1.21,2,10,4,8,171.37,7.48,10.16
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ACTAVIS LABORATORIES FL INC,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
ACTAVIS LABORATORIES FL INC,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
ACTAVIS LABORATORIES FL INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS LABORATORIES FL INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",DESMOPRESSIN ACETATE,1069.24,,,,,,,,
ACTAVIS LABORATORIES FL INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ACTAVIS LABORATORIES FL INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C01 Infections,DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
ACTAVIS LABORATORIES FL INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
ACTAVIS LABORATORIES FL INC,C15 Hemic and Lymphatic Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,F01 Behavior and Behavior Mechanisms,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ACTAVIS LABORATORIES FL INC,G08 Reproductive and Urinary Physiological Phenomena,PAROXETINE MESYLATE,329.37,3.15,2,4,1,4,39.72,9.77,
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ACTAVIS LABORATORIES FL INC,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
ACTAVIS LABORATORIES FL INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS LABORATORIES FL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C25 Chemically-Induced Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
ACTAVIS LABORATORIES FL INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
ACTAVIS LABORATORIES FL INC,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS LABORATORIES FL INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ACTAVIS LABORATORIES FL INC,C01 Infections,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ACTAVIS LABORATORIES FL INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ACTAVIS LABORATORIES FL INC,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
ACTAVIS LABORATORIES FL INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS LABORATORIES FL INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ACTAVIS LABORATORIES FL INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ACTAVIS LABORATORIES FL INC,C26 Wounds and Injuries,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS LABORATORIES FL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ACTAVIS LABORATORIES FL INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ACTAVIS LABORATORIES FL INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS LABORATORIES FL INC,C01 Infections,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ACTAVIS LABORATORIES FL INC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS LABORATORIES FL INC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ACTAVIS LABORATORIES FL INC,C13 Female Urogenital Diseases and Pregnancy Complications,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ACTAVIS LABORATORIES FL INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS LABORATORIES FL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS LABORATORIES FL INC,C13 Female Urogenital Diseases and Pregnancy Complications,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE SULFATE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
ACTAVIS LABORATORIES FL INC,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
ACTAVIS LABORATORIES FL INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ACTAVIS LABORATORIES FL INC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ACTAVIS LABORATORIES FL INC,G08 Reproductive and Urinary Physiological Phenomena,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
ACTAVIS LABORATORIES FL INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS LABORATORIES FL INC,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ACTAVIS LABORATORIES FL INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ACTAVIS LABORATORIES FL INC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,TETRABENAZINE,317.43,3.4,1,4,0,4,38.77,7.33,
ACTAVIS LABORATORIES FL INC,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
ACTAVIS LABORATORIES FL INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS LABORATORIES FL INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C25 Chemically-Induced Disorders,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C13 Female Urogenital Diseases and Pregnancy Complications,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
ACTAVIS LABORATORIES FL INC,F01 Behavior and Behavior Mechanisms,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
ACTAVIS LABORATORIES FL INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ACTAVIS LABORATORIES FL INC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ACTAVIS LABORATORIES FL INC,C14 Cardiovascular Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C01 Infections,PYRIDOXINE HYDROCHLORIDE,169.18,-0.95,1,4,3,2,73.58,5.58,9.4
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",PYRIDOXINE HYDROCHLORIDE,169.18,-0.95,1,4,3,2,73.58,5.58,9.4
ACTAVIS LABORATORIES FL INC,C15 Hemic and Lymphatic Diseases,PYRIDOXINE HYDROCHLORIDE,169.18,-0.95,1,4,3,2,73.58,5.58,9.4
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
ACTAVIS LABORATORIES FL INC,C25 Chemically-Induced Disorders,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
ACTAVIS LABORATORIES FL INC,C08 Respiratory Tract Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ACTAVIS LABORATORIES FL INC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ACTAVIS LABORATORIES FL INC,C26 Wounds and Injuries,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,PYRIDOXINE HYDROCHLORIDE,169.18,-0.95,1,4,3,2,73.58,5.58,9.4
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ACTAVIS LABORATORIES FL INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ACTAVIS LABORATORIES FL INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ACTAVIS LABORATORIES FL INC,C01 Infections,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS LABORATORIES FL INC,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
ACTAVIS LABORATORIES FL INC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ACTAVIS LABORATORIES FL INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS LABORATORIES FL INC,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS LABORATORIES FL INC,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ACTAVIS LABORATORIES FL INC,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ACTAVIS LABORATORIES FL INC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ACTAVIS LABORATORIES FL INC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,G08 Reproductive and Urinary Physiological Phenomena,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
ACTAVIS LABORATORIES UT INC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACTAVIS LABORATORIES UT INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ACTAVIS LABORATORIES UT INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACTAVIS LABORATORIES UT INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACTAVIS LABORATORIES UT INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACTAVIS LABORATORIES UT INC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACTAVIS LABORATORIES UT INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ACTAVIS LABORATORIES UT INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ACTAVIS LABORATORIES UT INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACTAVIS LABORATORIES UT INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ACTAVIS LABORATORIES UT INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
ACTAVIS LABORATORIES UT INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ACTAVIS LABORATORIES UT INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ACTAVIS LABORATORIES UT INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS LABORATORIES UT INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ACTAVIS MID ATLANTIC LLC,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
ACTAVIS MID ATLANTIC LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ACTAVIS MID ATLANTIC LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
ACTAVIS MID ATLANTIC LLC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
ACTAVIS MID ATLANTIC LLC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
ACTAVIS MID ATLANTIC LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
ACTAVIS MID ATLANTIC LLC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
ACTAVIS MID ATLANTIC LLC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ACTAVIS MID ATLANTIC LLC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
ACTAVIS MID ATLANTIC LLC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ACTAVIS MID ATLANTIC LLC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ACTAVIS MID ATLANTIC LLC,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ACTAVIS MID ATLANTIC LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
ACTAVIS MID ATLANTIC LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS MID ATLANTIC LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS MID ATLANTIC LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS MID ATLANTIC LLC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS MID ATLANTIC LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS MID ATLANTIC LLC,C01 Infections,GRISEOFULVIN,352.77,2.17,1,6,0,3,71.06,,
ACTAVIS MID ATLANTIC LLC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS MID ATLANTIC LLC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS MID ATLANTIC LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS MID ATLANTIC LLC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ACTAVIS MID ATLANTIC LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS MID ATLANTIC LLC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
ACTAVIS MID ATLANTIC LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ACTAVIS MID ATLANTIC LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS MID ATLANTIC LLC,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ACTAVIS MID ATLANTIC LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ACTAVIS MID ATLANTIC LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC,C14 Cardiovascular Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
ACTAVIS MID ATLANTIC LLC,C11 Eye Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
ACTAVIS MID ATLANTIC LLC,C01 Infections,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
ACTAVIS MID ATLANTIC LLC,C08 Respiratory Tract Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
ACTAVIS MID ATLANTIC LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ACTAVIS MID ATLANTIC LLC,C04 Neoplasms,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS MID ATLANTIC LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ACTAVIS TOTOWA LLC,F03 Mental Disorders,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
ACTAVIS TOTOWA LLC,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
ACTAVIS TOTOWA LLC,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACTAVIS TOTOWA LLC,C04 Neoplasms,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
ACTAVIS TOTOWA LLC,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
ACTAVIS TOTOWA LLC,C10 Nervous System Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
ACTAVIS TOTOWA LLC,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACTAVIS TOTOWA LLC,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACTAVIS TOTOWA LLC,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACTAVIS TOTOWA LLC,"C23 Pathological Conditions, Signs and Symptoms",DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
ACTAVIS TOTOWA LLC,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ACTAVIS TOTOWA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
ACTAVIS TOTOWA LLC,C18 Nutritional and Metabolic Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
ACTELION PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ACTELION PHARMACEUTICALS LTD,C01 Infections,MIGLUSTAT,219.28,-1.18,0,5,4,4,84.16,8.49,12.9
ACTELION PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ACTELION PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ACTELION PHARMACEUTICALS LTD,C11 Eye Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ACTELION PHARMACEUTICALS LTD,C06 Digestive System Diseases,MIGLUSTAT,219.28,-1.18,0,5,4,4,84.16,8.49,12.9
ACTELION PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ACTELION PHARMACEUTICALS LTD,C04 Neoplasms,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ACTELION PHARMACEUTICALS LTD,C10 Nervous System Diseases,MIGLUSTAT,219.28,-1.18,0,5,4,4,84.16,8.49,12.9
ACTELION PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ACTELION PHARMACEUTICALS LTD,C06 Digestive System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ACTELION PHARMACEUTICALS LTD,C10 Nervous System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ACTELION PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ADARE PHARMACEUTICALS INC,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
AILEX PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
AILEX PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AILEX PHARMACEUTICALS LLC,C04 Neoplasms,BISMUTH SUBSALICYLATE,362.09,,,,,,,,
AILEX PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
AILEX PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LTD,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LTD,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
AJANTA PHARMA LTD,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
AJANTA PHARMA LTD,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AJANTA PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
AJANTA PHARMA LTD,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AJANTA PHARMA LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AJANTA PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AJANTA PHARMA LTD,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AJANTA PHARMA LTD,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AJANTA PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
AJANTA PHARMA LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AJANTA PHARMA LTD,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AJANTA PHARMA LTD,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AJANTA PHARMA LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AJANTA PHARMA LTD,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
AJANTA PHARMA LTD,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
AJANTA PHARMA LTD,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
AJANTA PHARMA LTD,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
AJANTA PHARMA LTD,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AJANTA PHARMA LTD,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C10 Nervous System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
AJANTA PHARMA LTD,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AJANTA PHARMA LTD,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AJANTA PHARMA LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AJANTA PHARMA LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AJANTA PHARMA LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AJANTA PHARMA LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AJANTA PHARMA LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
AJANTA PHARMA LTD,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AJANTA PHARMA LTD,C04 Neoplasms,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
AJANTA PHARMA LTD,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
AJANTA PHARMA LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
AJANTA PHARMA LTD,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
AJANTA PHARMA LTD,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,C06 Digestive System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
AJANTA PHARMA LTD,C05 Musculoskeletal Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
AJANTA PHARMA LTD,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AJANTA PHARMA LTD,C08 Respiratory Tract Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
AJANTA PHARMA LTD,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AJANTA PHARMA LTD,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
AJANTA PHARMA LTD,C18 Nutritional and Metabolic Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
AJANTA PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
AJANTA PHARMA LTD,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
AJANTA PHARMA LTD,C14 Cardiovascular Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
AJANTA PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AJANTA PHARMA LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AJANTA PHARMA LTD,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AJANTA PHARMA LTD,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AJANTA PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AJANTA PHARMA LTD,C10 Nervous System Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
AJANTA PHARMA LTD,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AJANTA PHARMA LTD,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AJANTA PHARMA LTD,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AJANTA PHARMA LTD,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AJANTA PHARMA LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AJANTA PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AJANTA PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AJANTA PHARMA LTD,C10 Nervous System Diseases,ALMOTRIPTAN MALATE,335.47,1.52,2,3,1,6,56.41,9.55,
AJANTA PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
AJANTA PHARMA LTD,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
AJANTA PHARMA LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AJANTA PHARMA LTD,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AJANTA PHARMA LTD,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AJANTA PHARMA LTD,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AJANTA PHARMA LTD,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AJANTA PHARMA LTD,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
AJANTA PHARMA LTD,C25 Chemically-Induced Disorders,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
AJANTA PHARMA LTD,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AJANTA PHARMA LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
AJANTA PHARMA LTD,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
AJANTA PHARMA LTD,C18 Nutritional and Metabolic Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
AJANTA PHARMA LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
AJANTA PHARMA LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AJANTA PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AJANTA PHARMA LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AJANTA PHARMA LTD,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AJANTA PHARMA LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AJANTA PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AJANTA PHARMA LTD,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AKORN INC,C15 Hemic and Lymphatic Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,C04 Neoplasms,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AKORN INC,F03 Mental Disorders,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,"C23 Pathological Conditions, Signs and Symptoms",RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C01 Infections,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AKORN INC,C05 Musculoskeletal Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C10 Nervous System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AKORN INC,C14 Cardiovascular Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C01 Infections,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,C08 Respiratory Tract Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,C06 Digestive System Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,C05 Musculoskeletal Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,C01 Infections,ETHAMBUTOL HYDROCHLORIDE,204.31,-0.06,0,4,4,9,64.52,9.55,
AKORN INC,"C23 Pathological Conditions, Signs and Symptoms",DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,C10 Nervous System Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,C12 Male Urogenital Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C15 Hemic and Lymphatic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AKORN INC,C06 Digestive System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
AKORN INC,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AKORN INC,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AKORN INC,C06 Digestive System Diseases,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
AKORN INC,C10 Nervous System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
AKORN INC,C01 Infections,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
AKORN INC,F03 Mental Disorders,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
AKORN INC,C08 Respiratory Tract Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C13 Female Urogenital Diseases and Pregnancy Complications,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C01 Infections,PYRAZINAMIDE,123.11,-1.23,1,3,1,1,68.87,,13.06
AKORN INC,F01 Behavior and Behavior Mechanisms,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,C25 Chemically-Induced Disorders,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
AKORN INC,C18 Nutritional and Metabolic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
AKORN INC,C01 Infections,DEMECLOCYCLINE HYDROCHLORIDE,464.86,-3.17,1,9,6,2,181.62,8.54,2.59
AKORN INC,C06 Digestive System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALEMBIC PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ALEMBIC PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,DESVENLAFAXINE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,DESVENLAFAXINE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,DESVENLAFAXINE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ALEMBIC PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
ALEMBIC PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ALEMBIC PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALEMBIC PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
ALEMBIC PHARMACEUTICALS LTD,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
ALEMBIC PHARMACEUTICALS LTD,C09 Otorhinolaryngologic Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ALEMBIC PHARMACEUTICALS LTD,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ALEMBIC PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALEMBIC PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ALEMBIC PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,VARDENAFIL HYDROCHLORIDE,488.61,1.43,3,8,1,8,112.9,6.21,11.75
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,MEPROBAMATE,218.25,0.93,0,4,2,6,104.64,,
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ALEMBIC PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALEMBIC PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ALEMBIC PHARMACEUTICALS LTD,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALEMBIC PHARMACEUTICALS LTD,C20 Immune System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
ALEMBIC PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALEMBIC PHARMACEUTICALS LTD,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ALEMBIC PHARMACEUTICALS LTD,G08 Reproductive and Urinary Physiological Phenomena,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ALEMBIC PHARMACEUTICALS LTD,C11 Eye Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ALEMBIC PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
ALEMBIC PHARMACEUTICALS LTD,C20 Immune System Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ALEMBIC PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALEMBIC PHARMACEUTICALS LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALEMBIC PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALEMBIC PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALEMBIC PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ALEMBIC PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
ALEMBIC PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
ALEMBIC PHARMACEUTICALS LTD,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ALEMBIC PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
ALEMBIC PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ALEMBIC PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
ALEMBIC PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
ALEMBIC PHARMACEUTICALS LTD,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ALEMBIC PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ALEMBIC PHARMACEUTICALS LTD,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
ALEMBIC PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALEMBIC PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ALEMBIC PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ALEMBIC PHARMACEUTICALS LTD,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALEMBIC PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
ALEMBIC PHARMACEUTICALS LTD,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALEMBIC PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ALEMBIC PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALIGNSCIENCE PHARMA INC,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALIGNSCIENCE PHARMA INC,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALIGNSCIENCE PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALIGNSCIENCE PHARMA INC,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALIGNSCIENCE PHARMA INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALIGNSCIENCE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALIGNSCIENCE PHARMA INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALIGNSCIENCE PHARMA INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALIGNSCIENCE PHARMA INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALIGNSCIENCE PHARMA INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALIGNSCIENCE PHARMA INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALIGNSCIENCE PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALKALOIDA CHEMICAL CO ZRT,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
ALKALOIDA CHEMICAL CO ZRT,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
ALKALOIDA CHEMICAL CO ZRT,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
ALKEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ALKEM LABORATORIES LTD,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ALKEM LABORATORIES LTD,C01 Infections,CEFUROXIME AXETIL,510.48,-0.43,1,12,2,9,189.06,,10.92
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C09 Otorhinolaryngologic Diseases,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
ALKEM LABORATORIES LTD,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
ALKEM LABORATORIES LTD,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
ALKEM LABORATORIES LTD,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ALKEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ALKEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALKEM LABORATORIES LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ALKEM LABORATORIES LTD,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
ALKEM LABORATORIES LTD,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ALKEM LABORATORIES LTD,C04 Neoplasms,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ALKEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALKEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALKEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ALKEM LABORATORIES LTD,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
ALKEM LABORATORIES LTD,C01 Infections,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ALKEM LABORATORIES LTD,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
ALKEM LABORATORIES LTD,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALKEM LABORATORIES LTD,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ALKEM LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ALKEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ALKEM LABORATORIES LTD,C04 Neoplasms,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALKEM LABORATORIES LTD,C11 Eye Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ALKEM LABORATORIES LTD,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C01 Infections,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ALKEM LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALKEM LABORATORIES LTD,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ALKEM LABORATORIES LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ALKEM LABORATORIES LTD,C05 Musculoskeletal Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ALKEM LABORATORIES LTD,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ALKEM LABORATORIES LTD,C07 Stomatognathic Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ALKEM LABORATORIES LTD,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ALKEM LABORATORIES LTD,C08 Respiratory Tract Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
ALKEM LABORATORIES LTD,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
ALKEM LABORATORIES LTD,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ALKEM LABORATORIES LTD,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ALKEM LABORATORIES LTD,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
ALKEM LABORATORIES LTD,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
ALKEM LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALKEM LABORATORIES LTD,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ALKEM LABORATORIES LTD,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
ALKEM LABORATORIES LTD,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
ALKEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ALKEM LABORATORIES LTD,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALKEM LABORATORIES LTD,C01 Infections,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALKEM LABORATORIES LTD,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ALKEM LABORATORIES LTD,C04 Neoplasms,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ALKEM LABORATORIES LTD,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ALKEM LABORATORIES LTD,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
ALKEM LABORATORIES LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALKEM LABORATORIES LTD,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ALKEM LABORATORIES LTD,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
ALKEM LABORATORIES LTD,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ALKEM LABORATORIES LTD,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALKEM LABORATORIES LTD,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ALKEM LABORATORIES LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
ALKEM LABORATORIES LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
ALKEM LABORATORIES LTD,F03 Mental Disorders,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ALKEM LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALKEM LABORATORIES LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALKEM LABORATORIES LTD,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALKEM LABORATORIES LTD,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ALKEM LABORATORIES LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ALKEM LABORATORIES LTD,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ALKEM LABORATORIES LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ALKEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ALKEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALKEM LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALKEM LABORATORIES LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALKEM LABORATORIES LTD,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ALKEM LABORATORIES LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALKEM LABORATORIES LTD,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ALKEM LABORATORIES LTD,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALKEM LABORATORIES LTD,C04 Neoplasms,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
ALKEM LABORATORIES LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ALKEM LABORATORIES LTD,C10 Nervous System Diseases,RASAGILINE MESYLATE,171.24,2.3,1,1,1,2,12.03,8.4,
ALKEM LABORATORIES LTD,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALKEM LABORATORIES LTD,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALKEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALKEM LABORATORIES LTD,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ALKEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALKEM LABORATORIES LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ALKEM LABORATORIES LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN SALES LLC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALLERGAN SALES LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
ALLERGAN SALES LLC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN SALES LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN SALES LLC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,C06 Digestive System Diseases,SUCRALFATE,2072.71,,,,,,,,
ALLERGAN SALES LLC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALLERGAN SALES LLC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
ALLERGAN SALES LLC,C04 Neoplasms,LINACLOTIDE,1526.77,,,,,,,,
ALLERGAN SALES LLC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALLERGAN SALES LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ALLERGAN SALES LLC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN SALES LLC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALLERGAN SALES LLC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ALLERGAN SALES LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALLERGAN SALES LLC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALLERGAN SALES LLC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ALLERGAN SALES LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,F03 Mental Disorders,VILAZODONE HYDROCHLORIDE,441.54,3.72,4,5,2,7,102.29,8.6,
ALLERGAN SALES LLC,C06 Digestive System Diseases,LINACLOTIDE,1526.77,,,,,,,,
ALLERGAN SALES LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",LINACLOTIDE,1526.77,,,,,,,,
ALLERGAN SALES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALLERGAN SALES LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
ALLERGAN SALES LLC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALLERGAN SALES LLC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALLERGAN SALES LLC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALLERGAN SALES LLC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ALLERGAN SALES LLC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALLERGAN SALES LLC,C14 Cardiovascular Diseases,NEBIVOLOL HYDROCHLORIDE,405.44,3.21,2,5,3,6,70.95,8.9,13.52
ALLERGAN SALES LLC,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ALLERGAN SALES LLC,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ALLERGAN SALES LLC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ALLERGAN SALES LLC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ALLERGAN SALES LLC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",MILNACIPRAN HYDROCHLORIDE,246.35,1.42,1,2,1,5,46.33,9.83,
ALLERGAN SALES LLC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ALLERGAN SALES LLC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALLERGAN SALES LLC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN SALES LLC,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ALLERGAN SALES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ALLERGAN SALES LLC,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
ALLERGAN SALES LLC,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ALLERGAN SALES LLC,C05 Musculoskeletal Diseases,MILNACIPRAN HYDROCHLORIDE,246.35,1.42,1,2,1,5,46.33,9.83,
ALLERGAN SALES LLC,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ALLERGAN SALES LLC,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ALLERGAN SALES LLC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALLERGAN SALES LLC,C12 Male Urogenital Diseases,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
ALLERGAN SALES LLC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALLERGAN SALES LLC,C04 Neoplasms,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
ALLERGAN SALES LLC,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
ALLERGAN SALES LLC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALLERGAN SALES LLC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN SALES LLC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
ALLERGAN SALES LLC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ALLERGAN SALES LLC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALLERGAN SALES LLC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
ALLERGAN SALES LLC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ALLERGAN SALES LLC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C01 Infections,BISMUTH SUBCITRATE POTASSIUM,704.47,,,,,,,,
ALLERGAN SALES LLC,C06 Digestive System Diseases,BISMUTH SUBCITRATE POTASSIUM,704.47,,,,,,,,
ALLERGAN SALES LLC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ALLERGAN SALES LLC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ALLERGAN SALES LLC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALLIED PHARMA INC,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ALLIED PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ALLIED PHARMA INC,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ALLIED PHARMA INC,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ALLIED PHARMA INC,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ALLIED PHARMA INC,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ALLIED PHARMA INC,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ALLIED PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ALLIED PHARMA INC,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ALLIED PHARMA INC,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ALLIED PHARMA INC,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ALLIED PHARMA INC,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
ALMIRALL LLC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALMIRALL LLC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ALPHARMA PHARMACEUTICALS LLC,F03 Mental Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
ALPHARMA PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALPHARMA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALPHARMA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALPHARMA PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
ALPHARMA PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALPHARMA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALPHARMA PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALPHARMA PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALPHARMA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
ALPHARMA PHARMACEUTICALS LLC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ALRA LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ALRA LABORATORIES INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ALRA LABORATORIES INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ALRA LABORATORIES INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ALRA LABORATORIES INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALRA LABORATORIES INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ALVOGEN GROUP HOLDINGS 2 LLC,C04 Neoplasms,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
ALVOGEN GROUP HOLDINGS 2 LLC,C11 Eye Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
ALVOGEN GROUP HOLDINGS 2 LLC,C14 Cardiovascular Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
ALVOGEN INC,G07 Physiological Phenomena,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,F01 Behavior and Behavior Mechanisms,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C10 Nervous System Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C15 Hemic and Lymphatic Diseases,PRIMAQUINE PHOSPHATE,259.35,1.64,2,4,2,6,60.17,10.2,
ALVOGEN INC,C14 Cardiovascular Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C11 Eye Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C25 Chemically-Induced Disorders,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
ALVOGEN INC,C05 Musculoskeletal Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C17 Skin and Connective Tissue Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,F03 Mental Disorders,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C12 Male Urogenital Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C09 Otorhinolaryngologic Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C08 Respiratory Tract Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C18 Nutritional and Metabolic Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C15 Hemic and Lymphatic Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C01 Infections,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C04 Neoplasms,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C06 Digestive System Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C26 Wounds and Injuries,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
ALVOGEN INC,C01 Infections,PRIMAQUINE PHOSPHATE,259.35,1.64,2,4,2,6,60.17,10.2,
ALVOGEN MALTA OPERATIONS LTD,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
ALVOGEN MALTA OPERATIONS LTD,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
ALVOGEN MALTA OPERATIONS LTD,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ALVOGEN MALTA OPERATIONS LTD,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
ALVOGEN MALTA OPERATIONS LTD,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ALVOGEN MALTA OPERATIONS LTD,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ALVOGEN MALTA OPERATIONS LTD,F03 Mental Disorders,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
ALVOGEN MALTA OPERATIONS LTD,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ALVOGEN MALTA OPERATIONS LTD,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ALVOGEN MALTA OPERATIONS LTD,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ALVOGEN MALTA OPERATIONS LTD,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ALVOGEN MALTA OPERATIONS LTD,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALVOGEN MALTA OPERATIONS LTD,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ALVOGEN MALTA OPERATIONS LTD,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALVOGEN MALTA OPERATIONS LTD,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALVOGEN MALTA OPERATIONS LTD,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALVOGEN MALTA OPERATIONS LTD,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALVOGEN MALTA OPERATIONS LTD,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALVOGEN MALTA OPERATIONS LTD,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ALVOGEN MALTA OPERATIONS LTD,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ALVOGEN MALTA OPERATIONS LTD,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ALVOGEN MALTA OPERATIONS LTD,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
ALVOGEN MALTA OPERATIONS LTD,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ALVOGEN MALTA OPERATIONS LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ALVOGEN MALTA OPERATIONS LTD,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ALVOGEN MALTA OPERATIONS LTD,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ALVOGEN MALTA OPERATIONS LTD,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ALVOGEN MALTA OPERATIONS LTD,C04 Neoplasms,EXEMESTANE,296.41,3.87,0,2,0,0,34.14,,
ALVOGEN MALTA OPERATIONS LTD,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
ALVOGEN MALTA OPERATIONS LTD,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ALVOGEN MALTA OPERATIONS LTD,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ALVOGEN MALTA OPERATIONS LTD,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ALVOGEN MALTA OPERATIONS LTD,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ALVOGEN MALTA OPERATIONS LTD,C01 Infections,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
ALVOGEN MALTA OPERATIONS LTD,C04 Neoplasms,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
ALVOGEN MALTA OPERATIONS LTD,C25 Chemically-Induced Disorders,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
ALVOGEN MALTA OPERATIONS LTD,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,C14 Cardiovascular Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
ALVOGEN MALTA OPERATIONS LTD,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
ALVOGEN MALTA OPERATIONS LTD,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ALVOGEN MALTA OPERATIONS LTD,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ALVOGEN MALTA OPERATIONS LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ALVOGEN MALTA OPERATIONS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
ALVOGEN MALTA OPERATIONS LTD,C08 Respiratory Tract Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
ALVOGEN MALTA OPERATIONS LTD,C04 Neoplasms,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
ALVOGEN MALTA OPERATIONS LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALVOGEN MALTA OPERATIONS LTD,C15 Hemic and Lymphatic Diseases,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
ALVOGEN MALTA OPERATIONS LTD,C01 Infections,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
ALVOGEN MALTA OPERATIONS LTD,C04 Neoplasms,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
ALVOGEN MALTA OPERATIONS LTD,C18 Nutritional and Metabolic Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
ALVOGEN MALTA OPERATIONS LTD,C06 Digestive System Diseases,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
ALVOGEN MALTA OPERATIONS LTD,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
ALVOGEN MALTA OPERATIONS LTD,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ALVOGEN MALTA OPERATIONS LTD,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
ALVOGEN MALTA OPERATIONS LTD,C06 Digestive System Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
ALVOGEN MALTA OPERATIONS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALVOGEN MALTA OPERATIONS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALVOGEN MALTA OPERATIONS LTD,C18 Nutritional and Metabolic Diseases,NATEGLINIDE,317.43,4.03,1,2,2,6,66.4,,4
ALVOGEN MALTA OPERATIONS LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALVOGEN MALTA OPERATIONS LTD,C10 Nervous System Diseases,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
ALVOGEN MALTA OPERATIONS LTD,C15 Hemic and Lymphatic Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
ALVOGEN MALTA OPERATIONS LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALVOGEN MALTA OPERATIONS LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALVOGEN MALTA OPERATIONS LTD,C20 Immune System Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
ALVOGEN MALTA OPERATIONS LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ALVOGEN MALTA OPERATIONS LTD,C01 Infections,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
ALVOGEN PINE BROOK INC,C10 Nervous System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK INC,C04 Neoplasms,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK INC,C18 Nutritional and Metabolic Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK INC,C08 Respiratory Tract Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK INC,C14 Cardiovascular Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK INC,"C23 Pathological Conditions, Signs and Symptoms",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK INC,C06 Digestive System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK INC,C17 Skin and Connective Tissue Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK INC,C11 Eye Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ALVOGEN PINE BROOK LLC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ALVOGEN PINE BROOK LLC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ALVOGEN PINE BROOK LLC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ALVOGEN PINE BROOK LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
AMERIGEN PHARMACEUTICALS LTD,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMERIGEN PHARMACEUTICALS LTD,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,C01 Infections,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
AMERIGEN PHARMACEUTICALS LTD,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMERIGEN PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
AMERIGEN PHARMACEUTICALS LTD,C01 Infections,MIGLUSTAT,219.28,-1.18,0,5,4,4,84.16,8.49,12.9
AMERIGEN PHARMACEUTICALS LTD,F03 Mental Disorders,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
AMERIGEN PHARMACEUTICALS LTD,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
AMERIGEN PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
AMERIGEN PHARMACEUTICALS LTD,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
AMERIGEN PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
AMERIGEN PHARMACEUTICALS LTD,C10 Nervous System Diseases,MIGLUSTAT,219.28,-1.18,0,5,4,4,84.16,8.49,12.9
AMERIGEN PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
AMERIGEN PHARMACEUTICALS LTD,C06 Digestive System Diseases,MIGLUSTAT,219.28,-1.18,0,5,4,4,84.16,8.49,12.9
AMERIGEN PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
AMERIGEN PHARMACEUTICALS LTD,C04 Neoplasms,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C06 Digestive System Diseases,PENICILLAMINE,149.22,-2.15,0,3,3,2,63.32,9.09,2.56
AMERIGEN PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMERIGEN PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
AMERIGEN PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
AMERIGEN PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
AMERIGEN PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMERIGEN PHARMACEUTICALS LTD,C11 Eye Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C10 Nervous System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,G08 Reproductive and Urinary Physiological Phenomena,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,C04 Neoplasms,PENICILLAMINE,149.22,-2.15,0,3,3,2,63.32,9.09,2.56
AMERIGEN PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C20 Immune System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
AMERIGEN PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C06 Digestive System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMERIGEN PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
AMERIGEN PHARMACEUTICALS LTD,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
AMERIGEN PHARMACEUTICALS LTD,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMERIGEN PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
AMERIGEN PHARMACEUTICALS LTD,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
AMERIGEN PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMERIGEN PHARMACEUTICALS LTD,C04 Neoplasms,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
AMERIGEN PHARMACEUTICALS LTD,C10 Nervous System Diseases,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
AMERIGEN PHARMACEUTICALS LTD,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMERIGEN PHARMACEUTICALS LTD,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMERIGEN PHARMACEUTICALS LTD,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
AMNEAL PHARMACEUTICAL,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
AMNEAL PHARMACEUTICAL,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C01 Infections,DEMECLOCYCLINE HYDROCHLORIDE,464.86,-3.17,1,9,6,2,181.62,8.54,2.59
AMNEAL PHARMACEUTICAL,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,C10 Nervous System Diseases,PRIMIDONE,218.26,1.12,1,2,2,2,58.2,,11.5
AMNEAL PHARMACEUTICAL,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICAL,"C23 Pathological Conditions, Signs and Symptoms",FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
AMNEAL PHARMACEUTICAL,C14 Cardiovascular Diseases,FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
AMNEAL PHARMACEUTICAL,C14 Cardiovascular Diseases,ACEBUTOLOL HYDROCHLORIDE,336.43,1.53,1,5,3,10,87.66,9.57,13.91
AMNEAL PHARMACEUTICAL,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
AMNEAL PHARMACEUTICALS,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
AMNEAL PHARMACEUTICALS,G08 Reproductive and Urinary Physiological Phenomena,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
AMNEAL PHARMACEUTICALS,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AMNEAL PHARMACEUTICALS,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
AMNEAL PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AMNEAL PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS,C07 Stomatognathic Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AMNEAL PHARMACEUTICALS,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
AMNEAL PHARMACEUTICALS,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AMNEAL PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
AMNEAL PHARMACEUTICALS,C01 Infections,CLINDAMYCIN PALMITATE HYDROCHLORIDE,663.41,7.96,0,8,3,22,108.33,7.55,12.59
AMNEAL PHARMACEUTICALS,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AMNEAL PHARMACEUTICALS,C04 Neoplasms,RALOXIFENE HYDROCHLORIDE,473.59,5.69,4,6,2,7,70,7.95,8.89
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AMNEAL PHARMACEUTICALS,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
AMNEAL PHARMACEUTICALS,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AMNEAL PHARMACEUTICALS,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AMNEAL PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
AMNEAL PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
AMNEAL PHARMACEUTICALS,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS,C04 Neoplasms,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
AMNEAL PHARMACEUTICALS,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AMNEAL PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AMNEAL PHARMACEUTICALS,C25 Chemically-Induced Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AMNEAL PHARMACEUTICALS,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AMNEAL PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
AMNEAL PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
AMNEAL PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
AMNEAL PHARMACEUTICALS,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
AMNEAL PHARMACEUTICALS,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
AMNEAL PHARMACEUTICALS,C01 Infections,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AMNEAL PHARMACEUTICALS,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AMNEAL PHARMACEUTICALS,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
AMNEAL PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
AMNEAL PHARMACEUTICALS,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AMNEAL PHARMACEUTICALS,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
AMNEAL PHARMACEUTICALS,C01 Infections,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
AMNEAL PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,C04 Neoplasms,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
AMNEAL PHARMACEUTICALS,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C01 Infections,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
AMNEAL PHARMACEUTICALS,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS,C11 Eye Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
AMNEAL PHARMACEUTICALS,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AMNEAL PHARMACEUTICALS,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AMNEAL PHARMACEUTICALS,C04 Neoplasms,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
AMNEAL PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
AMNEAL PHARMACEUTICALS,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
AMNEAL PHARMACEUTICALS,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AMNEAL PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AMNEAL PHARMACEUTICALS,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
AMNEAL PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AMNEAL PHARMACEUTICALS,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AMNEAL PHARMACEUTICALS,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AMNEAL PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AMNEAL PHARMACEUTICALS,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
AMNEAL PHARMACEUTICALS,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
AMNEAL PHARMACEUTICALS,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
AMNEAL PHARMACEUTICALS,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
AMNEAL PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
AMNEAL PHARMACEUTICALS,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
AMNEAL PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
AMNEAL PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
AMNEAL PHARMACEUTICALS,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,NIZATIDINE,331.47,0.77,1,8,2,10,83.33,6.54,
AMNEAL PHARMACEUTICALS,C19 Endocrine System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
AMNEAL PHARMACEUTICALS,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
AMNEAL PHARMACEUTICALS,C11 Eye Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
AMNEAL PHARMACEUTICALS,C01 Infections,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
AMNEAL PHARMACEUTICALS,C04 Neoplasms,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
AMNEAL PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AMNEAL PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
AMNEAL PHARMACEUTICALS,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,WARFARIN SODIUM,308.33,2.74,3,4,1,4,67.51,,5.56
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AMNEAL PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
AMNEAL PHARMACEUTICALS,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
AMNEAL PHARMACEUTICALS,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AMNEAL PHARMACEUTICALS,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
AMNEAL PHARMACEUTICALS,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
AMNEAL PHARMACEUTICALS,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
AMNEAL PHARMACEUTICALS,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AMNEAL PHARMACEUTICALS,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AMNEAL PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AMNEAL PHARMACEUTICALS,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
AMNEAL PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AMNEAL PHARMACEUTICALS,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
AMNEAL PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AMNEAL PHARMACEUTICALS,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
AMNEAL PHARMACEUTICALS,C06 Digestive System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AMNEAL PHARMACEUTICALS,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
AMNEAL PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
AMNEAL PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
AMNEAL PHARMACEUTICALS CO GMBH,C26 Wounds and Injuries,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
AMNEAL PHARMACEUTICALS CO GMBH,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
AMNEAL PHARMACEUTICALS CO GMBH,C06 Digestive System Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
AMNEAL PHARMACEUTICALS CO GMBH,C07 Stomatognathic Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,SEVELAMER CARBONATE,149.62,,,,,,,,
AMNEAL PHARMACEUTICALS CO GMBH,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C08 Respiratory Tract Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AMNEAL PHARMACEUTICALS CO GMBH,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
AMNEAL PHARMACEUTICALS CO GMBH,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
AMNEAL PHARMACEUTICALS CO GMBH,C08 Respiratory Tract Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
AMNEAL PHARMACEUTICALS CO GMBH,F03 Mental Disorders,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
AMNEAL PHARMACEUTICALS CO GMBH,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,C01 Infections,SEVELAMER CARBONATE,149.62,,,,,,,,
AMNEAL PHARMACEUTICALS CO GMBH,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AMNEAL PHARMACEUTICALS CO GMBH,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
AMNEAL PHARMACEUTICALS CO GMBH,C05 Musculoskeletal Diseases,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
AMNEAL PHARMACEUTICALS CO GMBH,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
AMNEAL PHARMACEUTICALS CO GMBH,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,C18 Nutritional and Metabolic Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
AMNEAL PHARMACEUTICALS CO GMBH,C05 Musculoskeletal Diseases,PHYTONADIONE,450.71,9.7,1,2,0,14,34.14,,
AMNEAL PHARMACEUTICALS CO GMBH,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
AMNEAL PHARMACEUTICALS CO GMBH,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
AMNEAL PHARMACEUTICALS CO GMBH,C18 Nutritional and Metabolic Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
AMNEAL PHARMACEUTICALS CO GMBH,C17 Skin and Connective Tissue Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,F03 Mental Disorders,CLOMIPRAMINE HYDROCHLORIDE,314.86,4.88,2,2,0,4,6.48,9.2,
AMNEAL PHARMACEUTICALS CO GMBH,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
AMNEAL PHARMACEUTICALS CO GMBH,F03 Mental Disorders,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
AMNEAL PHARMACEUTICALS CO GMBH,C05 Musculoskeletal Diseases,OXAPROZIN,293.32,3.46,3,3,1,5,63.33,,4.95
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
AMNEAL PHARMACEUTICALS CO GMBH,C20 Immune System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AMNEAL PHARMACEUTICALS CO GMBH,C06 Digestive System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,PHYTONADIONE,450.71,9.7,1,2,0,14,34.14,,
AMNEAL PHARMACEUTICALS CO GMBH,C08 Respiratory Tract Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,PHYTONADIONE,450.71,9.7,1,2,0,14,34.14,,
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
AMNEAL PHARMACEUTICALS CO GMBH,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C05 Musculoskeletal Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
AMNEAL PHARMACEUTICALS CO GMBH,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C11 Eye Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
AMNEAL PHARMACEUTICALS CO GMBH,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
AMNEAL PHARMACEUTICALS CO GMBH,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
AMNEAL PHARMACEUTICALS CO GMBH,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,PHYTONADIONE,450.71,9.7,1,2,0,14,34.14,,
AMNEAL PHARMACEUTICALS CO GMBH,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
AMNEAL PHARMACEUTICALS CO GMBH,F01 Behavior and Behavior Mechanisms,TIAGABINE HYDROCHLORIDE,375.56,2.6,2,4,1,6,40.54,9.26,4.14
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AMNEAL PHARMACEUTICALS CO GMBH,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS CO GMBH,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
AMNEAL PHARMACEUTICALS CO GMBH,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
AMNEAL PHARMACEUTICALS CO GMBH,C01 Infections,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
AMNEAL PHARMACEUTICALS CO GMBH,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
AMNEAL PHARMACEUTICALS CO GMBH,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
AMNEAL PHARMACEUTICALS CO GMBH,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
AMNEAL PHARMACEUTICALS CO GMBH,C11 Eye Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS CO GMBH,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
AMNEAL PHARMACEUTICALS CO GMBH,C17 Skin and Connective Tissue Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
AMNEAL PHARMACEUTICALS CO GMBH,C04 Neoplasms,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
AMNEAL PHARMACEUTICALS CO GMBH,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AMNEAL PHARMACEUTICALS CO GMBH,F03 Mental Disorders,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
AMNEAL PHARMACEUTICALS CO GMBH,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
AMNEAL PHARMACEUTICALS CO GMBH,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AMNEAL PHARMACEUTICALS CO GMBH,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AMNEAL PHARMACEUTICALS CO GMBH,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AMNEAL PHARMACEUTICALS CO GMBH,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS CO GMBH,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
AMNEAL PHARMACEUTICALS CO GMBH,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AMNEAL PHARMACEUTICALS CO GMBH,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
AMNEAL PHARMACEUTICALS CO GMBH,C06 Digestive System Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
AMNEAL PHARMACEUTICALS CO GMBH,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS CO GMBH,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AMNEAL PHARMACEUTICALS CO GMBH,"C23 Pathological Conditions, Signs and Symptoms",DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
AMNEAL PHARMACEUTICALS CO GMBH,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AMNEAL PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AMNEAL PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AMNEAL PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AMNEAL PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,C01 Infections,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AMNEAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AMNEAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AMNEAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AMNEAL PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,C20 Immune System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C04 Neoplasms,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AMNEAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AMNEAL PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AMNEAL PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
AMNEAL PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C04 Neoplasms,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AMNEAL PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS LLC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AMNEAL PHARMACEUTICALS LLC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AMNEAL PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AMNEAL PHARMACEUTICALS LLC,C11 Eye Diseases,TRIENTINE HYDROCHLORIDE,146.24,-2.15,0,4,4,7,76.1,9.77,
AMNEAL PHARMACEUTICALS LLC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AMNEAL PHARMACEUTICALS LLC,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS NY LLC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
AMNEAL PHARMACEUTICALS NY LLC,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AMNEAL PHARMACEUTICALS NY LLC,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AMNEAL PHARMACEUTICALS NY LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AMNEAL PHARMACEUTICALS NY LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
AMNEAL PHARMACEUTICALS NY LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AMNEAL PHARMACEUTICALS NY LLC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS NY LLC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AMNEAL PHARMACEUTICALS NY LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS NY LLC,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AMNEAL PHARMACEUTICALS NY LLC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AMNEAL PHARMACEUTICALS NY LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AMNEAL PHARMACEUTICALS NY LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS NY LLC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AMNEAL PHARMACEUTICALS NY LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AMNEAL PHARMACEUTICALS NY LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AMNEAL PHARMACEUTICALS NY LLC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AMNEAL PHARMACEUTICALS NY LLC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AMNEAL PHARMACEUTICALS NY LLC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AMNEAL PHARMACEUTICALS NY LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AMNEAL PHARMACEUTICALS NY LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AMNEAL PHARMACEUTICALS NY LLC,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AMNEAL PHARMACEUTICALS NY LLC,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AMNEAL PHARMACEUTICALS NY LLC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AMNEAL PHARMACEUTICALS NY LLC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS NY LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AMNEAL PHARMACEUTICALS NY LLC,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AMNEAL PHARMACEUTICALS NY LLC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AMNEAL PHARMACEUTICALS NY LLC,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AMNEAL PHARMACEUTICALS NY LLC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
AMNEAL PHARMACEUTICALS NY LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
AMNEAL PHARMACEUTICALS NY LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AMNEAL PHARMACEUTICALS NY LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
AMNEAL PHARMACEUTICALS NY LLC,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AMNEAL PHARMACEUTICALS NY LLC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AMNEAL PHARMACEUTICALS NY LLC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AMNEAL PHARMACEUTICALS NY LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS NY LLC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AMNEAL PHARMACEUTICALS NY LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AMNEAL PHARMACEUTICALS NY LLC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AMNEAL PHARMACEUTICALS NY LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
AMNEAL PHARMACEUTICALS NY LLC,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AMNEAL PHARMACEUTICALS NY LLC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AMNEAL PHARMACEUTICALS NY LLC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AMNEAL PHARMACEUTICALS NY LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AMNEAL PHARMACEUTICALS NY LLC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AMNEAL PHARMACEUTICALS NY LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS NY LLC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AMNEAL PHARMACEUTICALS NY LLC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AMNEAL PHARMACEUTICALS NY LLC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AMNEAL PHARMACEUTICALS NY LLC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AMNEAL PHARMACEUTICALS NY LLC,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AMNEAL PHARMACEUTICALS NY LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS NY LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS NY LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C11 Eye Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C08 Respiratory Tract Diseases,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,EXEMESTANE,296.41,3.87,0,2,0,0,34.14,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C19 Endocrine System Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F01 Behavior and Behavior Mechanisms,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C25 Chemically-Induced Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C08 Respiratory Tract Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,PRASUGREL HYDROCHLORIDE,373.45,4.31,2,5,0,5,46.61,5.12,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F01 Behavior and Behavior Mechanisms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C19 Endocrine System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C25 Chemically-Induced Disorders,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,ALOSETRON HYDROCHLORIDE,294.36,1.21,3,3,1,2,53.92,6.81,13.32
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C13 Female Urogenital Diseases and Pregnancy Complications,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLERGONOVINE MALEATE,339.44,1.59,2,3,3,4,68.36,7.93,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C26 Wounds and Injuries,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C11 Eye Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C07 Stomatognathic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AMNEAL PHARMACEUTICALS OF NEW YORK LLC,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AMNEAL PHARMACEUTICALS OF NY LLC,C01 Infections,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
AMNEAL PHARMACEUTICALS OF NY LLC,C15 Hemic and Lymphatic Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
AMNEAL PHARMACEUTICALS OF NY LLC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
AMNEAL PHARMACEUTICALS OF NY LLC,C14 Cardiovascular Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS OF NY LLC,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C17 Skin and Connective Tissue Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
AMNEAL PHARMACEUTICALS OF NY LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,"C23 Pathological Conditions, Signs and Symptoms",PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C12 Male Urogenital Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
AMNEAL PHARMACEUTICALS OF NY LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
AMNEAL PHARMACEUTICALS OF NY LLC,C10 Nervous System Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
AMNEAL PHARMACEUTICALS OF NY LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
AMNEAL PHARMACEUTICALS OF NY LLC,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,F03 Mental Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C25 Chemically-Induced Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C04 Neoplasms,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C10 Nervous System Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C04 Neoplasms,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
AMNEAL PHARMACEUTICALS OF NY LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C01 Infections,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS OF NY LLC,C18 Nutritional and Metabolic Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS OF NY LLC,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
AMNEAL PHARMACEUTICALS OF NY LLC,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C04 Neoplasms,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
AMNEAL PHARMACEUTICALS OF NY LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS OF NY LLC,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AMNEAL PHARMACEUTICALS OF NY LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C10 Nervous System Diseases,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
AMNEAL PHARMACEUTICALS OF NY LLC,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AMNEAL PHARMACEUTICALS OF NY LLC,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AMNEAL PHARMACEUTICALS OF NY LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS OF NY LLC,C17 Skin and Connective Tissue Diseases,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
AMNEAL PHARMACEUTICALS OF NY LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,F03 Mental Disorders,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
AMNEAL PHARMACEUTICALS OF NY LLC,G08 Reproductive and Urinary Physiological Phenomena,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AMNEAL PHARMACEUTICALS OF NY LLC,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C12 Male Urogenital Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
AMNEAL PHARMACEUTICALS OF NY LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AMNEAL PHARMACEUTICALS OF NY LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AMNEAL PHARMACEUTICALS OF NY LLC,C26 Wounds and Injuries,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C13 Female Urogenital Diseases and Pregnancy Complications,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
AMNEAL PHARMACEUTICALS OF NY LLC,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AMNEAL PHARMACEUTICALS OF NY LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AMNEAL PHARMACEUTICALS OF NY LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ANCHEN PHARMACEUTICALS INC,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ANCHEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ALISKIREN FUMARATE,551.77,3.12,1,7,4,19,146.13,9.57,
ANCHEN PHARMACEUTICALS INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ANCHEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ANCHEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ANCHEN PHARMACEUTICALS INC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ANCHEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ANCHEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ANCHEN PHARMACEUTICALS INC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ANCHEN PHARMACEUTICALS INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ANCHEN PHARMACEUTICALS INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ANCHEN PHARMACEUTICALS INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ANCHEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ANCHEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ANCHEN PHARMACEUTICALS INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ANCHEN PHARMACEUTICALS INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ANCHEN PHARMACEUTICALS INC,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ANCHEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ANCHEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ANCHEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ANCHEN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ANCHEN PHARMACEUTICALS INC,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ANCHEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ANCHEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ANCHEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ANCHEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ANCHEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ANCHEN PHARMACEUTICALS INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ANCHEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ANCHEN PHARMACEUTICALS INC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ANCHEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ANCHEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ANCHEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ANCHEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ANCHEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
ANCHEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ANCHEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ANCHEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
ANCHEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ANCHEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
ANCHEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
ANCHEN PHARMACEUTICALS INC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ANCHEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
ANCHEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ANCHEN PHARMACEUTICALS INC,F03 Mental Disorders,FLUVOXAMINE MALEATE,318.34,2.8,1,4,1,9,56.84,8.86,
ANCHEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
ANCHEN PHARMACEUTICALS INC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ANCHEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ANCHEN PHARMACEUTICALS INC,C06 Digestive System Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
ANCHEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ANCHEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ANCHEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ANCHEN PHARMACEUTICALS INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ANCHEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ANCHEN PHARMACEUTICALS INC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ANCHEN PHARMACEUTICALS INC,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ANCHEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ANCHEN PHARMACEUTICALS INC,C04 Neoplasms,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
ANCHEN PHARMACEUTICALS INC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
"ANCHEN PHARMACEUTICALS, INC",C06 Digestive System Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C07 Stomatognathic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
"ANCHEN PHARMACEUTICALS, INC",C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C12 Male Urogenital Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C08 Respiratory Tract Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC","C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C15 Hemic and Lymphatic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C04 Neoplasms,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C01 Infections,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
"ANCHEN PHARMACEUTICALS, INC","C23 Pathological Conditions, Signs and Symptoms",CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
"ANCHEN PHARMACEUTICALS, INC",C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
"ANCHEN PHARMACEUTICALS, INC",C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
"ANCHEN PHARMACEUTICALS, INC",F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
"ANCHEN PHARMACEUTICALS, INC",C14 Cardiovascular Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
ANDOR PHARMACEUTICALS LLC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ANDOR PHARMACEUTICALS LLC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ANDOR PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ANDOR PHARMACEUTICALS LLC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ANI PHARMACEUTICALS INC,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ANI PHARMACEUTICALS INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ANI PHARMACEUTICALS INC,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ANI PHARMACEUTICALS INC,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ANI PHARMACEUTICALS INC,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
ANI PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,QUINAPRIL HYDROCHLORIDE,438.52,1.96,2,5,2,9,95.94,5.2,3.7
ANI PHARMACEUTICALS INC,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ANI PHARMACEUTICALS INC,C04 Neoplasms,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
ANI PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
ANI PHARMACEUTICALS INC,F03 Mental Disorders,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ANI PHARMACEUTICALS INC,F03 Mental Disorders,FLUVOXAMINE MALEATE,318.34,2.8,1,4,1,9,56.84,8.86,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ANI PHARMACEUTICALS INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
ANI PHARMACEUTICALS INC,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ANI PHARMACEUTICALS INC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
ANI PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ANI PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
ANI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PERINDOPRIL ERBUMINE,368.47,0.63,0,5,2,8,95.94,5.48,3.79
ANI PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ANI PHARMACEUTICALS INC,F03 Mental Disorders,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
ANI PHARMACEUTICALS INC,C04 Neoplasms,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ANI PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
ANI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ANI PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ANI PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
ANI PHARMACEUTICALS INC,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
ANI PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
ANI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ANI PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
ANI PHARMACEUTICALS INC,C04 Neoplasms,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ANI PHARMACEUTICALS INC,C01 Infections,CEFUROXIME AXETIL,510.48,-0.43,1,12,2,9,189.06,,10.92
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
ANI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
ANI PHARMACEUTICALS INC,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
ANI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ANI PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ANI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,TERBUTALINE SULFATE,225.29,0.44,1,4,4,3,72.72,9.76,8.86
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
ANI PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ANI PHARMACEUTICALS INC,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ANI PHARMACEUTICALS INC,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ANI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ANI PHARMACEUTICALS INC,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ANI PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
ANI PHARMACEUTICALS INC,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
ANI PHARMACEUTICALS INC,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ANI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ANI PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
ANI PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ANI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ANI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
ANI PHARMACEUTICALS INC,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ANI PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ANI PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C26 Wounds and Injuries,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ANI PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
ANI PHARMACEUTICALS INC,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ANI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ANI PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ANI PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ANI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ANI PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C04 Neoplasms,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ANI PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ANI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ANI PHARMACEUTICALS INC,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ANI PHARMACEUTICALS INC,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
ANI PHARMACEUTICALS INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ANI PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,NICARDIPINE HYDROCHLORIDE,479.53,3.56,2,8,1,9,111.01,8.1,
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NICARDIPINE HYDROCHLORIDE,479.53,3.56,2,8,1,9,111.01,8.1,
ANI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METHAZOLAMIDE,236.28,-0.59,1,6,1,1,107.41,,7.21
ANI PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
ANI PHARMACEUTICALS INC,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ANI PHARMACEUTICALS INC,C04 Neoplasms,METHAZOLAMIDE,236.28,-0.59,1,6,1,1,107.41,,7.21
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C12 Male Urogenital Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
ANI PHARMACEUTICALS INC,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
ANI PHARMACEUTICALS INC,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
ANI PHARMACEUTICALS INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ANI PHARMACEUTICALS INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PINDOLOL,248.33,1.69,2,3,3,6,57.28,9.67,
ANI PHARMACEUTICALS INC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ANI PHARMACEUTICALS INC,F03 Mental Disorders,PINDOLOL,248.33,1.69,2,3,3,6,57.28,9.67,
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ERYTHROMYCIN ETHYLSUCCINATE,862.06,3.37,0,17,4,12,226.28,7.87,12.68
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ANI PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ANI PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ANI PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ANI PHARMACEUTICALS INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ANI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
ANI PHARMACEUTICALS INC,C11 Eye Diseases,METHAZOLAMIDE,236.28,-0.59,1,6,1,1,107.41,,7.21
ANI PHARMACEUTICALS INC,C04 Neoplasms,NILUTAMIDE,317.22,2.25,1,4,1,2,92.55,,
ANI PHARMACEUTICALS INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ANI PHARMACEUTICALS INC,C01 Infections,ERYTHROMYCIN ETHYLSUCCINATE,862.06,3.37,0,17,4,12,226.28,7.87,12.68
ANI PHARMACEUTICALS INC,C01 Infections,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ANI PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ANI PHARMACEUTICALS INC,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
ANI PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ANI PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
ANI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
ANI PHARMACEUTICALS INC,C01 Infections,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ANI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ANI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ANI PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C11 Eye Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ANI PHARMACEUTICALS INC,C10 Nervous System Diseases,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ANI PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ANI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
ANI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
ANI PHARMACEUTICALS INC,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ANI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
ANI PHARMACEUTICALS INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ANI PHARMACEUTICALS INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ANI PHARMACEUTICALS INC,C06 Digestive System Diseases,NIZATIDINE,331.47,0.77,1,8,2,10,83.33,6.54,
ANI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
ANI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ANNORA PHARMA PRIVATE LTD,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ANNORA PHARMA PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ANNORA PHARMA PRIVATE LTD,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ANNORA PHARMA PRIVATE LTD,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ANNORA PHARMA PRIVATE LTD,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ANNORA PHARMA PRIVATE LTD,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ANNORA PHARMA PRIVATE LTD,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ANNORA PHARMA PRIVATE LTD,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ANNORA PHARMA PRIVATE LTD,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ANNORA PHARMA PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ANNORA PHARMA PRIVATE LTD,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
APNAR PHARMA LP,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
APNAR PHARMA LP,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APNAR PHARMA LP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
APNAR PHARMA LP,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APNAR PHARMA LP,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APNAR PHARMA LP,C10 Nervous System Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
APNAR PHARMA LP,C14 Cardiovascular Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
APNAR PHARMA LP,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
APNAR PHARMA LP,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
APNAR PHARMA LP,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APNAR PHARMA LP,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APNAR PHARMA LP,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
APNAR PHARMA LP,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APNAR PHARMA LP,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APNAR PHARMA LP,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
APNAR PHARMA LP,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APNAR PHARMA LP,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APOPHARMA INC,C01 Infections,DEFERIPRONE,139.15,0.61,1,3,1,0,42.23,,11.82
APOPHARMA INC,F03 Mental Disorders,DEFERIPRONE,139.15,0.61,1,3,1,0,42.23,,11.82
APOPHARMA INC,C12 Male Urogenital Diseases,DEFERIPRONE,139.15,0.61,1,3,1,0,42.23,,11.82
APOPHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEFERIPRONE,139.15,0.61,1,3,1,0,42.23,,11.82
APOPHARMA INC,C10 Nervous System Diseases,DEFERIPRONE,139.15,0.61,1,3,1,0,42.23,,11.82
APOPHARMA INC,C15 Hemic and Lymphatic Diseases,DEFERIPRONE,139.15,0.61,1,3,1,0,42.23,,11.82
APOTEX CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX CORP,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX CORP,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX CORP,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX CORP,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
APOTEX CORP,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
APOTEX CORP,C10 Nervous System Diseases,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
APOTEX CORP,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
APOTEX CORP,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX CORP,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
APOTEX CORP,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
APOTEX CORP,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
APOTEX CORP,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
APOTEX CORP,C14 Cardiovascular Diseases,QUINAPRIL HYDROCHLORIDE,438.52,1.96,2,5,2,9,95.94,5.2,3.7
APOTEX CORP,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX CORP,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX CORP,C04 Neoplasms,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
APOTEX CORP,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
APOTEX CORP,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
APOTEX CORP,F03 Mental Disorders,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
APOTEX INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C10 Nervous System Diseases,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
APOTEX INC,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
APOTEX INC,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
APOTEX INC,C04 Neoplasms,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C05 Musculoskeletal Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,C11 Eye Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
APOTEX INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
APOTEX INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C26 Wounds and Injuries,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
APOTEX INC,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
APOTEX INC,C05 Musculoskeletal Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C08 Respiratory Tract Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
APOTEX INC,C12 Male Urogenital Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
APOTEX INC,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
APOTEX INC,C15 Hemic and Lymphatic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C01 Infections,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C25 Chemically-Induced Disorders,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
APOTEX INC,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
APOTEX INC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
APOTEX INC,C06 Digestive System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
APOTEX INC,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
APOTEX INC,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
APOTEX INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APOTEX INC,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
APOTEX INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C14 Cardiovascular Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C20 Immune System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C12 Male Urogenital Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
APOTEX INC,C07 Stomatognathic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
APOTEX INC,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
APOTEX INC,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
APOTEX INC,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
APOTEX INC,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
APOTEX INC,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
APOTEX INC,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
APOTEX INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
APOTEX INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C15 Hemic and Lymphatic Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
APOTEX INC,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
APOTEX INC,C10 Nervous System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C26 Wounds and Injuries,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
APOTEX INC,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
APOTEX INC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,C04 Neoplasms,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
APOTEX INC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
APOTEX INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APOTEX INC,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
APOTEX INC,C08 Respiratory Tract Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
APOTEX INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C01 Infections,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
APOTEX INC,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
APOTEX INC,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
APOTEX INC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C11 Eye Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C17 Skin and Connective Tissue Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
APOTEX INC,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
APOTEX INC,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,C18 Nutritional and Metabolic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
APOTEX INC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOSPORINE,1202.63,,,,,,,,
APOTEX INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APOTEX INC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
APOTEX INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
APOTEX INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
APOTEX INC,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
APOTEX INC,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
APOTEX INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
APOTEX INC,C18 Nutritional and Metabolic Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
APOTEX INC,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
APOTEX INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C04 Neoplasms,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
APOTEX INC,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
APOTEX INC,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
APOTEX INC,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
APOTEX INC,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
APOTEX INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,C14 Cardiovascular Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
APOTEX INC,C15 Hemic and Lymphatic Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
APOTEX INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
APOTEX INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,F03 Mental Disorders,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
APOTEX INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C10 Nervous System Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
APOTEX INC,C04 Neoplasms,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
APOTEX INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
APOTEX INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
APOTEX INC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
APOTEX INC,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
APOTEX INC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
APOTEX INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
APOTEX INC,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
APOTEX INC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
APOTEX INC,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
APOTEX INC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
APOTEX INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
APOTEX INC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
APOTEX INC,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
APOTEX INC,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
APOTEX INC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
APOTEX INC,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
APOTEX INC,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
APOTEX INC,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
APOTEX INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
APOTEX INC,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
APOTEX INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
APOTEX INC,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
APOTEX INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
APOTEX INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
APOTEX INC,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
APOTEX INC,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
APOTEX INC,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
APOTEX INC,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
APOTEX INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
APOTEX INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
APOTEX INC,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
APOTEX INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
APOTEX INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
APOTEX INC,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
APOTEX INC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
APOTEX INC,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC,C12 Male Urogenital Diseases,ALFUZOSIN HYDROCHLORIDE,389.46,1.19,2,8,2,8,111.83,7.3,
APOTEX INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
APOTEX INC,C20 Immune System Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
APOTEX INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
APOTEX INC,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
APOTEX INC,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
APOTEX INC,C15 Hemic and Lymphatic Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C26 Wounds and Injuries,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
APOTEX INC,C01 Infections,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
APOTEX INC,C14 Cardiovascular Diseases,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
APOTEX INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
APOTEX INC,C10 Nervous System Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
APOTEX INC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
APOTEX INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
APOTEX INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
APOTEX INC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
APOTEX INC,C06 Digestive System Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
APOTEX INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
APOTEX INC,F03 Mental Disorders,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
APOTEX INC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
APOTEX INC,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
APOTEX INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
APOTEX INC,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
APOTEX INC,C20 Immune System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
APOTEX INC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
APOTEX INC,C01 Infections,CEFPROZIL,389.43,-1.92,1,6,4,5,132.96,7.22,3.3
APOTEX INC,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
APOTEX INC,C14 Cardiovascular Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C04 Neoplasms,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C10 Nervous System Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
APOTEX INC,C06 Digestive System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
APOTEX INC,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
APOTEX INC,C01 Infections,ADEFOVIR DIPIVOXIL,501.48,3.06,2,13,1,11,166.98,3.75,
APOTEX INC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
APOTEX INC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
APOTEX INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
APOTEX INC,C05 Musculoskeletal Diseases,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
APOTEX INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC,C05 Musculoskeletal Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
APOTEX INC,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
APOTEX INC,F03 Mental Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
APOTEX INC,C01 Infections,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
APOTEX INC,C12 Male Urogenital Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
APOTEX INC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
APOTEX INC,C25 Chemically-Induced Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
APOTEX INC,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
APOTEX INC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
APOTEX INC,C12 Male Urogenital Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
APOTEX INC,C08 Respiratory Tract Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
APOTEX INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
APOTEX INC,F03 Mental Disorders,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
APOTEX INC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
APOTEX INC,C01 Infections,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
APOTEX INC,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
APOTEX INC,C12 Male Urogenital Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
APOTEX INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C01 Infections,CEFUROXIME AXETIL,510.48,-0.43,1,12,2,9,189.06,,10.92
APOTEX INC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
APOTEX INC,C08 Respiratory Tract Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
APOTEX INC,C06 Digestive System Diseases,MELPHALAN,305.21,0.25,1,3,2,8,66.56,9.51,1.29
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
APOTEX INC,C19 Endocrine System Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
APOTEX INC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
APOTEX INC,C05 Musculoskeletal Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
APOTEX INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
APOTEX INC,C04 Neoplasms,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC,C11 Eye Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
APOTEX INC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
APOTEX INC,C12 Male Urogenital Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
APOTEX INC,C14 Cardiovascular Diseases,SOTALOL HYDROCHLORIDE,272.37,-0.4,1,4,3,6,78.43,9.43,10.07
APOTEX INC,C18 Nutritional and Metabolic Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
APOTEX INC,C10 Nervous System Diseases,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
APOTEX INC,C04 Neoplasms,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
APOTEX INC,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,C14 Cardiovascular Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
APOTEX INC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
APOTEX INC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
APOTEX INC,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
APOTEX INC,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APOTEX INC,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
APOTEX INC,C17 Skin and Connective Tissue Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,F03 Mental Disorders,ZIPRASIDONE HYDROCHLORIDE,412.95,4.3,3,5,1,4,48.47,7.09,12.21
APOTEX INC,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
APOTEX INC,C09 Otorhinolaryngologic Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
APOTEX INC,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
APOTEX INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
APOTEX INC,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,C04 Neoplasms,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C01 Infections,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
APOTEX INC,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APOTEX INC,C08 Respiratory Tract Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
APOTEX INC,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
APOTEX INC,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
APOTEX INC,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
APOTEX INC,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
APOTEX INC,C05 Musculoskeletal Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,C05 Musculoskeletal Diseases,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
APOTEX INC,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
APOTEX INC,F03 Mental Disorders,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
APOTEX INC,C04 Neoplasms,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
APOTEX INC,C06 Digestive System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C12 Male Urogenital Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C04 Neoplasms,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
APOTEX INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C01 Infections,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
APOTEX INC,C08 Respiratory Tract Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C05 Musculoskeletal Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
APOTEX INC,C01 Infections,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,C07 Stomatognathic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C11 Eye Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C06 Digestive System Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
APOTEX INC,C26 Wounds and Injuries,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
APOTEX INC,C04 Neoplasms,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
APOTEX INC,C12 Male Urogenital Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
APOTEX INC,C18 Nutritional and Metabolic Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
APOTEX INC,C10 Nervous System Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
APOTEX INC,C01 Infections,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C26 Wounds and Injuries,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C06 Digestive System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
APOTEX INC,C10 Nervous System Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
APOTEX INC,C10 Nervous System Diseases,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
APOTEX INC,C01 Infections,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
APOTEX INC,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
APOTEX INC,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
APOTEX INC,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
APOTEX INC,C10 Nervous System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
APOTEX INC,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
APOTEX INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
APOTEX INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
APOTEX INC,C25 Chemically-Induced Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
APOTEX INC,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APOTEX INC,C14 Cardiovascular Diseases,MOEXIPRIL HYDROCHLORIDE,498.58,1.5,2,7,2,11,114.4,5.2,3.46
APOTEX INC,C25 Chemically-Induced Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
APOTEX INC,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
APOTEX INC,C06 Digestive System Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,C08 Respiratory Tract Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
APOTEX INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C10 Nervous System Diseases,SUMATRIPTAN SUCCINATE,295.41,0.74,2,3,2,6,65.2,9.54,11.24
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
APOTEX INC,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
APOTEX INC,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
APOTEX INC,C26 Wounds and Injuries,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,F03 Mental Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
APOTEX INC,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
APOTEX INC,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
APOTEX INC,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
APOTEX INC,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
APOTEX INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
APOTEX INC,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
APOTEX INC,C04 Neoplasms,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
APOTEX INC,C14 Cardiovascular Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
APOTEX INC,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
APOTEX INC,C06 Digestive System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
APOTEX INC,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
APOTEX INC,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
APOTEX INC,C04 Neoplasms,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,F03 Mental Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C10 Nervous System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
APOTEX INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APOTEX INC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
APOTEX INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
APOTEX INC,F03 Mental Disorders,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
APOTEX INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
APOTEX INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
APOTEX INC,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
APOTEX INC,C10 Nervous System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
APOTEX INC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
APOTEX INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
APOTEX INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
APOTEX INC,C04 Neoplasms,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
APOTEX INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
APOTEX INC,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
APOTEX INC,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
APOTEX INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
APOTEX INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
APOTEX INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
APOTEX INC,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
APOTEX INC,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
APOTEX INC,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
APOTEX INC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
APOTEX INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
APOTEX INC,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
APOTEX INC,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
APOTEX INC,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
APOTEX INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
APOTEX INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
APOTEX INC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
APOTEX INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
APOTEX INC,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
APOTEX INC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
APOTEX INC,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
APOTEX INC,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC,C05 Musculoskeletal Diseases,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
APOTEX INC,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
APOTEX INC,C14 Cardiovascular Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
APOTEX INC,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
APOTEX INC,F03 Mental Disorders,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
APOTEX INC,C01 Infections,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
APOTEX INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
APOTEX INC,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
APOTEX INC,F03 Mental Disorders,FLUVOXAMINE MALEATE,318.34,2.8,1,4,1,9,56.84,8.86,
APOTEX INC,C08 Respiratory Tract Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
APOTEX INC,"C23 Pathological Conditions, Signs and Symptoms",IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
APOTEX INC,C17 Skin and Connective Tissue Diseases,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
APOTEX INC,C05 Musculoskeletal Diseases,NABUMETONE,228.29,3.22,2,2,0,4,26.3,,
APOTEX INC,C04 Neoplasms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,C01 Infections,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,F01 Behavior and Behavior Mechanisms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
APOTEX INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
APOTEX INC,C17 Skin and Connective Tissue Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
APOTEX INC,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
APOTEX INC,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
APOTEX INC,C18 Nutritional and Metabolic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
APOTEX INC,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
APOTEX INC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
APOTEX INC,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
APOTEX INC,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
APOTEX INC,C09 Otorhinolaryngologic Diseases,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
APOTEX INC,C04 Neoplasms,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
APOTEX INC ETOBICOKE SITE,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
APOTEX INC ETOBICOKE SITE,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
APOTEX INC ETOBICOKE SITE,C18 Nutritional and Metabolic Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
APOTEX INC ETOBICOKE SITE,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
APOTEX INC ETOBICOKE SITE,C11 Eye Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",DESMOPRESSIN ACETATE,1069.24,,,,,,,,
APOTEX INC ETOBICOKE SITE,C25 Chemically-Induced Disorders,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
APOTEX INC ETOBICOKE SITE,C26 Wounds and Injuries,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC ETOBICOKE SITE,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
APOTEX INC ETOBICOKE SITE,C12 Male Urogenital Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
APOTEX INC ETOBICOKE SITE,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
APOTEX INC ETOBICOKE SITE,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
APOTEX INC ETOBICOKE SITE,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
APOTEX INC ETOBICOKE SITE,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APOTEX INC ETOBICOKE SITE,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APOTEX INC ETOBICOKE SITE,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
APOTEX INC ETOBICOKE SITE,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC ETOBICOKE SITE,C05 Musculoskeletal Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
APOTEX INC ETOBICOKE SITE,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
APOTEX INC ETOBICOKE SITE,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC ETOBICOKE SITE,C20 Immune System Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC ETOBICOKE SITE,C05 Musculoskeletal Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
APOTEX INC ETOBICOKE SITE,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC ETOBICOKE SITE,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C04 Neoplasms,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
APOTEX INC ETOBICOKE SITE,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC ETOBICOKE SITE,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,FOSINOPRIL SODIUM,563.67,5.62,1,6,1,14,110.21,,3.87
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
APOTEX INC ETOBICOKE SITE,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
APOTEX INC ETOBICOKE SITE,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
APOTEX INC ETOBICOKE SITE,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
APOTEX INC ETOBICOKE SITE,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC ETOBICOKE SITE,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
APOTEX INC ETOBICOKE SITE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC ETOBICOKE SITE,C05 Musculoskeletal Diseases,OXAPROZIN,293.32,3.46,3,3,1,5,63.33,,4.95
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC ETOBICOKE SITE,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
APOTEX INC ETOBICOKE SITE,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
APOTEX INC ETOBICOKE SITE,C12 Male Urogenital Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
APOTEX INC ETOBICOKE SITE,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
APOTEX INC ETOBICOKE SITE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC ETOBICOKE SITE,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
APOTEX INC ETOBICOKE SITE,C17 Skin and Connective Tissue Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
APOTEX INC ETOBICOKE SITE,C08 Respiratory Tract Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC ETOBICOKE SITE,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC ETOBICOKE SITE,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
APOTEX INC ETOBICOKE SITE,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
APOTEX INC ETOBICOKE SITE,C04 Neoplasms,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC ETOBICOKE SITE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
APOTEX INC ETOBICOKE SITE,C05 Musculoskeletal Diseases,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
APOTEX INC ETOBICOKE SITE,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
APOTEX INC ETOBICOKE SITE,C01 Infections,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
APOTEX INC ETOBICOKE SITE,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
APOTEX INC ETOBICOKE SITE,C18 Nutritional and Metabolic Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
APOTEX INC ETOBICOKE SITE,C13 Female Urogenital Diseases and Pregnancy Complications,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
APOTEX INC ETOBICOKE SITE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
APOTEX INC ETOBICOKE SITE,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC ETOBICOKE SITE,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
APOTEX INC ETOBICOKE SITE,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
APOTEX INC ETOBICOKE SITE,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,F01 Behavior and Behavior Mechanisms,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
APOTEX INC ETOBICOKE SITE,C25 Chemically-Induced Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
APOTEX INC ETOBICOKE SITE,C06 Digestive System Diseases,BALSALAZIDE DISODIUM,357.32,3.17,2,6,4,7,148.65,,3.06
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
APOTEX INC ETOBICOKE SITE,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
APOTEX INC ETOBICOKE SITE,C25 Chemically-Induced Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
APOTEX INC ETOBICOKE SITE,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
APOTEX INC ETOBICOKE SITE,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
APOTEX INC ETOBICOKE SITE,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,C09 Otorhinolaryngologic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
APOTEX INC ETOBICOKE SITE,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
APOTEX INC ETOBICOKE SITE,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
APOTEX INC ETOBICOKE SITE,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
APOTEX INC ETOBICOKE SITE,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC ETOBICOKE SITE,C18 Nutritional and Metabolic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
APOTEX INC ETOBICOKE SITE,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
APOTEX INC ETOBICOKE SITE,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
APOTEX INC ETOBICOKE SITE,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
APOTEX INC ETOBICOKE SITE,F03 Mental Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
APOTEX INC ETOBICOKE SITE,"C23 Pathological Conditions, Signs and Symptoms",MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
APOTEX INC ETOBICOKE SITE,C10 Nervous System Diseases,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
APPCO PHARMA LLC,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
APPCO PHARMA LLC,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
APPCO PHARMA LLC,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
APPCO PHARMA LLC,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
APPCO PHARMA LLC,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
APPCO PHARMA LLC,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
APPCO PHARMA LLC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
APPCO PHARMA LLC,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
APPCO PHARMA LLC,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
APPCO PHARMA LLC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
APPCO PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
APPCO PHARMA LLC,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
APPCO PHARMA LLC,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
APPCO PHARMA LLC,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
APPCO PHARMA LLC,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
APPCO PHARMA LLC,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
APPCO PHARMA LLC,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
APPCO PHARMA LLC,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
APPCO PHARMA LLC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
APPCO PHARMA LLC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
APPCO PHARMA LLC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
APPCO PHARMA LLC,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
APPCO PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
APPCO PHARMA LLC,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
APTAPHARMA INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
APTAPHARMA INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AQUESTIVE THERAPEUTICS,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AQUESTIVE THERAPEUTICS,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AQUESTIVE THERAPEUTICS,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
AQUESTIVE THERAPEUTICS,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
ARBOR PHARMACEUTICALS LLC,C06 Digestive System Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
ARBOR PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
ARBOR PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,GABAPENTIN ENACARBIL,329.39,2.76,0,5,2,7,101.93,,4.35
ARBOR PHARMACEUTICALS LLC,F03 Mental Disorders,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
ARBOR PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ARBOR PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
ARBOR PHARMACEUTICALS LLC,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
ARBOR PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,AZILSARTAN KAMEDOXOMIL,568.54,6.03,6,11,1,9,155.59,1.48,5.91
ARBOR PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ARBOR PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
ARBOR PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
ARBOR PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ARBOR PHARMACEUTICALS LLC,C10 Nervous System Diseases,GABAPENTIN ENACARBIL,329.39,2.76,0,5,2,7,101.93,,4.35
ARBOR PHARMACEUTICALS LLC,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
ARBOR PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
ARBOR PHARMACEUTICALS LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ARBOR PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ARBOR PHARMACEUTICALS LLC,C01 Infections,ERYTHROMYCIN ETHYLSUCCINATE,862.06,3.37,0,17,4,12,226.28,7.87,12.68
ARBOR PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
ARBOR PHARMACEUTICALS LLC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ARBOR PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ERYTHROMYCIN ETHYLSUCCINATE,862.06,3.37,0,17,4,12,226.28,7.87,12.68
ARBOR PHARMACEUTICALS LLC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ARBOR PHARMACEUTICALS LLC,C10 Nervous System Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
ARBOR PHARMACEUTICALS LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ARBOR PHARMACEUTICALS LLC,F03 Mental Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
ARBOR PHARMACEUTICALS LLC,C04 Neoplasms,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
ARBOR PHARMACEUTICALS LLC,C01 Infections,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
ARBOR PHARMACEUTICALS LLC,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ARBOR PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
ARBOR PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,SOTALOL HYDROCHLORIDE,272.37,-0.4,1,4,3,6,78.43,9.43,10.07
ARBOR PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
ARBOR PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
ARBOR PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
ARISE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ARISE PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ARISE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ARISE PHARMACEUTICALS LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ARISE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ARISE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
ASCENT PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ASCENT PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C01 Infections,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
ASCENT PHARMACEUTICALS INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C07 Stomatognathic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C26 Wounds and Injuries,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
ASCENT PHARMACEUTICALS INC,C11 Eye Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
ASCENT PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ASCENT PHARMACEUTICALS INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ASCENT PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
ASCENT PHARMACEUTICALS INC,C01 Infections,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
ASCENT PHARMACEUTICALS INC,C06 Digestive System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C10 Nervous System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ASCENT PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ASCENT PHARMACEUTICALS INC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ASCENT PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ASCENT PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
ASCENT PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ASCENT PHARMACEUTICALS INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,F03 Mental Disorders,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ASCENT PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C14 Cardiovascular Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ASCENT PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
ASCENT PHARMACEUTICALS INC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ASCENT PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ASCENT PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ASCENT PHARMACEUTICALS INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
ASCENT PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
ASCENT PHARMACEUTICALS INC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ASCENT PHARMACEUTICALS INC,C04 Neoplasms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ASCENT PHARMACEUTICALS INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
ASCENT PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ASCENT PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASCENT PHARMACEUTICALS INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ASPEN GLOBAL INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C15 Hemic and Lymphatic Diseases,THIOGUANINE,167.2,-0.26,2,4,3,0,83.38,1.84,9.46
ASPEN GLOBAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C15 Hemic and Lymphatic Diseases,BUSULFAN,246.31,-0.76,0,6,0,7,86.74,,
ASPEN GLOBAL INC,C05 Musculoskeletal Diseases,BUSULFAN,246.31,-0.76,0,6,0,7,86.74,,
ASPEN GLOBAL INC,C04 Neoplasms,BUSULFAN,246.31,-0.76,0,6,0,7,86.74,,
ASPEN GLOBAL INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C04 Neoplasms,THIOGUANINE,167.2,-0.26,2,4,3,0,83.38,1.84,9.46
ASPEN GLOBAL INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C08 Respiratory Tract Diseases,BUSULFAN,246.31,-0.76,0,6,0,7,86.74,,
ASPEN GLOBAL INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C08 Respiratory Tract Diseases,THIOGUANINE,167.2,-0.26,2,4,3,0,83.38,1.84,9.46
ASPEN GLOBAL INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C04 Neoplasms,CHLORAMBUCIL,304.22,3.94,1,2,1,9,40.54,1.72,4.46
ASPEN GLOBAL INC,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
ASPEN GLOBAL INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
ASPEN GLOBAL INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C20 Immune System Diseases,BUSULFAN,246.31,-0.76,0,6,0,7,86.74,,
ASPEN GLOBAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BUSULFAN,246.31,-0.76,0,6,0,7,86.74,,
ASPEN GLOBAL INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASPEN GLOBAL INC,C10 Nervous System Diseases,BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
ASPEN GLOBAL INC,C01 Infections,BUSULFAN,246.31,-0.76,0,6,0,7,86.74,,
ASPEN GLOBAL INC,"C23 Pathological Conditions, Signs and Symptoms",BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
ASPEN GLOBAL INC,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
ASPEN GLOBAL INC,"C23 Pathological Conditions, Signs and Symptoms",BUSULFAN,246.31,-0.76,0,6,0,7,86.74,,
ASPEN GLOBAL INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ASSERTIO THERAPEUTICS INC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,C05 Musculoskeletal Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
ASSERTIO THERAPEUTICS INC,C07 Stomatognathic Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
ASSERTIO THERAPEUTICS INC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,C06 Digestive System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
ASSERTIO THERAPEUTICS INC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,C10 Nervous System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
ASSERTIO THERAPEUTICS INC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
ASSERTIO THERAPEUTICS INC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASSERTIO THERAPEUTICS INC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ASTELLAS PHARMA US INC,C17 Skin and Connective Tissue Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
ASTELLAS PHARMA US INC,C20 Immune System Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
ASTRAZENECA AB,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ASTRAZENECA AB,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ASTRAZENECA AB,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ASTRAZENECA AB,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ASTRAZENECA AB,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ASTRAZENECA AB,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ASTRAZENECA AB,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ASTRAZENECA AB,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ASTRAZENECA AB,C18 Nutritional and Metabolic Diseases,SAXAGLIPTIN HYDROCHLORIDE,315.42,-0.08,0,4,2,2,90.35,7.9,
ASTRAZENECA PHARMACEUTICALS LP,C04 Neoplasms,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
ASTRAZENECA PHARMACEUTICALS LP,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ASTRAZENECA PHARMACEUTICALS LP,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ASTRAZENECA PHARMACEUTICALS LP,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ASTRAZENECA PHARMACEUTICALS LP,C17 Skin and Connective Tissue Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
ASTRAZENECA PHARMACEUTICALS LP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ASTRAZENECA PHARMACEUTICALS LP,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
ASTRAZENECA PHARMACEUTICALS LP,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ASTRAZENECA PHARMACEUTICALS LP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
ASTRAZENECA PHARMACEUTICALS LP,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ASTRAZENECA PHARMACEUTICALS LP,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ASTRAZENECA PHARMACEUTICALS LP,C06 Digestive System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
ASTRAZENECA PHARMACEUTICALS LP,C01 Infections,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
ASTRAZENECA PHARMACEUTICALS LP,F03 Mental Disorders,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
ASTRAZENECA PHARMACEUTICALS LP,C04 Neoplasms,GEFITINIB,446.91,3.75,3,7,1,8,68.74,6.85,
ASTRAZENECA PHARMACEUTICALS LP,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ASTRAZENECA PHARMACEUTICALS LP,C12 Male Urogenital Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
ASTRAZENECA PHARMACEUTICALS LP,C18 Nutritional and Metabolic Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
ASTRAZENECA PHARMACEUTICALS LP,C01 Infections,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
ASTRAZENECA PHARMACEUTICALS LP,C06 Digestive System Diseases,OMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ASTRAZENECA PHARMACEUTICALS LP,"C23 Pathological Conditions, Signs and Symptoms",TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
ASTRAZENECA PHARMACEUTICALS LP,C18 Nutritional and Metabolic Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
ASTRAZENECA PHARMACEUTICALS LP,C08 Respiratory Tract Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
ASTRAZENECA PHARMACEUTICALS LP,C10 Nervous System Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
ASTRAZENECA PHARMACEUTICALS LP,C15 Hemic and Lymphatic Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
ASTRAZENECA PHARMACEUTICALS LP,C14 Cardiovascular Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
ASTRAZENECA PHARMACEUTICALS LP,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
ASTRAZENECA PHARMACEUTICALS LP,C10 Nervous System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
ASTRAZENECA PHARMACEUTICALS LP,C08 Respiratory Tract Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
ATNAHS PHARMA US LTD,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ATNAHS PHARMA US LTD,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AUCTA PHARMACEUTICALS INC,C10 Nervous System Diseases,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
AUCTA PHARMACEUTICALS INC,C04 Neoplasms,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
AUCTA PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
AUROBINDO PHARMA LIMITED,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AUROBINDO PHARMA LIMITED,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
AUROBINDO PHARMA LIMITED,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AUROBINDO PHARMA LIMITED,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LIMITED,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
AUROBINDO PHARMA LIMITED,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AUROBINDO PHARMA LIMITED,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LIMITED,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LIMITED,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AUROBINDO PHARMA LIMITED,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LIMITED,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
AUROBINDO PHARMA LIMITED,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LIMITED,C14 Cardiovascular Diseases,FOSINOPRIL SODIUM,563.67,5.62,1,6,1,14,110.21,,3.87
AUROBINDO PHARMA LIMITED,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LIMITED,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
AUROBINDO PHARMA LTD,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
AUROBINDO PHARMA LTD,C04 Neoplasms,DIDANOSINE,236.23,-0.87,2,6,2,2,93.03,0.6,8.93
AUROBINDO PHARMA LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
AUROBINDO PHARMA LTD,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
AUROBINDO PHARMA LTD,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AUROBINDO PHARMA LTD,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
AUROBINDO PHARMA LTD,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
AUROBINDO PHARMA LTD,C09 Otorhinolaryngologic Diseases,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C01 Infections,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
AUROBINDO PHARMA LTD,C04 Neoplasms,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
AUROBINDO PHARMA LTD,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
AUROBINDO PHARMA LTD,C01 Infections,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AUROBINDO PHARMA LTD,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
AUROBINDO PHARMA LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
AUROBINDO PHARMA LTD,C04 Neoplasms,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AUROBINDO PHARMA LTD,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
AUROBINDO PHARMA LTD,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AUROBINDO PHARMA LTD,C01 Infections,DIDANOSINE,236.23,-0.87,2,6,2,2,93.03,0.6,8.93
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AUROBINDO PHARMA LTD,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C04 Neoplasms,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
AUROBINDO PHARMA LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
AUROBINDO PHARMA LTD,C01 Infections,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
AUROBINDO PHARMA LTD,C04 Neoplasms,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,F03 Mental Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C09 Otorhinolaryngologic Diseases,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
AUROBINDO PHARMA LTD,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
AUROBINDO PHARMA LTD,F03 Mental Disorders,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
AUROBINDO PHARMA LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
AUROBINDO PHARMA LTD,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,TRANDOLAPRIL,430.55,1.95,1,5,2,9,95.94,5.21,3.8
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
AUROBINDO PHARMA LTD,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
AUROBINDO PHARMA LTD,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AUROBINDO PHARMA LTD,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,F03 Mental Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
AUROBINDO PHARMA LTD,C04 Neoplasms,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C01 Infections,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
AUROBINDO PHARMA LTD,C01 Infections,CEFPROZIL,389.43,-1.92,1,6,4,5,132.96,7.22,3.3
AUROBINDO PHARMA LTD,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
AUROBINDO PHARMA LTD,C01 Infections,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,F03 Mental Disorders,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
AUROBINDO PHARMA LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
AUROBINDO PHARMA LTD,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
AUROBINDO PHARMA LTD,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
AUROBINDO PHARMA LTD,C01 Infections,CEFADROXIL,363.39,-2.45,1,6,4,4,132.96,7.22,3.25
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AUROBINDO PHARMA LTD,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AUROBINDO PHARMA LTD,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
AUROBINDO PHARMA LTD,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
AUROBINDO PHARMA LTD,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AUROBINDO PHARMA LTD,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
AUROBINDO PHARMA LTD,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,C04 Neoplasms,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AUROBINDO PHARMA LTD,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AUROBINDO PHARMA LTD,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
AUROBINDO PHARMA LTD,C20 Immune System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
AUROBINDO PHARMA LTD,C01 Infections,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
AUROBINDO PHARMA LTD,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
AUROBINDO PHARMA LTD,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
AUROBINDO PHARMA LTD,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
AUROBINDO PHARMA LTD,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AUROBINDO PHARMA LTD,C04 Neoplasms,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
AUROBINDO PHARMA LTD,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C01 Infections,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
AUROBINDO PHARMA LTD,C04 Neoplasms,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
AUROBINDO PHARMA LTD,F03 Mental Disorders,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
AUROBINDO PHARMA LTD,C09 Otorhinolaryngologic Diseases,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,C01 Infections,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,FOSINOPRIL SODIUM,563.67,5.62,1,6,1,14,110.21,,3.87
AUROBINDO PHARMA LTD,C09 Otorhinolaryngologic Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
AUROBINDO PHARMA LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
AUROBINDO PHARMA LTD,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
AUROBINDO PHARMA LTD,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
AUROBINDO PHARMA LTD,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,F03 Mental Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
AUROBINDO PHARMA LTD,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AUROBINDO PHARMA LTD,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AUROBINDO PHARMA LTD,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AUROBINDO PHARMA LTD,C01 Infections,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AUROBINDO PHARMA LTD,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
AUROBINDO PHARMA LTD,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AUROBINDO PHARMA LTD,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
AUROBINDO PHARMA LTD,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AUROBINDO PHARMA LTD,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
AUROBINDO PHARMA LTD,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
AUROBINDO PHARMA LTD,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
AUROBINDO PHARMA LTD,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
AUROBINDO PHARMA LTD,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
AUROBINDO PHARMA LTD,C04 Neoplasms,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AUROBINDO PHARMA LTD,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
AUROBINDO PHARMA LTD,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
AUROBINDO PHARMA LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
AUROBINDO PHARMA LTD,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
AUROBINDO PHARMA LTD,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
AUROBINDO PHARMA LTD,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
AUROBINDO PHARMA LTD,C01 Infections,CEFUROXIME AXETIL,510.48,-0.43,1,12,2,9,189.06,,10.92
AUROBINDO PHARMA LTD,C04 Neoplasms,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AUROBINDO PHARMA LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AUROBINDO PHARMA LTD,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
AUROBINDO PHARMA LTD,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AUROBINDO PHARMA LTD,C01 Infections,STAVUDINE,224.22,-0.23,1,5,2,2,84.32,,9.95
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
AUROBINDO PHARMA LTD,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
AUROBINDO PHARMA LTD,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C01 Infections,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
AUROBINDO PHARMA LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AUROBINDO PHARMA LTD,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
AUROBINDO PHARMA LTD,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,PERINDOPRIL ERBUMINE,368.47,0.63,0,5,2,8,95.94,5.48,3.79
AUROBINDO PHARMA LTD,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AUROBINDO PHARMA LTD,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
AUROBINDO PHARMA LTD,C04 Neoplasms,RALOXIFENE HYDROCHLORIDE,473.59,5.69,4,6,2,7,70,7.95,8.89
AUROBINDO PHARMA LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AUROBINDO PHARMA LTD,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
AUROBINDO PHARMA LTD,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AUROBINDO PHARMA LTD,F03 Mental Disorders,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
AUROBINDO PHARMA LTD,C01 Infections,TERBINAFINE HYDROCHLORIDE,291.44,5.53,2,1,0,4,3.24,8.86,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,OMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
AUROBINDO PHARMA LTD,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
AUROBINDO PHARMA LTD,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
AUROBINDO PHARMA LTD,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AUROBINDO PHARMA LTD,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
AUROBINDO PHARMA LTD,C04 Neoplasms,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,C01 Infections,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
AUROBINDO PHARMA LTD,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
AUROBINDO PHARMA LTD,C11 Eye Diseases,VALGANCICLOVIR HYDROCHLORIDE,354.37,-1.21,2,10,4,8,171.37,7.48,10.16
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
AUROBINDO PHARMA LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AUROBINDO PHARMA LTD,F03 Mental Disorders,ZIPRASIDONE HYDROCHLORIDE,412.95,4.3,3,5,1,4,48.47,7.09,12.21
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
AUROBINDO PHARMA LTD,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AUROBINDO PHARMA LTD,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AUROBINDO PHARMA LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AUROBINDO PHARMA LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AUROBINDO PHARMA LTD,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
AUROBINDO PHARMA LTD,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
AUROBINDO PHARMA LTD,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
AUROBINDO PHARMA LTD,F03 Mental Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
AUROBINDO PHARMA LTD,C01 Infections,ATAZANAVIR SULFATE,704.87,4.54,3,9,5,14,171.22,4.42,11.92
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
AUROBINDO PHARMA LTD,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
AUROBINDO PHARMA LTD,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,G08 Reproductive and Urinary Physiological Phenomena,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AUROBINDO PHARMA LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C26 Wounds and Injuries,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
AUROBINDO PHARMA LTD,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
AUROBINDO PHARMA LTD,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
AUROBINDO PHARMA LTD,C09 Otorhinolaryngologic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
AUROBINDO PHARMA LTD,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LTD,C01 Infections,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
AUROBINDO PHARMA LTD,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AUROBINDO PHARMA LTD,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,ALFUZOSIN HYDROCHLORIDE,389.46,1.19,2,8,2,8,111.83,7.3,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
AUROBINDO PHARMA LTD,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,PITAVASTATIN CALCIUM,421.47,2.92,3,4,3,8,90.65,4.86,4.13
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
AUROBINDO PHARMA LTD,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
AUROBINDO PHARMA LTD,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
AUROBINDO PHARMA LTD,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
AUROBINDO PHARMA LTD,C01 Infections,METHENAMINE HIPPURATE,140.19,0.39,0,4,0,0,12.96,5.88,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
AUROBINDO PHARMA LTD,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AUROBINDO PHARMA LTD,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,PRASUGREL HYDROCHLORIDE,373.45,4.31,2,5,0,5,46.61,5.12,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
AUROBINDO PHARMA LTD,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
AUROBINDO PHARMA LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AUROBINDO PHARMA LTD,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
AUROBINDO PHARMA LTD,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
AUROBINDO PHARMA LTD,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,FESOTERODINE FUMARATE,411.59,5.7,2,4,1,10,49.77,10.64,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AUROBINDO PHARMA LTD,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
AUROBINDO PHARMA LTD,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
AUROBINDO PHARMA LTD,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
AUROBINDO PHARMA LTD,C01 Infections,SEVELAMER CARBONATE,149.62,,,,,,,,
AUROBINDO PHARMA LTD,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
AUROBINDO PHARMA LTD,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,SEVELAMER CARBONATE,149.62,,,,,,,,
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
AUROBINDO PHARMA LTD,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
AUROBINDO PHARMA LTD,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
AUROBINDO PHARMA LTD,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
AUROBINDO PHARMA LTD,F03 Mental Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
AUROBINDO PHARMA LTD,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AUROBINDO PHARMA LTD,C01 Infections,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
AUROBINDO PHARMA LTD,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
AUROBINDO PHARMA LTD,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
AUROBINDO PHARMA LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
AUROBINDO PHARMA LTD,C04 Neoplasms,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
AUROBINDO PHARMA LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AUROBINDO PHARMA LTD,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,SUMATRIPTAN SUCCINATE,295.41,0.74,2,3,2,6,65.2,9.54,11.24
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
AUROBINDO PHARMA LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C01 Infections,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
AUROBINDO PHARMA LTD,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AUROBINDO PHARMA LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
AUROBINDO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
AUROBINDO PHARMA LTD,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AUROBINDO PHARMA LTD,C04 Neoplasms,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
AUROBINDO PHARMA LTD,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
AUROBINDO PHARMA LTD,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
AUROBINDO PHARMA LTD,C01 Infections,CEFPODOXIME PROXETIL,557.61,1.33,1,14,2,10,180.97,3.28,10.99
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
AUROBINDO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
AUROBINDO PHARMA LTD,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
AUROBINDO PHARMA LTD,C19 Endocrine System Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
AUROBINDO PHARMA LTD,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
AUROBINDO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AUROBINDO PHARMA LTD,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
AUROBINDO PHARMA LTD,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
AUROBINDO PHARMA LTD,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C01 Infections,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,DOFETILIDE,441.58,0.24,2,6,2,11,104.81,8.99,10.15
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
AUROBINDO PHARMA LTD,C01 Infections,CLINDAMYCIN PALMITATE HYDROCHLORIDE,663.41,7.96,0,8,3,22,108.33,7.55,12.59
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROBINDO PHARMA LTD,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
AUROBINDO PHARMA LTD,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
AUROBINDO PHARMA LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
AUROBINDO PHARMA LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
AUROBINDO PHARMA LTD,F03 Mental Disorders,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
AUROBINDO PHARMA LTD,C04 Neoplasms,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
AUROBINDO PHARMA LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
AUROBINDO PHARMA LTD,C11 Eye Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
AUROBINDO PHARMA LTD,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
AUROBINDO PHARMA LTD,C18 Nutritional and Metabolic Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
AUROBINDO PHARMA LTD,C25 Chemically-Induced Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
AUROBINDO PHARMA LTD,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
AUROBINDO PHARMA LTD,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
AUROBINDO PHARMA LTD,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
AUROBINDO PHARMA LTD,C14 Cardiovascular Diseases,QUINAPRIL HYDROCHLORIDE,438.52,1.96,2,5,2,9,95.94,5.2,3.7
AUROLIFE PHARMA LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AUROLIFE PHARMA LLC,C05 Musculoskeletal Diseases,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
AUROLIFE PHARMA LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AUROLIFE PHARMA LLC,C01 Infections,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
AUROLIFE PHARMA LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AUROLIFE PHARMA LLC,C06 Digestive System Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
AUROLIFE PHARMA LLC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AUROLIFE PHARMA LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AUROLIFE PHARMA LLC,C05 Musculoskeletal Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
AUROLIFE PHARMA LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AUROLIFE PHARMA LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C25 Chemically-Induced Disorders,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
AUROLIFE PHARMA LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AUROLIFE PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
AUROLIFE PHARMA LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AUROLIFE PHARMA LLC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
AUROLIFE PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AUROLIFE PHARMA LLC,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
AUROLIFE PHARMA LLC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AUROLIFE PHARMA LLC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
AUROLIFE PHARMA LLC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AUROLIFE PHARMA LLC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AUROLIFE PHARMA LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
AUROLIFE PHARMA LLC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AUROLIFE PHARMA LLC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AUROLIFE PHARMA LLC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AUROLIFE PHARMA LLC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AUROLIFE PHARMA LLC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
AUROLIFE PHARMA LLC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
AUROLIFE PHARMA LLC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
AUROLIFE PHARMA LLC,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
AUROLIFE PHARMA LLC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AUROLIFE PHARMA LLC,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
AUROLIFE PHARMA LLC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
AUROLIFE PHARMA LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
AUROLIFE PHARMA LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUROLIFE PHARMA LLC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
AUROLIFE PHARMA LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AUROLIFE PHARMA LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
AUROLIFE PHARMA LLC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AUROLIFE PHARMA LLC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AUROLIFE PHARMA LLC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
AUROLIFE PHARMA LLC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AUROLIFE PHARMA LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
AUROLIFE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
AUROLIFE PHARMA LLC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
AUROLIFE PHARMA LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AUSTARPHARMA LLC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUSTARPHARMA LLC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUSTARPHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUSTARPHARMA LLC,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
AUSTARPHARMA LLC,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
AUSTARPHARMA LLC,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
AUSTARPHARMA LLC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUSTARPHARMA LLC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUSTARPHARMA LLC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUSTARPHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
AUSTARPHARMA LLC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUSTARPHARMA LLC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUSTARPHARMA LLC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUSTARPHARMA LLC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
AUXILIUM PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
AUXILIUM PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
AUXILIUM PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
AUXILIUM PHARMACEUTICALS LLC,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
AUXILIUM PHARMACEUTICALS LLC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
AUXILIUM PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
AUXILIUM PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
AUXILIUM PHARMACEUTICALS LLC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
AUXILIUM PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
AUXILIUM PHARMACEUTICALS LLC,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
AUXILIUM PHARMACEUTICALS LLC,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
AUXILIUM PHARMACEUTICALS LLC,C20 Immune System Diseases,ACRIVASTINE,348.45,1.71,2,3,1,6,53.43,8.63,3.5
AUXILIUM PHARMACEUTICALS LLC,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
AUXILIUM PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
AUXILIUM PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
AVANTHI INC,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AVANTHI INC,C17 Skin and Connective Tissue Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
AVANTHI INC,C01 Infections,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
AVANTHI INC,C08 Respiratory Tract Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
AVANTHI INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AVANTHI INC,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
AVANTHI INC,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AVANTHI INC,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
AVANTHI INC,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
AVANTHI INC,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
AVANTHI INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AVANTHI INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AVANTHI INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AVANTHI INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
AVEMA PHARMA SOLUTIONS,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVEMA PHARMA SOLUTIONS,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
AVION PHARMACEUTICALS LLC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AVION PHARMACEUTICALS LLC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AVION PHARMACEUTICALS LLC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AVION PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AVION PHARMACEUTICALS LLC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AVION PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVION PHARMACEUTICALS LLC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AVION PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AVION PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
AVION PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
AVONDALE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
AVONDALE PHARMACEUTICALS LLC,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BARR LABORATORIES INC,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
BARR LABORATORIES INC,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C10 Nervous System Diseases,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C01 Infections,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
BARR LABORATORIES INC,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BARR LABORATORIES INC,C04 Neoplasms,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,C01 Infections,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
BARR LABORATORIES INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
BARR LABORATORIES INC,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
BARR LABORATORIES INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
BARR LABORATORIES INC,C04 Neoplasms,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
BARR LABORATORIES INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
BARR LABORATORIES INC,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BARR LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BARR LABORATORIES INC,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
BARR LABORATORIES INC,C14 Cardiovascular Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
BARR LABORATORIES INC,F03 Mental Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
BARR LABORATORIES INC,C01 Infections,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BARR LABORATORIES INC,C25 Chemically-Induced Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
BARR LABORATORIES INC,C12 Male Urogenital Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
BARR LABORATORIES INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C11 Eye Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
BARR LABORATORIES INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
BARR LABORATORIES INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
BARR LABORATORIES INC,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BARR LABORATORIES INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C14 Cardiovascular Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
BARR LABORATORIES INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
BARR LABORATORIES INC,C14 Cardiovascular Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
BARR LABORATORIES INC,C08 Respiratory Tract Diseases,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
BARR LABORATORIES INC,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
BARR LABORATORIES INC,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BARR LABORATORIES INC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
BARR LABORATORIES INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BARR LABORATORIES INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C09 Otorhinolaryngologic Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
BARR LABORATORIES INC,C04 Neoplasms,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
BARR LABORATORIES INC,C10 Nervous System Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
BARR LABORATORIES INC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
BARR LABORATORIES INC,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
BARR LABORATORIES INC,C01 Infections,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BARR LABORATORIES INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
BARR LABORATORIES INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BARR LABORATORIES INC,C04 Neoplasms,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BARR LABORATORIES INC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BARR LABORATORIES INC,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C01 Infections,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BARR LABORATORIES INC,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BARR LABORATORIES INC,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BARR LABORATORIES INC,C04 Neoplasms,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
BARR LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
BARR LABORATORIES INC,C10 Nervous System Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
BARR LABORATORIES INC,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
BARR LABORATORIES INC,C14 Cardiovascular Diseases,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
BARR LABORATORIES INC,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BARR LABORATORIES INC,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
BARR LABORATORIES INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
BARR LABORATORIES INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
BARR LABORATORIES INC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BARR LABORATORIES INC,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BARR LABORATORIES INC,C19 Endocrine System Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
BARR LABORATORIES INC,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C12 Male Urogenital Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
BARR LABORATORIES INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C12 Male Urogenital Diseases,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
BARR LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C04 Neoplasms,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
BARR LABORATORIES INC,F03 Mental Disorders,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
BARR LABORATORIES INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BARR LABORATORIES INC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
BARR LABORATORIES INC,C20 Immune System Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
BARR LABORATORIES INC,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
BARR LABORATORIES INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BARR LABORATORIES INC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
BARR LABORATORIES INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
BARR LABORATORIES INC,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,C06 Digestive System Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
BARR LABORATORIES INC,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C01 Infections,DEMECLOCYCLINE HYDROCHLORIDE,464.86,-3.17,1,9,6,2,181.62,8.54,2.59
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
BARR LABORATORIES INC,C14 Cardiovascular Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
BARR LABORATORIES INC,F03 Mental Disorders,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
BARR LABORATORIES INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,C08 Respiratory Tract Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BARR LABORATORIES INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
BARR LABORATORIES INC,F03 Mental Disorders,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
BARR LABORATORIES INC,C14 Cardiovascular Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
BARR LABORATORIES INC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
BARR LABORATORIES INC,C10 Nervous System Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BARR LABORATORIES INC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BARR LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
BARR LABORATORIES INC,C01 Infections,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
BARR LABORATORIES INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C10 Nervous System Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
BARR LABORATORIES INC,C04 Neoplasms,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
BARR LABORATORIES INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
BARR LABORATORIES INC,C10 Nervous System Diseases,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
BARR LABORATORIES INC,C04 Neoplasms,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
BARR LABORATORIES INC,C14 Cardiovascular Diseases,WARFARIN SODIUM,308.33,2.74,3,4,1,4,67.51,,5.56
BARR LABORATORIES INC,C01 Infections,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
BARR LABORATORIES INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
BARR LABORATORIES INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
BARR LABORATORIES INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BARR LABORATORIES INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,F01 Behavior and Behavior Mechanisms,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
BARR LABORATORIES INC,C10 Nervous System Diseases,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
BARR LABORATORIES INC,F03 Mental Disorders,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
BARR LABORATORIES INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
BARR LABORATORIES INC,C10 Nervous System Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
BARR LABORATORIES INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
BARR LABORATORIES INC,C06 Digestive System Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
BARR LABORATORIES INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
BARR LABORATORIES INC,F01 Behavior and Behavior Mechanisms,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BARR LABORATORIES INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
BARR LABORATORIES INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
BARR LABORATORIES INC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
BARR LABORATORIES INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
BARR LABORATORIES INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
BARR LABORATORIES INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,C26 Wounds and Injuries,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
BARR LABORATORIES INC,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C14 Cardiovascular Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BARR LABORATORIES INC,C01 Infections,ETHAMBUTOL HYDROCHLORIDE,204.31,-0.06,0,4,4,9,64.52,9.55,
BARR LABORATORIES INC,C12 Male Urogenital Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,C06 Digestive System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C08 Respiratory Tract Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BARR LABORATORIES INC,C25 Chemically-Induced Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
BARR LABORATORIES INC,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BARR LABORATORIES INC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BARR LABORATORIES INC,C04 Neoplasms,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,C04 Neoplasms,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C01 Infections,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
BARR LABORATORIES INC,C10 Nervous System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BARR LABORATORIES INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BARR LABORATORIES INC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
BARR LABORATORIES INC,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BARR LABORATORIES INC,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
BARR LABORATORIES INC,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
BARR LABORATORIES INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BARR LABORATORIES INC,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
BARR LABORATORIES INC,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BARR LABORATORIES INC,C05 Musculoskeletal Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
BARR LABORATORIES INC,F03 Mental Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
BARR LABORATORIES INC,C08 Respiratory Tract Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
BARR LABORATORIES INC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BARR LABORATORIES INC,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BARR LABORATORIES INC,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
BAUSCH HEALTH US LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BAUSCH HEALTH US LLC,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
BAUSCH HEALTH US LLC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
BAUSCH HEALTH US LLC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
BAUSCH HEALTH US LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BAUSCH HEALTH US LLC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
BAUSCH HEALTH US LLC,C10 Nervous System Diseases,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
BAUSCH HEALTH US LLC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
BAUSCH HEALTH US LLC,C14 Cardiovascular Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
BAUSCH HEALTH US LLC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
BAUSCH HEALTH US LLC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
BAUSCH HEALTH US LLC,C14 Cardiovascular Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
BAUSCH HEALTH US LLC,C14 Cardiovascular Diseases,METYROSINE,195.22,-1.06,1,3,3,3,83.55,9.93,2.06
BAUSCH HEALTH US LLC,C10 Nervous System Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
BAUSCH HEALTH US LLC,C05 Musculoskeletal Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
BAUSCH HEALTH US LLC,F03 Mental Disorders,METYROSINE,195.22,-1.06,1,3,3,3,83.55,9.93,2.06
BAUSCH HEALTH US LLC,C04 Neoplasms,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
BAUSCH HEALTH US LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BAUSCH HEALTH US LLC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
BAUSCH HEALTH US LLC,C01 Infections,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
BAUSCH HEALTH US LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BAUSCH HEALTH US LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BAUSCH HEALTH US LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
BAUSCH HEALTH US LLC,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
BAUSCH HEALTH US LLC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
BAUSCH HEALTH US LLC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
BAUSCH HEALTH US LLC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
BAUSCH HEALTH US LLC,C10 Nervous System Diseases,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
BAUSCH HEALTH US LLC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
BAUSCH HEALTH US LLC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
BAUSCH HEALTH US LLC,C25 Chemically-Induced Disorders,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
BAUSCH HEALTH US LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BAUSCH HEALTH US LLC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
BAUSCH HEALTH US LLC,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
BAUSCH HEALTH US LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BAUSCH HEALTH US LLC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
BAUSCH HEALTH US LLC,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
BAUSCH HEALTH US LLC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
BAYER HEALTHCARE LLC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
BAYER HEALTHCARE LLC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
BAYER HEALTHCARE LLC,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
BAYER HEALTHCARE LLC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
BAYER HEALTHCARE LLC,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
BAYER HEALTHCARE LLC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
BAYER HEALTHCARE LLC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
BAYER HEALTHCARE LLC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
BAYER HEALTHCARE LLC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
BAYER HEALTHCARE LLC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
BAYER HEALTHCARE LLC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
BAYER HEALTHCARE LLC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
BAYER HEALTHCARE LLC,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
BAYER HEALTHCARE LLC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE SULFATE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
BAYER HEALTHCARE LLC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
BAYER HEALTHCARE LLC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BAYER HEALTHCARE LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
BAYER HEALTHCARE LLC,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
BAYER HEALTHCARE LLC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE LLC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BAYER HEALTHCARE PHARMACEUTICALS INC,C19 Endocrine System Diseases,ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BAYER HEALTHCARE PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BAYER HEALTHCARE PHARMACEUTICALS INC,C06 Digestive System Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
BAYER HEALTHCARE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BAYER HEALTHCARE PHARMACEUTICALS INC,C11 Eye Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
BAYER HEALTHCARE PHARMACEUTICALS INC,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BAYER HEALTHCARE PHARMACEUTICALS INC,C01 Infections,PRAZIQUANTEL,312.41,2.3,1,2,0,1,40.62,,
BAYER HEALTHCARE PHARMACEUTICALS INC,C01 Infections,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
BAYER HEALTHCARE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C04 Neoplasms,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
BAYER HEALTHCARE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BAYER HEALTHCARE PHARMACEUTICALS INC,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
BAYER HEALTHCARE PHARMACEUTICALS INC,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C01 Infections,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,VARDENAFIL HYDROCHLORIDE,488.61,1.43,3,8,1,8,112.9,6.21,11.75
BAYER HEALTHCARE PHARMACEUTICALS INC,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,LEVOMEFOLATE CALCIUM,459.46,-2.98,2,9,7,9,202.77,5.3,2.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,LEVOMEFOLATE CALCIUM,459.46,-2.98,2,9,7,9,202.77,5.3,2.56
BAYER HEALTHCARE PHARMACEUTICALS INC,G07 Physiological Phenomena,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
BAYER HEALTHCARE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
BAYER HEALTHCARE PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C10 Nervous System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
BAYER HEALTHCARE PHARMACEUTICALS INC,C06 Digestive System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
BAYER HEALTHCARE PHARMACEUTICALS INC,C04 Neoplasms,REGORAFENIB,482.82,4.49,3,4,3,5,92.35,3.02,10.52
BAYER HEALTHCARE PHARMACEUTICALS INC,C11 Eye Diseases,REGORAFENIB,482.82,4.49,3,4,3,5,92.35,3.02,10.52
BAYER HEALTHCARE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
BAYER HEALTHCARE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C06 Digestive System Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C04 Neoplasms,SORAFENIB TOSYLATE,464.83,4.34,3,4,3,5,92.35,3.03,11.55
BAYER HEALTHCARE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,C04 Neoplasms,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYER HEALTHCARE PHARMACEUTICALS INC,F03 Mental Disorders,DIENOGEST,311.42,2.31,0,3,1,1,61.09,,13.78
BAYER HEALTHCARE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
BAYER HEALTHCARE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DIENOGEST,311.42,2.31,0,3,1,1,61.09,,13.78
BAYER HEALTHCARE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,DIENOGEST,311.42,2.31,0,3,1,1,61.09,,13.78
BAYER HEALTHCARE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
BAYSHORE PHARMACEUTICALS LLC,C10 Nervous System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
BAYSHORE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
BAYSHORE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
BAYSHORE PHARMACEUTICALS LLC,C11 Eye Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
BAYSHORE PHARMACEUTICALS LLC,C06 Digestive System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
BEIJING YILING BIO-ENGEERING AND TECHNOLOGY CO LTD,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
BELCHER PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
BELCHER PHARMACEUTICALS LLC,C01 Infections,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
BELCHER PHARMACEUTICALS LLC,C04 Neoplasms,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
BELCHER PHARMACEUTICALS LLC,C01 Infections,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
BELCHER PHARMACEUTICALS LLC,C04 Neoplasms,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
BELCHER PHARMACEUTICALS LLC,C04 Neoplasms,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
BELCHER PHARMACEUTICALS LLC,C11 Eye Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
BELCHER PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,MEFENAMIC ACID,241.29,5.4,2,2,2,3,49.33,,3.89
BELCHER PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
BELCHER PHARMACEUTICALS LLC,C20 Immune System Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
BELCHER PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
BELCHER PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
BELCHER PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
BELCHER PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",MEFENAMIC ACID,241.29,5.4,2,2,2,3,49.33,,3.89
BELCHER PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
BELCHER PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
BELCHER PHARMACEUTICALS LLC,C20 Immune System Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
BELCHER PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,MEFENAMIC ACID,241.29,5.4,2,2,2,3,49.33,,3.89
BELCHER PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
BELCHER PHARMACEUTICALS LLC,C01 Infections,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
BEXIMCO PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
BEXIMCO PHARMACEUTICALS USA INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BEXIMCO PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BEXIMCO PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
BEXIMCO PHARMACEUTICALS USA INC,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
BEXIMCO PHARMACEUTICALS USA INC,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
BEXIMCO PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,SOTALOL HYDROCHLORIDE,272.37,-0.4,1,4,3,6,78.43,9.43,10.07
BEXIMCO PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BEXIMCO PHARMACEUTICALS USA INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
BEXIMCO PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
BEXIMCO PHARMACEUTICALS USA INC,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
BEXIMCO PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
BEXIMCO PHARMACEUTICALS USA INC,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BEXIMCO PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BEXIMCO PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
BEXIMCO PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
BEXIMCO PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
BEXIMCO PHARMACEUTICALS USA INC,F03 Mental Disorders,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
BEXIMCO PHARMACEUTICALS USA INC,C04 Neoplasms,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
BEXIMCO PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BEXIMCO PHARMACEUTICALS USA INC,C01 Infections,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
BEXIMCO PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
BEXIMCO PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
BEXIMCO PHARMACEUTICALS USA INC,C06 Digestive System Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
BEXIMCO PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
BEXIMCO PHARMACEUTICALS USA INC,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
BEXIMCO PHARMACEUTICALS USA INC,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
BEXIMCO PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BEXIMCO PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
BEXIMCO PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
BEXIMCO PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BIOCON LIMITED,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIOCON LIMITED,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
BIONPHARMA INC,C06 Digestive System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BIONPHARMA INC,C04 Neoplasms,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
BIONPHARMA INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,C25 Chemically-Induced Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
BIONPHARMA INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
BIONPHARMA INC,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
BIONPHARMA INC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C06 Digestive System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
BIONPHARMA INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C05 Musculoskeletal Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
BIONPHARMA INC,C10 Nervous System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
BIONPHARMA INC,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
BIONPHARMA INC,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
BIONPHARMA INC,C07 Stomatognathic Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
BIONPHARMA INC,C06 Digestive System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
BIONPHARMA INC,C14 Cardiovascular Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
BIONPHARMA INC,C10 Nervous System Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
BIONPHARMA INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C12 Male Urogenital Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
BIONPHARMA INC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
BIONPHARMA INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,F03 Mental Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
BIONPHARMA INC,C25 Chemically-Induced Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
BIONPHARMA INC,F03 Mental Disorders,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
BIONPHARMA INC,C18 Nutritional and Metabolic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BIONPHARMA INC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
BIONPHARMA INC,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
BIONPHARMA INC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
BIONPHARMA INC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C14 Cardiovascular Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BIONPHARMA INC,C18 Nutritional and Metabolic Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BIONPHARMA INC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BIONPHARMA INC,C10 Nervous System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
BIONPHARMA INC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C15 Hemic and Lymphatic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
BIONPHARMA INC,C10 Nervous System Diseases,TETRABENAZINE,317.43,3.4,1,4,0,4,38.77,7.33,
BIONPHARMA INC,C04 Neoplasms,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,F03 Mental Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
BIONPHARMA INC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BIONPHARMA INC,C10 Nervous System Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
BIONPHARMA INC,C25 Chemically-Induced Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BIONPHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
BIONPHARMA INC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
BIONPHARMA INC,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
BIONPHARMA INC,C05 Musculoskeletal Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
BIONPHARMA INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BIONPHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C12 Male Urogenital Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
BIONPHARMA INC,C18 Nutritional and Metabolic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
BIONPHARMA INC,C01 Infections,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
BIONPHARMA INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BIONPHARMA INC,C09 Otorhinolaryngologic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
BIONPHARMA INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,F03 Mental Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
BIONPHARMA INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
BIONPHARMA INC,C01 Infections,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
BIONPHARMA INC,F03 Mental Disorders,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
BIONPHARMA INC,C04 Neoplasms,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
BIONPHARMA INC,C12 Male Urogenital Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C17 Skin and Connective Tissue Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C17 Skin and Connective Tissue Diseases,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
BIONPHARMA INC,C19 Endocrine System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,G08 Reproductive and Urinary Physiological Phenomena,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C10 Nervous System Diseases,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
BIONPHARMA INC,C26 Wounds and Injuries,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
BIONPHARMA INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C14 Cardiovascular Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
BIONPHARMA INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
BIONPHARMA INC,C10 Nervous System Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
BIONPHARMA INC,C04 Neoplasms,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
BIONPHARMA INC,C01 Infections,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C20 Immune System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
BIONPHARMA INC,C10 Nervous System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
BIONPHARMA INC,C12 Male Urogenital Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
BIONPHARMA INC,C08 Respiratory Tract Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
BIONPHARMA INC,C19 Endocrine System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
BIONPHARMA INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,F03 Mental Disorders,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C04 Neoplasms,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,G08 Reproductive and Urinary Physiological Phenomena,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C12 Male Urogenital Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C26 Wounds and Injuries,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C06 Digestive System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C18 Nutritional and Metabolic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C17 Skin and Connective Tissue Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C05 Musculoskeletal Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C08 Respiratory Tract Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C14 Cardiovascular Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,F03 Mental Disorders,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
BIONPHARMA INC,C14 Cardiovascular Diseases,DOFETILIDE,441.58,0.24,2,6,2,11,104.81,8.99,10.15
BIONPHARMA INC,C19 Endocrine System Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
BIONPHARMA INC,C15 Hemic and Lymphatic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BIONPHARMA INC,C18 Nutritional and Metabolic Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
BIONPHARMA INC,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
BIONPHARMA INC,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
BIONPHARMA INC,C10 Nervous System Diseases,RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
BIONPHARMA INC,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
BIONPHARMA INC,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
BIONPHARMA INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
BIONPHARMA INC,C04 Neoplasms,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
BIONPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
BIONPHARMA INC,C10 Nervous System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
BOEHRINGER INGELHEIM,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
BOEHRINGER INGELHEIM,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BOEHRINGER INGELHEIM,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BOEHRINGER INGELHEIM,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM,C12 Male Urogenital Diseases,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BOEHRINGER INGELHEIM,F03 Mental Disorders,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BOEHRINGER INGELHEIM,C14 Cardiovascular Diseases,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
BOEHRINGER INGELHEIM,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
BOEHRINGER INGELHEIM,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BOEHRINGER INGELHEIM,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
BOEHRINGER INGELHEIM,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BOEHRINGER INGELHEIM,C04 Neoplasms,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM,C18 Nutritional and Metabolic Diseases,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
BOEHRINGER INGELHEIM,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C10 Nervous System Diseases,DABIGATRAN ETEXILATE MESYLATE,627.75,4.59,4,9,2,15,154.03,4.48,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C01 Infections,TIPRANAVIR,602.68,7.14,3,6,2,11,105.59,,4.43
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C12 Male Urogenital Diseases,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,F03 Mental Disorders,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C14 Cardiovascular Diseases,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C04 Neoplasms,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,LINAGLIPTIN,472.55,2.8,4,10,1,4,116.86,9.86,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
BOEHRINGER INGELHEIM PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DABIGATRAN ETEXILATE MESYLATE,627.75,4.59,4,9,2,15,154.03,4.48,
BOSCOGEN INC,C08 Respiratory Tract Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
BOSCOGEN INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
BOSCOGEN INC,C14 Cardiovascular Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
BOSCOGEN INC,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
BOSCOGEN INC,C04 Neoplasms,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
BOSCOGEN INC,C18 Nutritional and Metabolic Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
BOSCOGEN INC,C12 Male Urogenital Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
BOSCOGEN INC,C10 Nervous System Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
BOSCOGEN INC,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
BOSCOGEN INC,C11 Eye Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
BOSCOGEN INC,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
BOSCOGEN INC,C18 Nutritional and Metabolic Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
BOSCOGEN INC,C25 Chemically-Induced Disorders,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
BOSCOGEN INC,C10 Nervous System Diseases,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
BOSCOGEN INC,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
BOSCOGEN INC,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
BRAINTREE LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",BISACODYL,361.4,3.61,3,5,0,5,65.49,4.08,
BRAINTREE LABORATORIES INC,C17 Skin and Connective Tissue Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C11 Eye Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,C06 Digestive System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,C10 Nervous System Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C04 Neoplasms,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,G07 Physiological Phenomena,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C05 Musculoskeletal Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C18 Nutritional and Metabolic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,A10 Tissues,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C19 Endocrine System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C08 Respiratory Tract Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,C20 Immune System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C01 Infections,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C12 Male Urogenital Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,C25 Chemically-Induced Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C15 Hemic and Lymphatic Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,F03 Mental Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C01 Infections,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C26 Wounds and Injuries,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C14 Cardiovascular Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C09 Otorhinolaryngologic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C14 Cardiovascular Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,C26 Wounds and Injuries,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C08 Respiratory Tract Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C25 Chemically-Induced Disorders,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C10 Nervous System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,C06 Digestive System Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C05 Musculoskeletal Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,F01 Behavior and Behavior Mechanisms,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C07 Stomatognathic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C09 Otorhinolaryngologic Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C04 Neoplasms,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C12 Male Urogenital Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,MAGNESIUM SULFATE,120.37,,,,,,,,
BRAINTREE LABORATORIES INC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,C15 Hemic and Lymphatic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRAINTREE LABORATORIES INC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
BRAINTREE LABORATORIES INC,D01 Inorganic Chemicals,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
BRECKENRIDGE PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
BRECKENRIDGE PHARMACEUTICAL INC,C11 Eye Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
BRECKENRIDGE PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
BRECKENRIDGE PHARMACEUTICAL INC,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C14 Cardiovascular Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
BRECKENRIDGE PHARMACEUTICAL INC,C12 Male Urogenital Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BRECKENRIDGE PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BRECKENRIDGE PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
BRECKENRIDGE PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
BRECKENRIDGE PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
BRECKENRIDGE PHARMACEUTICAL INC,C09 Otorhinolaryngologic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
BRECKENRIDGE PHARMACEUTICAL INC,C19 Endocrine System Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
BRECKENRIDGE PHARMACEUTICAL INC,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
BRECKENRIDGE PHARMACEUTICAL INC,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BRECKENRIDGE PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BRECKENRIDGE PHARMACEUTICAL INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
BRECKENRIDGE PHARMACEUTICAL INC,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BRECKENRIDGE PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BRECKENRIDGE PHARMACEUTICAL INC,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
BRECKENRIDGE PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BRECKENRIDGE PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
BRECKENRIDGE PHARMACEUTICAL INC,C14 Cardiovascular Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
BRECKENRIDGE PHARMACEUTICAL INC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
BRECKENRIDGE PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
BRECKENRIDGE PHARMACEUTICAL INC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
BRECKENRIDGE PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
BRECKENRIDGE PHARMACEUTICAL INC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
BRECKENRIDGE PHARMACEUTICAL INC,C06 Digestive System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
BRECKENRIDGE PHARMACEUTICAL INC,C26 Wounds and Injuries,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
BRECKENRIDGE PHARMACEUTICAL INC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C07 Stomatognathic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BRECKENRIDGE PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
BRECKENRIDGE PHARMACEUTICAL INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
BRECKENRIDGE PHARMACEUTICAL INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C06 Digestive System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
BRECKENRIDGE PHARMACEUTICAL INC,A10 Tissues,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C19 Endocrine System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C11 Eye Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
BRECKENRIDGE PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C20 Immune System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
BRECKENRIDGE PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
BRECKENRIDGE PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,D01 Inorganic Chemicals,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,TERBINAFINE HYDROCHLORIDE,291.44,5.53,2,1,0,4,3.24,8.86,
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
BRECKENRIDGE PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BRECKENRIDGE PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
BRECKENRIDGE PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BRECKENRIDGE PHARMACEUTICAL INC,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
BRECKENRIDGE PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
BRECKENRIDGE PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
BRECKENRIDGE PHARMACEUTICAL INC,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
BRECKENRIDGE PHARMACEUTICAL INC,F03 Mental Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C14 Cardiovascular Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C01 Infections,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
BRECKENRIDGE PHARMACEUTICAL INC,C12 Male Urogenital Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
BRECKENRIDGE PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BRECKENRIDGE PHARMACEUTICAL INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
BRECKENRIDGE PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
BRECKENRIDGE PHARMACEUTICAL INC,G07 Physiological Phenomena,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
BRECKENRIDGE PHARMACEUTICAL INC,C04 Neoplasms,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
BRECKENRIDGE PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
BRECKENRIDGE PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
BRECKENRIDGE PHARMACEUTICAL INC,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
BRECKENRIDGE PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
BRECKENRIDGE PHARMACEUTICAL INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
BRISTOL MYERS SQUIBB CO,C10 Nervous System Diseases,DASATINIB,488.02,3.83,3,9,3,7,106.51,7.19,8.52
BRISTOL MYERS SQUIBB CO,C04 Neoplasms,DASATINIB,488.02,3.83,3,9,3,7,106.51,7.19,8.52
BRISTOL MYERS SQUIBB CO,C12 Male Urogenital Diseases,DASATINIB,488.02,3.83,3,9,3,7,106.51,7.19,8.52
BRISTOL MYERS SQUIBB CO,C08 Respiratory Tract Diseases,DASATINIB,488.02,3.83,3,9,3,7,106.51,7.19,8.52
BRISTOL MYERS SQUIBB CO,C01 Infections,ATAZANAVIR SULFATE,704.87,4.54,3,9,5,14,171.22,4.42,11.92
BRISTOL MYERS SQUIBB CO,C04 Neoplasms,DIDANOSINE,236.23,-0.87,2,6,2,2,93.03,0.6,8.93
BRISTOL MYERS SQUIBB CO,C15 Hemic and Lymphatic Diseases,DASATINIB,488.02,3.83,3,9,3,7,106.51,7.19,8.52
BRISTOL MYERS SQUIBB CO,C17 Skin and Connective Tissue Diseases,DASATINIB,488.02,3.83,3,9,3,7,106.51,7.19,8.52
BRISTOL MYERS SQUIBB CO,C01 Infections,DASATINIB,488.02,3.83,3,9,3,7,106.51,7.19,8.52
BRISTOL MYERS SQUIBB CO,C01 Infections,DIDANOSINE,236.23,-0.87,2,6,2,2,93.03,0.6,8.93
BRISTOL MYERS SQUIBB CO,C15 Hemic and Lymphatic Diseases,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
BRISTOL MYERS SQUIBB CO,C04 Neoplasms,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
BRISTOL MYERS SQUIBB CO,C10 Nervous System Diseases,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
BRISTOL MYERS SQUIBB CO,C04 Neoplasms,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
BRISTOL MYERS SQUIBB CO,C01 Infections,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
BRISTOL MYERS SQUIBB CO,C01 Infections,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
BRISTOL MYERS SQUIBB CO,C08 Respiratory Tract Diseases,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
CADILA HEALTHCARE LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CADILA HEALTHCARE LTD,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CADILA HEALTHCARE LTD,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
CADILA HEALTHCARE LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CADILA HEALTHCARE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CADILA HEALTHCARE LTD,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
CADILA HEALTHCARE LTD,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
CADILA HEALTHCARE LTD,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
CADILA HEALTHCARE LTD,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
CADILA HEALTHCARE LTD,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
CADILA HEALTHCARE LTD,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CADILA HEALTHCARE LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CADILA HEALTHCARE LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CADILA HEALTHCARE LTD,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
CADILA HEALTHCARE LTD,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
CADILA HEALTHCARE LTD,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
CADILA HEALTHCARE LTD,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CADILA HEALTHCARE LTD,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CADILA HEALTHCARE LTD,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CADILA HEALTHCARE LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CADILA HEALTHCARE LTD,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CADILA HEALTHCARE LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CADILA HEALTHCARE LTD,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
CADILA HEALTHCARE LTD,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
CADILA HEALTHCARE LTD,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
CADILA HEALTHCARE LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CADILA HEALTHCARE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CADILA HEALTHCARE LTD,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
CADILA HEALTHCARE LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CADILA HEALTHCARE LTD,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
CADILA HEALTHCARE LTD,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
CADILA HEALTHCARE LTD,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
CADILA HEALTHCARE LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CADILA HEALTHCARE LTD,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
CADILA HEALTHCARE LTD,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CADILA HEALTHCARE LTD,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
CADILA HEALTHCARE LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CADILA HEALTHCARE LTD,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
CADILA HEALTHCARE LTD,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CADILA HEALTHCARE LTD,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
CADILA HEALTHCARE LTD,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
CADILA HEALTHCARE LTD,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
CADILA HEALTHCARE LTD,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CADILA HEALTHCARE LTD,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
CADILA HEALTHCARE LTD,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
CADILA HEALTHCARE LTD,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CADILA HEALTHCARE LTD,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
CADILA HEALTHCARE LTD,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA HEALTHCARE LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
CADILA PHARMACEUTICALS LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CADILA PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
CADILA PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CADILA PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
CADILA PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
CADILA PHARMACEUTICALS LTD,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
CADILA PHARMACEUTICALS LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CADILA PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
CADILA PHARMACEUTICALS LTD,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
CADILA PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C01 Infections,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CADILA PHARMACEUTICALS LTD,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
CADILA PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
CADILA PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA PHARMACEUTICALS LTD,C11 Eye Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CADILA PHARMACEUTICALS LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
CADILA PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
CADILA PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
CADILA PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CADILA PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
CADILA PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
CADILA PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CADILA PHARMACEUTICALS LTD,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C10 Nervous System Diseases,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
CADILA PHARMACEUTICALS LTD,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA PHARMACEUTICALS LTD,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
CADILA PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
CADILA PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
CADILA PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
CADILA PHARMACEUTICALS LTD,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CADILA PHARMACEUTICALS LTD,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
CADILA PHARMACEUTICALS LTD,C09 Otorhinolaryngologic Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CADILA PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CADILA PHARMACEUTICALS LTD,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CADILA PHARMACEUTICALS LTD,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CADILA PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
CADILA PHARMACEUTICALS LTD,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
CADILA PHARMACEUTICALS LTD,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
CADILA PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CADILA PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CADILA PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
CADILA PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,NATEGLINIDE,317.43,4.03,1,2,2,6,66.4,,4
CADILA PHARMACEUTICALS LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
CADILA PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
CADILA PHARMACEUTICALS LTD,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
CADILA PHARMACEUTICALS LTD,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
CADILA PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA PHARMACEUTICALS LTD,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA PHARMACEUTICALS LTD,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
CADILA PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
CADILA PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
CADILA PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
CADILA PHARMACEUTICALS LTD,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
CADILA PHARMACEUTICALS LTD,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA PHARMACEUTICALS LTD,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADILA PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CADILA PHARMACEUTICALS LTD,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
CADILA PHARMACEUTICALS LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CADILA PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
CADISTA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
CADISTA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CADISTA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CADISTA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CADISTA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
CADISTA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
CADISTA PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CADISTA PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CADISTA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CADISTA PHARMACEUTICALS INC,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
CADISTA PHARMACEUTICALS INC,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
CADISTA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CAPELLON PHARMACEUTICALS LLC,C20 Immune System Diseases,DEXCHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
CAPELLON PHARMACEUTICALS LLC,C10 Nervous System Diseases,DEXCHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
CAPELLON PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,DEXCHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
CARACO PHARMACEUTICAL LABORATORIES LTD,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CARACO PHARMACEUTICAL LABORATORIES LTD,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CARACO PHARMACEUTICAL LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
CARACO PHARMACEUTICAL LABORATORIES LTD,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CARACO PHARMACEUTICAL LABORATORIES LTD,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
CARACO PHARMACEUTICAL LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CARACO PHARMACEUTICAL LABORATORIES LTD,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
CARACO PHARMACEUTICAL LABORATORIES LTD,C10 Nervous System Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
CARACO PHARMACEUTICAL LABORATORIES LTD,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
CARACO PHARMACEUTICAL LABORATORIES LTD,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CARACO PHARMACEUTICAL LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
CARACO PHARMACEUTICAL LABORATORIES LTD,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CARACO PHARMACEUTICAL LABORATORIES LTD,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CARACO PHARMACEUTICAL LABORATORIES LTD,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
CARACO PHARMACEUTICAL LABORATORIES LTD,F03 Mental Disorders,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
CARACO PHARMACEUTICAL LABORATORIES LTD,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
CARACO PHARMACEUTICAL LABORATORIES LTD,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
CARACO PHARMACEUTICAL LABORATORIES LTD,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
CARACO PHARMACEUTICAL LABORATORIES LTD,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CARACO PHARMACEUTICAL LABORATORIES LTD,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CARIBE HOLDINGS CAYMAN CO LTD DBA PURACAP CARIBE,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CARLSBAD TECHNOLOGY INC,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CARLSBAD TECHNOLOGY INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
CARLSBAD TECHNOLOGY INC,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
CARLSBAD TECHNOLOGY INC,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
CARLSBAD TECHNOLOGY INC,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
CARLSBAD TECHNOLOGY INC,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CARLSBAD TECHNOLOGY INC,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
CARLSBAD TECHNOLOGY INC,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
CARLSBAD TECHNOLOGY INC,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
CARLSBAD TECHNOLOGY INC,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
CARLSBAD TECHNOLOGY INC,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CARLSBAD TECHNOLOGY INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CARLSBAD TECHNOLOGY INC,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
CARLSBAD TECHNOLOGY INC,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
CARLSBAD TECHNOLOGY INC,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CARLSBAD TECHNOLOGY INC,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
CARLSBAD TECHNOLOGY INC,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CARLSBAD TECHNOLOGY INC,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
CARLSBAD TECHNOLOGY INC,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
CARLSBAD TECHNOLOGY INC,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
CARLSBAD TECHNOLOGY INC,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
CARLSBAD TECHNOLOGY INC,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,F03 Mental Disorders,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
CASI PHARMACEUTICALS INC,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
CASI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
CASI PHARMACEUTICALS INC,C10 Nervous System Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
CASI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
CASI PHARMACEUTICALS INC,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
CASI PHARMACEUTICALS INC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
CASI PHARMACEUTICALS INC,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,F03 Mental Disorders,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
CASI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
CASI PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
CASI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,C10 Nervous System Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
CASI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
CASI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
CASI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
CASI PHARMACEUTICALS INC,C01 Infections,CEFPROZIL,389.43,-1.92,1,6,4,5,132.96,7.22,3.3
CASI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,C10 Nervous System Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
CASI PHARMACEUTICALS INC,C06 Digestive System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,C11 Eye Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
CASI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
CASI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CASI PHARMACEUTICALS INC,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CASI PHARMACEUTICALS INC,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CASI PHARMACEUTICALS INC,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
CASI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
CASI PHARMACEUTICALS INC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
CASI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
CASI PHARMACEUTICALS INC,C04 Neoplasms,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
CASI PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,C07 Stomatognathic Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
CASI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
CASI PHARMACEUTICALS INC,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
CASI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
CASI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,NABUMETONE,228.29,3.22,2,2,0,4,26.3,,
CASI PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CASI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,C10 Nervous System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CASI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
CASI PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
CASPER PHARMA LLC,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
CASPER PHARMA LLC,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
CASPER PHARMA LLC,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CASPER PHARMA LLC,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
CATALENT PHARMA SOLUTIONS LLC,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
CATALENT PHARMA SOLUTIONS LLC,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
CATALENT PHARMA SOLUTIONS LLC,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
CATALENT PHARMA SOLUTIONS LLC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
CATALENT PHARMA SOLUTIONS LLC,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
CATALENT PHARMA SOLUTIONS LLC,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
CATALENT PHARMA SOLUTIONS LLC,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
CATALENT PHARMA SOLUTIONS LLC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
CATALENT PHARMA SOLUTIONS LLC,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
CATALENT PHARMA SOLUTIONS LLC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
CATALENT PHARMA SOLUTIONS LLC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
CATALENT PHARMA SOLUTIONS LLC,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
CATALENT PHARMA SOLUTIONS LLC,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
CEDIPROF INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
CEDIPROF INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
CEDIPROF INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
CEDIPROF INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
CEDIPROF INC,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
CELGENE CORP,C10 Nervous System Diseases,LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,"C23 Pathological Conditions, Signs and Symptoms",LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,C15 Hemic and Lymphatic Diseases,LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,C06 Digestive System Diseases,LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,C01 Infections,LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,F03 Mental Disorders,LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,C20 Immune System Diseases,LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,C18 Nutritional and Metabolic Diseases,LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,C01 Infections,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C10 Nervous System Diseases,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C18 Nutritional and Metabolic Diseases,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C04 Neoplasms,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C06 Digestive System Diseases,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C04 Neoplasms,LENALIDOMIDE,259.26,-0.71,1,4,2,1,92.5,2.31,11.61
CELGENE CORP,C08 Respiratory Tract Diseases,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C13 Female Urogenital Diseases and Pregnancy Complications,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C15 Hemic and Lymphatic Diseases,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C17 Skin and Connective Tissue Diseases,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,"C23 Pathological Conditions, Signs and Symptoms",THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C05 Musculoskeletal Diseases,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C14 Cardiovascular Diseases,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELGENE CORP,C20 Immune System Diseases,THALIDOMIDE,258.23,0.02,1,4,1,1,83.55,,11.59
CELLTRION INC,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
CELLTRION INC,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
CELLTRION INC,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
CELLTRION INC,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
CELLTRION INC,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CELLTRION INC,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
CELLTRION INC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
CELLTRION INC,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
CELLTRION INC,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
CELLTRION INC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
CELLTRION INC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
CELLTRION INC,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CELLTRION INC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
CELLTRION INC,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
CELLTRION INC,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CELLTRION INC,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
CELLTRION INC,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CELLTRION INC,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
CELLTRION INC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
CELLTRION INC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
CEPHALON INC,F03 Mental Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C04 Neoplasms,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C08 Respiratory Tract Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C25 Chemically-Induced Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C06 Digestive System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,"C23 Pathological Conditions, Signs and Symptoms",ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C09 Otorhinolaryngologic Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C10 Nervous System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C26 Wounds and Injuries,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C18 Nutritional and Metabolic Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,F03 Mental Disorders,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C04 Neoplasms,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,"C23 Pathological Conditions, Signs and Symptoms",MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C10 Nervous System Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,C08 Respiratory Tract Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CEPHALON INC,F01 Behavior and Behavior Mechanisms,TIAGABINE HYDROCHLORIDE,375.56,2.6,2,4,1,6,40.54,9.26,4.14
CEPHALON INC,C01 Infections,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
CHARTWELL LIFE SCIENCE LLC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CHARTWELL LIFE SCIENCE LLC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CHARTWELL LIFE SCIENCE LLC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CHARTWELL LIFE SCIENCE LLC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CHARTWELL LIFE SCIENCE LLC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CHARTWELL LIFE SCIENCE LLC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CHARTWELL LIFE SCIENCE LLC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
CHARTWELL LIFE SCIENCE LLC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CHARTWELL LIFE SCIENCE LLC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CHARTWELL MOLECULAR HOLDINGS LLC,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CHARTWELL MOLECULAR HOLDINGS LLC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
CHARTWELL MOLECULAR HOLDINGS LLC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
CHARTWELL MOLECULAR HOLDINGS LLC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
CHARTWELL MOLECULAR HOLDINGS LLC,"C23 Pathological Conditions, Signs and Symptoms",GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
CHARTWELL MOLECULAR HOLDINGS LLC,C04 Neoplasms,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
CHARTWELL MOLECULAR HOLDINGS LLC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
CHARTWELL MOLECULAR HOLDINGS LLC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
CHARTWELL MOLECULAR HOLDINGS LLC,C01 Infections,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
CHARTWELL MOLECULAR HOLDINGS LLC,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
CHARTWELL MOLECULAR HOLDINGS LLC,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
CHARTWELL MOLECULAR HOLDINGS LLC,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
CHARTWELL MOLECULAR HOLDINGS LLC,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
CHARTWELL MOLECULAR HOLDINGS LLC,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
CHARTWELL MOLECULAR HOLDINGS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
CHARTWELL MOLECULAR HOLDINGS LLC,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
CHARTWELL MOLECULAR HOLDINGS LLC,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
CHARTWELL MOLECULAR HOLDINGS LLC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
CHARTWELL MOLECULAR HOLDINGS LLC,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CHARTWELL MOLECULAR HOLDINGS LLC,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CHARTWELL MOLECULAR HOLDINGS LLC,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CHARTWELL MOLECULAR HOLDINGS LLC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
CHARTWELL MOLECULAR HOLDINGS LLC,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CHARTWELL MOLECULAR HOLDINGS LLC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
CHARTWELL MOLECULAR HOLDINGS LLC,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CHARTWELL MOLECULAR HOLDINGS LLC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
CHARTWELL MOLECULAR HOLDINGS LLC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
CHARTWELL MOLECULAR HOLDINGS LLC,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CHARTWELL MOLECULAR HOLDINGS LLC,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CHARTWELL MOLECULAR HOLDINGS LLC,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
CHARTWELL MOLECULAR HOLDINGS LLC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
CHARTWELL MOLECULAR HOLDINGS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
CHARTWELL MOLECULES LLC,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CHARTWELL MOLECULES LLC,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CHARTWELL MOLECULES LLC,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
CHARTWELL MOLECULES LLC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
CHARTWELL MOLECULES LLC,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CHARTWELL MOLECULES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
CHARTWELL MOLECULES LLC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
CHARTWELL MOLECULES LLC,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CHARTWELL MOLECULES LLC,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CHARTWELL MOLECULES LLC,C04 Neoplasms,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
CHARTWELL MOLECULES LLC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
CHARTWELL MOLECULES LLC,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
CHARTWELL MOLECULES LLC,C01 Infections,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
CHARTWELL MOLECULES LLC,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
CHARTWELL MOLECULES LLC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
CHARTWELL MOLECULES LLC,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
CHARTWELL MOLECULES LLC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
CHARTWELL MOLECULES LLC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
CHARTWELL MOLECULES LLC,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
CHARTWELL MOLECULES LLC,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CHARTWELL MOLECULES LLC,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CHARTWELL MOLECULES LLC,C05 Musculoskeletal Diseases,NABUMETONE,228.29,3.22,2,2,0,4,26.3,,
CHARTWELL MOLECULES LLC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
CHARTWELL MOLECULES LLC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
CHARTWELL MOLECULES LLC,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
CHARTWELL MOLECULES LLC,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
CHARTWELL MOLECULES LLC,C25 Chemically-Induced Disorders,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
CHARTWELL MOLECULES LLC,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
CHARTWELL MOLECULES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
CHARTWELL RX SCIENCES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
CHARTWELL RX SCIENCES LLC,F03 Mental Disorders,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
CHARTWELL RX SCIENCES LLC,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
CHARTWELL RX SCIENCES LLC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
CHARTWELL RX SCIENCES LLC,C01 Infections,GRISEOFULVIN,352.77,2.17,1,6,0,3,71.06,,
CHARTWELL RX SCIENCES LLC,C14 Cardiovascular Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
CHARTWELL RX SCIENCES LLC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
CHARTWELL RX SCIENCES LLC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
CHARTWELL RX SCIENCES LLC,C10 Nervous System Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
CHARTWELL RX SCIENCES LLC,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
CHARTWELL RX SCIENCES LLC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
CHARTWELL RX SCIENCES LLC,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,C14 Cardiovascular Diseases,MOEXIPRIL HYDROCHLORIDE,498.58,1.5,2,7,2,11,114.4,5.2,3.46
CHARTWELL RX SCIENCES LLC,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
CHARTWELL RX SCIENCES LLC,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,C10 Nervous System Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CHARTWELL RX SCIENCES LLC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CHARTWELL RX SCIENCES LLC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
CHARTWELL RX SCIENCES LLC,C11 Eye Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CHARTWELL RX SCIENCES LLC,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
CHARTWELL RX SCIENCES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
CHARTWELL RX SCIENCES LLC,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,"C23 Pathological Conditions, Signs and Symptoms",CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
CHARTWELL RX SCIENCES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,C08 Respiratory Tract Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CHARTWELL RX SCIENCES LLC,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
CHARTWELL RX SCIENCES LLC,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
CHARTWELL RX SCIENCES LLC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
CHARTWELL RX SCIENCES LLC,C01 Infections,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CHEMO RESEARCH SL,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
CHEMO RESEARCH SL,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
CHEMO RESEARCH SL,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
CHEMO RESEARCH SL,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
CHEMO RESEARCH SL,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
CHEMO RESEARCH SL,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
CHEMO RESEARCH SL,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
CHEMO RESEARCH SL,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
CHEMO RESEARCH SL,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
CIPHER PHARMACEUTICALS INC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPHER PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPHER PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPHER PHARMACEUTICALS INC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPHER PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPHER PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
CIPHER PHARMACEUTICALS INC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPHER PHARMACEUTICALS INC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPHER PHARMACEUTICALS INC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPHER PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
CIPHER PHARMACEUTICALS INC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPHER PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
CIPLA LTD,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
CIPLA LTD,F01 Behavior and Behavior Mechanisms,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
CIPLA LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
CIPLA LTD,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
CIPLA LTD,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
CIPLA LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
CIPLA LTD,C10 Nervous System Diseases,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
CIPLA LTD,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
CIPLA LTD,F03 Mental Disorders,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
CIPLA LTD,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
CIPLA LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
CIPLA LTD,C01 Infections,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
CIPLA LTD,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
CIPLA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
CIPLA LTD,C11 Eye Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
CIPLA LTD,C18 Nutritional and Metabolic Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
CIPLA LTD,C08 Respiratory Tract Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
CIPLA LTD,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
CIPLA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
CIPLA LTD,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
CIPLA LTD,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,C12 Male Urogenital Diseases,FLUTAMIDE,276.21,3.27,1,3,1,3,72.24,,12.81
CIPLA LTD,C14 Cardiovascular Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
CIPLA LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
CIPLA LTD,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
CIPLA LTD,C01 Infections,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
CIPLA LTD,C05 Musculoskeletal Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
CIPLA LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
CIPLA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
CIPLA LTD,C10 Nervous System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
CIPLA LTD,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
CIPLA LTD,C09 Otorhinolaryngologic Diseases,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
CIPLA LTD,C06 Digestive System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
CIPLA LTD,C01 Infections,TERBINAFINE HYDROCHLORIDE,291.44,5.53,2,1,0,4,3.24,8.86,
CIPLA LTD,C04 Neoplasms,FLUTAMIDE,276.21,3.27,1,3,1,3,72.24,,12.81
CIPLA LTD,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
CIPLA LTD,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
CIPLA LTD,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
CIPLA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
CIPLA LTD,C14 Cardiovascular Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
CIPLA LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CIPLA LTD,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
CIPLA LTD,C15 Hemic and Lymphatic Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
CIPLA LTD,C12 Male Urogenital Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C08 Respiratory Tract Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
CIPLA LTD,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
CIPLA LTD,C20 Immune System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,C08 Respiratory Tract Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C17 Skin and Connective Tissue Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
CIPLA LTD,G08 Reproductive and Urinary Physiological Phenomena,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
CIPLA LTD,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
CIPLA LTD,C14 Cardiovascular Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
CIPLA LTD,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
CIPLA LTD,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
CIPLA LTD,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
CIPLA LTD,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
CIPLA LTD,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
CIPLA LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
CIPLA LTD,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
CIPLA LTD,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
CIPLA LTD,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
CIPLA LTD,C11 Eye Diseases,VALGANCICLOVIR HYDROCHLORIDE,354.37,-1.21,2,10,4,8,171.37,7.48,10.16
CIPLA LTD,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
CIPLA LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
CIPLA LTD,C01 Infections,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
CIPLA LTD,C04 Neoplasms,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
CIPLA LTD,C18 Nutritional and Metabolic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C15 Hemic and Lymphatic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,C05 Musculoskeletal Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C07 Stomatognathic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
CIPLA LTD,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
CIPLA LTD,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
CIPLA LTD,C06 Digestive System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
CIPLA LTD,"C23 Pathological Conditions, Signs and Symptoms",CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,C10 Nervous System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
CIPLA LTD,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,C18 Nutritional and Metabolic Diseases,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
CIPLA LTD,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
CIPLA LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
CIPLA LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
CIPLA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C04 Neoplasms,EXEMESTANE,296.41,3.87,0,2,0,0,34.14,,
CIPLA LTD,C01 Infections,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
CIPLA LTD,C17 Skin and Connective Tissue Diseases,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
CIPLA LTD,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
CIPLA LTD,C01 Infections,GRISEOFULVIN,352.77,2.17,1,6,0,3,71.06,,
CIPLA LTD,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
CIPLA LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C18 Nutritional and Metabolic Diseases,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
CIPLA LTD,C01 Infections,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
CIPLA LTD,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,C04 Neoplasms,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
CIPLA LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
CIPLA LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
CIPLA LTD,C01 Infections,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
CIPLA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
CIPLA LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
CIPLA LTD,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CIPLA LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
CIPLA LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
CIPLA LTD,C01 Infections,ATAZANAVIR SULFATE,704.87,4.54,3,9,5,14,171.22,4.42,11.92
CIPLA LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
CIPLA LTD,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
CIPLA LTD,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
CIPLA LTD,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
CIPLA LTD,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
CIPLA LTD,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
CIPLA LTD,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
CIPLA LTD,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CIPLA LTD,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
CIPLA LTD,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
CIPLA LTD,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CIPLA LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
CIPLA LTD,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
CIPLA LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
CIPLA LTD,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
CIPLA LTD,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
CIPLA LTD,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
CIPLA LTD,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
CIPLA LTD,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
CIPLA LTD,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
CIPLA LTD,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
CIPLA LTD,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
CIPLA LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CIPLA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
CIPLA LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
CIPLA LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CIPLA LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
CIPLA LTD,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
CIPLA LTD,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
CIPLA LTD,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
CIPLA LTD,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
COEPTIS PHARMACEUTICALS INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
COEPTIS PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
COEPTIS PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
COEPTIS PHARMACEUTICALS INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
COEPTIS PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
CONCORD BIOTECH LTD,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORD BIOTECH LTD,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
CONCORDIA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
CONCORDIA PHARMACEUTICALS INC,C04 Neoplasms,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
CONCORDIA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
CONCORDIA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CONCORDIA PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CONCORDIA PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
CONCORDIA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ALFUZOSIN HYDROCHLORIDE,389.46,1.19,2,8,2,8,111.83,7.3,
CONCORDIA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CONCORDIA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
CONCORDIA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
CONCORDIA PHARMACEUTICALS INC,C11 Eye Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CONCORDIA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
CONCORDIA PHARMACEUTICALS INC,C01 Infections,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CONCORDIA PHARMACEUTICALS INC,C10 Nervous System Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
CONCORDIA PHARMACEUTICALS INC,C04 Neoplasms,NILUTAMIDE,317.22,2.25,1,4,1,2,92.55,,
CONCORDIA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
CONCORDIA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
CONCORDIA PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CONCORDIA PHARMACEUTICALS INC,C10 Nervous System Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CONCORDIA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
CONCORDIA PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CONCORDIA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
CONCORDIA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,F03 Mental Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CONCORDIA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CONCORDIA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
CONCORDIA PHARMACEUTICALS INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
CONCORDIA PHARMACEUTICALS INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
CONCORDIA PHARMACEUTICALS INC,C01 Infections,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
CONCORDIA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
CONTRACT PHARMACAL CORP,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
CONTRACT PHARMACAL CORP,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
CONTRACT PHARMACAL CORP,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
CONTRACT PHARMACAL CORP,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
CONTRACT PHARMACAL CORP,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
CONTRACT PHARMACAL CORP,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
CONTRACT PHARMACAL CORP,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
CONTRACT PHARMACAL CORP,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
CONTRACT PHARMACAL CORP,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
CONTRACT PHARMACAL CORP,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
COUNTY LINE PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
COUNTY LINE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
COUNTY LINE PHARMACEUTICALS LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
COUNTY LINE PHARMACEUTICALS LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
COUNTY LINE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
COUNTY LINE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
COUNTY LINE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
COUNTY LINE PHARMACEUTICALS LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
COUNTY LINE PHARMACEUTICALS LLC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
COUNTY LINE PHARMACEUTICALS LLC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
COUNTY LINE PHARMACEUTICALS LLC,C10 Nervous System Diseases,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
COUNTY LINE PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
COUNTY LINE PHARMACEUTICALS LLC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
COUNTY LINE PHARMACEUTICALS LLC,C01 Infections,METHENAMINE HIPPURATE,140.19,0.39,0,4,0,0,12.96,5.88,
COUNTY LINE PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COUNTY LINE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
COVIS PHARMA BV,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
COVIS PHARMA BV,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,C04 Neoplasms,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
COVIS PHARMA BV,C06 Digestive System Diseases,OMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
COVIS PHARMA BV,C10 Nervous System Diseases,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
COVIS PHARMA BV,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,C14 Cardiovascular Diseases,SOTALOL HYDROCHLORIDE,272.37,-0.4,1,4,3,6,78.43,9.43,10.07
COVIS PHARMA BV,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,F03 Mental Disorders,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
COVIS PHARMA BV,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
COVIS PHARMA BV,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
COVIS PHARMA BV,C14 Cardiovascular Diseases,NISOLDIPINE,388.42,3.06,1,7,1,6,107.77,,
COVIS PHARMA BV,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
CROSSMEDIKA SA,C12 Male Urogenital Diseases,VARDENAFIL HYDROCHLORIDE,488.61,1.43,3,8,1,8,112.9,6.21,11.75
CSPC OUYI PHARMACEUTICAL CO LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
CSPC OUYI PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
CSPC OUYI PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CSPC OUYI PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
CSPC OUYI PHARMACEUTICAL CO LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
CSPC OUYI PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
CSPC OUYI PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CSPC OUYI PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
CSPC OUYI PHARMACEUTICAL CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
CSPC OUYI PHARMACEUTICAL CO LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CSPC OUYI PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CSPC OUYI PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
CSPC OUYI PHARMACEUTICAL CO LTD,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CSPC OUYI PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
CSPC OUYI PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
CSPC OUYI PHARMACEUTICAL CO LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CSPC OUYI PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CSPC OUYI PHARMACEUTICAL CO LTD,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CSPC OUYI PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
CSPC OUYI PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CSPC OUYI PHARMACEUTICAL CO LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CSPC OUYI PHARMACEUTICAL CO LTD,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
CSPC OUYI PHARMACEUTICAL CO LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CSPC OUYI PHARMACEUTICAL CO LTD,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CSPC OUYI PHARMACEUTICAL CO LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
CSPC OUYI PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
CSPC OUYI PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
CSPC OUYI PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CSPC OUYI PHARMACEUTICAL CO LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
CSPC OUYI PHARMACEUTICAL CO LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
CSPC OUYI PHARMACEUTICAL CO LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
CSPC OUYI PHARMACEUTICAL CO LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
CSPC OUYI PHARMACEUTICAL CO LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
CSPC OUYI PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
CSPC OUYI PHARMACEUTICAL CO LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
CSPC OUYI PHARMACEUTICAL CO LTD,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
CSPC OUYI PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
CUMBERLAND PHARMACEUTICALS INC,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CUMBERLAND PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
CUMBERLAND PHARMACEUTICALS INC,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
CUMBERLAND PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CUMBERLAND PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CUMBERLAND PHARMACEUTICALS INC,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
CUMBERLAND PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
CUMBERLAND PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
CUMBERLAND PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
CUMBERLAND PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CUMBERLAND PHARMACEUTICALS INC,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
CUMBERLAND PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
CUMBERLAND PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
CUMBERLAND PHARMACEUTICALS INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
CUMBERLAND PHARMACEUTICALS INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CUMBERLAND PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CUMBERLAND PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
CUMBERLAND PHARMACEUTICALS INC,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CUMBERLAND PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
CUMBERLAND PHARMACEUTICALS INC,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CUMBERLAND PHARMACEUTICALS INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
CUMBERLAND PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CUMBERLAND PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
CUMBERLAND PHARMACEUTICALS INC,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
CYCLE PHARMACEUTICALS LTD,C11 Eye Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
CYCLE PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
CYCLE PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
CYCLE PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
CYCLE PHARMACEUTICALS LTD,C10 Nervous System Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
CYCLE PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
CYCLE PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
CYCLE PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
DAIICHI SANKYO INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAIICHI SANKYO INC,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
DAIICHI SANKYO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DAIICHI SANKYO INC,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
DAIICHI SANKYO INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DAIICHI SANKYO INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DAIICHI SANKYO INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DAIICHI SANKYO INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAIICHI SANKYO INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAIICHI SANKYO INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAIICHI SANKYO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAIICHI SANKYO INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DAIICHI SANKYO INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAIICHI SANKYO INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DAIICHI SANKYO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DAIICHI SANKYO INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DAIICHI SANKYO INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DAIICHI SANKYO INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DAIICHI SANKYO INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAIICHI SANKYO INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DAIICHI SANKYO INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAIICHI SANKYO INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DAVA PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
DAVA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
DAVA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAVA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
DAVA PHARMACEUTICALS INC,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
DAVA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
DAVA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
DAVA PHARMACEUTICALS INC,C01 Infections,PYRAZINAMIDE,123.11,-1.23,1,3,1,1,68.87,,13.06
DAVA PHARMACEUTICALS INC,C11 Eye Diseases,PROPYLTHIOURACIL,170.24,1.2,1,2,2,2,48.65,,8.09
DAVA PHARMACEUTICALS INC,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAVA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAVA PHARMACEUTICALS INC,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
DAVA PHARMACEUTICALS INC,C10 Nervous System Diseases,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
DAVA PHARMACEUTICALS INC,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,AMPICILLIN,349.41,-2,1,5,3,4,112.73,7.23,3.24
DAVA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,C19 Endocrine System Diseases,PROPYLTHIOURACIL,170.24,1.2,1,2,2,2,48.65,,8.09
DAVA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAVA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAVA PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAVA PHARMACEUTICALS INC,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAVA PHARMACEUTICALS INC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
DAVA PHARMACEUTICALS INC,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
DAVA PHARMACEUTICALS INC,C01 Infections,AMPICILLIN,349.41,-2,1,5,3,4,112.73,7.23,3.24
DAVA PHARMACEUTICALS INC,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
DAVA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
DAVA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
DAVA PHARMACEUTICALS INC,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
DAVA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
DAVA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
DAVA PHARMACEUTICALS INC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
DAVA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
DAVA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
DEXCEL LTD,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
DEXCEL LTD,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
DEXCEL LTD,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
DEXCEL PHARMA TECHNOLOGIES LTD,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DEXCEL PHARMA TECHNOLOGIES LTD,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DEXCEL PHARMA TECHNOLOGIES LTD,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DEXCEL PHARMA TECHNOLOGIES LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
DEXCEL PHARMA TECHNOLOGIES LTD,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DEXCEL PHARMA TECHNOLOGIES LTD,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
DEXCEL PHARMA TECHNOLOGIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DEXCEL PHARMA TECHNOLOGIES LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DEXCEL PHARMA TECHNOLOGIES LTD,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DEXCEL PHARMA TECHNOLOGIES LTD,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DEXCEL PHARMA TECHNOLOGIES LTD,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DEXCEL PHARMA TECHNOLOGIES LTD,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DEXCEL PHARMA TECHNOLOGIES LTD,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DEXCEL PHARMA TECHNOLOGIES LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DEXCEL PHARMA TECHNOLOGIES LTD,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
DEXCEL PHARMA TECHNOLOGIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DEXCEL PHARMA TECHNOLOGIES LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DOCTOR REDDYS LABORATORIES LTD,C11 Eye Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DOCTOR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
DOCTOR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
DOCTOR REDDYS LABORATORIES LTD,C01 Infections,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DOCTOR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DOCTOR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DOCTOR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
DOCTOR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
DOCTOR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DOCTOR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
DOCTOR REDDYS LABORATORIES LTD,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
DOCTOR REDDYS LABORATORIES LTD,C20 Immune System Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DOCTOR REDDYS LABORATORIES LTD,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
DOCTOR REDDYS LABORATORIES LTD,C04 Neoplasms,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DR REDDYS LABORATORIES INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
DR REDDYS LABORATORIES INC,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
DR REDDYS LABORATORIES INC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
DR REDDYS LABORATORIES INC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
DR REDDYS LABORATORIES INC,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
DR REDDYS LABORATORIES INC,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,SUMATRIPTAN SUCCINATE,295.41,0.74,2,3,2,6,65.2,9.54,11.24
DR REDDYS LABORATORIES INC,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
DR REDDYS LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
DR REDDYS LABORATORIES INC,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
DR REDDYS LABORATORIES INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
DR REDDYS LABORATORIES INC,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
DR REDDYS LABORATORIES INC,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES INC,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
DR REDDYS LABORATORIES INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
DR REDDYS LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C14 Cardiovascular Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C25 Chemically-Induced Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
DR REDDYS LABORATORIES INC,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
DR REDDYS LABORATORIES INC,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES INC,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES INC,C04 Neoplasms,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES INC,F03 Mental Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES INC,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
DR REDDYS LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES INC,C12 Male Urogenital Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES INC,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
DR REDDYS LABORATORIES INC,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
DR REDDYS LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
DR REDDYS LABORATORIES INC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES INC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
DR REDDYS LABORATORIES INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES INC,C01 Infections,TERBINAFINE HYDROCHLORIDE,291.44,5.53,2,1,0,4,3.24,8.86,
DR REDDYS LABORATORIES INC,C01 Infections,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
DR REDDYS LABORATORIES INC,C26 Wounds and Injuries,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
DR REDDYS LABORATORIES INC,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
DR REDDYS LABORATORIES INC,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
DR REDDYS LABORATORIES INC,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
DR REDDYS LABORATORIES INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
DR REDDYS LABORATORIES INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
DR REDDYS LABORATORIES INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
DR REDDYS LABORATORIES INC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
DR REDDYS LABORATORIES INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
DR REDDYS LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
DR REDDYS LABORATORIES INC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
DR REDDYS LABORATORIES INC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
DR REDDYS LABORATORIES INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
DR REDDYS LABORATORIES INC,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
DR REDDYS LABORATORIES INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
DR REDDYS LABORATORIES INC,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
DR REDDYS LABORATORIES INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
DR REDDYS LABORATORIES INC,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,F03 Mental Disorders,ZIPRASIDONE HYDROCHLORIDE,412.95,4.3,3,5,1,4,48.47,7.09,12.21
DR REDDYS LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
DR REDDYS LABORATORIES INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES INC,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LOUISIANA LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LOUISIANA LLC,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LOUISIANA LLC,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DR REDDYS LABORATORIES LTD,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES LTD,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
DR REDDYS LABORATORIES LTD,C20 Immune System Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,TETRABENAZINE,317.43,3.4,1,4,0,4,38.77,7.33,
DR REDDYS LABORATORIES LTD,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
DR REDDYS LABORATORIES LTD,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DR REDDYS LABORATORIES LTD,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
DR REDDYS LABORATORIES LTD,C01 Infections,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
DR REDDYS LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,SEVELAMER CARBONATE,149.62,,,,,,,,
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
DR REDDYS LABORATORIES LTD,C01 Infections,SEVELAMER CARBONATE,149.62,,,,,,,,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,VALGANCICLOVIR HYDROCHLORIDE,354.37,-1.21,2,10,4,8,171.37,7.48,10.16
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
DR REDDYS LABORATORIES LTD,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES LTD,C04 Neoplasms,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DR REDDYS LABORATORIES LTD,C01 Infections,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
DR REDDYS LABORATORIES LTD,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
DR REDDYS LABORATORIES LTD,C01 Infections,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
DR REDDYS LABORATORIES LTD,C09 Otorhinolaryngologic Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
DR REDDYS LABORATORIES LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
DR REDDYS LABORATORIES LTD,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C01 Infections,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
DR REDDYS LABORATORIES LTD,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
DR REDDYS LABORATORIES LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C01 Infections,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
DR REDDYS LABORATORIES LTD,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
DR REDDYS LABORATORIES LTD,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
DR REDDYS LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,TRIENTINE HYDROCHLORIDE,146.24,-2.15,0,4,4,7,76.1,9.77,
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
DR REDDYS LABORATORIES LTD,C20 Immune System Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE SULFATE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,ZAFIRLUKAST,575.69,6.4,4,7,2,8,115.73,,4.29
DR REDDYS LABORATORIES LTD,C04 Neoplasms,ZAFIRLUKAST,575.69,6.4,4,7,2,8,115.73,,4.29
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
DR REDDYS LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
DR REDDYS LABORATORIES LTD,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
DR REDDYS LABORATORIES LTD,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
DR REDDYS LABORATORIES LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
DR REDDYS LABORATORIES LTD,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
DR REDDYS LABORATORIES LTD,C04 Neoplasms,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,DIPHENHYDRAMINE CITRATE,255.36,3.65,2,2,0,6,12.47,8.87,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,DIPHENHYDRAMINE CITRATE,255.36,3.65,2,2,0,6,12.47,8.87,
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
DR REDDYS LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
DR REDDYS LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
DR REDDYS LABORATORIES LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
DR REDDYS LABORATORIES LTD,C19 Endocrine System Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
DR REDDYS LABORATORIES LTD,C01 Infections,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
DR REDDYS LABORATORIES LTD,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DR REDDYS LABORATORIES LTD,C04 Neoplasms,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
DR REDDYS LABORATORIES LTD,C09 Otorhinolaryngologic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
DR REDDYS LABORATORIES LTD,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
DR REDDYS LABORATORIES LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
DR REDDYS LABORATORIES LTD,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
DR REDDYS LABORATORIES LTD,C01 Infections,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
DR REDDYS LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
DR REDDYS LABORATORIES LTD,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,OXAPROZIN,293.32,3.46,3,3,1,5,63.33,,4.95
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
DR REDDYS LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
DR REDDYS LABORATORIES LTD,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
DR REDDYS LABORATORIES LTD,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C01 Infections,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
DR REDDYS LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
DR REDDYS LABORATORIES LTD,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
DR REDDYS LABORATORIES LTD,G07 Physiological Phenomena,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,NATEGLINIDE,317.43,4.03,1,2,2,6,66.4,,4
DR REDDYS LABORATORIES LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
DR REDDYS LABORATORIES LTD,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
DR REDDYS LABORATORIES LTD,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
DR REDDYS LABORATORIES LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
DR REDDYS LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
DR REDDYS LABORATORIES LTD,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C04 Neoplasms,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,OMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
DR REDDYS LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
DR REDDYS LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
DR REDDYS LABORATORIES LTD,C25 Chemically-Induced Disorders,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
DR REDDYS LABORATORIES LTD,C11 Eye Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
DR REDDYS LABORATORIES LTD,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
DR REDDYS LABORATORIES LTD,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
DR REDDYS LABORATORIES LTD,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
DR REDDYS LABORATORIES LTD,C04 Neoplasms,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
DR REDDYS LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
DR REDDYS LABORATORIES LTD,C06 Digestive System Diseases,NIZATIDINE,331.47,0.77,1,8,2,10,83.33,6.54,
DR REDDYS LABORATORIES LTD,C20 Immune System Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
DR REDDYS LABORATORIES LTD,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
DR REDDYS LABORATORIES LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES LTD,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES LTD,C10 Nervous System Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
DR REDDYS LABORATORIES LTD,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
DR REDDYS LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
DR REDDYS LABORATORIES SA,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
DR REDDYS LABORATORIES SA,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
DR REDDYS LABORATORIES SA,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
DR REDDYS LABORATORIES SA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
DR REDDYS LABORATORIES SA,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
DR REDDYS LABORATORIES SA,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
DR REDDYS LABORATORIES SA,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
DR REDDYS LABORATORIES SA,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C26 Wounds and Injuries,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
DR REDDYS LABORATORIES SA,F03 Mental Disorders,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
DR REDDYS LABORATORIES SA,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C25 Chemically-Induced Disorders,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
DR REDDYS LABORATORIES SA,C10 Nervous System Diseases,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
DR REDDYS LABORATORIES SA,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C04 Neoplasms,MERCAPTOPURINE,152.18,0.35,2,4,2,0,54.46,2.19,7.51
DR REDDYS LABORATORIES SA,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C06 Digestive System Diseases,MERCAPTOPURINE,152.18,0.35,2,4,2,0,54.46,2.19,7.51
DR REDDYS LABORATORIES SA,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C08 Respiratory Tract Diseases,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
DR REDDYS LABORATORIES SA,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
DR REDDYS LABORATORIES SA,C08 Respiratory Tract Diseases,MERCAPTOPURINE,152.18,0.35,2,4,2,0,54.46,2.19,7.51
DR REDDYS LABORATORIES SA,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DR REDDYS LABORATORIES SA,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C04 Neoplasms,NORGESTREL,312.45,3.66,0,2,1,1,37.3,,
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
ECI PHARMACEUTICALS LLC,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ECI PHARMACEUTICALS LLC,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ECI PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
ECI PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ECI PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ECI PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ECI PHARMACEUTICALS LLC,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ECI PHARMACEUTICALS LLC,C04 Neoplasms,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
ECI PHARMACEUTICALS LLC,C11 Eye Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
ECI PHARMACEUTICALS LLC,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ECI PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
ECI PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ECI PHARMACEUTICALS LLC,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
ECI PHARMACEUTICALS LLC,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ECI PHARMACEUTICALS LLC,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ECI PHARMACEUTICALS LLC,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ECI PHARMACEUTICALS LLC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ECI PHARMACEUTICALS LLC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ECI PHARMACEUTICALS LLC,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ECI PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ECI PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ECI PHARMACEUTICALS LLC,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
ECI PHARMACEUTICALS LLC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ECR PHARMACEUTICALS,C26 Wounds and Injuries,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C04 Neoplasms,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C14 Cardiovascular Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C19 Endocrine System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C12 Male Urogenital Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C01 Infections,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C05 Musculoskeletal Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C11 Eye Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C10 Nervous System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C06 Digestive System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C08 Respiratory Tract Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C20 Immune System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C07 Stomatognathic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
ECR PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
EDENBRIDGE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
EDENBRIDGE PHARMACEUTICALS LLC,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
EDENBRIDGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
EDENBRIDGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
EDENBRIDGE PHARMACEUTICALS LLC,C04 Neoplasms,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
EDENBRIDGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
EDENBRIDGE PHARMACEUTICALS LLC,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
EDENBRIDGE PHARMACEUTICALS LLC,C01 Infections,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
EDENBRIDGE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
EDENBRIDGE PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
EDENBRIDGE PHARMACEUTICALS LLC,C01 Infections,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
EDENBRIDGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
EDENBRIDGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
EDENBRIDGE PHARMACEUTICALS LLC,C04 Neoplasms,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
EDENBRIDGE PHARMACEUTICALS LLC,C26 Wounds and Injuries,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
EDENBRIDGE PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",IVERMECTIN,1736.18,,,,,,,,
EDENBRIDGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
EDENBRIDGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,IVERMECTIN,1736.18,,,,,,,,
EDENBRIDGE PHARMACEUTICALS LLC,C11 Eye Diseases,IVERMECTIN,1736.18,,,,,,,,
EDENBRIDGE PHARMACEUTICALS LLC,C01 Infections,IVERMECTIN,1736.18,,,,,,,,
EDENBRIDGE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
EDENBRIDGE PHARMACEUTICALS LLC,C11 Eye Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
EDENBRIDGE PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,IVERMECTIN,1736.18,,,,,,,,
EDENBRIDGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
EDENBRIDGE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
EDENBRIDGE PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
EDENBRIDGE PHARMACEUTICALS LLC,C04 Neoplasms,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
EDENBRIDGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
EDENBRIDGE PHARMACEUTICALS LLC,C11 Eye Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
EDENBRIDGE PHARMACEUTICALS LLC,C01 Infections,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
EDENBRIDGE PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
EGALET US INC,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EGALET US INC,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EGALET US INC,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
EGALET US INC,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
EGALET US INC,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
EGALET US INC,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
EGALET US INC,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
EGALET US INC,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
EGALET US INC,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EGALET US INC,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EGALET US INC,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EGALET US INC,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EGALET US INC,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EGALET US INC,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EGALET US INC,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EGALET US INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
EISAI INC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
EISAI INC,C25 Chemically-Induced Disorders,PERAMPANEL,349.39,4.11,4,4,0,3,58.68,4.01,
EISAI INC,C10 Nervous System Diseases,PERAMPANEL,349.39,4.11,4,4,0,3,58.68,4.01,
EISAI INC,F03 Mental Disorders,PERAMPANEL,349.39,4.11,4,4,0,3,58.68,4.01,
EISAI INC,"C23 Pathological Conditions, Signs and Symptoms",RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
EISAI INC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
EISAI INC,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
EISAI INC,C10 Nervous System Diseases,RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
EISAI INC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
EISAI INC,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
EISAI INC,F01 Behavior and Behavior Mechanisms,LORCASERIN HYDROCHLORIDE,195.69,2.83,1,1,1,0,12.03,10.12,
EISAI INC,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
EISAI INC,C18 Nutritional and Metabolic Diseases,LORCASERIN HYDROCHLORIDE,195.69,2.83,1,1,1,0,12.03,10.12,
ELI LILLY AND CO,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ELI LILLY AND CO,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
ELI LILLY AND CO,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ELI LILLY AND CO,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,C14 Cardiovascular Diseases,PRASUGREL HYDROCHLORIDE,373.45,4.31,2,5,0,5,46.61,5.12,
ELI LILLY AND CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ELI LILLY AND CO,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ELI LILLY AND CO,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ELI LILLY AND CO,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ELI LILLY AND CO,C04 Neoplasms,RALOXIFENE HYDROCHLORIDE,473.59,5.69,4,6,2,7,70,7.95,8.89
ELI LILLY AND CO,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ELI LILLY AND CO,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ELI LILLY AND CO,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ELI LILLY AND CO,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ELI LILLY AND CO,C10 Nervous System Diseases,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
ELI LILLY AND CO,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,C25 Chemically-Induced Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
ELI LILLY AND CO,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ELI LILLY AND CO,F03 Mental Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
ELI LILLY AND CO,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ELI LILLY AND CO,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY AND CO,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ELI LILLY CO,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELI LILLY CO,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ELITE LABORATORIES INC,C25 Chemically-Induced Disorders,ISRADIPINE,371.39,2,2,8,1,4,103.55,,
ELITE LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C10 Nervous System Diseases,ISRADIPINE,371.39,2,2,8,1,4,103.55,,
ELITE LABORATORIES INC,C14 Cardiovascular Diseases,ISRADIPINE,371.39,2,2,8,1,4,103.55,,
ELITE LABORATORIES INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C25 Chemically-Induced Disorders,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
ELITE LABORATORIES INC,C05 Musculoskeletal Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
ELITE LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C06 Digestive System Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
ELITE LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
ELITE LABORATORIES INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,F03 Mental Disorders,ISRADIPINE,371.39,2,2,8,1,4,103.55,,
ELITE LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
ELITE LABORATORIES INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C26 Wounds and Injuries,DANTROLENE SODIUM,314.26,1.26,2,6,1,4,118.05,,8.23
ELITE LABORATORIES INC,C25 Chemically-Induced Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
ELITE LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
ELITE LABORATORIES INC,F03 Mental Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
ELITE LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
ELITE LABORATORIES INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ELITE LABORATORIES INC,C01 Infections,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
ELITE LABORATORIES INC,C05 Musculoskeletal Diseases,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
ELITE LABORATORIES INC,C09 Otorhinolaryngologic Diseases,DANTROLENE SODIUM,314.26,1.26,2,6,1,4,118.05,,8.23
ELITE LABORATORIES INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EMCURE PHARMACEUTICALS LTD,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
EMCURE PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
EMCURE PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
EMCURE PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
EMCURE PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
EMCURE PHARMACEUTICALS LTD,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
EMCURE PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
EMCURE PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
EMCURE PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
EMCURE PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
EMCURE PHARMACEUTICALS LTD,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
EMCURE PHARMACEUTICALS LTD,C06 Digestive System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
EMCURE PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,FOSINOPRIL SODIUM,563.67,5.62,1,6,1,14,110.21,,3.87
EMCURE PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
EMCURE PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
EMCURE PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
EMCURE PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
EMCURE PHARMACEUTICALS LTD,C10 Nervous System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
EMCURE PHARMACEUTICALS LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
EMCURE PHARMACEUTICALS LTD,G07 Physiological Phenomena,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
EMD SERONO INC,C15 Hemic and Lymphatic Diseases,CLADRIBINE,285.69,-0.28,2,8,3,2,119.31,2.22,13.89
EMD SERONO INC,C04 Neoplasms,CLADRIBINE,285.69,-0.28,2,8,3,2,119.31,2.22,13.89
EMD SERONO INC,C10 Nervous System Diseases,CLADRIBINE,285.69,-0.28,2,8,3,2,119.31,2.22,13.89
EMD SERONO INC,C08 Respiratory Tract Diseases,CLADRIBINE,285.69,-0.28,2,8,3,2,119.31,2.22,13.89
EMD SERONO INC,C20 Immune System Diseases,CLADRIBINE,285.69,-0.28,2,8,3,2,119.31,2.22,13.89
EMD SERONO INC,C06 Digestive System Diseases,CLADRIBINE,285.69,-0.28,2,8,3,2,119.31,2.22,13.89
EMMAUS MEDICAL INC,C04 Neoplasms,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C26 Wounds and Injuries,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C15 Hemic and Lymphatic Diseases,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C12 Male Urogenital Diseases,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C05 Musculoskeletal Diseases,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C14 Cardiovascular Diseases,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C07 Stomatognathic Diseases,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C10 Nervous System Diseases,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C06 Digestive System Diseases,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C18 Nutritional and Metabolic Diseases,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,"C23 Pathological Conditions, Signs and Symptoms",GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C17 Skin and Connective Tissue Diseases,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
EMMAUS MEDICAL INC,C01 Infections,GLUTAMINE,146.15,-4,0,3,3,4,106.41,9.31,2.15
ENDO PHARMACEUTICALS INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C04 Neoplasms,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
ENDO PHARMACEUTICALS INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
ENDO PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C10 Nervous System Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
ENDO PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
ENDO PHARMACEUTICALS INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C01 Infections,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
ENDO PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
ENDO PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C11 Eye Diseases,VALGANCICLOVIR HYDROCHLORIDE,354.37,-1.21,2,10,4,8,171.37,7.48,10.16
ENDO PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ENDO PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
ENDO PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
EPIC PHARMA INC,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C14 Cardiovascular Diseases,SOTALOL HYDROCHLORIDE,272.37,-0.4,1,4,3,6,78.43,9.43,10.07
EPIC PHARMA INC,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C14 Cardiovascular Diseases,MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
EPIC PHARMA INC,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
EPIC PHARMA INC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
EPIC PHARMA INC,C14 Cardiovascular Diseases,NICARDIPINE HYDROCHLORIDE,479.53,3.56,2,8,1,9,111.01,8.1,
EPIC PHARMA INC,C10 Nervous System Diseases,NICARDIPINE HYDROCHLORIDE,479.53,3.56,2,8,1,9,111.01,8.1,
EPIC PHARMA LLC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
EPIC PHARMA LLC,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
EPIC PHARMA LLC,C04 Neoplasms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
EPIC PHARMA LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
EPIC PHARMA LLC,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
EPIC PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
EPIC PHARMA LLC,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
EPIC PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C20 Immune System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
EPIC PHARMA LLC,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
EPIC PHARMA LLC,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
EPIC PHARMA LLC,F03 Mental Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
EPIC PHARMA LLC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,C10 Nervous System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
EPIC PHARMA LLC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
EPIC PHARMA LLC,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
EPIC PHARMA LLC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
EPIC PHARMA LLC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C11 Eye Diseases,BETAXOLOL HYDROCHLORIDE,307.43,2.54,1,4,2,11,50.72,9.67,
EPIC PHARMA LLC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
EPIC PHARMA LLC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
EPIC PHARMA LLC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
EPIC PHARMA LLC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
EPIC PHARMA LLC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
EPIC PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
EPIC PHARMA LLC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
EPIC PHARMA LLC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
EPIC PHARMA LLC,C01 Infections,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
EPIC PHARMA LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
EPIC PHARMA LLC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
EPIC PHARMA LLC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
EPIC PHARMA LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C05 Musculoskeletal Diseases,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
EPIC PHARMA LLC,C25 Chemically-Induced Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
EPIC PHARMA LLC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,C26 Wounds and Injuries,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
EPIC PHARMA LLC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
EPIC PHARMA LLC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
EPIC PHARMA LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
EPIC PHARMA LLC,C10 Nervous System Diseases,BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
EPIC PHARMA LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
EPIC PHARMA LLC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
EPIC PHARMA LLC,C14 Cardiovascular Diseases,TRANDOLAPRIL,430.55,1.95,1,5,2,9,95.94,5.21,3.8
EPIC PHARMA LLC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
EPIC PHARMA LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
EPIC PHARMA LLC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
EPIC PHARMA LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
EPIC PHARMA LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
EPIC PHARMA LLC,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
EPIC PHARMA LLC,C05 Musculoskeletal Diseases,SULINDAC,356.42,2.93,2,2,1,4,54.37,,4.09
EPIC PHARMA LLC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
EPIC PHARMA LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
EPIC PHARMA LLC,F01 Behavior and Behavior Mechanisms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
EPIC PHARMA LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
EPIC PHARMA LLC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
EPIC PHARMA LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
EPIC PHARMA LLC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
EPIC PHARMA LLC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
EPIC PHARMA LLC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
EPIC PHARMA LLC,C04 Neoplasms,SULINDAC,356.42,2.93,2,2,1,4,54.37,,4.09
EPIC PHARMA LLC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
EPIC PHARMA LLC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
EPIC PHARMA LLC,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
EPIC PHARMA LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C15 Hemic and Lymphatic Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
EPIC PHARMA LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
EPIC PHARMA LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
EPIC PHARMA LLC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
EPIC PHARMA LLC,C01 Infections,DEMECLOCYCLINE HYDROCHLORIDE,464.86,-3.17,1,9,6,2,181.62,8.54,2.59
EPIC PHARMA LLC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
EPIC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
EPIC PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
EPIC PHARMA LLC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
EPIC PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
EPIC PHARMA LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
ESPERO BIOPHARMA INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ESPERO BIOPHARMA INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
EUGIA PHARMA SPECIALITIES LTD,C26 Wounds and Injuries,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,F03 Mental Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,C01 Infections,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,"C23 Pathological Conditions, Signs and Symptoms",PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,C10 Nervous System Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,C25 Chemically-Induced Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,C12 Male Urogenital Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,C04 Neoplasms,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
EUGIA PHARMA SPECIALITIES LTD,C18 Nutritional and Metabolic Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
EUGIA PHARMA SPECIALITIES LTD,G08 Reproductive and Urinary Physiological Phenomena,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
EUGIA PHARMA SPECIALITIES LTD,C14 Cardiovascular Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
EUGIA PHARMA SPECIALITIES LTD,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
EUGIA PHARMA SPECIALITIES LTD,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
EUGIA PHARMA SPECIALITIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
EUGIA PHARMA SPECIALITIES LTD,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
EUGIA PHARMA SPECIALITIES LTD,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
EXELA HOLDINGS INC,G08 Reproductive and Urinary Physiological Phenomena,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
EXELA HOLDINGS INC,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
EXELA HOLDINGS INC,C18 Nutritional and Metabolic Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
EXELA HOLDINGS INC,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
EXELA HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
EXELA HOLDINGS INC,C13 Female Urogenital Diseases and Pregnancy Complications,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
EXELA HOLDINGS INC,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
EXELA HOLDINGS INC,C04 Neoplasms,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
EXELA HOLDINGS INC,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
EXELA HOLDINGS INC,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
EXELA HOLDINGS INC,C06 Digestive System Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
EXELA HOLDINGS INC,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
EXELA HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
EXELA HOLDINGS INC,C01 Infections,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
EXELA HOLDINGS INC,C05 Musculoskeletal Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
EXELTIS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
EXELTIS USA INC,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
EXELTIS USA INC,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
EXELTIS USA INC,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
EXELTIS USA INC,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
EXELTIS USA INC,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
EYWA PHARMA PTE LTD,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
EYWA PHARMA PTE LTD,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
EYWA PHARMA PTE LTD,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
EYWA PHARMA PTE LTD,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
EYWA PHARMA PTE LTD,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
EYWA PHARMA PTE LTD,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
EYWA PHARMA PTE LTD,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
EYWA PHARMA PTE LTD,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
FERA PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C01 Infections,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C11 Eye Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C19 Endocrine System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C04 Neoplasms,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C26 Wounds and Injuries,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C10 Nervous System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C06 Digestive System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C20 Immune System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERA PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
FERRING PHARMACEUTICALS INC,C01 Infections,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM PICOSULFATE,437.45,-1.52,3,7,2,7,140.09,4.08,-2.49
FERRING PHARMACEUTICALS INC,C04 Neoplasms,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,MAGNESIUM OXIDE,40.3,,,,,,,,
FERRING PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,MAGNESIUM OXIDE,40.3,,,,,,,,
FERRING PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
FERRING PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CITRIC ACID,192.12,-1.32,0,4,4,5,132.13,,3.05
FERRING PHARMACEUTICALS INC,C10 Nervous System Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DESMOPRESSIN ACETATE,1069.24,,,,,,,,
FERRING PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,C11 Eye Diseases,CITRIC ACID,192.12,-1.32,0,4,4,5,132.13,,3.05
FERRING PHARMACEUTICALS INC,C26 Wounds and Injuries,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,C12 Male Urogenital Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
FERRING PHARMACEUTICALS INC,C14 Cardiovascular Diseases,MAGNESIUM OXIDE,40.3,,,,,,,,
FERRING PHARMACEUTICALS INC,C10 Nervous System Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
FERRING PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CITRIC ACID,192.12,-1.32,0,4,4,5,132.13,,3.05
FERRING PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CITRIC ACID,192.12,-1.32,0,4,4,5,132.13,,3.05
FERRING PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FERRING PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,CITRIC ACID,192.12,-1.32,0,4,4,5,132.13,,3.05
FERRING PHARMACEUTICALS INC,C06 Digestive System Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
FLAMINGO PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FLAMINGO PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FLAMINGO PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FLAMINGO PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
FLAMINGO PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FLAMINGO PHARMACEUTICALS LTD,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FLAMINGO PHARMACEUTICALS LTD,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
FLAMINGO PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FLAMINGO PHARMACEUTICALS LTD,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FLAMINGO PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
FLAMINGO PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FLAMINGO PHARMACEUTICALS LTD,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FLAMINGO PHARMACEUTICALS LTD,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
FRESENIUS KABI USA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
FRESENIUS KABI USA LLC,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
FRESENIUS KABI USA LLC,C11 Eye Diseases,"CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
FRESENIUS KABI USA LLC,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
FRESENIUS KABI USA LLC,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
FRESENIUS KABI USA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,"CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
FRESENIUS KABI USA LLC,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
FRESENIUS KABI USA LLC,"C23 Pathological Conditions, Signs and Symptoms","CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
FRESENIUS KABI USA LLC,C06 Digestive System Diseases,"CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
FRESENIUS KABI USA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
FRESENIUS KABI USA LLC,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
FRESENIUS KABI USA LLC,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
FRESENIUS KABI USA LLC,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
FRESENIUS KABI USA LLC,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
FRESENIUS KABI USA LLC,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
FRESENIUS KABI USA LLC,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
FRESENIUS KABI USA LLC,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
FRESENIUS KABI USA LLC,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
FRESENIUS KABI USA LLC,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
FRESENIUS KABI USA LLC,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
G AND W LABORATORIES INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
GALDERMA LABORATORIES LP,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALDERMA LABORATORIES LP,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
GALT PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ORPHENADRINE CITRATE,269.39,4.17,2,2,0,6,12.47,8.87,
GALT PHARMACEUTICALS LLC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GALT PHARMACEUTICALS LLC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GALT PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GD SEARLE LLC,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
GD SEARLE LLC,C05 Musculoskeletal Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
GD SEARLE LLC,C01 Infections,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
GD SEARLE LLC,C13 Female Urogenital Diseases and Pregnancy Complications,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
GD SEARLE LLC,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
GD SEARLE LLC,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
GD SEARLE LLC,C06 Digestive System Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
GD SEARLE LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GD SEARLE LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GD SEARLE LLC,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
GD SEARLE LLC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
GD SEARLE LLC,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
GD SEARLE LLC,"C23 Pathological Conditions, Signs and Symptoms",MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
GD SEARLE LLC,C08 Respiratory Tract Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
GD SEARLE LLC,C14 Cardiovascular Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
GD SEARLE LLC,C04 Neoplasms,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
GD SEARLE LLC,C19 Endocrine System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
GD SEARLE LLC,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
GD SEARLE LLC,C06 Digestive System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
GD SEARLE LLC,C12 Male Urogenital Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
GD SEARLE LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GD SEARLE LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GD SEARLE LLC,G08 Reproductive and Urinary Physiological Phenomena,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
GD SEARLE LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GD SEARLE LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GD SEARLE LLC,C18 Nutritional and Metabolic Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
GD SEARLE LLC,C11 Eye Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
GD SEARLE LLC,C17 Skin and Connective Tissue Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
GD SEARLE LLC,C04 Neoplasms,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
GD SEARLE LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GD SEARLE LLC,C14 Cardiovascular Diseases,DISOPYRAMIDE PHOSPHATE,339.48,3.47,2,3,1,8,59.22,10.42,
GD SEARLE LLC,C05 Musculoskeletal Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
GD SEARLE LLC,C10 Nervous System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
GD SEARLE LLC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,C08 Respiratory Tract Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
GD SEARLE LLC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,C11 Eye Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
GD SEARLE LLC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,C06 Digestive System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
GD SEARLE LLC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
GD SEARLE LLC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,"C23 Pathological Conditions, Signs and Symptoms",ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
GD SEARLE LLC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,C05 Musculoskeletal Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
GD SEARLE LLC,C04 Neoplasms,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
GD SEARLE LLC,C14 Cardiovascular Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
GD SEARLE LLC,C18 Nutritional and Metabolic Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
GD SEARLE LLC,C05 Musculoskeletal Diseases,OXAPROZIN,293.32,3.46,3,3,1,5,63.33,,4.95
GD SEARLE LLC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
GD SEARLE LLC,C12 Male Urogenital Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
GD SEARLE LLC,C11 Eye Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
GD SEARLE LLC,C19 Endocrine System Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
GE HEALTHCARE,C01 Infections,IOHEXOL,821.14,-1.95,1,9,8,12,199.89,,11.73
GE HEALTHCARE,C12 Male Urogenital Diseases,IOHEXOL,821.14,-1.95,1,9,8,12,199.89,,11.73
GENBIOPRO INC,G08 Reproductive and Urinary Physiological Phenomena,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENBIOPRO INC,F01 Behavior and Behavior Mechanisms,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENBIOPRO INC,C04 Neoplasms,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENBIOPRO INC,F03 Mental Disorders,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENBIOPRO INC,C19 Endocrine System Diseases,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENBIOPRO INC,C01 Infections,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENBIOPRO INC,C11 Eye Diseases,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENBIOPRO INC,C10 Nervous System Diseases,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENBIOPRO INC,C25 Chemically-Induced Disorders,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENBIOPRO INC,C13 Female Urogenital Diseases and Pregnancy Complications,MIFEPRISTONE,429.6,5.13,1,3,1,2,40.54,4.89,12.87
GENUS LIFE SCIENCES INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GENUS LIFE SCIENCES INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFE SCIENCES INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GENUS LIFESCIENCES INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
GENUS LIFESCIENCES INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
GENUS LIFESCIENCES INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
GENUS LIFESCIENCES INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
GENUS LIFESCIENCES INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
GENUS LIFESCIENCES INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GENUS LIFESCIENCES INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
GENUS LIFESCIENCES INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GILEAD SCIENCES INC,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
GILEAD SCIENCES INC,C01 Infections,RILPIVIRINE HYDROCHLORIDE,366.43,5.47,3,6,2,5,97.42,4.44,11.43
GILEAD SCIENCES INC,C14 Cardiovascular Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
GILEAD SCIENCES INC,C06 Digestive System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GILEAD SCIENCES INC,C08 Respiratory Tract Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GILEAD SCIENCES INC,C08 Respiratory Tract Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
GILEAD SCIENCES INC,C18 Nutritional and Metabolic Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GILEAD SCIENCES INC,C05 Musculoskeletal Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GILEAD SCIENCES INC,C18 Nutritional and Metabolic Diseases,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
GILEAD SCIENCES INC,C15 Hemic and Lymphatic Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
GILEAD SCIENCES INC,C01 Infections,COBICISTAT,776.04,4.99,4,10,3,19,138.02,6.69,
GILEAD SCIENCES INC,C18 Nutritional and Metabolic Diseases,COBICISTAT,776.04,4.99,4,10,3,19,138.02,6.69,
GILEAD SCIENCES INC,C10 Nervous System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GILEAD SCIENCES INC,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
GILEAD SCIENCES INC,C01 Infections,ELVITEGRAVIR,447.89,4.67,3,5,2,7,88.76,,5.97
GILEAD SCIENCES INC,C18 Nutritional and Metabolic Diseases,ELVITEGRAVIR,447.89,4.67,3,5,2,7,88.76,,5.97
GILEAD SCIENCES INC,C01 Infections,ADEFOVIR DIPIVOXIL,501.48,3.06,2,13,1,11,166.98,3.75,
GILEAD SCIENCES INC,C14 Cardiovascular Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GILEAD SCIENCES INC,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
GILEAD SCIENCES INC,C04 Neoplasms,COBICISTAT,776.04,4.99,4,10,3,19,138.02,6.69,
GILEAD SCIENCES INC,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
GILEAD SCIENCES INC,C01 Infections,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
GLAXOSMITHKLINE,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GLAXOSMITHKLINE,C15 Hemic and Lymphatic Diseases,CHLOROGUANIDE HYDROCHLORIDE,253.74,2.38,1,2,5,2,83.79,10.4,
GLAXOSMITHKLINE,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
GLAXOSMITHKLINE,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
GLAXOSMITHKLINE,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GLAXOSMITHKLINE,C10 Nervous System Diseases,SUMATRIPTAN SUCCINATE,295.41,0.74,2,3,2,6,65.2,9.54,11.24
GLAXOSMITHKLINE,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
GLAXOSMITHKLINE,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
GLAXOSMITHKLINE,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
GLAXOSMITHKLINE,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
GLAXOSMITHKLINE,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
GLAXOSMITHKLINE,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GLAXOSMITHKLINE,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
GLAXOSMITHKLINE,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
GLAXOSMITHKLINE,C01 Infections,CHLOROGUANIDE HYDROCHLORIDE,253.74,2.38,1,2,5,2,83.79,10.4,
GLAXOSMITHKLINE,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
GLAXOSMITHKLINE,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
GLAXOSMITHKLINE,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
GLAXOSMITHKLINE,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
GLAXOSMITHKLINE,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
GLAXOSMITHKLINE,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
GLAXOSMITHKLINE,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
GLAXOSMITHKLINE,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
GLAXOSMITHKLINE,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
GLAXOSMITHKLINE,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
GLAXOSMITHKLINE,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GLAXOSMITHKLINE,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GLAXOSMITHKLINE,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
GLAXOSMITHKLINE CONSUMER HEALTHCARE,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ORLISTAT,495.75,8.11,0,5,1,23,81.7,,12.74
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C12 Male Urogenital Diseases,ORLISTAT,495.75,8.11,0,5,1,23,81.7,,12.74
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
GLAXOSMITHKLINE CONSUMER HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C04 Neoplasms,ORLISTAT,495.75,8.11,0,5,1,23,81.7,,12.74
GLAXOSMITHKLINE CONSUMER HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C18 Nutritional and Metabolic Diseases,ORLISTAT,495.75,8.11,0,5,1,23,81.7,,12.74
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
GLAXOSMITHKLINE CONSUMER HEALTHCARE,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GLAXOSMITHKLINE LLC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
GLAXOSMITHKLINE LLC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
GLAXOSMITHKLINE LLC,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
GLAXOSMITHKLINE LLC,C10 Nervous System Diseases,NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
GLAXOSMITHKLINE LLC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLAXOSMITHKLINE LLC,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
GLAXOSMITHKLINE LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLAXOSMITHKLINE LLC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLAXOSMITHKLINE LLC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLAXOSMITHKLINE LLC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLAXOSMITHKLINE LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLAXOSMITHKLINE LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLAXOSMITHKLINE LLC,"C23 Pathological Conditions, Signs and Symptoms",NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
GLAXOSMITHKLINE LLC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
GLAXOSMITHKLINE LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLAXOSMITHKLINE LLC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLAXOSMITHKLINE LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLAXOSMITHKLINE LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLAXOSMITHKLINE LLC,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
GLAXOSMITHKLINE LLC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
GLAXOSMITHKLINE LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLAXOSMITHKLINE LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLAXOSMITHKLINE LLC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLAXOSMITHKLINE LLC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
GLAXOSMITHKLINE LLC,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
GLAXOSMITHKLINE LLC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLAXOSMITHKLINE LLC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LIMITED,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
GLENMARK GENERICS LIMITED,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
GLENMARK GENERICS LIMITED,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LIMITED,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
GLENMARK GENERICS LIMITED,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LIMITED,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
GLENMARK GENERICS LIMITED,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LIMITED,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LIMITED,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
GLENMARK GENERICS LIMITED,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LIMITED,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LIMITED,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LIMITED,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LTD,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
GLENMARK GENERICS LTD,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
GLENMARK GENERICS LTD,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
GLENMARK GENERICS LTD,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
GLENMARK GENERICS LTD,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
GLENMARK GENERICS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
GLENMARK GENERICS LTD,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
GLENMARK GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
GLENMARK GENERICS LTD,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
GLENMARK GENERICS LTD,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
GLENMARK GENERICS LTD,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK GENERICS LTD,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
GLENMARK GENERICS LTD,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
GLENMARK GENERICS LTD,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LTD,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
GLENMARK GENERICS LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
GLENMARK GENERICS LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LTD,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
GLENMARK GENERICS LTD,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LTD,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
GLENMARK GENERICS LTD,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
GLENMARK GENERICS LTD,C25 Chemically-Induced Disorders,ACAMPROSATE CALCIUM,181.21,-2.75,0,3,2,4,83.47,,-0.88
GLENMARK GENERICS LTD,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LTD,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
GLENMARK GENERICS LTD,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
GLENMARK GENERICS LTD,C15 Hemic and Lymphatic Diseases,CHLOROGUANIDE HYDROCHLORIDE,253.74,2.38,1,2,5,2,83.79,10.4,
GLENMARK GENERICS LTD,C01 Infections,CHLOROGUANIDE HYDROCHLORIDE,253.74,2.38,1,2,5,2,83.79,10.4,
GLENMARK GENERICS LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LTD,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
GLENMARK GENERICS LTD,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
GLENMARK GENERICS LTD,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LTD,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
GLENMARK GENERICS LTD,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
GLENMARK GENERICS LTD,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
GLENMARK GENERICS LTD,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LTD,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
GLENMARK GENERICS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
GLENMARK GENERICS LTD,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
GLENMARK GENERICS LTD,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK GENERICS LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LTD,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LTD,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
GLENMARK GENERICS LTD,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,MOEXIPRIL HYDROCHLORIDE,498.58,1.5,2,7,2,11,114.4,5.2,3.46
GLENMARK GENERICS LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LTD,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
GLENMARK GENERICS LTD,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
GLENMARK GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
GLENMARK GENERICS LTD,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
GLENMARK GENERICS LTD,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK GENERICS LTD,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
GLENMARK GENERICS LTD,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
GLENMARK GENERICS LTD,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
GLENMARK GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C10 Nervous System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK GENERICS LTD,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GLENMARK GENERICS LTD,C25 Chemically-Induced Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK GENERICS LTD,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK GENERICS LTD,F03 Mental Disorders,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
GLENMARK GENERICS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK GENERICS LTD,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
GLENMARK GENERICS LTD,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
GLENMARK GENERICS LTD,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
GLENMARK GENERICS LTD,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
GLENMARK GENERICS LTD,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
GLENMARK GENERICS LTD,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
GLENMARK GENERICS LTD,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK GENERICS LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GLENMARK GENERICS LTD,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,TRANDOLAPRIL,430.55,1.95,1,5,2,9,95.94,5.21,3.8
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GLENMARK GENERICS LTD,C04 Neoplasms,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
GLENMARK GENERICS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK GENERICS LTD,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
GLENMARK GENERICS LTD,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
GLENMARK GENERICS LTD,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
GLENMARK GENERICS LTD,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C01 Infections,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD,F03 Mental Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK GENERICS LTD,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
GLENMARK GENERICS LTD,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
GLENMARK GENERICS LTD,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
GLENMARK GENERICS LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
GLENMARK GENERICS LTD,C06 Digestive System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
GLENMARK GENERICS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
GLENMARK GENERICS LTD,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GLENMARK GENERICS LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LTD,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK GENERICS LTD,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
GLENMARK GENERICS LTD,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
GLENMARK GENERICS LTD,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
GLENMARK GENERICS LTD,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
GLENMARK GENERICS LTD,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
GLENMARK GENERICS LTD,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
GLENMARK GENERICS LTD,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GLENMARK GENERICS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK GENERICS LTD,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
GLENMARK GENERICS LTD,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK GENERICS LTD,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK GENERICS LTD,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK GENERICS LTD,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
GLENMARK GENERICS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GLENMARK GENERICS LTD,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
GLENMARK GENERICS LTD,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
GLENMARK GENERICS LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
GLENMARK GENERICS LTD,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK GENERICS LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
GLENMARK GENERICS LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GLENMARK GENERICS LTD,C01 Infections,TERBINAFINE HYDROCHLORIDE,291.44,5.53,2,1,0,4,3.24,8.86,
GLENMARK GENERICS LTD INDIA,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD INDIA,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK GENERICS LTD INDIA,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
GLENMARK GENERICS LTD INDIA,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD INDIA,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD INDIA,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK GENERICS LTD INDIA,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK GENERICS LTD INDIA,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK GENERICS LTD INDIA,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK GENERICS LTD INDIA,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD INDIA,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD INDIA,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK GENERICS LTD INDIA,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
GLENMARK GENERICS LTD INDIA,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK GENERICS LTD INDIA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK GENERICS LTD INDIA,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD INDIA,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK GENERICS LTD INDIA,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK GENERICS LTD INDIA,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS INC,C20 Immune System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
GLENMARK PHARMACEUTICALS INC,C10 Nervous System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
GLENMARK PHARMACEUTICALS INC USA,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
GLENMARK PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
GLENMARK PHARMACEUTICALS LTD,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
GLENMARK PHARMACEUTICALS LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
GLENMARK PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK PHARMACEUTICALS LTD,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
GLENMARK PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLENMARK PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
GLENMARK PHARMACEUTICALS LTD,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
GLENMARK PHARMACEUTICALS LTD,F03 Mental Disorders,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
GLENMARK PHARMACEUTICALS LTD,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,RALOXIFENE HYDROCHLORIDE,473.59,5.69,4,6,2,7,70,7.95,8.89
GLENMARK PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
GLENMARK PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
GLENMARK PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
GLENMARK PHARMACEUTICALS LTD,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
GLENMARK PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK PHARMACEUTICALS LTD,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GLENMARK PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
GLENMARK PHARMACEUTICALS LTD,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
GLENMARK PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
GLENMARK PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GLENMARK PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
GLENMARK PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
GLENMARK PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
GLENMARK PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
GLENMARK PHARMACEUTICALS LTD,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GLENMARK PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK PHARMACEUTICALS LTD,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
GLENMARK PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",DESMOPRESSIN ACETATE,1069.24,,,,,,,,
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
GLENMARK PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
GLENMARK PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,TRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
GLENMARK PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
GLENMARK PHARMACEUTICALS LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
GLENMARK PHARMACEUTICALS LTD,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLENMARK PHARMACEUTICALS LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK PHARMACEUTICALS LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
GLENMARK PHARMACEUTICALS LTD,F03 Mental Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
GLENMARK PHARMACEUTICALS LTD,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
GLENMARK PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
GLENMARK PHARMACEUTICALS LTD,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
GLENMARK PHARMACEUTICALS LTD,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS LTD,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
GLENMARK PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GLENMARK PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
GLENMARK PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
GLENMARK PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
GLENMARK PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,MOEXIPRIL HYDROCHLORIDE,498.58,1.5,2,7,2,11,114.4,5.2,3.46
GLENMARK PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
GLENMARK PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
GLENMARK PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
GLENMARK PHARMACEUTICALS SA,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS SA,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS SA,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
GLENMARK PHARMACEUTICALS SA,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS SA,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
GLENMARK PHARMACEUTICALS SA,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
GLENMARK PHARMACEUTICALS SA,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS SA,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
GLENMARK PHARMACEUTICALS SA,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS SA,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS SA,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
GLENMARK PHARMACEUTICALS SA,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK PHARMACEUTICALS SA,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK PHARMACEUTICALS SA,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
GLENMARK PHARMACEUTICALS SA,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
GLENMARK PHARMACEUTICALS SA,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK PHARMACEUTICALS SA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
GLENMARK PHARMACEUTICALS SA,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK PHARMACEUTICALS SA,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK PHARMACEUTICALS SA,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK PHARMACEUTICALS SA,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK PHARMACEUTICALS SA,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK PHARMACEUTICALS SA,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
GLENMARK PHARMACEUTICALS SA,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK PHARMACEUTICALS SA,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
GLENMARK PHARMACEUTICALS SA,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
GLENMARK PHARMACEUTICALS SA,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
GLENMARK PHARMACEUTICALS SA,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
GLENMARK PHARMACEUTICALS SA SWITZERLAND,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,"C23 Pathological Conditions, Signs and Symptoms",APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
GLENMARK PHARMACEUTICALS SA SWITZERLAND,F03 Mental Disorders,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C04 Neoplasms,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C17 Skin and Connective Tissue Diseases,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C25 Chemically-Induced Disorders,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C01 Infections,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
GLENMARK PHARMACEUTICALS SA SWITZERLAND,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C06 Digestive System Diseases,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GLENMARK PHARMACEUTICALS SA SWITZERLAND,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
GRANULES INDIA LTD,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GRANULES INDIA LTD,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GRANULES INDIA LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GRANULES INDIA LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GRANULES INDIA LTD,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
GRANULES INDIA LTD,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
GRANULES INDIA LTD,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GRANULES INDIA LTD,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GRANULES INDIA LTD,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GRANULES INDIA LTD,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
GRANULES INDIA LTD,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
GRANULES INDIA LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
GRANULES INDIA LTD,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
GRANULES INDIA LTD,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
GRANULES INDIA LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
GRANULES INDIA LTD,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
GRANULES INDIA LTD,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
GRANULES INDIA LTD,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
GRANULES INDIA LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
GRANULES INDIA LTD,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
GRANULES INDIA LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES INDIA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GRANULES INDIA LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
GRANULES PHARMACEUTICALS INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
GRANULES PHARMACEUTICALS INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
GRANULES PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
GRANULES PHARMACEUTICALS INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
GRANULES PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLERGONOVINE MALEATE,339.44,1.59,2,3,3,4,68.36,7.93,
GRAVITI PHARMACEUTICALS PRIVATE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GRAVITI PHARMACEUTICALS PRIVATE LTD,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GRAVITI PHARMACEUTICALS PRIVATE LTD,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GRAVITI PHARMACEUTICALS PRIVATE LTD,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
GRAVITI PHARMACEUTICALS PRIVATE LTD,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GRAVITI PHARMACEUTICALS PRIVATE LTD,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
GRAVITI PHARMACEUTICALS PRIVATE LTD,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
GRAVITI PHARMACEUTICALS PRIVATE LTD,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
GRAVITI PHARMACEUTICALS PRIVATE LTD,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
GRAVITI PHARMACEUTICALS PRIVATE LTD,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GRAVITI PHARMACEUTICALS PRIVATE LTD,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
GUARDIAN DRUG CO,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
GUARDIAN DRUG CO,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
GUARDIAN DRUG CO,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
GUARDIAN DRUG CO,C01 Infections,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
GUARDIAN DRUG CO,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
GUARDIAN DRUG CO,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C08 Respiratory Tract Diseases,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
GUARDIAN DRUG CO,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
GUARDIAN DRUG CO,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
GUARDIAN DRUG CO,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
GUARDIAN DRUG CO,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
GUARDIAN DRUG CO,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
GUARDIAN DRUG CO,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HANGZHOU MINSHENG BINJIANG PHARMACEUTICAL CO LTD,C05 Musculoskeletal Diseases,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
HANGZHOU MINSHENG BINJIANG PHARMACEUTICAL CO LTD,C04 Neoplasms,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
HANGZHOU MINSHENG BINJIANG PHARMACEUTICAL CO LTD,F03 Mental Disorders,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HEC PHARM USA INC,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
HEC PHARM USA INC,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
HEC PHARM USA INC,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
HEC PHARM USA INC,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
HEC PHARM USA INC,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
HEC PHARM USA INC,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HEC PHARM USA INC,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
HEC PHARM USA INC,C14 Cardiovascular Diseases,PRASUGREL HYDROCHLORIDE,373.45,4.31,2,5,0,5,46.61,5.12,
HEC PHARM USA INC,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
HEC PHARM USA INC,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
HEC PHARM USA INC,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
HERITAGE LIFE SCIENCES BARBADOS INC,C10 Nervous System Diseases,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
HERITAGE LIFE SCIENCES BARBADOS INC,F03 Mental Disorders,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
HERITAGE LIFE SCIENCES BARBADOS INC,F01 Behavior and Behavior Mechanisms,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
HERITAGE PHARMA LABS INC,C13 Female Urogenital Diseases and Pregnancy Complications,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
HERITAGE PHARMA LABS INC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
HERITAGE PHARMA LABS INC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
HERITAGE PHARMA LABS INC,F03 Mental Disorders,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",DESMOPRESSIN ACETATE,1069.24,,,,,,,,
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
HERITAGE PHARMA LABS INC,C05 Musculoskeletal Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
HERITAGE PHARMA LABS INC,C17 Skin and Connective Tissue Diseases,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
HERITAGE PHARMA LABS INC,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
HERITAGE PHARMA LABS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HERITAGE PHARMA LABS INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,ALFUZOSIN HYDROCHLORIDE,389.46,1.19,2,8,2,8,111.83,7.3,
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMA LABS INC,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMA LABS INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMA LABS INC,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMA LABS INC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
HERITAGE PHARMA LABS INC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HERITAGE PHARMA LABS INC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HERITAGE PHARMA LABS INC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HERITAGE PHARMA LABS INC,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
HERITAGE PHARMA LABS INC,C04 Neoplasms,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
HERITAGE PHARMA LABS INC,C01 Infections,TERBINAFINE HYDROCHLORIDE,291.44,5.53,2,1,0,4,3.24,8.86,
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HERITAGE PHARMA LABS INC,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HERITAGE PHARMA LABS INC,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HERITAGE PHARMA LABS INC,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HERITAGE PHARMA LABS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HERITAGE PHARMA LABS INC,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
HERITAGE PHARMA LABS INC,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HERITAGE PHARMA LABS INC,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HERITAGE PHARMA LABS INC,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HERITAGE PHARMA LABS INC,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HERITAGE PHARMA LABS INC,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HERITAGE PHARMA LABS INC,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HERITAGE PHARMA LABS INC,C18 Nutritional and Metabolic Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
HERITAGE PHARMA LABS INC,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
HERITAGE PHARMA LABS INC,F03 Mental Disorders,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
HERITAGE PHARMA LABS INC,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
HERITAGE PHARMA LABS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
HERITAGE PHARMA LABS INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
HERITAGE PHARMA LABS INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
HERITAGE PHARMA LABS INC,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
HERITAGE PHARMA LABS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
HERITAGE PHARMA LABS INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
HERITAGE PHARMA LABS INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
HERITAGE PHARMA LABS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
HERITAGE PHARMA LABS INC,C18 Nutritional and Metabolic Diseases,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
HERITAGE PHARMA LABS INC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
HERITAGE PHARMA LABS INC,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HERITAGE PHARMA LABS INC,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
HERITAGE PHARMA LABS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMA LABS INC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
HERITAGE PHARMA LABS INC,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
HERITAGE PHARMA LABS INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
HERITAGE PHARMA LABS INC,C05 Musculoskeletal Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
HERITAGE PHARMA LABS INC,C11 Eye Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
HERITAGE PHARMA LABS INC,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,C04 Neoplasms,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
HERITAGE PHARMA LABS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
HERITAGE PHARMA LABS INC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
HERITAGE PHARMA LABS INC,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
HERITAGE PHARMA LABS INC,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
HERITAGE PHARMA LABS INC,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
HERITAGE PHARMA LABS INC,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
HERITAGE PHARMA LABS INC,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
HERITAGE PHARMA LABS INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMA LABS INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMA LABS INC,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
HERITAGE PHARMA LABS INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
HERITAGE PHARMA LABS INC,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMA LABS INC,C18 Nutritional and Metabolic Diseases,DIFLUNISAL,250.2,3.91,2,2,2,2,57.53,,2.69
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,DIFLUNISAL,250.2,3.91,2,2,2,2,57.53,,2.69
HERITAGE PHARMA LABS INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
HERITAGE PHARMA LABS INC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
HERITAGE PHARMA LABS INC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
HERITAGE PHARMA LABS INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
HERITAGE PHARMA LABS INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
HERITAGE PHARMA LABS INC,C15 Hemic and Lymphatic Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
HERITAGE PHARMA LABS INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
HERITAGE PHARMA LABS INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
HERITAGE PHARMA LABS INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMA LABS INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMA LABS INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMA LABS INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",DIFLUNISAL,250.2,3.91,2,2,2,2,57.53,,2.69
HERITAGE PHARMA LABS INC,C06 Digestive System Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
HERITAGE PHARMA LABS INC,C01 Infections,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
HERITAGE PHARMA LABS INC,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
HERITAGE PHARMA LABS INC,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
HERITAGE PHARMA LABS INC,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
HERITAGE PHARMA LABS INC,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
HERITAGE PHARMA LABS INC,F03 Mental Disorders,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
HERITAGE PHARMA LABS INC,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
HERITAGE PHARMA LABS INC,C08 Respiratory Tract Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
HERITAGE PHARMA LABS INC,C20 Immune System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
HERITAGE PHARMA LABS INC,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
HERITAGE PHARMA LABS INC,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
HERITAGE PHARMA LABS INC,C04 Neoplasms,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
HERITAGE PHARMA LABS INC,C04 Neoplasms,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
HERITAGE PHARMA LABS INC,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HERITAGE PHARMA LABS INC,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
HERITAGE PHARMA LABS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMA LABS INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMA LABS INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMA LABS INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMA LABS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMA LABS INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMA LABS INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C01 Infections,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HERITAGE PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HERITAGE PHARMACEUTICALS INC,C01 Infections,CLINDAMYCIN PALMITATE HYDROCHLORIDE,663.41,7.96,0,8,3,22,108.33,7.55,12.59
HERITAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HERITAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
HERITAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
HERITAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
HERITAGE PHARMACEUTICALS INC,C20 Immune System Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
HERITAGE PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
HERITAGE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
HERITAGE PHARMACEUTICALS INC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMACEUTICALS INC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
HERITAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C01 Infections,PAROMOMYCIN SULFATE,615.63,-8.31,0,19,13,9,347.32,9.59,12.15
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
HERITAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,MOEXIPRIL HYDROCHLORIDE,498.58,1.5,2,7,2,11,114.4,5.2,3.46
HERITAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
HERITAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
HERITAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
HERITAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
HERITAGE PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
HERITAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
HERITAGE PHARMACEUTICALS INC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
HERITAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMACEUTICALS INC,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
HERITAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
HERITAGE PHARMACEUTICALS INC,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
HERITAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
HERITAGE PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
HERITAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HERITAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,C11 Eye Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
HERITAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
HERITAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
HERITAGE PHARMACEUTICALS INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
HERITAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
HERITAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HERITAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
HERITAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HERITAGE PHARMACEUTICALS INC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HERITAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
HERITAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HERITAGE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HERITAGE PHARMACEUTICALS INC,C01 Infections,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
HERITAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HERITAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HERITAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HERITAGE PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HERITAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
HERITAGE PHARMACEUTICALS INC,C04 Neoplasms,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HERITAGE PHARMACEUTICALS INC,C01 Infections,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
HERITAGE PHARMACEUTICALS INC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
HERITAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HERITAGE PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HERITAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HERITAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HERITAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HERITAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
HERITAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HERITAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HETERO LABS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
HETERO LABS LTD,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
HETERO LABS LTD,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
HETERO LABS LTD,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
HETERO LABS LTD,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
HETERO LABS LTD,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
HETERO LABS LTD,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
HETERO LABS LTD UNIT III,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
HETERO LABS LTD UNIT III,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HETERO LABS LTD UNIT III,G08 Reproductive and Urinary Physiological Phenomena,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
HETERO LABS LTD UNIT III,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
HETERO LABS LTD UNIT III,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C14 Cardiovascular Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
HETERO LABS LTD UNIT III,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
HETERO LABS LTD UNIT III,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
HETERO LABS LTD UNIT III,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
HETERO LABS LTD UNIT III,C08 Respiratory Tract Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
HETERO LABS LTD UNIT III,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
HETERO LABS LTD UNIT III,C12 Male Urogenital Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
HETERO LABS LTD UNIT III,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C18 Nutritional and Metabolic Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
HETERO LABS LTD UNIT III,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
HETERO LABS LTD UNIT III,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
HETERO LABS LTD UNIT III,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
HETERO LABS LTD UNIT III,C04 Neoplasms,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
HETERO LABS LTD UNIT III,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
HETERO LABS LTD UNIT III,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,C01 Infections,STAVUDINE,224.22,-0.23,1,5,2,2,84.32,,9.95
HETERO LABS LTD UNIT III,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
HETERO LABS LTD UNIT III,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT III,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT III,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT III,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT III,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT III,C01 Infections,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
HETERO LABS LTD UNIT III,C04 Neoplasms,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
HETERO LABS LTD UNIT III,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
HETERO LABS LTD UNIT III,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
HETERO LABS LTD UNIT III,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
HETERO LABS LTD UNIT III,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
HETERO LABS LTD UNIT III,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
HETERO LABS LTD UNIT III,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
HETERO LABS LTD UNIT III,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
HETERO LABS LTD UNIT III,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HETERO LABS LTD UNIT III,C01 Infections,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
HETERO LABS LTD UNIT III,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HETERO LABS LTD UNIT III,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
HETERO LABS LTD UNIT III,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HETERO LABS LTD UNIT III,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HETERO LABS LTD UNIT III,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HETERO LABS LTD UNIT III,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HETERO LABS LTD UNIT III,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HETERO LABS LTD UNIT III,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
HETERO LABS LTD UNIT III,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
HETERO LABS LTD UNIT III,C08 Respiratory Tract Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
HETERO LABS LTD UNIT III,C13 Female Urogenital Diseases and Pregnancy Complications,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
HETERO LABS LTD UNIT III,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
HETERO LABS LTD UNIT III,C18 Nutritional and Metabolic Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
HETERO LABS LTD UNIT III,C17 Skin and Connective Tissue Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
HETERO LABS LTD UNIT III,C04 Neoplasms,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
HETERO LABS LTD UNIT III,F03 Mental Disorders,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
HETERO LABS LTD UNIT III,C01 Infections,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
HETERO LABS LTD UNIT III,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
HETERO LABS LTD UNIT III,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
HETERO LABS LTD UNIT III,C18 Nutritional and Metabolic Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
HETERO LABS LTD UNIT III,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
HETERO LABS LTD UNIT III,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
HETERO LABS LTD UNIT III,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
HETERO LABS LTD UNIT III,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
HETERO LABS LTD UNIT III,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
HETERO LABS LTD UNIT III,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
HETERO LABS LTD UNIT III,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
HETERO LABS LTD UNIT III,C12 Male Urogenital Diseases,TOLTERODINE TARTRATE,325.5,5.12,2,2,1,7,23.47,11.01,10.28
HETERO LABS LTD UNIT III,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C14 Cardiovascular Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
HETERO LABS LTD UNIT III,C17 Skin and Connective Tissue Diseases,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
HETERO LABS LTD UNIT III,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
HETERO LABS LTD UNIT III,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
HETERO LABS LTD UNIT III,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
HETERO LABS LTD UNIT III,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C01 Infections,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
HETERO LABS LTD UNIT III,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
HETERO LABS LTD UNIT III,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
HETERO LABS LTD UNIT III,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
HETERO LABS LTD UNIT III,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
HETERO LABS LTD UNIT III,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
HETERO LABS LTD UNIT III,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
HETERO LABS LTD UNIT III,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
HETERO LABS LTD UNIT III,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
HETERO LABS LTD UNIT III,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
HETERO LABS LTD UNIT III,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
HETERO LABS LTD UNIT III,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
HETERO LABS LTD UNIT V,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
HETERO LABS LTD UNIT V,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
HETERO LABS LTD UNIT V,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
HETERO LABS LTD UNIT V,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
HETERO LABS LTD UNIT V,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,C11 Eye Diseases,VALGANCICLOVIR HYDROCHLORIDE,354.37,-1.21,2,10,4,8,171.37,7.48,10.16
HETERO LABS LTD UNIT V,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
HETERO LABS LTD UNIT V,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
HETERO LABS LTD UNIT V,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HETERO LABS LTD UNIT V,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
HETERO LABS LTD UNIT V,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
HETERO LABS LTD UNIT V,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HETERO LABS LTD UNIT V,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
HETERO LABS LTD UNIT V,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
HETERO LABS LTD UNIT V,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HETERO LABS LTD UNIT V,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
HETERO LABS LTD UNIT V,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
HETERO LABS LTD UNIT V,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT V,C09 Otorhinolaryngologic Diseases,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
HETERO LABS LTD UNIT V,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,C01 Infections,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
HETERO LABS LTD UNIT V,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT V,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HETERO LABS LTD UNIT V,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HETERO LABS LTD UNIT V,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HETERO LABS LTD UNIT V,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HETERO LABS LTD UNIT V,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT V,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT V,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT V,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HETERO LABS LTD UNIT V,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
HETERO LABS LTD UNIT V,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HETERO LABS LTD UNIT V,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
HETERO LABS LTD UNIT V,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HETERO LABS LTD UNIT V,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
HETERO LABS LTD UNIT V,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
HETERO LABS LTD UNIT V,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
HETERO LABS LTD UNIT V,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
HETERO LABS LTD UNIT V,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
HETERO LABS LTD UNIT V,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
HETERO LABS LTD UNIT V,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HETERO LABS LTD UNIT V,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
HETERO LABS LTD UNIT V,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
HETERO LABS LTD UNIT V,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
HETERO LABS LTD UNIT V,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
HETERO LABS LTD UNIT V,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HETERO LABS LTD UNIT V,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HETERO LABS LTD UNIT V,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
HETERO LABS LTD UNIT V,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HETERO LABS LTD UNIT V,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
HETERO LABS LTD UNIT V,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
HETERO LABS LTD UNIT V,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HETERO LABS LTD UNIT V,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
HETERO LABS LTD UNIT V,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
HETERO LABS LTD UNIT V,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HETERO LABS LTD UNIT V,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HETERO LABS LTD UNIT V,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HETERO LABS LTD UNIT V,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
HETERO LABS LTD UNIT V,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HETERO LABS LTD UNIT V,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
HETERO LABS LTD UNIT V,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HETERO LABS LTD UNIT V,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HETERO LABS LTD UNIT V,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HETERO LABS LTD UNIT V,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
HETERO LABS LTD UNIT V,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
HETERO LABS LTD UNIT V,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
HETERO LABS LTD UNIT V,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
HETERO LABS LTD UNIT V,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
HETERO LABS LTD UNIT V,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HETERO LABS LTD UNIT V,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
HETERO LABS LTD UNIT V,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HETERO LABS LTD UNIT V,C10 Nervous System Diseases,TETRABENAZINE,317.43,3.4,1,4,0,4,38.77,7.33,
HETERO LABS LTD UNIT V,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HETERO LABS LTD UNIT V,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HETERO LABS LTD UNIT V,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
HI TECH PHARMACAL CO INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
HI TECH PHARMACAL CO INC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,C18 Nutritional and Metabolic Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
HI TECH PHARMACAL CO INC,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C19 Endocrine System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
HI TECH PHARMACAL CO INC,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
HI TECH PHARMACAL CO INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
HI TECH PHARMACAL CO INC,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
HI TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HI TECH PHARMACAL CO INC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
HI TECH PHARMACAL CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HI TECH PHARMACAL CO INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HI TECH PHARMACAL CO INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
HI TECH PHARMACAL CO INC,C11 Eye Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
HI TECH PHARMACAL CO INC,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
HI TECH PHARMACAL CO INC,C01 Infections,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HI TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
HI TECH PHARMACAL CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
HI TECH PHARMACAL CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
HI TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
HI TECH PHARMACAL CO INC,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
HI TECH PHARMACAL CO INC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
HI TECH PHARMACAL CO INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C14 Cardiovascular Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C07 Stomatognathic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C14 Cardiovascular Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,C04 Neoplasms,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
HI TECH PHARMACAL CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,C01 Infections,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C05 Musculoskeletal Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C15 Hemic and Lymphatic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
HI TECH PHARMACAL CO INC,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
HI TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
HI TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C12 Male Urogenital Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C19 Endocrine System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
HI TECH PHARMACAL CO INC,C12 Male Urogenital Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,C15 Hemic and Lymphatic Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
HI TECH PHARMACAL CO INC,C11 Eye Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C26 Wounds and Injuries,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HI TECH PHARMACAL CO INC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
HI TECH PHARMACAL CO INC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
HI TECH PHARMACAL CO INC,C07 Stomatognathic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HI TECH PHARMACAL CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
HI TECH PHARMACAL CO INC,C20 Immune System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C15 Hemic and Lymphatic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HI TECH PHARMACAL CO INC,C04 Neoplasms,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
HI TECH PHARMACAL CO INC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HI TECH PHARMACAL CO INC,C18 Nutritional and Metabolic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
HI TECH PHARMACAL CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C04 Neoplasms,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HI TECH PHARMACAL CO INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C12 Male Urogenital Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HI TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
HI TECH PHARMACAL CO INC,C01 Infections,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
HI TECH PHARMACAL CO INC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HI TECH PHARMACAL CO INC,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
HI TECH PHARMACAL CO INC,C01 Infections,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
HI TECH PHARMACAL CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HI TECH PHARMACAL CO INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
HI TECH PHARMACAL CO INC,C04 Neoplasms,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
HI TECH PHARMACAL CO INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HI TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HI TECH PHARMACAL CO INC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
HI TECH PHARMACAL CO INC,C14 Cardiovascular Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
HI TECH PHARMACAL CO INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C26 Wounds and Injuries,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
HI TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,E03 Anesthesia and Analgesia,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
HI TECH PHARMACAL CO INC,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
HI TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
HI TECH PHARMACAL CO INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HI TECH PHARMACAL CO INC,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
HI TECH PHARMACAL CO INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
HI TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HI TECH PHARMACAL CO INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HI TECH PHARMACAL CO INC,C18 Nutritional and Metabolic Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
HI TECH PHARMACAL CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
HI TECH PHARMACAL CO INC,C04 Neoplasms,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
HI TECH PHARMACAL CO INC,F03 Mental Disorders,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
HI TECH PHARMACAL CO INC,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
HI TECH PHARMACAL CO INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
HI TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
HI TECH PHARMACAL CO INC,G08 Reproductive and Urinary Physiological Phenomena,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
HI TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C10 Nervous System Diseases,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
HI TECH PHARMACAL CO INC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
HI TECH PHARMACAL CO INC,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
HI TECH PHARMACAL CO INC,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
HI TECH PHARMACAL CO INC,C01 Infections,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
HI-TECH PHARMACAL CO INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HI-TECH PHARMACAL CO INC,C14 Cardiovascular Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
HI-TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
HI-TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HI-TECH PHARMACAL CO INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HI-TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
HI-TECH PHARMACAL CO INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HI-TECH PHARMACAL CO INC,C18 Nutritional and Metabolic Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
HI-TECH PHARMACAL CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HI-TECH PHARMACAL CO INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C10 Nervous System Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
HI-TECH PHARMACAL CO INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HI-TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
HI-TECH PHARMACAL CO INC,C01 Infections,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
HI-TECH PHARMACAL CO INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HI-TECH PHARMACAL CO INC,C01 Infections,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
HI-TECH PHARMACAL CO INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
HI-TECH PHARMACAL CO INC,C11 Eye Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
HI-TECH PHARMACAL CO INC,C04 Neoplasms,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
HI-TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
HI-TECH PHARMACAL CO INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HI-TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
HI-TECH PHARMACAL CO INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HI-TECH PHARMACAL CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
HI-TECH PHARMACAL CO INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HI-TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
HI-TECH PHARMACAL CO INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HI-TECH PHARMACAL CO INC,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HI-TECH PHARMACAL CO INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
HI-TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
HI-TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HI-TECH PHARMACAL CO INC,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HI-TECH PHARMACAL CO INC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
HI-TECH PHARMACAL CO INC,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HI-TECH PHARMACAL CO INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
HI-TECH PHARMACAL CO INC,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HI-TECH PHARMACAL CO INC,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HI-TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HI-TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HI-TECH PHARMACAL CO INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HI-TECH PHARMACAL CO INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HI-TECH PHARMACAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
HI-TECH PHARMACAL CO INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
HI-TECH PHARMACAL CO INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
HI-TECH PHARMACAL CO INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
HI-TECH PHARMACAL CO INC,C04 Neoplasms,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
HI-TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
HI-TECH PHARMACAL CO INC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
HI-TECH PHARMACAL CO INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HI-TECH PHARMACAL CO INC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,G07 Physiological Phenomena,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C19 Endocrine System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C04 Neoplasms,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,F03 Mental Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C26 Wounds and Injuries,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C01 Infections,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C11 Eye Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,PRIMIDONE,218.26,1.12,1,2,2,2,58.2,,11.5
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C04 Neoplasms,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C01 Infections,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C04 Neoplasms,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C20 Immune System Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C01 Infections,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C11 Eye Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C04 Neoplasms,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C11 Eye Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C01 Infections,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,ERGOTAMINE TARTRATE,581.67,2.6,3,6,3,4,118.21,7.78,9.69
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C19 Endocrine System Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C11 Eye Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C04 Neoplasms,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C10 Nervous System Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,F03 Mental Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C26 Wounds and Injuries,CORTISONE ACETATE,402.49,2.1,0,6,1,3,97.74,,12.6
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
HIKMA INTERNATIONAL PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
HIKMA PHARMACEUTICALS,C01 Infections,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
HIKMA PHARMACEUTICALS,C07 Stomatognathic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
HIKMA PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HIKMA PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HIKMA PHARMACEUTICALS,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
HIKMA PHARMACEUTICALS,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
HIKMA PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
HIKMA PHARMACEUTICALS,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HIKMA PHARMACEUTICALS,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
HIKMA PHARMACEUTICALS,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
HIKMA PHARMACEUTICALS,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HIKMA PHARMACEUTICALS,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
HIKMA PHARMACEUTICALS,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
HIKMA PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,CEFACLOR,367.81,-2.31,1,5,3,4,112.73,7.23,2.83
HIKMA PHARMACEUTICALS,C04 Neoplasms,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
HIKMA PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
HIKMA PHARMACEUTICALS,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,C25 Chemically-Induced Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HIKMA PHARMACEUTICALS,C10 Nervous System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HIKMA PHARMACEUTICALS,F03 Mental Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HIKMA PHARMACEUTICALS,C04 Neoplasms,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HIKMA PHARMACEUTICALS,C06 Digestive System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HIKMA PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HIKMA PHARMACEUTICALS,C01 Infections,CEFADROXIL,363.39,-2.45,1,6,4,4,132.96,7.22,3.25
HIKMA PHARMACEUTICALS,C08 Respiratory Tract Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HIKMA PHARMACEUTICALS,C01 Infections,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HIKMA PHARMACEUTICALS,C01 Infections,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
HIKMA PHARMACEUTICALS,C10 Nervous System Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
HIKMA PHARMACEUTICALS,C04 Neoplasms,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
HIKMA PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
HIKMA PHARMACEUTICALS,F03 Mental Disorders,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
HIKMA PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
HIKMA PHARMACEUTICALS,C01 Infections,CEFACLOR,367.81,-2.31,1,5,3,4,112.73,7.23,2.83
HIKMA PHARMACEUTICALS,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
HIKMA PHARMACEUTICALS,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
HIKMA PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
HIKMA PHARMACEUTICALS,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
HIKMA PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,C12 Male Urogenital Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
HIKMA PHARMACEUTICALS,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,C19 Endocrine System Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
HIKMA PHARMACEUTICALS,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,C12 Male Urogenital Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
HIKMA PHARMACEUTICALS,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
HIKMA PHARMACEUTICALS,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
HIKMA PHARMACEUTICALS,C01 Infections,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
HIKMA PHARMACEUTICALS,C09 Otorhinolaryngologic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
HIKMA PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
HIKMA PHARMACEUTICALS,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HIKMA PHARMACEUTICALS,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
HIKMA PHARMACEUTICALS,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
HIKMA PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HIKMA PHARMACEUTICALS,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HIKMA PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
HIKMA PHARMACEUTICALS,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HIKMA PHARMACEUTICALS,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
HIKMA PHARMACEUTICALS,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
HIKMA PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
HIKMA PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
HIKMA PHARMACEUTICALS,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
HIKMA PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,LITHIUM CITRATE,209.92,,,,,,,,
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",CODEINE SULFATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
HIKMA PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
HIKMA PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
HIKMA PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
HIKMA PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
HIKMA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
HIKMA PHARMACEUTICALS LLC,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
HIKMA PHARMACEUTICALS LLC,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
HIKMA PHARMACEUTICALS LLC,C01 Infections,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
HIKMA PHARMACEUTICALS LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
HIKMA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
HIKMA PHARMACEUTICALS LLC,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
HIKMA PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C10 Nervous System Diseases,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
HIKMA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,F03 Mental Disorders,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
HIKMA PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
HIKMA PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
HIKMA PHARMACEUTICALS LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
HIKMA PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
HIKMA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
HIKMA PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
HIKMA PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
HIKMA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C04 Neoplasms,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
HIKMA PHARMACEUTICALS LLC,C06 Digestive System Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
HIKMA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
HIKMA PHARMACEUTICALS LLC,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
HIKMA PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
HIKMA PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HIKMA PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
HIKMA PHARMACEUTICALS LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
HIKMA PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
HIKMA PHARMACEUTICALS LLC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
HIKMA PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
HIKMA PHARMACEUTICALS LLC,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
HISUN PHARMACEUTICAL (HANGZHOU) CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C15 Hemic and Lymphatic Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C10 Nervous System Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
HISUN PHARMACEUTICAL HANGZHOU CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HISUN PHARMACEUTICAL HANGZHOU CO LTD,"C23 Pathological Conditions, Signs and Symptoms",TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C01 Infections,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C08 Respiratory Tract Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C18 Nutritional and Metabolic Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C14 Cardiovascular Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C12 Male Urogenital Diseases,TICAGRELOR,522.58,2.28,3,11,4,10,138.44,1.06,12.94
HISUN PHARMACEUTICAL HANGZHOU CO LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
HISUN PHARMACEUTICAL HANGZHOU CO LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
HOFFMANN LA ROCHE INC,F03 Mental Disorders,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
HOFFMANN LA ROCHE INC,C04 Neoplasms,VEMURAFENIB,489.93,4.62,4,4,2,7,91.92,2.3,8.87
HOFFMANN LA ROCHE INC,C26 Wounds and Injuries,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
HOFFMANN LA ROCHE INC,C08 Respiratory Tract Diseases,VEMURAFENIB,489.93,4.62,4,4,2,7,91.92,2.3,8.87
HOFFMANN LA ROCHE INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
HOFFMANN LA ROCHE INC,"C23 Pathological Conditions, Signs and Symptoms",DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
HOFFMANN LA ROCHE INC,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
HOFFMANN LA ROCHE INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
HOFFMANN LA ROCHE INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
HOFFMANN LA ROCHE INC,F01 Behavior and Behavior Mechanisms,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
HOFFMANN LA ROCHE INC,C10 Nervous System Diseases,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
HOFFMANN LA ROCHE INC,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
HOFFMANN LA ROCHE INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
HOFFMANN LA ROCHE INC,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
HOFFMANN LA ROCHE INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
HOFFMANN LA ROCHE INC,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
HOFFMANN LA ROCHE INC,"C23 Pathological Conditions, Signs and Symptoms",IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
HOFFMANN LA ROCHE INC,C04 Neoplasms,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
HOFFMANN LA ROCHE INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
HOFFMANN LA ROCHE INC,C11 Eye Diseases,VALGANCICLOVIR HYDROCHLORIDE,354.37,-1.21,2,10,4,8,171.37,7.48,10.16
HOFFMANN LA ROCHE INC,C05 Musculoskeletal Diseases,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
HORIZON MEDICINES LLC,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
HORIZON MEDICINES LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
HORIZON MEDICINES LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HORIZON MEDICINES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
HORIZON MEDICINES LLC,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HORIZON MEDICINES LLC,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HORIZON MEDICINES LLC,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HORIZON MEDICINES LLC,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
HORIZON MEDICINES LLC,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HORIZON MEDICINES LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HORIZON MEDICINES LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
HORIZON MEDICINES LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HORIZON MEDICINES LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HORIZON MEDICINES LLC,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
HORIZON MEDICINES LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HORIZON MEDICINES LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
HORIZON MEDICINES LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HORIZON MEDICINES LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HORIZON MEDICINES LLC,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
HORIZON MEDICINES LLC,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HORIZON MEDICINES LLC,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
HORIZON PHARMA USA INC,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C08 Respiratory Tract Diseases,CYSTEAMINE BITARTRATE,77.15,-0.42,0,2,2,1,26.02,10.4,9.42
HORIZON PHARMA USA INC,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYSTEAMINE BITARTRATE,77.15,-0.42,0,2,2,1,26.02,10.4,9.42
HORIZON PHARMA USA INC,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C06 Digestive System Diseases,CYSTEAMINE BITARTRATE,77.15,-0.42,0,2,2,1,26.02,10.4,9.42
HORIZON PHARMA USA INC,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C18 Nutritional and Metabolic Diseases,CYSTEAMINE BITARTRATE,77.15,-0.42,0,2,2,1,26.02,10.4,9.42
HORIZON PHARMA USA INC,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HORIZON PHARMA USA INC,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
HOSPIRA INC,F01 Behavior and Behavior Mechanisms,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C04 Neoplasms,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C06 Digestive System Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C08 Respiratory Tract Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C15 Hemic and Lymphatic Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C25 Chemically-Induced Disorders,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C14 Cardiovascular Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C01 Infections,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,G07 Physiological Phenomena,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,F03 Mental Disorders,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C10 Nervous System Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C26 Wounds and Injuries,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C09 Otorhinolaryngologic Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C12 Male Urogenital Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C17 Skin and Connective Tissue Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C05 Musculoskeletal Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C11 Eye Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HOSPIRA INC,C18 Nutritional and Metabolic Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
HUMANWELL PURACAP PHARMACEUTICAL WUHAN CO LTD,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IMPAX LABORATORIES INC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
IMPAX LABORATORIES INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
IMPAX LABORATORIES INC,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
IMPAX LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,METHYLTESTOSTERONE,302.46,3.65,0,2,1,0,37.3,,
IMPAX LABORATORIES INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
IMPAX LABORATORIES INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
IMPAX LABORATORIES INC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
IMPAX LABORATORIES INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
IMPAX LABORATORIES INC,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IMPAX LABORATORIES INC,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IMPAX LABORATORIES INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
IMPAX LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IMPAX LABORATORIES INC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C10 Nervous System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C15 Hemic and Lymphatic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
IMPAX LABORATORIES INC,C07 Stomatognathic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C09 Otorhinolaryngologic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C26 Wounds and Injuries,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
IMPAX LABORATORIES INC,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DESMOPRESSIN ACETATE,1069.24,,,,,,,,
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
IMPAX LABORATORIES INC,C04 Neoplasms,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
IMPAX LABORATORIES INC,C10 Nervous System Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
IMPAX LABORATORIES INC,C01 Infections,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
IMPAX LABORATORIES INC,C19 Endocrine System Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
IMPAX LABORATORIES INC,C01 Infections,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
IMPAX LABORATORIES INC,C01 Infections,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
IMPAX LABORATORIES INC,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
IMPAX LABORATORIES INC,C17 Skin and Connective Tissue Diseases,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
IMPAX LABORATORIES INC,C10 Nervous System Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
IMPAX LABORATORIES INC,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
IMPAX LABORATORIES INC,F03 Mental Disorders,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
IMPAX LABORATORIES INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
IMPAX LABORATORIES INC,C04 Neoplasms,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,F03 Mental Disorders,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
IMPAX LABORATORIES INC,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
IMPAX LABORATORIES INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
IMPAX LABORATORIES INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
IMPAX LABORATORIES INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
IMPAX LABORATORIES INC,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IMPAX LABORATORIES INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
IMPAX LABORATORIES INC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
IMPAX LABORATORIES INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
IMPAX LABORATORIES INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
IMPAX LABORATORIES INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
IMPAX LABORATORIES INC,C04 Neoplasms,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C11 Eye Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C06 Digestive System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,F03 Mental Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C26 Wounds and Injuries,DANTROLENE SODIUM,314.26,1.26,2,6,1,4,118.05,,8.23
IMPAX LABORATORIES INC,C19 Endocrine System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C09 Otorhinolaryngologic Diseases,DANTROLENE SODIUM,314.26,1.26,2,6,1,4,118.05,,8.23
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
IMPAX LABORATORIES INC,C17 Skin and Connective Tissue Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,G07 Physiological Phenomena,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
IMPAX LABORATORIES INC,C10 Nervous System Diseases,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
IMPAX LABORATORIES INC,C09 Otorhinolaryngologic Diseases,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
IMPAX LABORATORIES INC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
IMPAX LABORATORIES INC,C04 Neoplasms,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX LABORATORIES INC,C06 Digestive System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
IMPAX LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
IMPAX LABORATORIES INC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
IMPAX LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
IMPAX LABORATORIES INC,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
IMPAX LABORATORIES INC,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
IMPAX LABORATORIES INC,C10 Nervous System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
IMPAX LABORATORIES INC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
IMPAX LABORATORIES INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
IMPAX LABORATORIES INC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
IMPAX LABORATORIES INC,C10 Nervous System Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,TERBUTALINE SULFATE,225.29,0.44,1,4,4,3,72.72,9.76,8.86
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
IMPAX LABORATORIES INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX LABORATORIES INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
IMPAX LABORATORIES INC,C15 Hemic and Lymphatic Diseases,MEBENDAZOLE,295.3,3.26,3,4,2,3,84.08,3.93,8.44
IMPAX LABORATORIES INC,F03 Mental Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX LABORATORIES INC,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
IMPAX LABORATORIES INC,C01 Infections,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX LABORATORIES INC,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
IMPAX LABORATORIES INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
IMPAX LABORATORIES INC,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
IMPAX LABORATORIES INC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
IMPAX LABORATORIES INC,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
IMPAX LABORATORIES INC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
IMPAX LABORATORIES INC,C17 Skin and Connective Tissue Diseases,MEBENDAZOLE,295.3,3.26,3,4,2,3,84.08,3.93,8.44
IMPAX LABORATORIES INC,C01 Infections,METHENAMINE HIPPURATE,140.19,0.39,0,4,0,0,12.96,5.88,
IMPAX LABORATORIES INC,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
IMPAX LABORATORIES INC,C01 Infections,MEBENDAZOLE,295.3,3.26,3,4,2,3,84.08,3.93,8.44
IMPAX LABORATORIES INC,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
IMPAX LABORATORIES INC,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
IMPAX LABORATORIES INC,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
IMPAX LABORATORIES INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
IMPAX LABORATORIES INC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,C10 Nervous System Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
IMPAX LABORATORIES INC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,C15 Hemic and Lymphatic Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
IMPAX LABORATORIES INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
IMPAX LABORATORIES INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
IMPAX LABORATORIES INC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
IMPAX LABORATORIES INC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,NABUMETONE,228.29,3.22,2,2,0,4,26.3,,
IMPAX LABORATORIES INC,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
IMPAX LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
IMPAX LABORATORIES INC,G07 Physiological Phenomena,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
IMPAX LABORATORIES INC,C01 Infections,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
IMPAX LABORATORIES INC,C04 Neoplasms,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
IMPAX LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
IMPAX LABORATORIES INC,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
IMPAX LABORATORIES INC,C10 Nervous System Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,SEVELAMER CARBONATE,149.62,,,,,,,,
IMPAX LABORATORIES INC,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
IMPAX LABORATORIES INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,F03 Mental Disorders,FLUDROCORTISONE ACETATE,422.49,1.76,0,6,2,3,100.9,,12.58
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IMPAX LABORATORIES INC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
IMPAX LABORATORIES INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
IMPAX LABORATORIES INC,F01 Behavior and Behavior Mechanisms,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
IMPAX LABORATORIES INC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
IMPAX LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
IMPAX LABORATORIES INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
IMPAX LABORATORIES INC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,BENDROFLUMETHIAZIDE,421.42,1.7,2,5,3,3,118.36,,9.04
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
IMPAX LABORATORIES INC,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
IMPAX LABORATORIES INC,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
IMPAX LABORATORIES INC,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IMPAX LABORATORIES INC,C14 Cardiovascular Diseases,CARVEDILOL PHOSPHATE,406.48,3.42,4,5,3,10,75.74,8.74,
IMPAX LABORATORIES INC,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
IMPAX LABORATORIES INC,C04 Neoplasms,CARVEDILOL PHOSPHATE,406.48,3.42,4,5,3,10,75.74,8.74,
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IMPAX LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
IMPAX LABORATORIES INC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,C04 Neoplasms,MEBENDAZOLE,295.3,3.26,3,4,2,3,84.08,3.93,8.44
IMPAX LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
IMPAX LABORATORIES INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
IMPAX LABORATORIES INC,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IMPAX LABORATORIES INC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
IMPAX LABORATORIES INC,C10 Nervous System Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
IMPAX LABORATORIES INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,C15 Hemic and Lymphatic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX LABORATORIES INC,F03 Mental Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX LABORATORIES INC,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IMPAX LABORATORIES INC,C08 Respiratory Tract Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
IMPAX LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
IMPAX LABORATORIES INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IMPAX LABORATORIES INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
IMPAX LABORATORIES INC,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IMPAX LABORATORIES INC,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
IMPAX LABORATORIES INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
IMPAX LABORATORIES INC,C01 Infections,SEVELAMER CARBONATE,149.62,,,,,,,,
IMPAX LABORATORIES INC,C25 Chemically-Induced Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
IMPAX PHARMACEUTICALS,C01 Infections,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
IMPAX PHARMACEUTICALS,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
IMPAX PHARMACEUTICALS,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
IMPAX PHARMACEUTICALS,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
IMPAX PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
IMPAX PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",ORPHENADRINE CITRATE,269.39,4.17,2,2,0,6,12.47,8.87,
IMPAX PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
IMPAX PHARMACEUTICALS,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
IMPAX PHARMACEUTICALS,C10 Nervous System Diseases,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
IMPAX PHARMACEUTICALS,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
IMPAX PHARMACEUTICALS,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
IMPAX PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
INDICUS PHARMA LLC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INDICUS PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
INDICUS PHARMA LLC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INDICUS PHARMA LLC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INDICUS PHARMA LLC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
INDICUS PHARMA LLC,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
INDICUS PHARMA LLC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
INDICUS PHARMA LLC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INDICUS PHARMA LLC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
INDICUS PHARMA LLC,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
INDICUS PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INDICUS PHARMA LLC,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
INDICUS PHARMA LLC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INDICUS PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INDICUS PHARMA LLC,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
INDICUS PHARMA LLC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INDOCO REMEDIES LTD,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
INDOCO REMEDIES LTD,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INDOCO REMEDIES LTD,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
INGENUS PHARMACEUTICALS LLC,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
INGENUS PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
INGENUS PHARMACEUTICALS LLC,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
INGENUS PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS LLC,F03 Mental Disorders,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
INGENUS PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
INGENUS PHARMACEUTICALS LLC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
INGENUS PHARMACEUTICALS LLC,C04 Neoplasms,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
INGENUS PHARMACEUTICALS LLC,C04 Neoplasms,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
INGENUS PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS LLC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS LLC,C10 Nervous System Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
INGENUS PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
INGENUS PHARMACEUTICALS LLC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS LLC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
INGENUS PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
INGENUS PHARMACEUTICALS LLC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS LLC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
INGENUS PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INGENUS PHARMACEUTICALS NJ LLC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
INGENUS PHARMACEUTICALS NJ LLC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
INGENUS PHARMACEUTICALS NJ LLC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
INGENUS PHARMACEUTICALS NJ LLC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
INGENUS PHARMACEUTICALS NJ LLC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
INNOGENIX LLC,C10 Nervous System Diseases,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
INNOGENIX LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
INNOGENIX LLC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INNOGENIX LLC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INNOGENIX LLC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INNOGENIX LLC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INNOGENIX LLC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INNOGENIX LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INNOGENIX LLC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INNOGENIX LLC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INNOGENIX LLC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INNOGENIX LLC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
INTELLIPHARMACEUTICS CORP,C05 Musculoskeletal Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
INTELLIPHARMACEUTICS CORP,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
INTELLIPHARMACEUTICS CORP,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INTELLIPHARMACEUTICS CORP,G08 Reproductive and Urinary Physiological Phenomena,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
INTELLIPHARMACEUTICS CORP,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
INTELLIPHARMACEUTICS CORP,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INTELLIPHARMACEUTICS CORP,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INTELLIPHARMACEUTICS CORP,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
INTELLIPHARMACEUTICS CORP,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INTELLIPHARMACEUTICS CORP,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
INTELLIPHARMACEUTICS CORP,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INTELLIPHARMACEUTICS CORP,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INTELLIPHARMACEUTICS CORP,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INTELLIPHARMACEUTICS CORP,C10 Nervous System Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
INTELLIPHARMACEUTICS CORP,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INTELLIPHARMACEUTICS CORP,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INTELLIPHARMACEUTICS CORP,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INTELLIPHARMACEUTICS CORP,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INTELLIPHARMACEUTICS CORP,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INTELLIPHARMACEUTICS CORP,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INTELLIPHARMACEUTICS CORP,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INTELLIPHARMACEUTICS CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
INTELLIPHARMACEUTICS CORP,F03 Mental Disorders,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
INTELLIPHARMACEUTICS CORP,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
INTELLIPHARMACEUTICS CORP,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
INTELLIPHARMACEUTICS CORP,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
INTELLIPHARMACEUTICS CORP,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
INTELLIPHARMACEUTICS CORP,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
INTELLIPHARMACEUTICS CORP,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
INTELLIPHARMACEUTICS CORP,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
INVAGEN PHARMACEUTICALS INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
INVAGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
INVAGEN PHARMACEUTICALS INC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
INVAGEN PHARMACEUTICALS INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
INVAGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
INVAGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
INVAGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
INVAGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
INVAGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
INVAGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FOSINOPRIL SODIUM,563.67,5.62,1,6,1,14,110.21,,3.87
INVAGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
INVAGEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
INVAGEN PHARMACEUTICALS INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
INVAGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
INVAGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
INVAGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
INVAGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
INVAGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,WARFARIN SODIUM,308.33,2.74,3,4,1,4,67.51,,5.56
INVAGEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
INVAGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SEVELAMER CARBONATE,149.62,,,,,,,,
INVAGEN PHARMACEUTICALS INC,C01 Infections,TERBINAFINE HYDROCHLORIDE,291.44,5.53,2,1,0,4,3.24,8.86,
INVAGEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INVAGEN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INVAGEN PHARMACEUTICALS INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C04 Neoplasms,RALOXIFENE HYDROCHLORIDE,473.59,5.69,4,6,2,7,70,7.95,8.89
INVAGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
INVAGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
INVAGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
INVAGEN PHARMACEUTICALS INC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
INVAGEN PHARMACEUTICALS INC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
INVAGEN PHARMACEUTICALS INC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
INVAGEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
INVAGEN PHARMACEUTICALS INC,C01 Infections,SEVELAMER CARBONATE,149.62,,,,,,,,
INVAGEN PHARMACEUTICALS INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,NABUMETONE,228.29,3.22,2,2,0,4,26.3,,
INVAGEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
INVAGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
INVAGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
INVAGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,MEPROBAMATE,218.25,0.93,0,4,2,6,104.64,,
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
INVAGEN PHARMACEUTICALS INC,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
INVAGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
INVAGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
INVAGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
INVAGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
INVAGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
INVAGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
INVAGEN PHARMACEUTICALS INC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
INVAGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
INVAGEN PHARMACEUTICALS INC,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
INVAGEN PHARMACEUTICALS INC,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
INVAGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
INVAGEN PHARMACEUTICALS INC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
INVAGEN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,QUINAPRIL HYDROCHLORIDE,438.52,1.96,2,5,2,9,95.94,5.2,3.7
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
INVAGEN PHARMACEUTICALS INC,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
INVAGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
INVAGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
INVAGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
INVAGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
INVAGEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
INVAGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
INVAGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ALFUZOSIN HYDROCHLORIDE,389.46,1.19,2,8,2,8,111.83,7.3,
INVAGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
INVAGEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
INVAGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,LURASIDONE HYDROCHLORIDE,492.69,4.56,2,6,0,5,56.75,8.5,
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
INVAGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ORPHENADRINE CITRATE,269.39,4.17,2,2,0,6,12.47,8.87,
INVAGEN PHARMACEUTICALS INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
INVAGEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
INVAGEN PHARMACEUTICALS INC,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
INVAGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
INVAGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
INVATECH PHARMA SOLUTIONS LLC,C19 Endocrine System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C18 Nutritional and Metabolic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C10 Nervous System Diseases,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
INVATECH PHARMA SOLUTIONS LLC,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C12 Male Urogenital Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
INVATECH PHARMA SOLUTIONS LLC,C06 Digestive System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C11 Eye Diseases,TIMOLOL MALEATE,316.43,1.34,1,8,2,6,79.74,9.76,
INVATECH PHARMA SOLUTIONS LLC,C17 Skin and Connective Tissue Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
INVATECH PHARMA SOLUTIONS LLC,C01 Infections,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C10 Nervous System Diseases,TIMOLOL MALEATE,316.43,1.34,1,8,2,6,79.74,9.76,
INVATECH PHARMA SOLUTIONS LLC,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
INVATECH PHARMA SOLUTIONS LLC,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C14 Cardiovascular Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
INVATECH PHARMA SOLUTIONS LLC,C04 Neoplasms,TIMOLOL MALEATE,316.43,1.34,1,8,2,6,79.74,9.76,
INVATECH PHARMA SOLUTIONS LLC,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C15 Hemic and Lymphatic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
INVATECH PHARMA SOLUTIONS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C05 Musculoskeletal Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,F03 Mental Disorders,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
INVATECH PHARMA SOLUTIONS LLC,C04 Neoplasms,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
INVATECH PHARMA SOLUTIONS LLC,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
INVATECH PHARMA SOLUTIONS LLC,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVATECH PHARMA SOLUTIONS LLC,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
INVENTIA HEALTHCARE PRIVATE LTD,F03 Mental Disorders,ILOPERIDONE,426.49,3.22,3,6,0,8,64.8,7.91,
INVENTIA HEALTHCARE PRIVATE LTD,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
INVENTIA HEALTHCARE PRIVATE LTD,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
INVENTIA HEALTHCARE PRIVATE LTD,C06 Digestive System Diseases,ILOPERIDONE,426.49,3.22,3,6,0,8,64.8,7.91,
INVENTIA HEALTHCARE PRIVATE LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INVENTIA HEALTHCARE PRIVATE LTD,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
INVENTIA HEALTHCARE PRIVATE LTD,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
INVENTIA HEALTHCARE PRIVATE LTD,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
INVENTIA HEALTHCARE PRIVATE LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
INVENTIA HEALTHCARE PRIVATE LTD,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
INVENTIA HEALTHCARE PRIVATE LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
INVENTIA HEALTHCARE PRIVATE LTD,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
INVENTIA HEALTHCARE PRIVATE LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
INVENTIA HEALTHCARE PRIVATE LTD,C10 Nervous System Diseases,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
INVENTIA HEALTHCARE PRIVATE LTD,F03 Mental Disorders,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
INVENTIA HEALTHCARE PRIVATE LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INVENTIA HEALTHCARE PRIVATE LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
INVENTIA HEALTHCARE PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
INVENTIA HEALTHCARE PRIVATE LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
INVENTIA HEALTHCARE PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
INVENTIA HEALTHCARE PRIVATE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
INVENTIA HEALTHCARE PRIVATE LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
INVENTIA HEALTHCARE PRIVATE LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
INVENTIA HEALTHCARE PRIVATE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INVENTIA HEALTHCARE PRIVATE LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INVENTIA HEALTHCARE PRIVATE LTD,F01 Behavior and Behavior Mechanisms,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
INVENTIA HEALTHCARE PRIVATE LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
INVENTIA HEALTHCARE PRIVATE LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
INVENTIA HEALTHCARE PRIVATE LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
INVENTIA HEALTHCARE PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INVENTIA HEALTHCARE PRIVATE LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
INVENTIA HEALTHCARE PRIVATE LTD,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
INVENTIA HEALTHCARE PRIVATE LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INVENTIA HEALTHCARE PRIVATE LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INVENTIA HEALTHCARE PRIVATE LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
INVENTIA HEALTHCARE PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
INVENTIA HEALTHCARE PRIVATE LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
INVENTIA HEALTHCARE PRIVATE LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
IPCA LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
IPCA LABORATORIES LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IPCA LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
IPCA LABORATORIES LTD,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
IPCA LABORATORIES LTD,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
IPCA LABORATORIES LTD,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
IPCA LABORATORIES LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
IPCA LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
IPCA LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
IPCA LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IPCA LABORATORIES LTD,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
IPCA LABORATORIES LTD,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
IPCA LABORATORIES LTD,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
IPCA LABORATORIES LTD,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IPCA LABORATORIES LTD,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
IPCA LABORATORIES LTD,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IPCA LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
IPCA LABORATORIES LTD,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IPCA LABORATORIES LTD,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
IPCA LABORATORIES LTD,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
IPCA LABORATORIES LTD,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
IPCA LABORATORIES LTD,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
IPCA LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
IPCA LABORATORIES LTD,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IPCA LABORATORIES LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
IPCA LABORATORIES LTD,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
IPCA LABORATORIES LTD,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
IPCA LABORATORIES LTD,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
IPCA LABORATORIES LTD,C14 Cardiovascular Diseases,WARFARIN SODIUM,308.33,2.74,3,4,1,4,67.51,,5.56
IPCA LABORATORIES LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
IPCA LABORATORIES LTD,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IPCA LABORATORIES LTD,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
IPCA LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IPCA LABORATORIES LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
IPCA LABORATORIES LTD,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IPCA LABORATORIES LTD,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
IPCA LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
IPCA LABORATORIES LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
IPCA LABORATORIES LTD,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
IPCA LABORATORIES LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
IPCA LABORATORIES LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IPCA LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IPCA LABORATORIES LTD,C05 Musculoskeletal Diseases,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
IPCA LABORATORIES LTD,C01 Infections,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
IPCA LABORATORIES LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
IPCA LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IPCA LABORATORIES LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
IPCA LABORATORIES LTD,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
IPCA LABORATORIES LTD,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IPCA LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
IPCA LABORATORIES LTD,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
IPCA LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
IPCA LABORATORIES LTD,C14 Cardiovascular Diseases,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
ITALFARMACO SPA,C10 Nervous System Diseases,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
ITALFARMACO SPA,F03 Mental Disorders,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
ITALFARMACO SPA,C04 Neoplasms,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,F03 Mental Disorders,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C04 Neoplasms,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,F03 Mental Disorders,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C04 Neoplasms,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,PRAZOSIN HYDROCHLORIDE,383.41,1.65,3,8,1,4,106.95,7.24,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C11 Eye Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C26 Wounds and Injuries,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,OXAPROZIN,293.32,3.46,3,3,1,5,63.33,,4.95
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,TOLTERODINE TARTRATE,325.5,5.12,2,2,1,7,23.47,11.01,10.28
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C01 Infections,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C04 Neoplasms,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C07 Stomatognathic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C26 Wounds and Injuries,CYCLOSPORINE,1202.63,,,,,,,,
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JANSSEN PHARMACEUTICALS INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JANSSEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
JANSSEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,C04 Neoplasms,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
JANSSEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
JANSSEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
JANSSEN PHARMACEUTICALS INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
JANSSEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ALMOTRIPTAN MALATE,335.47,1.52,2,3,1,6,56.41,9.55,
JANSSEN PHARMACEUTICALS INC,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
JANSSEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
JANSSEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
JANSSEN PHARMACEUTICALS INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JANSSEN PHARMACEUTICALS INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JANSSEN PHARMACEUTICALS INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JANSSEN PHARMACEUTICALS INC,F03 Mental Disorders,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
JANSSEN PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C20 Immune System Diseases,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,C01 Infections,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
JANSSEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
JANSSEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
JANSSEN PHARMACEUTICALS INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JANSSEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
JANSSEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
JANSSEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
JANSSEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
JANSSEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
JANSSEN PHARMACEUTICALS INC,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
JANSSEN PHARMACEUTICALS INC,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
JANSSEN PHARMACEUTICALS INC,C06 Digestive System Diseases,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
JANSSEN PHARMACEUTICALS INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
JANSSEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
JANSSEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JANSSEN PHARMACEUTICALS INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
JANSSEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
JANSSEN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JANSSEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
JANSSEN PHARMACEUTICALS INC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
JANSSEN PHARMACEUTICALS INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
JANSSEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
JANSSEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JANSSEN PHARMACEUTICALS INC,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
JANSSEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
JANSSEN PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
JANSSEN PHARMACEUTICALS INC,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JANSSEN PHARMACEUTICALS INC,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
JANSSEN PHARMACEUTICALS INC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
JANSSEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JANSSEN PHARMACEUTICALS INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,RIVAROXABAN,435.89,1.9,2,6,1,5,88.18,,13.6
JANSSEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JANSSEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JANSSEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
JANSSEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
JANSSEN PRODUCTS LP,C18 Nutritional and Metabolic Diseases,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
JANSSEN PRODUCTS LP,C04 Neoplasms,COBICISTAT,776.04,4.99,4,10,3,19,138.02,6.69,
JANSSEN PRODUCTS LP,C01 Infections,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
JANSSEN PRODUCTS LP,C01 Infections,DARUNAVIR ETHANOLATE,547.67,2.82,2,8,3,11,140.42,2.39,13.59
JANSSEN PRODUCTS LP,C01 Infections,COBICISTAT,776.04,4.99,4,10,3,19,138.02,6.69,
JANSSEN PRODUCTS LP,C18 Nutritional and Metabolic Diseases,COBICISTAT,776.04,4.99,4,10,3,19,138.02,6.69,
JEROME STEVENS PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,F03 Mental Disorders,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
JEROME STEVENS PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
JEROME STEVENS PHARMACEUTICALS INC,C04 Neoplasms,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
JEROME STEVENS PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
JEROME STEVENS PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C19 Endocrine System Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
JEROME STEVENS PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
JEROME STEVENS PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,F03 Mental Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JEROME STEVENS PHARMACEUTICALS INC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
JEROME STEVENS PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
JEROME STEVENS PHARMACEUTICALS INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C10 Nervous System Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JEROME STEVENS PHARMACEUTICALS INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
JEROME STEVENS PHARMACEUTICALS INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
JEROME STEVENS PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C01 Infections,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JEROME STEVENS PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JEROME STEVENS PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
JEROME STEVENS PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JEROME STEVENS PHARMACEUTICALS INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
JEROME STEVENS PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JEROME STEVENS PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
JEROME STEVENS PHARMACEUTICALS INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C04 Neoplasms,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JEROME STEVENS PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JEROME STEVENS PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JEROME STEVENS PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
JEROME STEVENS PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JIANGSU HENGRUI MEDICINE CO LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
JIANGSU HENGRUI MEDICINE CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
JIANGSU HENGRUI MEDICINE CO LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
JIANGSU HENGRUI MEDICINE CO LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
JIANGSU HENGRUI MEDICINE CO LTD,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
JIANGSU HENGRUI MEDICINE CO LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGSU HENGRUI MEDICINE CO LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
JIANGXI BOYA SEEHOT PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C12 Male Urogenital Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,"C23 Pathological Conditions, Signs and Symptoms",CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C05 Musculoskeletal Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C15 Hemic and Lymphatic Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C18 Nutritional and Metabolic Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C26 Wounds and Injuries,CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C01 Infections,CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C06 Digestive System Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C04 Neoplasms,CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C19 Endocrine System Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
JUBILANT CADISTA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT CADISTA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
JUBILANT CADISTA PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
JUBILANT CADISTA PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT CADISTA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
JUBILANT CADISTA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT CADISTA PHARMACEUTICALS INC,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT CADISTA PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT CADISTA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
JUBILANT CADISTA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT CADISTA PHARMACEUTICALS INC,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
JUBILANT CADISTA PHARMACEUTICALS INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT CADISTA PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT CADISTA PHARMACEUTICALS INC,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
JUBILANT CADISTA PHARMACEUTICALS INC,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
JUBILANT CADISTA PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
JUBILANT CADISTA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
JUBILANT CADISTA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
JUBILANT CADISTA PHARMACEUTICALS INC,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
JUBILANT CADISTA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
JUBILANT CADISTA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT CADISTA PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
JUBILANT CADISTA PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
JUBILANT CADISTA PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
JUBILANT CADISTA PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
JUBILANT CADISTA PHARMACEUTICALS INC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
JUBILANT CADISTA PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
JUBILANT CADISTA PHARMACEUTICALS INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
JUBILANT CADISTA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
JUBILANT CADISTA PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
JUBILANT GENERICS LTD,C19 Endocrine System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
JUBILANT GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JUBILANT GENERICS LTD,C05 Musculoskeletal Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
JUBILANT GENERICS LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
JUBILANT GENERICS LTD,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JUBILANT GENERICS LTD,C04 Neoplasms,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
JUBILANT GENERICS LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
JUBILANT GENERICS LTD,C08 Respiratory Tract Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
JUBILANT GENERICS LTD,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
JUBILANT GENERICS LTD,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
JUBILANT GENERICS LTD,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
JUBILANT GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
JUBILANT GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
JUBILANT GENERICS LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
JUBILANT GENERICS LTD,C06 Digestive System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
JUBILANT GENERICS LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT GENERICS LTD,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
JUBILANT GENERICS LTD,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
JUBILANT GENERICS LTD,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JUBILANT GENERICS LTD,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
JUBILANT GENERICS LTD,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
JUBILANT GENERICS LTD,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
JUBILANT GENERICS LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
JUBILANT GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT GENERICS LTD,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
JUBILANT GENERICS LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
JUBILANT GENERICS LTD,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
JUBILANT GENERICS LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
JUBILANT GENERICS LTD,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
JUBILANT GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JUBILANT GENERICS LTD,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
JUBILANT GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
JUBILANT GENERICS LTD,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
JUBILANT GENERICS LTD,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
JUBILANT GENERICS LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
JUBILANT GENERICS LTD,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
JUBILANT GENERICS LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
JUBILANT GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT GENERICS LTD,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
JUBILANT GENERICS LTD,C12 Male Urogenital Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
JUBILANT GENERICS LTD,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JUBILANT GENERICS LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT GENERICS LTD,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
JUBILANT GENERICS LTD,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
JUBILANT GENERICS LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
JUBILANT GENERICS LTD,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
JUBILANT GENERICS LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
JUBILANT GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JUBILANT GENERICS LTD,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JUBILANT GENERICS LTD,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
JUBILANT GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT GENERICS LTD,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
JUBILANT GENERICS LTD,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JUBILANT GENERICS LTD,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
JUBILANT GENERICS LTD,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JUBILANT GENERICS LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
JUBILANT GENERICS LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
JUBILANT GENERICS LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
JUBILANT GENERICS LTD,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
JUBILANT GENERICS LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
JUBILANT GENERICS LTD,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JUBILANT GENERICS LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
JUBILANT GENERICS LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
JUBILANT GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
JUBILANT GENERICS LTD,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
JUBILANT GENERICS LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
JUBILANT GENERICS LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
JUBILANT GENERICS LTD,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
JUBILANT GENERICS LTD,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
JUBILANT GENERICS LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
JUBILANT GENERICS LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
JUBILANT GENERICS LTD,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
JUBILANT GENERICS LTD,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
JUBILANT GENERICS LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
JUBILANT GENERICS LTD,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
JUBILANT GENERICS LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JUBILANT GENERICS LTD,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
JUBILANT GENERICS LTD,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
JUBILANT GENERICS LTD,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
JUBILANT GENERICS LTD,C17 Skin and Connective Tissue Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
JUBILANT GENERICS LTD,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JUBILANT GENERICS LTD,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JUBILANT GENERICS LTD,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JUBILANT GENERICS LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
JUBILANT GENERICS LTD,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
JUBILANT GENERICS LTD,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
JUBILANT GENERICS LTD,C11 Eye Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
JUBILANT GENERICS LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
JUBILANT GENERICS LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
JUBILANT GENERICS LTD,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
JUBILANT GENERICS LTD,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
JUBILANT GENERICS LTD,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
JUBILANT GENERICS LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT GENERICS LTD,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
JUBILANT GENERICS LTD,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
JUBILANT GENERICS LTD,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JUBILANT GENERICS LTD,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
JUBILANT GENERICS LTD,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
JUBILANT GENERICS LTD,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
JUBILANT GENERICS LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
JUBILANT GENERICS LTD,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
JUBILANT GENERICS LTD,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
JUBILANT GENERICS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
KENTON CHEMICALS AND PHARMACEUTICALS CORP,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
KENTON CHEMICALS AND PHARMACEUTICALS CORP,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
KENTON CHEMICALS AND PHARMACEUTICALS CORP,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
KING PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
KING PHARMACEUTICALS LLC,C11 Eye Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
KING PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
KING PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
KING PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
KING PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
KING PHARMACEUTICALS LLC,C04 Neoplasms,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
KING PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
KING PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
KING PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",TRIMETHOBENZAMIDE HYDROCHLORIDE,388.46,2.16,2,6,1,10,69.26,8.77,
KING PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
KING PHARMACEUTICALS LLC,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
KING PHARMACEUTICALS LLC,C10 Nervous System Diseases,TRIMETHOBENZAMIDE HYDROCHLORIDE,388.46,2.16,2,6,1,10,69.26,8.77,
KING PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
KING PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,BENDROFLUMETHIAZIDE,421.42,1.7,2,5,3,3,118.36,,9.04
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,"C23 Pathological Conditions, Signs and Symptoms",LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C04 Neoplasms,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C19 Endocrine System Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C05 Musculoskeletal Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C04 Neoplasms,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C14 Cardiovascular Diseases,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,F03 Mental Disorders,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C19 Endocrine System Diseases,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC,C10 Nervous System Diseases,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
KVK TECH INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
KVK TECH INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
KVK TECH INC,C11 Eye Diseases,BETAXOLOL HYDROCHLORIDE,307.43,2.54,1,4,2,11,50.72,9.67,
KVK TECH INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
KVK TECH INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
KVK TECH INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
KVK TECH INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
KVK TECH INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
KVK TECH INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
KVK TECH INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,C01 Infections,DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
L PERRIGO CO,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C08 Respiratory Tract Diseases,DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
L PERRIGO CO,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
L PERRIGO CO,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
L PERRIGO CO,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
L PERRIGO CO,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
L PERRIGO CO,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
L PERRIGO CO,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C04 Neoplasms,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
L PERRIGO CO,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
L PERRIGO CO,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
L PERRIGO CO,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
L PERRIGO CO,C10 Nervous System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
L PERRIGO CO,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
L PERRIGO CO,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
L PERRIGO CO,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
L PERRIGO CO,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
L PERRIGO CO,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
L PERRIGO CO,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
L PERRIGO CO,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
L PERRIGO CO,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
L PERRIGO CO,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
L PERRIGO CO,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
L PERRIGO CO,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C06 Digestive System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
L PERRIGO CO,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
L PERRIGO CO,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
L PERRIGO CO,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
L PERRIGO CO,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
L PERRIGO CO,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
L PERRIGO CO,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
L PERRIGO CO,C08 Respiratory Tract Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
L PERRIGO CO,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
L PERRIGO CO,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
L PERRIGO CO,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
L PERRIGO CO,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
L PERRIGO CO,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
L PERRIGO CO,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
L PERRIGO CO,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
L PERRIGO CO,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
L PERRIGO CO,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
L PERRIGO CO,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
L PERRIGO CO,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
L PERRIGO CO,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C20 Immune System Diseases,CLEMASTINE FUMARATE,343.9,4.92,2,2,0,6,12.47,9.55,
L PERRIGO CO,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
L PERRIGO CO,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
L PERRIGO CO,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
L PERRIGO CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
L PERRIGO CO,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
L PERRIGO CO,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
L PERRIGO CO,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
L PERRIGO CO,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
L PERRIGO CO,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
L PERRIGO CO,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LABORATORIOS LEON FARMA SA,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LABORATORIOS LEON FARMA SA,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LABORATORIOS LEON FARMA SA,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
LABORATORIOS LEON FARMA SA,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LABORATORIOS LEON FARMA SA,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LABORATORIOS LEON FARMA SA,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
LABORATORIOS LEON FARMA SA,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LABORATORIOS LEON FARMA SA,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LABORATORIOS LEON FARMA SA,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LABORATORIOS LEON FARMA SA,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LABORATORIOS LEON FARMA SA,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
LABORATORIOS LEON FARMA SA,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LABORATORIOS LEON FARMA SA,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LABORATORIOS LEON FARMA SA,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LABORATORIOS LEON FARMA SA,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LABORATORIOS LEON FARMA SA,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LABORATORIOS LEON FARMA SA,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LABORATORIOS LEON FARMA SA,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LABORATORIOS LEON FARMA SA,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LABORATORIOS LEON FARMA SA,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LABORATORIOS LEON FARMA SA,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LABORATORIOS LEON FARMA SA,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LABORATORIOS LEON FARMA SA,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LABORATORIOS LEON FARMA SA,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LANNETT CO INC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LANNETT CO INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
LANNETT CO INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
LANNETT CO INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C25 Chemically-Induced Disorders,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,C10 Nervous System Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
LANNETT CO INC,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT CO INC,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
LANNETT CO INC,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,C26 Wounds and Injuries,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
LANNETT CO INC,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
LANNETT CO INC,F01 Behavior and Behavior Mechanisms,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
LANNETT CO INC,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
LANNETT CO INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C07 Stomatognathic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
LANNETT CO INC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LANNETT CO INC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
LANNETT CO INC,C25 Chemically-Induced Disorders,METAPROTERENOL SULFATE,211.26,0.21,1,4,4,4,72.72,9.7,8.84
LANNETT CO INC,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
LANNETT CO INC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
LANNETT CO INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT CO INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
LANNETT CO INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
LANNETT CO INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
LANNETT CO INC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
LANNETT CO INC,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT CO INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
LANNETT CO INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
LANNETT CO INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT CO INC,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
LANNETT CO INC,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
LANNETT CO INC,C12 Male Urogenital Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
LANNETT CO INC,C04 Neoplasms,FLUPHENAZINE HYDROCHLORIDE,437.53,3.97,2,5,1,6,29.95,7.81,
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
LANNETT CO INC,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LANNETT CO INC,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
LANNETT CO INC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
LANNETT CO INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
LANNETT CO INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C08 Respiratory Tract Diseases,METAPROTERENOL SULFATE,211.26,0.21,1,4,4,4,72.72,9.7,8.84
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT CO INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C12 Male Urogenital Diseases,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C04 Neoplasms,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT CO INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C01 Infections,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
LANNETT CO INC,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT CO INC,C04 Neoplasms,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
LANNETT CO INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT CO INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
LANNETT CO INC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
LANNETT CO INC,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
LANNETT CO INC,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
LANNETT CO INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
LANNETT CO INC,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
LANNETT CO INC,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
LANNETT CO INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,C05 Musculoskeletal Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
LANNETT CO INC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C05 Musculoskeletal Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
LANNETT CO INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
LANNETT CO INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LANNETT CO INC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C01 Infections,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C06 Digestive System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
LANNETT CO INC,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
LANNETT CO INC,C04 Neoplasms,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LANNETT CO INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
LANNETT CO INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,C05 Musculoskeletal Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C10 Nervous System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
LANNETT CO INC,C01 Infections,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
LANNETT CO INC,C14 Cardiovascular Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C08 Respiratory Tract Diseases,TERBUTALINE SULFATE,225.29,0.44,1,4,4,3,72.72,9.76,8.86
LANNETT CO INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
LANNETT CO INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
LANNETT CO INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
LANNETT CO INC,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
LANNETT CO INC,C25 Chemically-Induced Disorders,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LANNETT CO INC,C19 Endocrine System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
LANNETT CO INC,C12 Male Urogenital Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LANNETT CO INC,C08 Respiratory Tract Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
LANNETT CO INC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
LANNETT CO INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
LANNETT CO INC,C20 Immune System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C06 Digestive System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
LANNETT CO INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
LANNETT CO INC,C10 Nervous System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
LANNETT CO INC,C11 Eye Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
LANNETT CO INC,C14 Cardiovascular Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C06 Digestive System Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
LANNETT CO INC,C08 Respiratory Tract Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
LANNETT CO INC,C10 Nervous System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
LANNETT CO INC,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
LANNETT CO INC,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
LANNETT CO INC,C07 Stomatognathic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
LANNETT CO INC,C05 Musculoskeletal Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
LANNETT CO INC,C04 Neoplasms,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
LANNETT CO INC,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C11 Eye Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
LANNETT CO INC,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
LANNETT CO INC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
LANNETT CO INC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,F03 Mental Disorders,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C06 Digestive System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
LANNETT CO INC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LANNETT CO INC,E03 Anesthesia and Analgesia,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
LANNETT CO INC,C26 Wounds and Injuries,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
LANNETT CO INC,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
LANNETT CO INC,C14 Cardiovascular Diseases,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
LANNETT CO INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
LANNETT CO INC,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
LANNETT CO INC,F01 Behavior and Behavior Mechanisms,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LANNETT CO INC,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,C10 Nervous System Diseases,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
LANNETT CO INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
LANNETT CO INC,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
LANNETT CO INC,C26 Wounds and Injuries,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C06 Digestive System Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,C01 Infections,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LANNETT CO INC,C08 Respiratory Tract Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,C06 Digestive System Diseases,DRONABINOL,314.47,5.94,1,2,1,4,29.46,,9.34
LANNETT CO INC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LANNETT CO INC,G08 Reproductive and Urinary Physiological Phenomena,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
LANNETT CO INC,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
LANNETT CO INC,C06 Digestive System Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
LANNETT CO INC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
LANNETT CO INC,C01 Infections,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
LANNETT CO INC,C04 Neoplasms,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
LANNETT CO INC,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
LANNETT CO INC,C14 Cardiovascular Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
LANNETT CO INC,C07 Stomatognathic Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
LANNETT CO INC,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,C04 Neoplasms,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
LANNETT CO INC,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C07 Stomatognathic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C20 Immune System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C19 Endocrine System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
LANNETT CO INC,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C04 Neoplasms,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C26 Wounds and Injuries,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
LANNETT CO INC,C12 Male Urogenital Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C08 Respiratory Tract Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,C12 Male Urogenital Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C09 Otorhinolaryngologic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C06 Digestive System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C10 Nervous System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,C11 Eye Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
LANNETT CO INC,C08 Respiratory Tract Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C05 Musculoskeletal Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,F03 Mental Disorders,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
LANNETT CO INC,C01 Infections,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LANNETT CO INC,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
LANNETT CO INC,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LANNETT CO INC,C14 Cardiovascular Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LANNETT CO INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LANNETT CO INC,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
LANNETT CO INC,C14 Cardiovascular Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
LANNETT CO INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
LANNETT CO INC,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
LANNETT CO INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
LANNETT CO INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
LANNETT CO INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LANNETT CO INC,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT CO INC,C26 Wounds and Injuries,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
LANNETT CO INC,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
LANNETT CO INC,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
LANNETT CO INC,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
LANNETT CO INC,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
LANNETT CO INC,C10 Nervous System Diseases,PRIMIDONE,218.26,1.12,1,2,2,2,58.2,,11.5
LANNETT CO INC,C14 Cardiovascular Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
LANNETT CO INC,C04 Neoplasms,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LANNETT CO INC,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LANNETT CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
LANNETT CO INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
LANNETT CO INC,C04 Neoplasms,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
LANNETT CO INC,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
LANNETT CO INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
LANNETT CO INC,C12 Male Urogenital Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
LANNETT CO INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
LANNETT CO INC,G08 Reproductive and Urinary Physiological Phenomena,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
LANNETT CO INC,C05 Musculoskeletal Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
LANNETT CO INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
LANNETT CO INC,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
LANNETT CO INC,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
LANNETT CO INC,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
LANNETT CO INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C01 Infections,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
LANNETT CO INC,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
LANNETT CO INC,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
LANNETT CO INC,C08 Respiratory Tract Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
LANNETT CO INC,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
LANNETT CO INC,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
LANNETT CO INC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
LANNETT CO INC,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
LANNETT CO INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
LANNETT CO INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,LOPINAVIR,628.81,4.69,3,5,4,15,120,,13.39
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE SULFATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
LANNETT CO INC,C01 Infections,LOPINAVIR,628.81,4.69,3,5,4,15,120,,13.39
LANNETT CO INC,C10 Nervous System Diseases,HALOPERIDOL LACTATE,375.87,3.66,2,3,1,6,40.54,8.05,13.96
LANNETT CO INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LANNETT CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
LANNETT CO INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
LANNETT CO INC,C14 Cardiovascular Diseases,METOLAZONE,365.84,2.94,2,4,2,2,92.5,,9.54
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
LANNETT CO INC,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
LANNETT CO INC,C06 Digestive System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
LANNETT CO INC,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
LANNETT CO INC,F03 Mental Disorders,HALOPERIDOL LACTATE,375.87,3.66,2,3,1,6,40.54,8.05,13.96
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
LANNETT CO INC,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
LANNETT CO INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT CO INC,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
LANNETT CO INC,C01 Infections,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
LANNETT CO INC,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
LANNETT CO INC,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
LANNETT CO INC,G08 Reproductive and Urinary Physiological Phenomena,LOPINAVIR,628.81,4.69,3,5,4,15,120,,13.39
LANNETT CO INC,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
LANNETT CO INC,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
LANNETT CO INC,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
LANNETT CO INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
LANNETT CO INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
LANNETT CO INC,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
LANNETT CO INC,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
LANNETT CO INC,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
LANNETT CO INC,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
LANNETT CO INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LANNETT CO INC,C18 Nutritional and Metabolic Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
LANNETT CO INC,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
LANNETT CO INC,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
LANNETT CO INC,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
LANNETT CO INC,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
LANNETT CO INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
LANNETT CO INC,C10 Nervous System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
LANNETT CO INC,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT CO INC,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
LANNETT HOLDINGS INC,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
LANNETT HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT HOLDINGS INC,C12 Male Urogenital Diseases,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT HOLDINGS INC,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT HOLDINGS INC,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT HOLDINGS INC,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
LANNETT HOLDINGS INC,C04 Neoplasms,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT HOLDINGS INC,C15 Hemic and Lymphatic Diseases,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT HOLDINGS INC,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT HOLDINGS INC,C13 Female Urogenital Diseases and Pregnancy Complications,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT HOLDINGS INC,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT HOLDINGS INC,C05 Musculoskeletal Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
LANNETT HOLDINGS INC,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
LANNETT HOLDINGS INC,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
LANNETT HOLDINGS INC,C25 Chemically-Induced Disorders,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
LANNETT HOLDINGS INC,C04 Neoplasms,FLUPHENAZINE HYDROCHLORIDE,437.53,3.97,2,5,1,6,29.95,7.81,
LANNETT HOLDINGS INC,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT HOLDINGS INC,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT HOLDINGS INC,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT HOLDINGS INC,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
LANNETT HOLDINGS INC,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
LANNETT HOLDINGS INC,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
LANNETT HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
LANNETT HOLDINGS INC,C17 Skin and Connective Tissue Diseases,DANAZOL,337.46,3.46,1,3,1,0,46.26,0.25,
LANNETT HOLDINGS INC,C06 Digestive System Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
LARKEN LABORATORIES INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C01 Infections,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LARKEN LABORATORIES INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C14 Cardiovascular Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LARKEN LABORATORIES INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LARKEN LABORATORIES INC,C14 Cardiovascular Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C05 Musculoskeletal Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C08 Respiratory Tract Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C15 Hemic and Lymphatic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C18 Nutritional and Metabolic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C12 Male Urogenital Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C11 Eye Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C10 Nervous System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C19 Endocrine System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C06 Digestive System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C09 Otorhinolaryngologic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LARKEN LABORATORIES INC,C04 Neoplasms,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C20 Immune System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C26 Wounds and Injuries,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C07 Stomatognathic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LARKEN LABORATORIES INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DIHYDROCODEINE BITARTRATE,301.39,1.55,1,4,1,1,41.93,9.33,
LARKEN LABORATORIES INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C01 Infections,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LARKEN LABORATORIES INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LARKEN LABORATORIES INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C09 Otorhinolaryngologic Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LARKEN LABORATORIES INC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
LARKEN LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
LARKEN LABORATORIES INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C11 Eye Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LARKEN LABORATORIES INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LARKEN LABORATORIES INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LARKEN LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
LAURUS LABS LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LAURUS LABS LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LAURUS LABS LTD,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
LAURUS LABS LTD,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
LAURUS LABS LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LAURUS LABS LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LAURUS LABS LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LAURUS LABS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LAURUS LABS LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LAURUS LABS LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LAURUS LABS LTD,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
LEADIANT BIOSCIENCES INC,C01 Infections,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADIANT BIOSCIENCES INC,C18 Nutritional and Metabolic Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADIANT BIOSCIENCES INC,C04 Neoplasms,PROCARBAZINE HYDROCHLORIDE,221.3,0.99,1,3,3,5,53.16,5.56,
LEADIANT BIOSCIENCES INC,C04 Neoplasms,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADIANT BIOSCIENCES INC,C14 Cardiovascular Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADIANT BIOSCIENCES INC,C12 Male Urogenital Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADIANT BIOSCIENCES INC,C15 Hemic and Lymphatic Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADIANT BIOSCIENCES INC,C19 Endocrine System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADIANT BIOSCIENCES INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADIANT BIOSCIENCES INC,C06 Digestive System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADIANT BIOSCIENCES INC,C10 Nervous System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LEADING PHARMA LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LEADING PHARMA LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LEADING PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
LEADING PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
LEADING PHARMA LLC,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
LEADING PHARMA LLC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LEADING PHARMA LLC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
LEADING PHARMA LLC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
LEADING PHARMA LLC,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LEADING PHARMA LLC,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
LEADING PHARMA LLC,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
LEADING PHARMA LLC,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
LEADING PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
LEADING PHARMA LLC,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
LEADING PHARMA LLC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
LEADING PHARMA LLC,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
LEADING PHARMA LLC,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
LEADING PHARMA LLC,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
LEADING PHARMA LLC,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LEADING PHARMA LLC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LEADING PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
LEADING PHARMA LLC,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
LEADING PHARMA LLC,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
LEADING PHARMA LLC,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LEADING PHARMA LLC,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
LEADING PHARMA LLC,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
LEADING PHARMA LLC,C10 Nervous System Diseases,BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
LEADING PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LEADING PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LEADING PHARMA LLC,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LEADING PHARMA LLC,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
LEADING PHARMA LLC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LEADING PHARMA LLC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LEADING PHARMA LLC,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
LEADING PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LEADING PHARMA LLC,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
LEADING PHARMA LLC,F03 Mental Disorders,IMIPRAMINE HYDROCHLORIDE,280.42,4.28,2,2,0,4,6.48,9.2,
LEADING PHARMA LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LEADING PHARMA LLC,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
LIFEPHARMA FZE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
LIFEPHARMA FZE,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
LIFEPHARMA FZE,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
LIFEPHARMA FZE,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
LNK INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
LNK INTERNATIONAL INC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
LNK INTERNATIONAL INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
LNK INTERNATIONAL INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C08 Respiratory Tract Diseases,DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
LNK INTERNATIONAL INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
LNK INTERNATIONAL INC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
LNK INTERNATIONAL INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C01 Infections,DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
LNK INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LNK INTERNATIONAL INC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
LNK INTERNATIONAL INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C19 Endocrine System Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C18 Nutritional and Metabolic Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C04 Neoplasms,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LOTUS PHARMACEUTICAL CO LTD NANTOU PLANT,C12 Male Urogenital Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
LUITPOLD PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C26 Wounds and Injuries,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C11 Eye Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C04 Neoplasms,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C01 Infections,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,F03 Mental Disorders,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C06 Digestive System Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C10 Nervous System Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUITPOLD PHARMACEUTICALS INC,G07 Physiological Phenomena,ACETYLCYSTEINE,163.2,-0.71,0,3,3,3,66.4,,3.82
LUPIN ATLANTIS HOLDINGS SA,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN ATLANTIS HOLDINGS SA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,F03 Mental Disorders,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
LUPIN ATLANTIS HOLDINGS SA,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN ATLANTIS HOLDINGS SA,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN ATLANTIS HOLDINGS SA,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
LUPIN ATLANTIS HOLDINGS SA,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,C04 Neoplasms,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
LUPIN ATLANTIS HOLDINGS SA,"C23 Pathological Conditions, Signs and Symptoms",LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
LUPIN ATLANTIS HOLDINGS SA,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,C19 Endocrine System Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
LUPIN ATLANTIS HOLDINGS SA,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN ATLANTIS HOLDINGS SA,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN ATLANTIS HOLDINGS SA,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN ATLANTIS HOLDINGS SA,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN ATLANTIS HOLDINGS SA,C05 Musculoskeletal Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
LUPIN ATLANTIS HOLDINGS SA,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN ATLANTIS HOLDINGS SA,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN INC,"C23 Pathological Conditions, Signs and Symptoms",ORPHENADRINE CITRATE,269.39,4.17,2,2,0,6,12.47,8.87,
LUPIN INC,C10 Nervous System Diseases,TRIMETHOBENZAMIDE HYDROCHLORIDE,388.46,2.16,2,6,1,10,69.26,8.77,
LUPIN INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN INC,"C23 Pathological Conditions, Signs and Symptoms",TRIMETHOBENZAMIDE HYDROCHLORIDE,388.46,2.16,2,6,1,10,69.26,8.77,
LUPIN INC,"C23 Pathological Conditions, Signs and Symptoms",PENTAZOCINE HYDROCHLORIDE,285.43,3.89,1,2,1,2,23.47,9.57,10.42
LUPIN INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN INC,C25 Chemically-Induced Disorders,NALOXONE HYDROCHLORIDE,327.38,1.62,1,5,2,2,70,7.84,10.07
LUPIN INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN INC,"C23 Pathological Conditions, Signs and Symptoms",NALOXONE HYDROCHLORIDE,327.38,1.62,1,5,2,2,70,7.84,10.07
LUPIN INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN INC,C14 Cardiovascular Diseases,QUINAPRIL HYDROCHLORIDE,438.52,1.96,2,5,2,9,95.94,5.2,3.7
LUPIN INC,F01 Behavior and Behavior Mechanisms,NALOXONE HYDROCHLORIDE,327.38,1.62,1,5,2,2,70,7.84,10.07
LUPIN LIMITED,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LIMITED,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LIMITED,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LIMITED,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LIMITED,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LIMITED,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LIMITED,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LIMITED,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LIMITED,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LIMITED,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LIMITED,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LIMITED,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LIMITED,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LIMITED,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LIMITED,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LIMITED,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
LUPIN LTD,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LUPIN LTD,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,F03 Mental Disorders,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
LUPIN LTD,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
LUPIN LTD,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
LUPIN LTD,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LUPIN LTD,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LUPIN LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN LTD,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C01 Infections,CEFADROXIL,363.39,-2.45,1,6,4,4,132.96,7.22,3.25
LUPIN LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
LUPIN LTD,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C01 Infections,CEFUROXIME AXETIL,510.48,-0.43,1,12,2,9,189.06,,10.92
LUPIN LTD,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
LUPIN LTD,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
LUPIN LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
LUPIN LTD,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
LUPIN LTD,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
LUPIN LTD,C14 Cardiovascular Diseases,QUINAPRIL HYDROCHLORIDE,438.52,1.96,2,5,2,9,95.94,5.2,3.7
LUPIN LTD,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
LUPIN LTD,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
LUPIN LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN LTD,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LUPIN LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
LUPIN LTD,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C01 Infections,ETHAMBUTOL HYDROCHLORIDE,204.31,-0.06,0,4,4,9,64.52,9.55,
LUPIN LTD,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C14 Cardiovascular Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
LUPIN LTD,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LUPIN LTD,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LUPIN LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LUPIN LTD,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
LUPIN LTD,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
LUPIN LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
LUPIN LTD,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C05 Musculoskeletal Diseases,MEFENAMIC ACID,241.29,5.4,2,2,2,3,49.33,,3.89
LUPIN LTD,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
LUPIN LTD,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
LUPIN LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
LUPIN LTD,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",MEFENAMIC ACID,241.29,5.4,2,2,2,3,49.33,,3.89
LUPIN LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,MEFENAMIC ACID,241.29,5.4,2,2,2,3,49.33,,3.89
LUPIN LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN LTD,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
LUPIN LTD,G08 Reproductive and Urinary Physiological Phenomena,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
LUPIN LTD,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,F03 Mental Disorders,CLOMIPRAMINE HYDROCHLORIDE,314.86,4.88,2,2,0,4,6.48,9.2,
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LUPIN LTD,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
LUPIN LTD,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
LUPIN LTD,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
LUPIN LTD,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LUPIN LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LTD,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
LUPIN LTD,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
LUPIN LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LUPIN LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
LUPIN LTD,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LUPIN LTD,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LUPIN LTD,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN LTD,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
LUPIN LTD,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
LUPIN LTD,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
LUPIN LTD,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
LUPIN LTD,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
LUPIN LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
LUPIN LTD,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LUPIN LTD,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LUPIN LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
LUPIN LTD,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
LUPIN LTD,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
LUPIN LTD,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
LUPIN LTD,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
LUPIN LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LUPIN LTD,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
LUPIN LTD,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
LUPIN LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
LUPIN LTD,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
LUPIN LTD,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
LUPIN LTD,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,C04 Neoplasms,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
LUPIN LTD,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
LUPIN LTD,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
LUPIN LTD,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
LUPIN LTD,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
LUPIN LTD,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
LUPIN LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
LUPIN LTD,C01 Infections,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
LUPIN LTD,C17 Skin and Connective Tissue Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
LUPIN LTD,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
LUPIN LTD,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,C15 Hemic and Lymphatic Diseases,LEVOMEFOLATE CALCIUM,459.46,-2.98,2,9,7,9,202.77,5.3,2.56
LUPIN LTD,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
LUPIN LTD,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN LTD,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
LUPIN LTD,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
LUPIN LTD,C17 Skin and Connective Tissue Diseases,LEVOMEFOLATE CALCIUM,459.46,-2.98,2,9,7,9,202.77,5.3,2.56
LUPIN LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN LTD,F03 Mental Disorders,LURASIDONE HYDROCHLORIDE,492.69,4.56,2,6,0,5,56.75,8.5,
LUPIN LTD,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LUPIN LTD,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
LUPIN LTD,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
LUPIN LTD,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
LUPIN LTD,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
LUPIN LTD,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN LTD,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
LUPIN LTD,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN LTD,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN LTD,C01 Infections,RIFABUTIN,847.02,3.88,1,14,5,4,205.55,7.87,6.88
LUPIN LTD,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,C06 Digestive System Diseases,RIFABUTIN,847.02,3.88,1,14,5,4,205.55,7.87,6.88
LUPIN LTD,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
LUPIN LTD,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C18 Nutritional and Metabolic Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
LUPIN LTD,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
LUPIN LTD,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
LUPIN LTD,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
LUPIN LTD,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
LUPIN LTD,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,F03 Mental Disorders,IMIPRAMINE HYDROCHLORIDE,280.42,4.28,2,2,0,4,6.48,9.2,
LUPIN LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
LUPIN LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LUPIN LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN LTD,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
LUPIN LTD,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
LUPIN LTD,C12 Male Urogenital Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
LUPIN LTD,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C18 Nutritional and Metabolic Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN LTD,C04 Neoplasms,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
LUPIN LTD,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
LUPIN LTD,C10 Nervous System Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
LUPIN LTD,C01 Infections,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
LUPIN LTD,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
LUPIN LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LUPIN LTD,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
LUPIN LTD,C09 Otorhinolaryngologic Diseases,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
LUPIN LTD,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
LUPIN LTD,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
LUPIN LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
LUPIN LTD,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
LUPIN LTD,C01 Infections,CEFPROZIL,389.43,-1.92,1,6,4,5,132.96,7.22,3.3
LUPIN LTD,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
LUPIN LTD,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
LUPIN LTD,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
LUPIN LTD,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
LUPIN LTD,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
LUPIN LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
LUPIN LTD,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C01 Infections,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
LUPIN LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
LUPIN LTD,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN LTD,C15 Hemic and Lymphatic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
LUPIN LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
LUPIN LTD,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN LTD,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LTD,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
LUPIN LTD,C04 Neoplasms,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
LUPIN LTD,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C14 Cardiovascular Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C25 Chemically-Induced Disorders,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C14 Cardiovascular Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
LUPIN LTD,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C08 Respiratory Tract Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,C05 Musculoskeletal Diseases,NABUMETONE,228.29,3.22,2,2,0,4,26.3,,
LUPIN LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
LUPIN LTD,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
LUPIN LTD,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
LUPIN LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
LUPIN LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C04 Neoplasms,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
LUPIN LTD,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
LUPIN LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
LUPIN LTD,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
LUPIN LTD,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN LTD,C01 Infections,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
LUPIN LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
LUPIN LTD,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
LUPIN LTD,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
LUPIN LTD,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
LUPIN LTD,C06 Digestive System Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
LUPIN LTD,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN LTD,F03 Mental Disorders,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
LUPIN LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
LUPIN LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
LUPIN LTD,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
LUPIN LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
LUPIN LTD,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
LUPIN LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
LUPIN LTD,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,C05 Musculoskeletal Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LTD,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
LUPIN LTD,C05 Musculoskeletal Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
LUPIN LTD,C10 Nervous System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
LUPIN LTD,F01 Behavior and Behavior Mechanisms,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C01 Infections,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
LUPIN LTD,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
LUPIN LTD,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
LUPIN LTD,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
LUPIN LTD,C04 Neoplasms,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C08 Respiratory Tract Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
LUPIN LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
LUPIN LTD,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
LUPIN LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
LUPIN LTD,C08 Respiratory Tract Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
LUPIN LTD,C17 Skin and Connective Tissue Diseases,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
LUPIN LTD,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,C12 Male Urogenital Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C06 Digestive System Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C10 Nervous System Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN LTD,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C06 Digestive System Diseases,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN LTD,C11 Eye Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
LUPIN LTD,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
LUPIN LTD,C14 Cardiovascular Diseases,TRANDOLAPRIL,430.55,1.95,1,5,2,9,95.94,5.21,3.8
LUPIN LTD,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
LUPIN LTD,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
LUPIN LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
LUPIN LTD,C06 Digestive System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
LUPIN LTD,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
LUPIN LTD,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
LUPIN LTD,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
LUPIN LTD,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
LUPIN LTD,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
LUPIN LTD,C07 Stomatognathic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
LUPIN LTD,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
LUPIN LTD,C09 Otorhinolaryngologic Diseases,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
LUPIN LTD,C26 Wounds and Injuries,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LTD,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
LUPIN LTD,C04 Neoplasms,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LUPIN LTD,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
LUPIN LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
LUPIN LTD,C01 Infections,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
LUPIN LTD,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIPROFLOXACIN,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
LUPIN LTD,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
LUPIN LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
LUPIN LTD,C10 Nervous System Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
LUPIN LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
LUPIN LTD,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
LUPIN LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
LUPIN LTD,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LTD,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
LUPIN LTD,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
LUPIN LTD,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,C08 Respiratory Tract Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
LUPIN LTD,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
LUPIN LTD,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C26 Wounds and Injuries,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
LUPIN LTD,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
LUPIN LTD,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
LUPIN LTD,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
LUPIN LTD,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN LTD,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
LUPIN LTD,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
LUPIN LTD,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
LUPIN LTD,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
LUPIN LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
LUPIN LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
LUPIN LTD,F03 Mental Disorders,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
LUPIN LTD,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
LUPIN LTD,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
LUPIN LTD,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
LUPIN LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
LUPIN LTD,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
LUPIN LTD,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
LUPIN LTD,C12 Male Urogenital Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,G08 Reproductive and Urinary Physiological Phenomena,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
LUPIN LTD,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
LUPIN LTD,C05 Musculoskeletal Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
LUPIN LTD,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN LTD,C12 Male Urogenital Diseases,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
LUPIN LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
LUPIN LTD,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
LUPIN PHARMACEUTICALS INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
LUPIN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
LUPIN PHARMACEUTICALS INC,C20 Immune System Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
LUPIN PHARMACEUTICALS INC,C10 Nervous System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
LUPIN PHARMACEUTICALS INC,C01 Infections,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN PHARMACEUTICALS INC,C04 Neoplasms,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C01 Infections,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
LUPIN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
LUPIN PHARMACEUTICALS INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,C06 Digestive System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
LUPIN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
LUPIN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
LUPIN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
LUPIN PHARMACEUTICALS INC,C01 Infections,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
LUPIN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
LUPIN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
LUPIN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
LUPIN PHARMACEUTICALS INC,C04 Neoplasms,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
LUPIN PHARMACEUTICALS INC,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
LUPIN PHARMACEUTICALS INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
LUPIN PHARMACEUTICALS INC,C04 Neoplasms,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
LUPIN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,F03 Mental Disorders,ZIPRASIDONE HYDROCHLORIDE,412.95,4.3,3,5,1,4,48.47,7.09,12.21
LUPIN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN PHARMACEUTICALS INC,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
LUPIN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,CEFIXIME,453.46,-1.28,1,10,4,8,184.51,3.95,2.62
LUPIN PHARMACEUTICALS INC,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN PHARMACEUTICALS INC,C11 Eye Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
LUPIN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
LUPIN PHARMACEUTICALS INC,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
LUPIN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
LUPIN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LUPIN PHARMACEUTICALS INC,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
LUPIN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
LYNE LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C01 Infections,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LYNE LABORATORIES INC,C01 Infections,CLINDAMYCIN PALMITATE HYDROCHLORIDE,663.41,7.96,0,8,3,22,108.33,7.55,12.59
LYNE LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C07 Stomatognathic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C09 Otorhinolaryngologic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
LYNE LABORATORIES INC,C14 Cardiovascular Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LYNE LABORATORIES INC,C19 Endocrine System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C12 Male Urogenital Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C18 Nutritional and Metabolic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C15 Hemic and Lymphatic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C04 Neoplasms,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C26 Wounds and Injuries,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C14 Cardiovascular Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C01 Infections,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C05 Musculoskeletal Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C08 Respiratory Tract Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C11 Eye Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C06 Digestive System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LYNE LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LYNE LABORATORIES INC,C20 Immune System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C10 Nervous System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C06 Digestive System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
LYNE LABORATORIES INC,C10 Nervous System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LYNE LABORATORIES INC,C19 Endocrine System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LYNE LABORATORIES INC,C15 Hemic and Lymphatic Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LYNE LABORATORIES INC,C12 Male Urogenital Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LYNE LABORATORIES INC,C18 Nutritional and Metabolic Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
LYNE LABORATORIES INC,C04 Neoplasms,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
MACLEODS PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
MACLEODS PHARMACEUTICALS LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
MACLEODS PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MACLEODS PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MACLEODS PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
MACLEODS PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MACLEODS PHARMACEUTICALS LTD,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MACLEODS PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MACLEODS PHARMACEUTICALS LTD,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
MACLEODS PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MACLEODS PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MACLEODS PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MACLEODS PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MACLEODS PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MACLEODS PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
MACLEODS PHARMACEUTICALS LTD,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MACLEODS PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
MACLEODS PHARMACEUTICALS LTD,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MACLEODS PHARMACEUTICALS LTD,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MACLEODS PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MACLEODS PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,ZIPRASIDONE HYDROCHLORIDE,412.95,4.3,3,5,1,4,48.47,7.09,12.21
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
MACLEODS PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MACLEODS PHARMACEUTICALS LTD,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
MACLEODS PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
MACLEODS PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MACLEODS PHARMACEUTICALS LTD,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MACLEODS PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MACLEODS PHARMACEUTICALS LTD,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
MACLEODS PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
MACLEODS PHARMACEUTICALS LTD,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
MACLEODS PHARMACEUTICALS LTD,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MACLEODS PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MACLEODS PHARMACEUTICALS LTD,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MACLEODS PHARMACEUTICALS LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MACLEODS PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MACLEODS PHARMACEUTICALS LTD,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
MACLEODS PHARMACEUTICALS LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
MACLEODS PHARMACEUTICALS LTD,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MACLEODS PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MACLEODS PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
MACLEODS PHARMACEUTICALS LTD,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MACLEODS PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
MACLEODS PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MACLEODS PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
MACLEODS PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MACLEODS PHARMACEUTICALS LTD,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MACLEODS PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MACLEODS PHARMACEUTICALS LTD,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MACLEODS PHARMACEUTICALS LTD,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MACLEODS PHARMACEUTICALS LTD,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
MACLEODS PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MACLEODS PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
MACLEODS PHARMACEUTICALS LTD,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MACLEODS PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
MACLEODS PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MACLEODS PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MACLEODS PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
MACLEODS PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MACLEODS PHARMACEUTICALS LTD,C09 Otorhinolaryngologic Diseases,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TOLTERODINE TARTRATE,325.5,5.12,2,2,1,7,23.47,11.01,10.28
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
MACLEODS PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MACLEODS PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MACLEODS PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
MACLEODS PHARMACEUTICALS LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
MACLEODS PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
MACLEODS PHARMACEUTICALS LTD,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
MACLEODS PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MACLEODS PHARMACEUTICALS LTD,C01 Infections,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
MACLEODS PHARMACEUTICALS LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
MACLEODS PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MACLEODS PHARMACEUTICALS LTD,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
MANKIND PHARMA LTD,F03 Mental Disorders,CLOMIPRAMINE HYDROCHLORIDE,314.86,4.88,2,2,0,4,6.48,9.2,
MARKSANS PHARMA LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MARKSANS PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
MARKSANS PHARMA LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MARKSANS PHARMA LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MARKSANS PHARMA LTD,C04 Neoplasms,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
MARKSANS PHARMA LTD,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MARKSANS PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MARKSANS PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MARKSANS PHARMA LTD,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MARKSANS PHARMA LTD,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C18 Nutritional and Metabolic Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
MARKSANS PHARMA LTD,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MARKSANS PHARMA LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MARKSANS PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
MARKSANS PHARMA LTD,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MARKSANS PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MARKSANS PHARMA LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MARKSANS PHARMA LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
MARKSANS PHARMA LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MARKSANS PHARMA LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MARKSANS PHARMA LTD,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MARKSANS PHARMA LTD,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MARKSANS PHARMA LTD,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
MARKSANS PHARMA LTD,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MARKSANS PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MARKSANS PHARMA LTD,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
MARKSANS PHARMA LTD,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MARKSANS PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MARKSANS PHARMA LTD,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MARKSANS PHARMA LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MARKSANS PHARMA LTD,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
MARKSANS PHARMA LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MARKSANS PHARMA LTD,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
MARKSANS PHARMA LTD,C19 Endocrine System Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
MARKSANS PHARMA LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MARKSANS PHARMA LTD,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
MARKSANS PHARMA LTD,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MARKSANS PHARMA LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
MARKSANS PHARMA LTD,C12 Male Urogenital Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
MARKSANS PHARMA LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MARKSANS PHARMA LTD,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MARKSANS PHARMA LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MAYNE PHARMA INC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
MAYNE PHARMA INC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
MAYNE PHARMA INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MAYNE PHARMA INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MAYNE PHARMA INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
MAYNE PHARMA INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
MAYNE PHARMA INC,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
MAYNE PHARMA INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
MAYNE PHARMA INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C19 Endocrine System Diseases,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
MAYNE PHARMA INC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C10 Nervous System Diseases,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C14 Cardiovascular Diseases,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
MAYNE PHARMA INC,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
MAYNE PHARMA INC,C04 Neoplasms,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
MAYNE PHARMA INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
MAYNE PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MAYNE PHARMA INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
MAYNE PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C14 Cardiovascular Diseases,DOFETILIDE,441.58,0.24,2,6,2,11,104.81,8.99,10.15
MAYNE PHARMA INC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C08 Respiratory Tract Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
MAYNE PHARMA INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
MAYNE PHARMA INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MAYNE PHARMA INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MAYNE PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
MAYNE PHARMA INC,C01 Infections,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MAYNE PHARMA INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
MAYNE PHARMA INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
MAYNE PHARMA INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MAYNE PHARMA INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MAYNE PHARMA INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
MAYNE PHARMA INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MAYNE PHARMA INC,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
MAYNE PHARMA INC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MAYNE PHARMA INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
MAYNE PHARMA INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C01 Infections,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
MAYNE PHARMA INC,C01 Infections,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
MAYNE PHARMA INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MAYNE PHARMA INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MAYNE PHARMA INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
MAYNE PHARMA INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
MAYNE PHARMA INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MAYNE PHARMA INC,C17 Skin and Connective Tissue Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
MAYNE PHARMA INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MAYNE PHARMA INC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
MAYNE PHARMA INC,C08 Respiratory Tract Diseases,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
MAYNE PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
MAYNE PHARMA INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MAYNE PHARMA INC,C14 Cardiovascular Diseases,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
MAYNE PHARMA INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
MAYNE PHARMA INTERNATIONAL PTY LTD,C08 Respiratory Tract Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
MAYNE PHARMA INTERNATIONAL PTY LTD,F03 Mental Disorders,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
MAYNE PHARMA INTERNATIONAL PTY LTD,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MAYNE PHARMA INTERNATIONAL PTY LTD,C12 Male Urogenital Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
MAYNE PHARMA INTERNATIONAL PTY LTD,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INTERNATIONAL PTY LTD,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MAYNE PHARMA INTERNATIONAL PTY LTD,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MAYNE PHARMA INTERNATIONAL PTY LTD,C06 Digestive System Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
MAYNE PHARMA INTERNATIONAL PTY LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
MAYNE PHARMA INTERNATIONAL PTY LTD,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MAYNE PHARMA INTERNATIONAL PTY LTD,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INTERNATIONAL PTY LTD,C01 Infections,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
MAYNE PHARMA INTERNATIONAL PTY LTD,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MAYNE PHARMA INTERNATIONAL PTY LTD,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INTERNATIONAL PTY LTD,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MAYNE PHARMA INTERNATIONAL PTY LTD,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INTERNATIONAL PTY LTD,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MAYNE PHARMA INTERNATIONAL PTY LTD,C04 Neoplasms,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
MAYNE PHARMA INTERNATIONAL PTY LTD,C17 Skin and Connective Tissue Diseases,ERYTHROMYCIN,733.94,2.6,0,14,5,7,193.91,8.38,12.45
MAYNE PHARMA INTERNATIONAL PTY LTD,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MAYNE PHARMA INTERNATIONAL PTY LTD,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MAYNE PHARMA LLC,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MAYNE PHARMA LLC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MAYNE PHARMA LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
MAYNE PHARMA LLC,C10 Nervous System Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MAYNE PHARMA LLC,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MAYNE PHARMA LLC,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MAYNE PHARMA LLC,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MAYNE PHARMA LLC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
MAYNE PHARMA LLC,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MAYNE PHARMA LLC,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MAYNE PHARMA LLC,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MAYNE PHARMA LLC,F01 Behavior and Behavior Mechanisms,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
MAYNE PHARMA LLC,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MAYNE PHARMA LLC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MAYNE PHARMA LLC,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
MAYNE PHARMA LLC,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
MAYNE PHARMA LLC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MAYNE PHARMA LLC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MAYNE PHARMA LLC,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MAYNE PHARMA LLC,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MAYNE PHARMA LLC,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
MAYNE PHARMA LLC,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MAYNE PHARMA LLC,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MAYNE PHARMA LLC,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MAYNE PHARMA LLC,C17 Skin and Connective Tissue Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
MAYNE PHARMA LLC,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
MAYNE PHARMA LLC,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MAYNE PHARMA LLC,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MAYNE PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
MAYNE PHARMA LLC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MAYNE PHARMA LLC,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MAYNE PHARMA LLC,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MAYNE PHARMA LLC,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MAYNE PHARMA LLC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MAYNE PHARMA LLC,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MAYNE PHARMA LLC,C04 Neoplasms,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MAYNE PHARMA LLC,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MAYNE PHARMA LLC,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
MAYNE PHARMA LLC,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MAYNE PHARMA LLC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MAYNE PHARMA LLC,C04 Neoplasms,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
MAYNE PHARMA LLC,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
MAYNE PHARMA LLC,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MAYNE PHARMA LLC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MAYNE PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MAYNE PHARMA LLC,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MAYNE PHARMA LLC,C26 Wounds and Injuries,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MAYNE PHARMA LLC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
MAYNE PHARMA LLC,F01 Behavior and Behavior Mechanisms,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MAYNE PHARMA LLC,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MAYNE PHARMA LLC,C20 Immune System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C10 Nervous System Diseases,ESTAZOLAM,294.75,2.9,3,4,0,1,43.07,4.9,
MAYNE PHARMA LLC,C04 Neoplasms,NORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MAYNE PHARMA LLC,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MAYNE PHARMA LLC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MAYNE PHARMA LLC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
MAYNE PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MAYNE PHARMA LLC,C05 Musculoskeletal Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MAYNE PHARMA LLC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MAYNE PHARMA LLC,C06 Digestive System Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
MAYNE PHARMA LLC,C14 Cardiovascular Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C05 Musculoskeletal Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
MAYNE PHARMA LLC,C01 Infections,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MAYNE PHARMA LLC,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
MAYNE PHARMA LLC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MAYNE PHARMA LLC,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
MAYNE PHARMA LLC,C01 Infections,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,F03 Mental Disorders,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MAYNE PHARMA LLC,C12 Male Urogenital Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C08 Respiratory Tract Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MAYNE PHARMA LLC,C11 Eye Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MAYNE PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C14 Cardiovascular Diseases,DISOPYRAMIDE PHOSPHATE,339.48,3.47,2,3,1,8,59.22,10.42,
MAYNE PHARMA LLC,C18 Nutritional and Metabolic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MAYNE PHARMA LLC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MAYNE PHARMA LLC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C17 Skin and Connective Tissue Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MAYNE PHARMA LLC,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
MAYNE PHARMA LLC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MAYNE PHARMA LLC,C04 Neoplasms,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MAYNE PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MAYNE PHARMA LLC,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C10 Nervous System Diseases,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
MAYNE PHARMA LLC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MAYNE PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MAYNE PHARMA LLC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MAYNE PHARMA LLC,F03 Mental Disorders,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
MAYNE PHARMA LLC,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MAYNE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
MAYNE PHARMA LLC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MAYNE PHARMA LLC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C07 Stomatognathic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MAYNE PHARMA LLC,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MAYNE PHARMA LLC,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
MAYNE PHARMA LLC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MAYNE PHARMA LLC,C10 Nervous System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C06 Digestive System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MAYNE PHARMA LLC,C12 Male Urogenital Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MAYNE PHARMA LLC,C14 Cardiovascular Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MAYNE PHARMA LLC,F03 Mental Disorders,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MAYNE PHARMA LLC,C15 Hemic and Lymphatic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C26 Wounds and Injuries,CYCLOSPORINE,1202.63,,,,,,,,
MAYNE PHARMA LLC,C10 Nervous System Diseases,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
MAYNE PHARMA LLC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERCK AND CO INC,C10 Nervous System Diseases,VORINOSTAT,264.32,2,1,3,3,8,78.43,,8.91
MERCK AND CO INC,C13 Female Urogenital Diseases and Pregnancy Complications,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,G08 Reproductive and Urinary Physiological Phenomena,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C17 Skin and Connective Tissue Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C12 Male Urogenital Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C19 Endocrine System Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C20 Immune System Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C11 Eye Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C06 Digestive System Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C14 Cardiovascular Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MERCK AND CO INC,C18 Nutritional and Metabolic Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C17 Skin and Connective Tissue Diseases,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK AND CO INC,F03 Mental Disorders,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C08 Respiratory Tract Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C05 Musculoskeletal Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C15 Hemic and Lymphatic Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,G07 Physiological Phenomena,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C10 Nervous System Diseases,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C04 Neoplasms,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,F03 Mental Disorders,VORINOSTAT,264.32,2,1,3,3,8,78.43,,8.91
MERCK AND CO INC,C06 Digestive System Diseases,VORINOSTAT,264.32,2,1,3,3,8,78.43,,8.91
MERCK AND CO INC,C01 Infections,VORINOSTAT,264.32,2,1,3,3,8,78.43,,8.91
MERCK AND CO INC,C01 Infections,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C26 Wounds and Injuries,CHOLECALCIFEROL,384.65,7.13,0,1,1,6,20.23,,
MERCK AND CO INC,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MERCK AND CO INC,C01 Infections,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK AND CO INC,C06 Digestive System Diseases,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK AND CO INC,F03 Mental Disorders,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK AND CO INC,C04 Neoplasms,VORINOSTAT,264.32,2,1,3,3,8,78.43,,8.91
MERCK AND CO INC,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MERCK AND CO INC,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
MERCK AND CO INC,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MERCK AND CO INC,C25 Chemically-Induced Disorders,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK AND CO INC,"C23 Pathological Conditions, Signs and Symptoms",APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK AND CO INC,C15 Hemic and Lymphatic Diseases,VORINOSTAT,264.32,2,1,3,3,8,78.43,,8.91
MERCK AND CO INC,C04 Neoplasms,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK AND CO INC,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
MERCK AND CO INC,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
MERCK AND CO INC,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
MERCK AND CO INC,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MERCK SHARP AND DOHME CORP,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MERCK SHARP AND DOHME CORP,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MERCK SHARP AND DOHME CORP,C25 Chemically-Induced Disorders,IVERMECTIN,1736.18,,,,,,,,
MERCK SHARP AND DOHME CORP,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MERCK SHARP AND DOHME CORP,C14 Cardiovascular Diseases,INDINAVIR SULFATE,613.8,2.81,3,7,4,11,118.03,6.76,13.01
MERCK SHARP AND DOHME CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",IVERMECTIN,1736.18,,,,,,,,
MERCK SHARP AND DOHME CORP,C11 Eye Diseases,IVERMECTIN,1736.18,,,,,,,,
MERCK SHARP AND DOHME CORP,F03 Mental Disorders,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
MERCK SHARP AND DOHME CORP,C01 Infections,IVERMECTIN,1736.18,,,,,,,,
MERCK SHARP AND DOHME CORP,C01 Infections,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
MERCK SHARP AND DOHME CORP,C04 Neoplasms,INDINAVIR SULFATE,613.8,2.81,3,7,4,11,118.03,6.76,13.01
MERCK SHARP AND DOHME CORP,C17 Skin and Connective Tissue Diseases,IVERMECTIN,1736.18,,,,,,,,
MERCK SHARP AND DOHME CORP,C01 Infections,RALTEGRAVIR POTASSIUM,444.42,-0.39,3,9,3,6,152.24,,7.02
MERCK SHARP AND DOHME CORP,C01 Infections,INDINAVIR SULFATE,613.8,2.81,3,7,4,11,118.03,6.76,13.01
MERCK SHARP AND DOHME CORP,C04 Neoplasms,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
MERCK SHARP AND DOHME CORP,C06 Digestive System Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
MERCK SHARP AND DOHME CORP,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MERCK SHARP AND DOHME CORP,C15 Hemic and Lymphatic Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
MERCK SHARP AND DOHME CORP,C04 Neoplasms,POSACONAZOLE,700.79,5.41,5,12,1,12,115.7,3.93,
MERCK SHARP AND DOHME CORP,C01 Infections,GRAZOPREVIR,766.92,3.35,2,11,3,7,195.22,1.79,3.77
MERCK SHARP AND DOHME CORP,C15 Hemic and Lymphatic Diseases,POSACONAZOLE,700.79,5.41,5,12,1,12,115.7,3.93,
MERCK SHARP AND DOHME CORP,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MERCK SHARP AND DOHME CORP,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MERCK SHARP AND DOHME CORP,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MERCK SHARP AND DOHME CORP,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MERCK SHARP AND DOHME CORP,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MERCK SHARP AND DOHME CORP,C01 Infections,POSACONAZOLE,700.79,5.41,5,12,1,12,115.7,3.93,
MERCK SHARP AND DOHME CORP,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MERCK SHARP AND DOHME CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
MERCK SHARP AND DOHME CORP,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MERCK SHARP AND DOHME CORP,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MERCK SHARP AND DOHME CORP,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MERCK SHARP AND DOHME CORP,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MERCK SHARP AND DOHME CORP,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MERCK SHARP AND DOHME CORP,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MERCK SHARP AND DOHME CORP,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE SULFATE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
MERCK SHARP AND DOHME CORP,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MERCK SHARP AND DOHME CORP,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MERCK SHARP AND DOHME CORP,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MERCK SHARP AND DOHME CORP,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MERCK SHARP AND DOHME CORP,C10 Nervous System Diseases,SITAGLIPTIN PHOSPHATE,407.32,1.26,2,5,1,4,77.04,8.78,
MERCK SHARP AND DOHME CORP,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MERCK SHARP AND DOHME CORP,C14 Cardiovascular Diseases,SITAGLIPTIN PHOSPHATE,407.32,1.26,2,5,1,4,77.04,8.78,
MERCK SHARP AND DOHME CORP,C12 Male Urogenital Diseases,SITAGLIPTIN PHOSPHATE,407.32,1.26,2,5,1,4,77.04,8.78,
MERCK SHARP AND DOHME CORP,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
MERCK SHARP AND DOHME CORP,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MERCK SHARP AND DOHME CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MERCK SHARP AND DOHME CORP,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
MERCK SHARP AND DOHME CORP,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MERCK SHARP AND DOHME CORP,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MERCK SHARP AND DOHME CORP,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MERCK SHARP AND DOHME CORP,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MERCK SHARP AND DOHME CORP,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MERCK SHARP AND DOHME CORP,C20 Immune System Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
MERCK SHARP AND DOHME CORP,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MERCK SHARP AND DOHME CORP,C17 Skin and Connective Tissue Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
MERCK SHARP AND DOHME CORP,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MERCK SHARP AND DOHME CORP,C04 Neoplasms,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
MERCK SHARP AND DOHME CORP,C01 Infections,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
MERCK SHARP AND DOHME CORP,C11 Eye Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
MERCK SHARP AND DOHME CORP,C18 Nutritional and Metabolic Diseases,SITAGLIPTIN PHOSPHATE,407.32,1.26,2,5,1,4,77.04,8.78,
MERCK SHARP AND DOHME CORP,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MERCK SHARP AND DOHME CORP,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MERCK SHARP AND DOHME CORP,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
MERCK SHARP AND DOHME CORP,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MERCK SHARP AND DOHME CORP,C08 Respiratory Tract Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
MERCK SHARP AND DOHME CORP,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MERCK SHARP AND DOHME CORP,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C17 Skin and Connective Tissue Diseases,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C01 Infections,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,F03 Mental Disorders,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C25 Chemically-Induced Disorders,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C04 Neoplasms,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C06 Digestive System Diseases,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,"C23 Pathological Conditions, Signs and Symptoms",APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MERRO PHARMACEUTICAL CO LTD,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MERRO PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MICRO LABS LTD,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C01 Infections,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
MICRO LABS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
MICRO LABS LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MICRO LABS LTD,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
MICRO LABS LTD,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
MICRO LABS LTD,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MICRO LABS LTD,C08 Respiratory Tract Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
MICRO LABS LTD,C06 Digestive System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
MICRO LABS LTD,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MICRO LABS LTD,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD,C18 Nutritional and Metabolic Diseases,MEFENAMIC ACID,241.29,5.4,2,2,2,3,49.33,,3.89
MICRO LABS LTD,"C23 Pathological Conditions, Signs and Symptoms",MEFENAMIC ACID,241.29,5.4,2,2,2,3,49.33,,3.89
MICRO LABS LTD,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
MICRO LABS LTD,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
MICRO LABS LTD,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
MICRO LABS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MICRO LABS LTD,C05 Musculoskeletal Diseases,MEFENAMIC ACID,241.29,5.4,2,2,2,3,49.33,,3.89
MICRO LABS LTD,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C10 Nervous System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
MICRO LABS LTD,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
MICRO LABS LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
MICRO LABS LTD,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MICRO LABS LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MICRO LABS LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
MICRO LABS LTD,C17 Skin and Connective Tissue Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
MICRO LABS LTD,C08 Respiratory Tract Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
MICRO LABS LTD,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,F03 Mental Disorders,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
MICRO LABS LTD,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C12 Male Urogenital Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
MICRO LABS LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MICRO LABS LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MICRO LABS LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MICRO LABS LTD,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
MICRO LABS LTD,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C04 Neoplasms,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
MICRO LABS LTD,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C18 Nutritional and Metabolic Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
MICRO LABS LTD,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
MICRO LABS LTD,C10 Nervous System Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
MICRO LABS LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MICRO LABS LTD,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD,C10 Nervous System Diseases,RASAGILINE MESYLATE,171.24,2.3,1,1,1,2,12.03,8.4,
MICRO LABS LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
MICRO LABS LTD,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
MICRO LABS LTD,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
MICRO LABS LTD,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MICRO LABS LTD INDIA,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD INDIA,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
MICRO LABS LTD INDIA,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD INDIA,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,C12 Male Urogenital Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
MICRO LABS LTD INDIA,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,C07 Stomatognathic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
MICRO LABS LTD INDIA,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
MICRO LABS LTD INDIA,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C17 Skin and Connective Tissue Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
MICRO LABS LTD INDIA,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C08 Respiratory Tract Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
MICRO LABS LTD INDIA,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MICRO LABS LTD INDIA,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD INDIA,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD INDIA,C09 Otorhinolaryngologic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
MICRO LABS LTD INDIA,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
MICRO LABS LTD INDIA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MICRO LABS LTD INDIA,C01 Infections,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
MIDATECH PHARMA US INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,C01 Infections,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,C14 Cardiovascular Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,F03 Mental Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,C08 Respiratory Tract Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,C10 Nervous System Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MIDATECH PHARMA US INC,C12 Male Urogenital Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MIDATECH PHARMA US INC,C04 Neoplasms,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,C01 Infections,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MIDATECH PHARMA US INC,C05 Musculoskeletal Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MIDATECH PHARMA US INC,C06 Digestive System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,C14 Cardiovascular Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MIDATECH PHARMA US INC,C10 Nervous System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,F03 Mental Disorders,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MIDATECH PHARMA US INC,C04 Neoplasms,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MIDATECH PHARMA US INC,C25 Chemically-Induced Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MIDATECH PHARMA US INC,"C23 Pathological Conditions, Signs and Symptoms",TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MIKART INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C14 Cardiovascular Diseases,MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
MIKART LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART LLC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
MIKART LLC,C14 Cardiovascular Diseases,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
MIKART LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
MIKART LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART LLC,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
MIKART LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,"C23 Pathological Conditions, Signs and Symptoms",MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
MIKART LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
MIKART LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
MIKART LLC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
MIKART LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
MIKART LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C01 Infections,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
MIKART LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
MIKART LLC,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
MIKART LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART LLC,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
MIKART LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
MIKART LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C10 Nervous System Diseases,ERGOTAMINE TARTRATE,581.67,2.6,3,6,3,4,118.21,7.78,9.69
MIKART LLC,C04 Neoplasms,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
MIKART LLC,C08 Respiratory Tract Diseases,METHAZOLAMIDE,236.28,-0.59,1,6,1,1,107.41,,7.21
MIKART LLC,C04 Neoplasms,METHAZOLAMIDE,236.28,-0.59,1,6,1,1,107.41,,7.21
MIKART LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C06 Digestive System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
MIKART LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C10 Nervous System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
MIKART LLC,C11 Eye Diseases,METHAZOLAMIDE,236.28,-0.59,1,6,1,1,107.41,,7.21
MIKART LLC,F03 Mental Disorders,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
MIKART LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
MIKART LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MIKART LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MISSION PHARMACAL CO,C04 Neoplasms,POTASSIUM IODIDE,166,,,,,,,,
MISSION PHARMACAL CO,C15 Hemic and Lymphatic Diseases,POTASSIUM IODIDE,166,,,,,,,,
MISSION PHARMACAL CO,G08 Reproductive and Urinary Physiological Phenomena,POTASSIUM IODIDE,166,,,,,,,,
MISSION PHARMACAL CO,C10 Nervous System Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MISSION PHARMACAL CO,C13 Female Urogenital Diseases and Pregnancy Complications,POTASSIUM IODIDE,166,,,,,,,,
MISSION PHARMACAL CO,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
MISSION PHARMACAL CO,C04 Neoplasms,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
MISSION PHARMACAL CO,C01 Infections,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
MISSION PHARMACAL CO,C12 Male Urogenital Diseases,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
MISSION PHARMACAL CO,C01 Infections,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MISSION PHARMACAL CO,C09 Otorhinolaryngologic Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MISSION PHARMACAL CO,C10 Nervous System Diseases,ACETOHYDROXAMIC ACID,75.07,-1.03,0,2,2,0,49.33,,8.94
MISSION PHARMACAL CO,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
MISSION PHARMACAL CO,C10 Nervous System Diseases,TIOPRONIN,163.2,-0.53,0,3,3,3,66.4,,3.86
MISSION PHARMACAL CO,C06 Digestive System Diseases,TIOPRONIN,163.2,-0.53,0,3,3,3,66.4,,3.86
MISSION PHARMACAL CO,C11 Eye Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MISSION PHARMACAL CO,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
MISSION PHARMACAL CO,C08 Respiratory Tract Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MOBERG PHARMA NORTH AMERICA LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MOBERG PHARMA NORTH AMERICA LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
MONARCH PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
MONARCH PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MONARCH PHARMACEUTICALS LLC,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
MONARCH PHARMACEUTICALS LLC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MONARCH PHARMACEUTICALS LLC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MONARCH PHARMACEUTICALS LLC,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
MONARCH PHARMACEUTICALS LLC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MONARCH PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
MONARCH PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
MONARCH PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MONARCH PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MONARCH PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
MONARCH PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
MONARCH PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MONARCH PHARMACEUTICALS LLC,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
MONARCH PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MONARCH PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
MSD INTERNATIONAL GMBH,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MSD INTERNATIONAL GMBH,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MSD INTERNATIONAL GMBH,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MSD INTERNATIONAL GMBH,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MSD INTERNATIONAL GMBH,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MSD INTERNATIONAL GMBH,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MSD INTERNATIONAL GMBH,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MSD INTERNATIONAL GMBH,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSD INTERNATIONAL GMBH,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
MSN LABORATORIES PRIVATE LTD,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,F01 Behavior and Behavior Mechanisms,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MSN LABORATORIES PRIVATE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
MSN LABORATORIES PRIVATE LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
MSN LABORATORIES PRIVATE LTD,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
MSN LABORATORIES PRIVATE LTD,F03 Mental Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MSN LABORATORIES PRIVATE LTD,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
MSN LABORATORIES PRIVATE LTD,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C06 Digestive System Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
MSN LABORATORIES PRIVATE LTD,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C04 Neoplasms,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
MSN LABORATORIES PRIVATE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
MSN LABORATORIES PRIVATE LTD,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C11 Eye Diseases,TRIENTINE HYDROCHLORIDE,146.24,-2.15,0,4,4,7,76.1,9.77,
MSN LABORATORIES PRIVATE LTD,C05 Musculoskeletal Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MSN LABORATORIES PRIVATE LTD,C12 Male Urogenital Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
MSN LABORATORIES PRIVATE LTD,C10 Nervous System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
MSN LABORATORIES PRIVATE LTD,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C12 Male Urogenital Diseases,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
MSN LABORATORIES PRIVATE LTD,C04 Neoplasms,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
MSN LABORATORIES PRIVATE LTD,C01 Infections,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
MSN LABORATORIES PRIVATE LTD,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
MSN LABORATORIES PRIVATE LTD,C25 Chemically-Induced Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MSN LABORATORIES PRIVATE LTD,C06 Digestive System Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
MSN LABORATORIES PRIVATE LTD,C10 Nervous System Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MSN LABORATORIES PRIVATE LTD,C11 Eye Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
MSN LABORATORIES PRIVATE LTD,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MSN LABORATORIES PRIVATE LTD,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
MSN LABORATORIES PRIVATE LTD,C20 Immune System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
MSN LABORATORIES PRIVATE LTD,C04 Neoplasms,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
MUTUAL PHARMACEUTICAL CO INC,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MUTUAL PHARMACEUTICAL CO INC,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MUTUAL PHARMACEUTICAL CO INC,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MUTUAL PHARMACEUTICAL CO INC,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
MUTUAL PHARMACEUTICAL CO INC,F03 Mental Disorders,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
MUTUAL PHARMACEUTICAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
MUTUAL PHARMACEUTICAL CO INC,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
MUTUAL PHARMACEUTICAL CO INC,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
MUTUAL PHARMACEUTICAL CO INC,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
MUTUAL PHARMACEUTICAL CO INC,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
MUTUAL PHARMACEUTICAL CO INC,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MUTUAL PHARMACEUTICAL CO INC,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
MUTUAL PHARMACEUTICAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
MUTUAL PHARMACEUTICAL CO INC,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
MUTUAL PHARMACEUTICAL CO INC,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
MUTUAL PHARMACEUTICAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C10 Nervous System Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
MUTUAL PHARMACEUTICAL CO INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MUTUAL PHARMACEUTICAL CO INC,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
MUTUAL PHARMACEUTICAL CO INC,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MUTUAL PHARMACEUTICAL CO INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MUTUAL PHARMACEUTICAL CO INC,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MUTUAL PHARMACEUTICAL CO INC,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MUTUAL PHARMACEUTICAL CO INC,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C17 Skin and Connective Tissue Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
MUTUAL PHARMACEUTICAL CO INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MUTUAL PHARMACEUTICAL CO INC,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MUTUAL PHARMACEUTICAL CO INC,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MUTUAL PHARMACEUTICAL CO INC,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MUTUAL PHARMACEUTICAL CO INC,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MUTUAL PHARMACEUTICAL CO INC,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MUTUAL PHARMACEUTICAL CO INC,C17 Skin and Connective Tissue Diseases,MINOXIDIL,209.25,0,1,5,2,1,95.11,1.69,
MUTUAL PHARMACEUTICAL CO INC,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MUTUAL PHARMACEUTICAL CO INC,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MUTUAL PHARMACEUTICAL CO INC,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
MUTUAL PHARMACEUTICAL CO INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MUTUAL PHARMACEUTICAL CO INC,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C14 Cardiovascular Diseases,MINOXIDIL,209.25,0,1,5,2,1,95.11,1.69,
MUTUAL PHARMACEUTICAL CO INC,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MUTUAL PHARMACEUTICAL CO INC,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MUTUAL PHARMACEUTICAL CO INC,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN IRELAND LTD,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
MYLAN IRELAND LTD,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN IRELAND LTD,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN IRELAND LTD,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN IRELAND LTD,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
MYLAN IRELAND LTD,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
MYLAN IRELAND LTD,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
MYLAN IRELAND LTD,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN IRELAND LTD,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
MYLAN IRELAND LTD,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
MYLAN IRELAND LTD,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN IRELAND LTD,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN IRELAND LTD,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
MYLAN IRELAND LTD,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
MYLAN IRELAND LTD,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
MYLAN IRELAND LTD,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
MYLAN LABORATORIES LTD,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
MYLAN LABORATORIES LTD,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MYLAN LABORATORIES LTD,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MYLAN LABORATORIES LTD,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
MYLAN LABORATORIES LTD,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MYLAN LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MYLAN LABORATORIES LTD,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MYLAN LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MYLAN LABORATORIES LTD,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MYLAN LABORATORIES LTD,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MYLAN LABORATORIES LTD,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MYLAN LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MYLAN LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
MYLAN LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MYLAN LABORATORIES LTD,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MYLAN LABORATORIES LTD,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
MYLAN LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MYLAN LABORATORIES LTD,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MYLAN LABORATORIES LTD,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MYLAN LABORATORIES LTD,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MYLAN LABORATORIES LTD,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MYLAN LABORATORIES LTD,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MYLAN LABORATORIES LTD,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MYLAN LABORATORIES LTD,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MYLAN LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MYLAN LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MYLAN LABORATORIES LTD,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MYLAN LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
MYLAN LABORATORIES LTD,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MYLAN LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
MYLAN LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MYLAN LABORATORIES LTD,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MYLAN LABORATORIES LTD,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
MYLAN LABORATORIES LTD,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
MYLAN LABORATORIES LTD,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MYLAN LABORATORIES LTD,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
MYLAN LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MYLAN LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MYLAN LABORATORIES LTD,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
MYLAN LABORATORIES LTD,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MYLAN LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
MYLAN LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
MYLAN LABORATORIES LTD,C04 Neoplasms,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
MYLAN LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MYLAN LABORATORIES LTD,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MYLAN LABORATORIES LTD,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
MYLAN LABORATORIES LTD,C01 Infections,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
MYLAN LABORATORIES LTD,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
MYLAN LABORATORIES LTD,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN LABORATORIES LTD,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C01 Infections,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C10 Nervous System Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C15 Hemic and Lymphatic Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C04 Neoplasms,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS,C26 Wounds and Injuries,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS,C06 Digestive System Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,C08 Respiratory Tract Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,C05 Musculoskeletal Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,C14 Cardiovascular Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,TRANEXAMIC ACID,157.21,-1.55,0,2,2,2,63.32,10.22,4.56
MYLAN PHARMACEUTICALS,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C01 Infections,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,EXEMESTANE,296.41,3.87,0,2,0,0,34.14,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
MYLAN PHARMACEUTICALS INC,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYSTEAMINE BITARTRATE,77.15,-0.42,0,2,2,1,26.02,10.4,9.42
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
MYLAN PHARMACEUTICALS INC,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CYSTEAMINE BITARTRATE,77.15,-0.42,0,2,2,1,26.02,10.4,9.42
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,CYSTEAMINE BITARTRATE,77.15,-0.42,0,2,2,1,26.02,10.4,9.42
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MYLAN PHARMACEUTICALS INC,C01 Infections,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
MYLAN PHARMACEUTICALS INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,EPROSARTAN MESYLATE,424.52,3.75,3,5,2,10,92.42,6.67,3.47
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
MYLAN PHARMACEUTICALS INC,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CYSTEAMINE BITARTRATE,77.15,-0.42,0,2,2,1,26.02,10.4,9.42
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
MYLAN PHARMACEUTICALS INC,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ETOPOSIDE,588.56,1.16,2,13,3,5,160.83,,9.33
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ETOPOSIDE,588.56,1.16,2,13,3,5,160.83,,9.33
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,ETOPOSIDE,588.56,1.16,2,13,3,5,160.83,,9.33
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ETOPOSIDE,588.56,1.16,2,13,3,5,160.83,,9.33
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
MYLAN PHARMACEUTICALS INC,C01 Infections,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
MYLAN PHARMACEUTICALS INC,C01 Infections,ETOPOSIDE,588.56,1.16,2,13,3,5,160.83,,9.33
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,TOLBUTAMIDE,270.35,2.3,1,3,2,5,75.27,,4.33
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TOLBUTAMIDE,270.35,2.3,1,3,2,5,75.27,,4.33
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C01 Infections,TOLBUTAMIDE,270.35,2.3,1,3,2,5,75.27,,4.33
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ETOPOSIDE,588.56,1.16,2,13,3,5,160.83,,9.33
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
MYLAN PHARMACEUTICALS INC,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
MYLAN PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
MYLAN PHARMACEUTICALS INC,C01 Infections,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,FLUPHENAZINE HYDROCHLORIDE,437.53,3.97,2,5,1,6,29.95,7.81,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MYLAN PHARMACEUTICALS INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
MYLAN PHARMACEUTICALS INC,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,QUINAPRIL HYDROCHLORIDE,438.52,1.96,2,5,2,9,95.94,5.2,3.7
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TOLTERODINE TARTRATE,325.5,5.12,2,2,1,7,23.47,11.01,10.28
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ALMOTRIPTAN MALATE,335.47,1.52,2,3,1,6,56.41,9.55,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TOLBUTAMIDE,270.35,2.3,1,3,2,5,75.27,,4.33
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METHYCLOTHIAZIDE,360.24,0.53,1,5,2,2,109.57,,9.29
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
MYLAN PHARMACEUTICALS INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,SULINDAC,356.42,2.93,2,2,1,4,54.37,,4.09
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DESMOPRESSIN ACETATE,1069.24,,,,,,,,
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
MYLAN PHARMACEUTICALS INC,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
MYLAN PHARMACEUTICALS INC,C01 Infections,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,G07 Physiological Phenomena,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NICARDIPINE HYDROCHLORIDE,479.53,3.56,2,8,1,9,111.01,8.1,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
MYLAN PHARMACEUTICALS INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,SULINDAC,356.42,2.93,2,2,1,4,54.37,,4.09
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
MYLAN PHARMACEUTICALS INC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NISOLDIPINE,388.42,3.06,1,7,1,6,107.77,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN PHARMACEUTICALS INC,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C01 Infections,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C01 Infections,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MYLAN PHARMACEUTICALS INC,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C01 Infections,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
MYLAN PHARMACEUTICALS INC,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,C01 Infections,SUNITINIB MALATE,398.48,2.93,2,3,3,7,77.23,9.04,11.46
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,SUNITINIB MALATE,398.48,2.93,2,3,3,7,77.23,9.04,11.46
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,SUNITINIB MALATE,398.48,2.93,2,3,3,7,77.23,9.04,11.46
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TOLAZAMIDE,311.41,1.91,1,4,2,3,78.51,1.61,4.07
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
MYLAN PHARMACEUTICALS INC,D01 Inorganic Chemicals,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,A10 Tissues,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,NICARDIPINE HYDROCHLORIDE,479.53,3.56,2,8,1,9,111.01,8.1,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CHLOROTHIAZIDE,295.73,-0.31,1,5,2,1,118.69,,6.49
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ACAMPROSATE CALCIUM,181.21,-2.75,0,3,2,4,83.47,,-0.88
MYLAN PHARMACEUTICALS INC,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CHLOROTHIAZIDE,295.73,-0.31,1,5,2,1,118.69,,6.49
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
MYLAN PHARMACEUTICALS INC,C01 Infections,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
MYLAN PHARMACEUTICALS INC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,CHLOROGUANIDE HYDROCHLORIDE,253.74,2.38,1,2,5,2,83.79,10.4,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ALFUZOSIN HYDROCHLORIDE,389.46,1.19,2,8,2,8,111.83,7.3,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
MYLAN PHARMACEUTICALS INC,C01 Infections,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METOLAZONE,365.84,2.94,2,4,2,2,92.5,,9.54
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,LEVOTHYROXINE SODIUM,776.87,3.73,2,4,3,5,92.78,9.43,0.27
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN PHARMACEUTICALS INC,C01 Infections,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
MYLAN PHARMACEUTICALS INC,C01 Infections,CHLOROGUANIDE HYDROCHLORIDE,253.74,2.38,1,2,5,2,83.79,10.4,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,CLOMIPRAMINE HYDROCHLORIDE,314.86,4.88,2,2,0,4,6.48,9.2,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
MYLAN PHARMACEUTICALS INC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
MYLAN PHARMACEUTICALS INC,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,TIMOLOL MALEATE,316.43,1.34,1,8,2,6,79.74,9.76,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,TIMOLOL MALEATE,316.43,1.34,1,8,2,6,79.74,9.76,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
MYLAN PHARMACEUTICALS INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PRAZOSIN HYDROCHLORIDE,383.41,1.65,3,8,1,4,106.95,7.24,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
MYLAN PHARMACEUTICALS INC,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,TIMOLOL MALEATE,316.43,1.34,1,8,2,6,79.74,9.76,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,THIOTHIXENE,443.64,3.36,2,5,0,5,43.86,8.16,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,CHLORDIAZEPOXIDE,299.76,0.19,2,3,1,1,50.46,7.06,-2.69
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,CHLORDIAZEPOXIDE,299.76,0.19,2,3,1,1,50.46,7.06,-2.69
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MYLAN PHARMACEUTICALS INC,C01 Infections,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,CHLORDIAZEPOXIDE,299.76,0.19,2,3,1,1,50.46,7.06,-2.69
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
MYLAN PHARMACEUTICALS INC,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
MYLAN PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
MYLAN PHARMACEUTICALS INC,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PRASUGREL HYDROCHLORIDE,373.45,4.31,2,5,0,5,46.61,5.12,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MYLAN PHARMACEUTICALS INC,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ERLOTINIB HYDROCHLORIDE,393.44,3.2,3,7,1,10,74.73,4.62,
MYLAN PHARMACEUTICALS INC,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MYLAN PHARMACEUTICALS INC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
MYLAN PHARMACEUTICALS INC,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
MYLAN PHARMACEUTICALS INC,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
MYLAN PHARMACEUTICALS INC,C01 Infections,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C01 Infections,STAVUDINE,224.22,-0.23,1,5,2,2,84.32,,9.95
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C01 Infections,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
MYLAN PHARMACEUTICALS INC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
MYLAN PHARMACEUTICALS INC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MYLAN PHARMACEUTICALS INC,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
MYLAN PHARMACEUTICALS INC,C01 Infections,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C01 Infections,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
MYLAN PHARMACEUTICALS INC,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,SOTALOL HYDROCHLORIDE,272.37,-0.4,1,4,3,6,78.43,9.43,10.07
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,NABUMETONE,228.29,3.22,2,2,0,4,26.3,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,MERCAPTOPURINE,152.18,0.35,2,4,2,0,54.46,2.19,7.51
MYLAN PHARMACEUTICALS INC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,MERCAPTOPURINE,152.18,0.35,2,4,2,0,54.46,2.19,7.51
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MERCAPTOPURINE,152.18,0.35,2,4,2,0,54.46,2.19,7.51
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
MYLAN PHARMACEUTICALS INC,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C01 Infections,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,INDAPAMIDE,365.84,2.64,2,4,2,3,92.5,0.1,8.85
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ACEBUTOLOL HYDROCHLORIDE,336.43,1.53,1,5,3,10,87.66,9.57,13.91
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,SUMATRIPTAN SUCCINATE,295.41,0.74,2,3,2,6,65.2,9.54,11.24
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C01 Infections,FOSAMPRENAVIR CALCIUM,585.62,1.92,2,8,4,13,177.72,2.45,1.22
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
MYLAN PHARMACEUTICALS INC,C01 Infections,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
MYLAN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MYLAN PHARMACEUTICALS INC,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
MYLAN PHARMACEUTICALS INC,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
MYLAN PHARMACEUTICALS INC,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
MYLAN PHARMACEUTICALS INC,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
MYLAN PHARMACEUTICALS INC,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
MYLAN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,C01 Infections,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MYLAN PHARMACEUTICALS INC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
MYLAN PHARMACEUTICALS INC,C01 Infections,ATAZANAVIR SULFATE,704.87,4.54,3,9,5,14,171.22,4.42,11.92
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
MYLAN PHARMACEUTICALS INC,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
MYLAN PHARMACEUTICALS INC,C01 Infections,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CHLORPROPAMIDE,276.75,1.94,1,3,2,4,75.27,,3.33
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
MYLAN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
MYLAN PHARMACEUTICALS INC,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PINDOLOL,248.33,1.69,2,3,3,6,57.28,9.67,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,PINDOLOL,248.33,1.69,2,3,3,6,57.28,9.67,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
MYLAN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
MYLAN PHARMACEUTICALS INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
MYLAN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,RASAGILINE MESYLATE,171.24,2.3,1,1,1,2,12.03,8.4,
MYLAN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
MYLAN PHARMACEUTICALS INC,C19 Endocrine System Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
MYLAN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
MYLAN PHARMACEUTICALS INC,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
MYLAN PHARMACEUTICALS INC,C11 Eye Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
MYLAN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
MYLAN PHARMACEUTICALS INC,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
MYLAN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
MYLAN PHARMACEUTICALS INC,C06 Digestive System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
MYLAN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
MYLAN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
MYLAN PHARMACEUTICALS INC,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
MYLAN PHARMACEUTICALS INC,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
MYLAN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
MYLAN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
MYLAN SPECIALTY LP,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,C20 Immune System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C10 Nervous System Diseases,NABILONE,372.55,6.36,1,3,1,6,46.53,,9.33
MYLAN SPECIALTY LP,C05 Musculoskeletal Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C25 Chemically-Induced Disorders,NABILONE,372.55,6.36,1,3,1,6,46.53,,9.33
MYLAN SPECIALTY LP,A10 Tissues,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C05 Musculoskeletal Diseases,NABILONE,372.55,6.36,1,3,1,6,46.53,,9.33
MYLAN SPECIALTY LP,C04 Neoplasms,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C12 Male Urogenital Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,F03 Mental Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C14 Cardiovascular Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,F01 Behavior and Behavior Mechanisms,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,C06 Digestive System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C07 Stomatognathic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C25 Chemically-Induced Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C17 Skin and Connective Tissue Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
MYLAN SPECIALTY LP,C12 Male Urogenital Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
MYLAN SPECIALTY LP,C26 Wounds and Injuries,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C18 Nutritional and Metabolic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C10 Nervous System Diseases,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
MYLAN SPECIALTY LP,F03 Mental Disorders,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
MYLAN SPECIALTY LP,C01 Infections,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C08 Respiratory Tract Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
MYLAN SPECIALTY LP,C17 Skin and Connective Tissue Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,D01 Inorganic Chemicals,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,"C23 Pathological Conditions, Signs and Symptoms",SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,C13 Female Urogenital Diseases and Pregnancy Complications,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C11 Eye Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,C14 Cardiovascular Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
MYLAN SPECIALTY LP,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,C04 Neoplasms,PENICILLAMINE,149.22,-2.15,0,3,3,2,63.32,9.09,2.56
MYLAN SPECIALTY LP,C18 Nutritional and Metabolic Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
MYLAN SPECIALTY LP,C13 Female Urogenital Diseases and Pregnancy Complications,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
MYLAN SPECIALTY LP,C06 Digestive System Diseases,PENICILLAMINE,149.22,-2.15,0,3,3,2,63.32,9.09,2.56
MYLAN SPECIALTY LP,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,C09 Otorhinolaryngologic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C10 Nervous System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,G07 Physiological Phenomena,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,C15 Hemic and Lymphatic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C08 Respiratory Tract Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,F03 Mental Disorders,NABILONE,372.55,6.36,1,3,1,6,46.53,,9.33
MYLAN SPECIALTY LP,C19 Endocrine System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
MYLAN SPECIALTY LP,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
MYLAN SPECIALTY LP,"C23 Pathological Conditions, Signs and Symptoms",NABILONE,372.55,6.36,1,3,1,6,46.53,,9.33
NATCO PHARMA LTD,C05 Musculoskeletal Diseases,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
NATCO PHARMA LTD,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
NATCO PHARMA LTD,C14 Cardiovascular Diseases,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
NATCO PHARMA LTD,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NATCO PHARMA LTD,C04 Neoplasms,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
NATCO PHARMA LTD,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NATCO PHARMA LTD,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NATCO PHARMA LTD,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NATCO PHARMA LTD,C14 Cardiovascular Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
NATCO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,F03 Mental Disorders,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
NATCO PHARMA LTD,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NATCO PHARMA LTD,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NATCO PHARMA LTD,C06 Digestive System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NATCO PHARMA LTD,C01 Infections,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
NATCO PHARMA LTD,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NATCO PHARMA LTD,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NATCO PHARMA LTD,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NATCO PHARMA LTD,C11 Eye Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,C04 Neoplasms,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
NATCO PHARMA LTD,C01 Infections,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
NATCO PHARMA LTD,C08 Respiratory Tract Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
NATCO PHARMA LTD,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NATCO PHARMA LTD,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NATCO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NATCO PHARMA LTD,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NATCO PHARMA LTD,C12 Male Urogenital Diseases,LANTHANUM CARBONATE,457.84,,,,,,,,
NATCO PHARMA LTD,C17 Skin and Connective Tissue Diseases,CHLOROQUINE PHOSPHATE,319.88,3.93,2,3,1,8,28.16,10.32,
NATCO PHARMA LTD,C26 Wounds and Injuries,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
NATCO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
NATCO PHARMA LTD,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NATCO PHARMA LTD,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NATCO PHARMA LTD,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
NATCO PHARMA LTD,C10 Nervous System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NATCO PHARMA LTD,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NATCO PHARMA LTD,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
NATCO PHARMA LTD,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NATCO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
NATCO PHARMA LTD,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NATCO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NATCO PHARMA LTD,C17 Skin and Connective Tissue Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,C08 Respiratory Tract Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,C10 Nervous System Diseases,ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
NATCO PHARMA LTD,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NATCO PHARMA LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
NATCO PHARMA LTD,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
NATCO PHARMA LTD,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NATCO PHARMA LTD,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
NATCO PHARMA LTD,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
NATCO PHARMA LTD,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
NATCO PHARMA LTD,C18 Nutritional and Metabolic Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,C04 Neoplasms,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
NATCO PHARMA LTD,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
NATCO PHARMA LTD,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NATCO PHARMA LTD,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
NATCO PHARMA LTD,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NATCO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
NATCO PHARMA LTD,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
NATCO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
NATCO PHARMA LTD,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NATCO PHARMA LTD,"C23 Pathological Conditions, Signs and Symptoms",ARMODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
NATCO PHARMA LTD,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
NATCO PHARMA LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
NATCO PHARMA LTD,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
NATCO PHARMA LTD,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NAVINTA LLC,C11 Eye Diseases,TRIENTINE HYDROCHLORIDE,146.24,-2.15,0,4,4,7,76.1,9.77,
NEOPHARMA INC,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
NEOPHARMA INC,C09 Otorhinolaryngologic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
NEOPHARMA INC,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NEOPHARMA INC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
NEOPHARMA INC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
NEOPHARMA INC,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NEOPHARMA INC,C01 Infections,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
NEOPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NEOPHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NEOPHARMA INC,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NEOPHARMA INC,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NEOPHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
NEOPHARMA INC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
NEOPHARMA INC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
NEOPHARMA INC,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NEOPHARMA INC,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NEOPHARMA INC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
NEOPHARMA INC,C07 Stomatognathic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
NEOPHARMA INC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
NEOPHARMA INC,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
NEOPHARMA INC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
NEOPHARMA INC,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NEOPHARMA INC,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NEOPHARMA INC,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
NEOPHARMA INC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
NEOPHARMA INC,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NEOPHARMA INC,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
NEOPHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
NEOPHARMA INC,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NEOPHARMA INC,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NEOPHARMA INC,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NEOPHARMA INC,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NEOPHARMA INC,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NEOPHARMA INC,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
NEOPHARMA INC,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NEOPHARMA INC,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
NEOPHARMA INC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
NEOPHARMA INC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
NEOPHARMA INC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
NEOPHARMA INC,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
NEOPHARMA INC,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
NESHER PHARMACEUTICALS USA LLC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NESHER PHARMACEUTICALS USA LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
NESHER PHARMACEUTICALS USA LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
NESHER PHARMACEUTICALS USA LLC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
NESHER PHARMACEUTICALS USA LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
NESHER PHARMACEUTICALS USA LLC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NESHER PHARMACEUTICALS USA LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NESHER PHARMACEUTICALS USA LLC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
NESHER PHARMACEUTICALS USA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
NESHER PHARMACEUTICALS USA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NESHER PHARMACEUTICALS USA LLC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
NESHER PHARMACEUTICALS USA LLC,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
NESHER PHARMACEUTICALS USA LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
NESHER PHARMACEUTICALS USA LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
NESHER PHARMACEUTICALS USA LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NESHER PHARMACEUTICALS USA LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
NESHER PHARMACEUTICALS USA LLC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NESHER PHARMACEUTICALS USA LLC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NESHER PHARMACEUTICALS USA LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NESHER PHARMACEUTICALS USA LLC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NESHER PHARMACEUTICALS USA LLC,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
NESHER PHARMACEUTICALS USA LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
NEXGEN PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
NEXGEN PHARMA INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
NEXGEN PHARMA INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C06 Digestive System Diseases,CHENODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
NEXGEN PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CHENODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
NEXGEN PHARMA INC,C10 Nervous System Diseases,CHENODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
NEXGEN PHARMA INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NEXGEN PHARMA INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NEXGEN PHARMA INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NEXGEN PHARMA INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NEXGEN PHARMA INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
NEXGEN PHARMA INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NEXGEN PHARMA INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
NEXGEN PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NEXGEN PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
NEXGEN PHARMA INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,F03 Mental Disorders,MECAMYLAMINE HYDROCHLORIDE,167.3,2.37,0,1,1,1,12.03,10.88,
NEXGEN PHARMA INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NEXGEN PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NORTHSTAR HEALTHCARE HOLDINGS LTD,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
NORTHSTAR HEALTHCARE HOLDINGS LTD,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
NORTHSTAR HEALTHCARE HOLDINGS LTD,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
NORTHSTAR HEALTHCARE HOLDINGS LTD,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
NORTHSTAR HEALTHCARE HOLDINGS LTD,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
NORTHSTAR HEALTHCARE HOLDINGS LTD,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
NORTHSTAR HEALTHCARE HOLDINGS LTD,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
NORTHSTAR HEALTHCARE HOLDINGS LTD,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
NORTHSTAR HEALTHCARE HOLDINGS LTD,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
NORTHSTAR HEALTHCARE HOLDINGS LTD,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
NORTHSTAR HEALTHCARE HOLDINGS LTD,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
NORTHSTAR HEALTHCARE HOLDINGS LTD,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
NORTHSTAR HEALTHCARE HOLDINGS LTD,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
NORTHSTAR HEALTHCARE HOLDINGS LTD,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
NORTHSTAR HEALTHCARE HOLDINGS LTD,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
NORTHSTAR HEALTHCARE HOLDINGS LTD,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
NORTHSTAR HEALTHCARE HOLDINGS LTD,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
NORTHSTAR HEALTHCARE HOLDINGS LTD,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
NORTHSTAR HEALTHCARE HOLDINGS LTD,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
NORTHSTAR HEALTHCARE HOLDINGS LTD,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
NORTHSTAR HEALTHCARE HOLDINGS LTD,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
NORTHSTAR HEALTHCARE HOLDINGS LTD,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
NORTHSTAR HEALTHCARE HOLDINGS LTD,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
NORTHSTAR HEALTHCARE HOLDINGS LTD,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
NOSTRUM LABORATORIES INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
NOSTRUM LABORATORIES INC,C14 Cardiovascular Diseases,PINDOLOL,248.33,1.69,2,3,3,6,57.28,9.67,
NOSTRUM LABORATORIES INC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
NOSTRUM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOSTRUM LABORATORIES INC,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
NOSTRUM LABORATORIES INC,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOSTRUM LABORATORIES INC,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
NOSTRUM LABORATORIES INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM LABORATORIES INC,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM LABORATORIES INC,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
NOSTRUM LABORATORIES INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOSTRUM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOSTRUM LABORATORIES INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOSTRUM LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM LABORATORIES INC,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM LABORATORIES INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
NOSTRUM LABORATORIES INC,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOSTRUM LABORATORIES INC,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM LABORATORIES INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
NOSTRUM LABORATORIES INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
NOSTRUM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
NOSTRUM LABORATORIES INC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
NOSTRUM LABORATORIES INC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
NOSTRUM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
NOSTRUM LABORATORIES INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM LABORATORIES INC,C15 Hemic and Lymphatic Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOSTRUM LABORATORIES INC,C10 Nervous System Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOSTRUM LABORATORIES INC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
NOSTRUM LABORATORIES INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOSTRUM LABORATORIES INC,C08 Respiratory Tract Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOSTRUM LABORATORIES INC,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOSTRUM LABORATORIES INC,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOSTRUM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM LABORATORIES INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
NOSTRUM LABORATORIES INC,C04 Neoplasms,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOSTRUM LABORATORIES INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM LABORATORIES INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOSTRUM LABORATORIES INC,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOSTRUM LABORATORIES INC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
NOSTRUM LABORATORIES INC,F03 Mental Disorders,PINDOLOL,248.33,1.69,2,3,3,6,57.28,9.67,
NOSTRUM LABORATORIES INC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
NOSTRUM LABORATORIES INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
NOSTRUM LABORATORIES INC,C01 Infections,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOSTRUM LABORATORIES INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOSTRUM LABORATORIES INC,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOSTRUM LABORATORIES INC,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOSTRUM LABORATORIES INC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
NOSTRUM LABORATORIES INC,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
NOSTRUM LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOSTRUM LABORATORIES INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOSTRUM LABORATORIES INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM LABORATORIES INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM LABORATORIES INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM LABORATORIES INC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
NOSTRUM LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOSTRUM PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM PHARMACEUTICALS LLC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM PHARMACEUTICALS LLC,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOSTRUM PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM PHARMACEUTICALS LLC,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOSTRUM PHARMACEUTICALS LLC,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,FINGOLIMOD HYDROCHLORIDE,307.48,4.06,1,3,3,12,66.48,9.38,
NOVARTIS PHARMACEUTICALS CORP,C06 Digestive System Diseases,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
NOVARTIS PHARMACEUTICALS CORP,C11 Eye Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
NOVARTIS PHARMACEUTICALS CORP,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
NOVARTIS PHARMACEUTICALS CORP,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
NOVARTIS PHARMACEUTICALS CORP,C17 Skin and Connective Tissue Diseases,NILOTINIB HYDROCHLORIDE MONOHYDRATE,529.53,5.36,5,7,2,6,97.62,5.92,12.38
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
NOVARTIS PHARMACEUTICALS CORP,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,PAZOPANIB HYDROCHLORIDE,437.53,3.55,4,8,2,5,119.03,4.36,10.41
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,NILOTINIB HYDROCHLORIDE MONOHYDRATE,529.53,5.36,5,7,2,6,97.62,5.92,12.38
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,ELTROMBOPAG OLAMINE,442.48,6.03,3,6,3,5,114.59,,3.97
NOVARTIS PHARMACEUTICALS CORP,C12 Male Urogenital Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
NOVARTIS PHARMACEUTICALS CORP,C15 Hemic and Lymphatic Diseases,ELTROMBOPAG OLAMINE,442.48,6.03,3,6,3,5,114.59,,3.97
NOVARTIS PHARMACEUTICALS CORP,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,NILOTINIB HYDROCHLORIDE MONOHYDRATE,529.53,5.36,5,7,2,6,97.62,5.92,12.38
NOVARTIS PHARMACEUTICALS CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
NOVARTIS PHARMACEUTICALS CORP,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVARTIS PHARMACEUTICALS CORP,C08 Respiratory Tract Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVARTIS PHARMACEUTICALS CORP,C11 Eye Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C15 Hemic and Lymphatic Diseases,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NOVARTIS PHARMACEUTICALS CORP,C18 Nutritional and Metabolic Diseases,FLUVASTATIN SODIUM,411.47,3.83,3,4,3,8,82.69,,4.54
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,C15 Hemic and Lymphatic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C15 Hemic and Lymphatic Diseases,TOPOTECAN HYDROCHLORIDE,421.45,-0.33,3,8,2,3,104.89,9.75,8
NOVARTIS PHARMACEUTICALS CORP,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NOVARTIS PHARMACEUTICALS CORP,C15 Hemic and Lymphatic Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C20 Immune System Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,C18 Nutritional and Metabolic Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,ARTEMETHER,298.38,3.48,0,5,0,1,46.15,,
NOVARTIS PHARMACEUTICALS CORP,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
NOVARTIS PHARMACEUTICALS CORP,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVARTIS PHARMACEUTICALS CORP,C25 Chemically-Induced Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVARTIS PHARMACEUTICALS CORP,C05 Musculoskeletal Diseases,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NOVARTIS PHARMACEUTICALS CORP,C14 Cardiovascular Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,C08 Respiratory Tract Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
NOVARTIS PHARMACEUTICALS CORP,C20 Immune System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
NOVARTIS PHARMACEUTICALS CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
NOVARTIS PHARMACEUTICALS CORP,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVARTIS PHARMACEUTICALS CORP,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
NOVARTIS PHARMACEUTICALS CORP,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,DEFERASIROX,373.37,4.74,4,6,3,4,108.47,,4.51
NOVARTIS PHARMACEUTICALS CORP,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,LAPATINIB DITOSYLATE,581.07,4.64,5,8,2,11,106.35,7.26,
NOVARTIS PHARMACEUTICALS CORP,C17 Skin and Connective Tissue Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,FLUVASTATIN SODIUM,411.47,3.83,3,4,3,8,82.69,,4.54
NOVARTIS PHARMACEUTICALS CORP,C06 Digestive System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
NOVARTIS PHARMACEUTICALS CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,C18 Nutritional and Metabolic Diseases,NATEGLINIDE,317.43,4.03,1,2,2,6,66.4,,4
NOVARTIS PHARMACEUTICALS CORP,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,TOPOTECAN HYDROCHLORIDE,421.45,-0.33,3,8,2,3,104.89,9.75,8
NOVARTIS PHARMACEUTICALS CORP,C11 Eye Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,C12 Male Urogenital Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,"C23 Pathological Conditions, Signs and Symptoms",EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
NOVARTIS PHARMACEUTICALS CORP,"C23 Pathological Conditions, Signs and Symptoms",TOPOTECAN HYDROCHLORIDE,421.45,-0.33,3,8,2,3,104.89,9.75,8
NOVARTIS PHARMACEUTICALS CORP,C05 Musculoskeletal Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
NOVARTIS PHARMACEUTICALS CORP,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,ARTEMETHER,298.38,3.48,0,5,0,1,46.15,,
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
NOVARTIS PHARMACEUTICALS CORP,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,TERBINAFINE HYDROCHLORIDE,291.44,5.53,2,1,0,4,3.24,8.86,
NOVARTIS PHARMACEUTICALS CORP,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVARTIS PHARMACEUTICALS CORP,F03 Mental Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
NOVARTIS PHARMACEUTICALS CORP,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
NOVARTIS PHARMACEUTICALS CORP,C12 Male Urogenital Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVARTIS PHARMACEUTICALS CORP,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NOVARTIS PHARMACEUTICALS CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
NOVARTIS PHARMACEUTICALS CORP,C07 Stomatognathic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
NOVARTIS PHARMACEUTICALS CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C14 Cardiovascular Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C20 Immune System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVARTIS PHARMACEUTICALS CORP,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
NOVARTIS PHARMACEUTICALS CORP,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NOVARTIS PHARMACEUTICALS CORP,C06 Digestive System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C14 Cardiovascular Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,LUMEFANTRINE,528.95,9.19,3,2,1,10,23.47,9.78,
NOVARTIS PHARMACEUTICALS CORP,C10 Nervous System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
NOVARTIS PHARMACEUTICALS CORP,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NOVARTIS PHARMACEUTICALS CORP,"C23 Pathological Conditions, Signs and Symptoms",CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NOVARTIS PHARMACEUTICALS CORP,C06 Digestive System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,C17 Skin and Connective Tissue Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C26 Wounds and Injuries,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C18 Nutritional and Metabolic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
NOVARTIS PHARMACEUTICALS CORP,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVARTIS PHARMACEUTICALS CORP,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
NOVARTIS PHARMACEUTICALS CORP,C01 Infections,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
NOVARTIS PHARMACEUTICALS CORP,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
NOVAST LABORATORIES LTD,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
NOVAST LABORATORIES LTD,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
NOVAST LABORATORIES LTD,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C04 Neoplasms,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVAST LABORATORIES LTD,C05 Musculoskeletal Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
NOVAST LABORATORIES LTD,C04 Neoplasms,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
NOVAST LABORATORIES LTD,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
NOVAST LABORATORIES LTD,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DESMOPRESSIN ACETATE,1069.24,,,,,,,,
NOVAST LABORATORIES LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
NOVAST LABORATORIES LTD,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
NOVAST LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
NOVAST LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
NOVAST LABORATORIES LTD,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOVAST LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
NOVAST LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
NOVAST LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
NOVAST LABORATORIES LTD,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
NOVAST LABORATORIES LTD,C01 Infections,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
NOVAST LABORATORIES LTD,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
NOVAST LABORATORIES LTD,C07 Stomatognathic Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
NOVAST LABORATORIES LTD,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
NOVAST LABORATORIES LTD,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,PRIMAQUINE PHOSPHATE,259.35,1.64,2,4,2,6,60.17,10.2,
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOVAST LABORATORIES LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOVAST LABORATORIES LTD,C12 Male Urogenital Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
NOVAST LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
NOVAST LABORATORIES LTD,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
NOVAST LABORATORIES LTD,C26 Wounds and Injuries,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
NOVAST LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
NOVAST LABORATORIES LTD,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOVAST LABORATORIES LTD,C01 Infections,PRIMAQUINE PHOSPHATE,259.35,1.64,2,4,2,6,60.17,10.2,
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
NOVAST LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
NOVAST LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVAST LABORATORIES LTD,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C12 Male Urogenital Diseases,DESMOPRESSIN ACETATE,1069.24,,,,,,,,
NOVAST LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVAST LABORATORIES LTD,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVAST LABORATORIES LTD,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C06 Digestive System Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
NOVAST LABORATORIES LTD,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
NOVAST LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOVAST LABORATORIES LTD,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
NOVAST LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOVAST LABORATORIES LTD,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
NOVAST LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
NOVAST LABORATORIES LTD,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOVAST LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
NOVAST LABORATORIES LTD,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
NOVAST LABORATORIES LTD,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
NOVAST LABORATORIES LTD,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
NOVAST LABORATORIES LTD,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
NOVAST LABORATORIES LTD,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C04 Neoplasms,NORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
NOVAST LABORATORIES LTD,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
NOVAST LABORATORIES LTD,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
NOVAST LABORATORIES LTD,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
NOVAST LABORATORIES LTD,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
NOVAST LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVAST LABORATORIES LTD,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVAST LABORATORIES LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOVAST LABORATORIES LTD,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
NOVAST LABORATORIES LTD,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVAST LABORATORIES LTD,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
NOVAST LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
NOVAST LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVAST LABORATORIES LTD,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOVAST LABORATORIES LTD,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
NOVAST LABORATORIES LTD,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
NOVAST LABORATORIES LTD,C05 Musculoskeletal Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
NOVAST LABORATORIES LTD,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
NOVAST LABORATORIES LTD,C01 Infections,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
NOVAST LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
NOVAST LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
NOVAST LABORATORIES LTD,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOVAST LABORATORIES LTD,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
NOVAST LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
NOVAST LABORATORIES LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
NOVAST LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
NOVAST LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
NOVAST LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
NOVAST LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
NOVAST LABORATORIES LTD,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
NOVAST LABORATORIES LTD,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
NOVAST LABORATORIES LTD,C11 Eye Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
NOVAST LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
NOVAST LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
NOVAST LABORATORIES LTD,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
NOVEL LABORATORIES INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
NOVEL LABORATORIES INC,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
NOVEL LABORATORIES INC,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
NOVEL LABORATORIES INC,F03 Mental Disorders,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
NOVEL LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
NOVEL LABORATORIES INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
NOVEL LABORATORIES INC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVEL LABORATORIES INC,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
NOVEL LABORATORIES INC,C09 Otorhinolaryngologic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C04 Neoplasms,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
NOVEL LABORATORIES INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
NOVEL LABORATORIES INC,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVEL LABORATORIES INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
NOVEL LABORATORIES INC,C06 Digestive System Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
NOVEL LABORATORIES INC,C01 Infections,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
NOVEL LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVEL LABORATORIES INC,G07 Physiological Phenomena,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C11 Eye Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
NOVEL LABORATORIES INC,C04 Neoplasms,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
NOVEL LABORATORIES INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOVEL LABORATORIES INC,C19 Endocrine System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
NOVEL LABORATORIES INC,C08 Respiratory Tract Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
NOVEL LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
NOVEL LABORATORIES INC,C10 Nervous System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
NOVEL LABORATORIES INC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVEL LABORATORIES INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVEL LABORATORIES INC,C01 Infections,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
NOVEL LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLERGONOVINE MALEATE,339.44,1.59,2,3,3,4,68.36,7.93,
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
NOVEL LABORATORIES INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVEL LABORATORIES INC,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
NOVEL LABORATORIES INC,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOVEL LABORATORIES INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
NOVEL LABORATORIES INC,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
NOVEL LABORATORIES INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOVEL LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
NOVEL LABORATORIES INC,C06 Digestive System Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVEL LABORATORIES INC,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
NOVEL LABORATORIES INC,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
NOVEL LABORATORIES INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
NOVEL LABORATORIES INC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C15 Hemic and Lymphatic Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVEL LABORATORIES INC,C09 Otorhinolaryngologic Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C10 Nervous System Diseases,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
NOVEL LABORATORIES INC,C01 Infections,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
NOVEL LABORATORIES INC,C04 Neoplasms,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
NOVEL LABORATORIES INC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C08 Respiratory Tract Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
NOVEL LABORATORIES INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
NOVEL LABORATORIES INC,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
NOVEL LABORATORIES INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
NOVEL LABORATORIES INC,C01 Infections,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C25 Chemically-Induced Disorders,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
NOVEL LABORATORIES INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
NOVEL LABORATORIES INC,C11 Eye Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
NOVEL LABORATORIES INC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVEL LABORATORIES INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
NOVEL LABORATORIES INC,C05 Musculoskeletal Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
NOVEL LABORATORIES INC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
NOVEL LABORATORIES INC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVEL LABORATORIES INC,C06 Digestive System Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
NOVEL LABORATORIES INC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
NOVEL LABORATORIES INC,C04 Neoplasms,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
NOVEL LABORATORIES INC,C10 Nervous System Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C04 Neoplasms,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
NOVEL LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
NOVEL LABORATORIES INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C18 Nutritional and Metabolic Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
NOVEL LABORATORIES INC,C01 Infections,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C08 Respiratory Tract Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C01 Infections,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
NOVEL LABORATORIES INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOVEL LABORATORIES INC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C14 Cardiovascular Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
NOVEL LABORATORIES INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
NOVEL LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
NOVEL LABORATORIES INC,C04 Neoplasms,PHENELZINE SULFATE,136.2,1.2,1,2,2,3,38.05,5.55,
NOVEL LABORATORIES INC,C05 Musculoskeletal Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
NOVEL LABORATORIES INC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
NOVEL LABORATORIES INC,F01 Behavior and Behavior Mechanisms,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
NOVEL LABORATORIES INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
NOVEL LABORATORIES INC,C26 Wounds and Injuries,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
NOVEL LABORATORIES INC,C10 Nervous System Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
NOVEL LABORATORIES INC,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
NOVEL LABORATORIES INC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
NOVEL LABORATORIES INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
NOVEL LABORATORIES INC,C14 Cardiovascular Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,F03 Mental Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
NOVEL LABORATORIES INC,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
NOVEL LABORATORIES INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C04 Neoplasms,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C25 Chemically-Induced Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C07 Stomatognathic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
NOVEL LABORATORIES INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVEL LABORATORIES INC,C17 Skin and Connective Tissue Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
NOVEL LABORATORIES INC,C18 Nutritional and Metabolic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
NOVEL LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
NOVEL LABORATORIES INC,C20 Immune System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C12 Male Urogenital Diseases,MAGNESIUM SULFATE,120.37,,,,,,,,
NOVEL LABORATORIES INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C05 Musculoskeletal Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
NOVEL LABORATORIES INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVEL LABORATORIES INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NOVEL LABORATORIES INC,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
NOVEL LABORATORIES INC,F01 Behavior and Behavior Mechanisms,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
NOVEL LABORATORIES INC,D01 Inorganic Chemicals,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,A10 Tissues,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C15 Hemic and Lymphatic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
NOVEL LABORATORIES INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
NOVEL LABORATORIES INC,C06 Digestive System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
NOVEL LABORATORIES INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
NOVEL LABORATORIES INC,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
NOVEL LABORATORIES INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
NOVEL LABORATORIES INC,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
NOVEL LABORATORIES INC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
NOVEL LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
NOVEL LABORATORIES INC,C26 Wounds and Injuries,SODIUM CHLORIDE,58.44,,,,,,,,
NOVELGENIX THERAPEUTICS PVT LTD,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
NOVELGENIX THERAPEUTICS PVT LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
NOVELGENIX THERAPEUTICS PVT LTD,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
NOVELGENIX THERAPEUTICS PVT LTD,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
NOVITIUM PHARMA LLC,C08 Respiratory Tract Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,C08 Respiratory Tract Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOVITIUM PHARMA LLC,F03 Mental Disorders,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,G07 Physiological Phenomena,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C01 Infections,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOVITIUM PHARMA LLC,C14 Cardiovascular Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C04 Neoplasms,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOVITIUM PHARMA LLC,F03 Mental Disorders,THIOTHIXENE,443.64,3.36,2,5,0,5,43.86,8.16,
NOVITIUM PHARMA LLC,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,C18 Nutritional and Metabolic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C17 Skin and Connective Tissue Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOVITIUM PHARMA LLC,C11 Eye Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,C14 Cardiovascular Diseases,PRAZOSIN HYDROCHLORIDE,383.41,1.65,3,8,1,4,106.95,7.24,
NOVITIUM PHARMA LLC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
NOVITIUM PHARMA LLC,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,C12 Male Urogenital Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C15 Hemic and Lymphatic Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NOVITIUM PHARMA LLC,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,C15 Hemic and Lymphatic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,C04 Neoplasms,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C05 Musculoskeletal Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C10 Nervous System Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C25 Chemically-Induced Disorders,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C20 Immune System Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C01 Infections,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C17 Skin and Connective Tissue Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C14 Cardiovascular Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
NOVITIUM PHARMA LLC,C07 Stomatognathic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
NOVITIUM PHARMA LLC,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
NOVITIUM PHARMA LLC,C10 Nervous System Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
NOVITIUM PHARMA LLC,C10 Nervous System Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
NUVO PHAMACEUTICALS INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
NUVO PHAMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
NUVO PHAMACEUTICALS INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
NUVO PHAMACEUTICALS INC,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
NUVO PHAMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OC PHARMA LLC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
OC PHARMA LLC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
OC PHARMA LLC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
OC PHARMA LLC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
OC PHARMA LLC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
OC PHARMA LLC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
OC PHARMA LLC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
OC PHARMA LLC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
OC PHARMA LLC,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
OC PHARMA LLC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
OC PHARMA LLC,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
OC PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
OC PHARMA LLC,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
OC PHARMA LLC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OC PHARMA LLC,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
OC PHARMA LLC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
OHM CORP,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM CORP,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
OHM LABORATORIES INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
OHM LABORATORIES INC,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
OHM LABORATORIES INC,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
OHM LABORATORIES INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
OHM LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
OHM LABORATORIES INC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
OHM LABORATORIES INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
OHM LABORATORIES INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
OHM LABORATORIES INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
OHM LABORATORIES INC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
OHM LABORATORIES INC,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
OHM LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
OHM LABORATORIES INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
OHM LABORATORIES INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
OHM LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
OHM LABORATORIES INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
OHM LABORATORIES INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ORCHID HEALTHCARE,C01 Infections,TERBINAFINE HYDROCHLORIDE,291.44,5.53,2,1,0,4,3.24,8.86,
ORCHID HEALTHCARE,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ORCHID HEALTHCARE,C05 Musculoskeletal Diseases,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
ORCHID HEALTHCARE,C25 Chemically-Induced Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ORCHID HEALTHCARE,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ORCHID HEALTHCARE,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ORCHID HEALTHCARE,C01 Infections,CEFUROXIME AXETIL,510.48,-0.43,1,12,2,9,189.06,,10.92
ORCHID HEALTHCARE,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
ORCHID HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
ORCHID HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
ORCHID HEALTHCARE,C04 Neoplasms,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
ORCHID HEALTHCARE,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORCHID HEALTHCARE,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ORCHID HEALTHCARE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ORCHID HEALTHCARE,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORCHID HEALTHCARE,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
ORCHID HEALTHCARE,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
ORCHID HEALTHCARE,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ORCHID HEALTHCARE,F03 Mental Disorders,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
ORCHID HEALTHCARE,C10 Nervous System Diseases,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
ORCHID HEALTHCARE,F01 Behavior and Behavior Mechanisms,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
ORCHID HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ORCHID HEALTHCARE,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ORCHID HEALTHCARE,C12 Male Urogenital Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ORCHID HEALTHCARE,C04 Neoplasms,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ORCHID HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
ORCHID HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
ORCHID HEALTHCARE,C01 Infections,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ORCHID HEALTHCARE,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ORCHID HEALTHCARE,C17 Skin and Connective Tissue Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ORCHID HEALTHCARE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
ORCHID HEALTHCARE,C10 Nervous System Diseases,NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
ORCHID HEALTHCARE,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ORCHID HEALTHCARE,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
ORCHID HEALTHCARE,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORCHID HEALTHCARE,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
ORCHID HEALTHCARE,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ORCHID HEALTHCARE,C04 Neoplasms,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
ORCHID HEALTHCARE,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ORCHID HEALTHCARE,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORCHID HEALTHCARE,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
ORCHID HEALTHCARE,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ORCHID HEALTHCARE,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORCHID HEALTHCARE,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ORCHID HEALTHCARE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
ORCHID HEALTHCARE,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ORCHID HEALTHCARE,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ORCHID HEALTHCARE,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
ORCHID HEALTHCARE,C01 Infections,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
ORCHID HEALTHCARE,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ORCHID HEALTHCARE,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ORCHID HEALTHCARE,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
ORCHID HEALTHCARE,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ORCHID HEALTHCARE,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORCHID HEALTHCARE,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,C10 Nervous System Diseases,SUMATRIPTAN SUCCINATE,295.41,0.74,2,3,2,6,65.2,9.54,11.24
ORCHID HEALTHCARE,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ORCHID HEALTHCARE,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
ORCHID HEALTHCARE,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,C20 Immune System Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
ORCHID HEALTHCARE,C01 Infections,CEFADROXIL,363.39,-2.45,1,6,4,4,132.96,7.22,3.25
ORCHID HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ORCHID HEALTHCARE,F03 Mental Disorders,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
ORCHID HEALTHCARE,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ORCHID HEALTHCARE,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ORCHID HEALTHCARE,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ORCHID HEALTHCARE,C09 Otorhinolaryngologic Diseases,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
ORCHID HEALTHCARE,C04 Neoplasms,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ORCHID HEALTHCARE,C01 Infections,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
ORCHID HEALTHCARE,C11 Eye Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
ORCHID HEALTHCARE,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
ORCHID HEALTHCARE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
ORCHID HEALTHCARE,C10 Nervous System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ORCHID HEALTHCARE,C10 Nervous System Diseases,RASAGILINE MESYLATE,171.24,2.3,1,1,1,2,12.03,8.4,
ORCHID HEALTHCARE,C04 Neoplasms,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
ORCHID HEALTHCARE,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ORCHID HEALTHCARE,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,F03 Mental Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ORCHID HEALTHCARE,C04 Neoplasms,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
ORCHID HEALTHCARE,C01 Infections,CEFPODOXIME PROXETIL,557.61,1.33,1,14,2,10,180.97,3.28,10.99
ORCHID HEALTHCARE,C06 Digestive System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ORCHID HEALTHCARE,C05 Musculoskeletal Diseases,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
ORCHID HEALTHCARE,C08 Respiratory Tract Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
ORCHID HEALTHCARE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ORCHID HEALTHCARE,C01 Infections,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
ORCHID HEALTHCARE,C01 Infections,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ORCHID HEALTHCARE,C01 Infections,CEFPROZIL,389.43,-1.92,1,6,4,5,132.96,7.22,3.3
ORCHID HEALTHCARE,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
ORCHID HEALTHCARE,C08 Respiratory Tract Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ORCHID HEALTHCARE,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ORCHID HEALTHCARE,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ORCHID HEALTHCARE,C01 Infections,GEMIFLOXACIN MESYLATE,389.39,-0.91,2,8,2,5,123.04,9.23,5.35
ORCHID HEALTHCARE,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,C17 Skin and Connective Tissue Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
ORCHID HEALTHCARE,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ORCHID HEALTHCARE,C09 Otorhinolaryngologic Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
ORIENT PHARMA CO LTD,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ORIENT PHARMA CO LTD,C06 Digestive System Diseases,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
ORIENT PHARMA CO LTD,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ORIENT PHARMA CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ORIENT PHARMA CO LTD,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ORIENT PHARMA CO LTD,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ORIENT PHARMA CO LTD,C01 Infections,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
ORION PHARMA,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ORION PHARMA,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ORION PHARMA,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ORION PHARMA,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ORION PHARMA,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ORION PHARMA,C10 Nervous System Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
ORION PHARMA,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ORION PHARMA,C25 Chemically-Induced Disorders,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
ORION PHARMA,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ORION PHARMA,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ORION PHARMA,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ORION PHARMA,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ORION PHARMA,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ORION PHARMA,C18 Nutritional and Metabolic Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
ORION PHARMA,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ORION PHARMA,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ORION PHARMA,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
ORIT LABORATORIES LLC,C01 Infections,CLINDAMYCIN PALMITATE HYDROCHLORIDE,663.41,7.96,0,8,3,22,108.33,7.55,12.59
ORIT LABORATORIES LLC,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
ORIT LABORATORIES LLC,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
ORIT LABORATORIES LLC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
ORIT LABORATORIES LLC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,C06 Digestive System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORIT LABORATORIES LLC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORIT LABORATORIES LLC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ORIT LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ORIT LABORATORIES LLC,F03 Mental Disorders,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C14 Cardiovascular Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
ORIT LABORATORIES LLC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,G08 Reproductive and Urinary Physiological Phenomena,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C12 Male Urogenital Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ORIT LABORATORIES LLC,C14 Cardiovascular Diseases,BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
ORIT LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C19 Endocrine System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORIT LABORATORIES LLC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
ORIT LABORATORIES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ORIT LABORATORIES LLC,C01 Infections,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C26 Wounds and Injuries,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORIT LABORATORIES LLC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ORIT LABORATORIES LLC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ORIT LABORATORIES LLC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
ORIT LABORATORIES LLC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ORIT LABORATORIES LLC,C10 Nervous System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C05 Musculoskeletal Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORIT LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
ORIT LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ORIT LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
ORIT LABORATORIES LLC,C08 Respiratory Tract Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C04 Neoplasms,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ORIT LABORATORIES LLC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
ORIT LABORATORIES LLC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
ORIT LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
ORIT LABORATORIES LLC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
ORIT LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
OSMOTICA PHARMACEUTICAL,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
OSMOTICA PHARMACEUTICAL,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
OSMOTICA PHARMACEUTICAL,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
OSMOTICA PHARMACEUTICAL,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
OTSUKA PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,TOLVAPTAN,448.95,5.35,3,3,2,3,69.64,,
OTSUKA PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,TOLVAPTAN,448.95,5.35,3,3,2,3,69.64,,
OTSUKA PHARMACEUTICAL CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
OTSUKA PHARMACEUTICAL CO LTD,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
OTSUKA PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,TOLVAPTAN,448.95,5.35,3,3,2,3,69.64,,
OTSUKA PHARMACEUTICAL CO LTD,C04 Neoplasms,TOLVAPTAN,448.95,5.35,3,3,2,3,69.64,,
OTSUKA PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
OTSUKA PHARMACEUTICAL CO LTD,C06 Digestive System Diseases,TOLVAPTAN,448.95,5.35,3,3,2,3,69.64,,
OTSUKA PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,TOLVAPTAN,448.95,5.35,3,3,2,3,69.64,,
OTSUKA PHARMACEUTICAL CO LTD,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
OTSUKA PHARMACEUTICAL CO LTD,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
OXFORD PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
OXFORD PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
OXFORD PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
OXFORD PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
OXFORD PHARMACEUTICALS LLC,C04 Neoplasms,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
OXFORD PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
OXFORD PHARMACEUTICALS LLC,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
OXFORD PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
OXFORD PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
OXFORD PHARMACEUTICALS LLC,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
OXFORD PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
OXFORD PHARMACEUTICALS LLC,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C06 Digestive System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C11 Eye Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
OXFORD PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
OXFORD PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
OXFORD PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
OXFORD PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
OXFORD PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
OXFORD PHARMACEUTICALS LLC,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,PRIMIDONE,218.26,1.12,1,2,2,2,58.2,,11.5
OXFORD PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
OXFORD PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
OXFORD PHARMACEUTICALS LLC,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
OXFORD PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
OXFORD PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
OXFORD PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
OXFORD PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
OXFORD PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
OXFORD PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
OXFORD PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
OXFORD PHARMACEUTICALS LLC,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
OXFORD PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
OXFORD PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
OXFORD PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
OXFORD PHARMACEUTICALS LLC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
OXFORD PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
OXFORD PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
OXFORD PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
OXFORD PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,SOTALOL HYDROCHLORIDE,272.37,-0.4,1,4,3,6,78.43,9.43,10.07
OXFORD PHARMACEUTICALS LLC,C06 Digestive System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
OXFORD PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
OXFORD PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
OXFORD PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
OXFORD PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
OXFORD PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
OXFORD PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
OXFORD PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
OXFORD PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
OXFORD PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
OXFORD PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
OXFORD PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
OXFORD PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
OXFORD PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
OXFORD PHARMACEUTICALS LLC,C19 Endocrine System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
OXFORD PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
OXFORD PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
OXFORD PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
OXFORD PHARMACEUTICALS LLC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C04 Neoplasms,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
OXFORD PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
OXFORD PHARMACEUTICALS LLC,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
OXFORD PHARMACEUTICALS LLC,C10 Nervous System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,C01 Infections,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
OXFORD PHARMACEUTICALS LLC,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
OXFORD PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
OXFORD PHARMACEUTICALS LLC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
OXFORD PHARMACEUTICALS LLC,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PADDOCK LABORATORIES LLC,C08 Respiratory Tract Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
PADDOCK LABORATORIES LLC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PADDOCK LABORATORIES LLC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PADDOCK LABORATORIES LLC,C07 Stomatognathic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C08 Respiratory Tract Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
PADDOCK LABORATORIES LLC,C10 Nervous System Diseases,NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
PADDOCK LABORATORIES LLC,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PADDOCK LABORATORIES LLC,C06 Digestive System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
PADDOCK LABORATORIES LLC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PADDOCK LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PADDOCK LABORATORIES LLC,F03 Mental Disorders,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
PADDOCK LABORATORIES LLC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PADDOCK LABORATORIES LLC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
PADDOCK LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
PADDOCK LABORATORIES LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PADDOCK LABORATORIES LLC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PADDOCK LABORATORIES LLC,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PADDOCK LABORATORIES LLC,A10 Tissues,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C11 Eye Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,C01 Infections,CLINDAMYCIN PALMITATE HYDROCHLORIDE,663.41,7.96,0,8,3,22,108.33,7.55,12.59
PADDOCK LABORATORIES LLC,C12 Male Urogenital Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C08 Respiratory Tract Diseases,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
PADDOCK LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
PADDOCK LABORATORIES LLC,C08 Respiratory Tract Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
PADDOCK LABORATORIES LLC,C06 Digestive System Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
PADDOCK LABORATORIES LLC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PADDOCK LABORATORIES LLC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PADDOCK LABORATORIES LLC,C01 Infections,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
PADDOCK LABORATORIES LLC,C04 Neoplasms,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,F03 Mental Disorders,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
PADDOCK LABORATORIES LLC,C10 Nervous System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
PADDOCK LABORATORIES LLC,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PADDOCK LABORATORIES LLC,C05 Musculoskeletal Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C01 Infections,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
PADDOCK LABORATORIES LLC,C20 Immune System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PADDOCK LABORATORIES LLC,C05 Musculoskeletal Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
PADDOCK LABORATORIES LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PADDOCK LABORATORIES LLC,C25 Chemically-Induced Disorders,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
PADDOCK LABORATORIES LLC,C01 Infections,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
PADDOCK LABORATORIES LLC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PADDOCK LABORATORIES LLC,C10 Nervous System Diseases,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
PADDOCK LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PADDOCK LABORATORIES LLC,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
PADDOCK LABORATORIES LLC,C12 Male Urogenital Diseases,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
PADDOCK LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
PADDOCK LABORATORIES LLC,C14 Cardiovascular Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
PADDOCK LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
PADDOCK LABORATORIES LLC,F01 Behavior and Behavior Mechanisms,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PADDOCK LABORATORIES LLC,C06 Digestive System Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
PADDOCK LABORATORIES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PADDOCK LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PADDOCK LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PADDOCK LABORATORIES LLC,C05 Musculoskeletal Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
PADDOCK LABORATORIES LLC,C25 Chemically-Induced Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PADDOCK LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
PADDOCK LABORATORIES LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PADDOCK LABORATORIES LLC,C12 Male Urogenital Diseases,TROSPIUM CHLORIDE,392.52,-0.5,2,3,1,4,46.53,,11.05
PADDOCK LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PADDOCK LABORATORIES LLC,C04 Neoplasms,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
PADDOCK LABORATORIES LLC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
PADDOCK LABORATORIES LLC,C01 Infections,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
PADDOCK LABORATORIES LLC,C14 Cardiovascular Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C01 Infections,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
PADDOCK LABORATORIES LLC,F03 Mental Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C12 Male Urogenital Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
PADDOCK LABORATORIES LLC,C04 Neoplasms,ATOVAQUONE,366.84,5,2,3,1,2,54.37,,5.73
PADDOCK LABORATORIES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
PADDOCK LABORATORIES LLC,C10 Nervous System Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
PADDOCK LABORATORIES LLC,C19 Endocrine System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C26 Wounds and Injuries,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C09 Otorhinolaryngologic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C01 Infections,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PADDOCK LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
PADDOCK LABORATORIES LLC,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PADDOCK LABORATORIES LLC,C10 Nervous System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,D01 Inorganic Chemicals,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,G07 Physiological Phenomena,SODIUM CHLORIDE,58.44,,,,,,,,
PADDOCK LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
PADDOCK LABORATORIES LLC,C19 Endocrine System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
PAR PHARMACEUTICAL,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
PAR PHARMACEUTICAL,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,PYRIDOXINE HYDROCHLORIDE,169.18,-0.95,1,4,3,2,73.58,5.58,9.4
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
PAR PHARMACEUTICAL INC,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
PAR PHARMACEUTICAL INC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
PAR PHARMACEUTICAL INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PAR PHARMACEUTICAL INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
PAR PHARMACEUTICAL INC,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,ALOSETRON HYDROCHLORIDE,294.36,1.21,3,3,1,2,53.92,6.81,13.32
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,PIMOZIDE,461.56,5.83,4,3,1,7,41.03,8.38,12.9
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
PAR PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,PIMOZIDE,461.56,5.83,4,3,1,7,41.03,8.38,12.9
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
PAR PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
PAR PHARMACEUTICAL INC,C01 Infections,DOXYLAMINE SUCCINATE,270.38,2.96,2,3,0,6,25.36,8.87,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,METAPROTERENOL SULFATE,211.26,0.21,1,4,4,4,72.72,9.7,8.84
PAR PHARMACEUTICAL INC,F03 Mental Disorders,PIMOZIDE,461.56,5.83,4,3,1,7,41.03,8.38,12.9
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,METAPROTERENOL SULFATE,211.26,0.21,1,4,4,4,72.72,9.7,8.84
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,ZAFIRLUKAST,575.69,6.4,4,7,2,8,115.73,,4.29
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PAR PHARMACEUTICAL INC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
PAR PHARMACEUTICAL INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C11 Eye Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
PAR PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PAR PHARMACEUTICAL INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C11 Eye Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
PAR PHARMACEUTICAL INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
PAR PHARMACEUTICAL INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",PYRIDOXINE HYDROCHLORIDE,169.18,-0.95,1,4,3,2,73.58,5.58,9.4
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C01 Infections,PYRIDOXINE HYDROCHLORIDE,169.18,-0.95,1,4,3,2,73.58,5.58,9.4
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C01 Infections,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PAR PHARMACEUTICAL INC,C04 Neoplasms,PYRIDOXINE HYDROCHLORIDE,169.18,-0.95,1,4,3,2,73.58,5.58,9.4
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
PAR PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PAR PHARMACEUTICAL INC,C04 Neoplasms,ZAFIRLUKAST,575.69,6.4,4,7,2,8,115.73,,4.29
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PAR PHARMACEUTICAL INC,F03 Mental Disorders,IMIPRAMINE HYDROCHLORIDE,280.42,4.28,2,2,0,4,6.48,9.2,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
PAR PHARMACEUTICAL INC,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
PAR PHARMACEUTICAL INC,C04 Neoplasms,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
PAR PHARMACEUTICAL INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PAR PHARMACEUTICAL INC,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",DEXLANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PAR PHARMACEUTICAL INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,C04 Neoplasms,CLOMIPHENE CITRATE,405.97,6.47,3,2,0,9,12.47,9.31,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,NATEGLINIDE,317.43,4.03,1,2,2,6,66.4,,4
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,C04 Neoplasms,DEXLANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C04 Neoplasms,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PAR PHARMACEUTICAL INC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
PAR PHARMACEUTICAL INC,C04 Neoplasms,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
PAR PHARMACEUTICAL INC,C01 Infections,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
PAR PHARMACEUTICAL INC,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PAR PHARMACEUTICAL INC,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
PAR PHARMACEUTICAL INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
PAR PHARMACEUTICAL INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,DEXLANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PAR PHARMACEUTICAL INC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
PAR PHARMACEUTICAL INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
PAR PHARMACEUTICAL INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,CLOMIPHENE CITRATE,405.97,6.47,3,2,0,9,12.47,9.31,
PAR PHARMACEUTICAL INC,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
PAR PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C01 Infections,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
PAR PHARMACEUTICAL INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
PAR PHARMACEUTICAL INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,MINOXIDIL,209.25,0,1,5,2,1,95.11,1.69,
PAR PHARMACEUTICAL INC,C04 Neoplasms,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,CLOMIPHENE CITRATE,405.97,6.47,3,2,0,9,12.47,9.31,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,DOFETILIDE,441.58,0.24,2,6,2,11,104.81,8.99,10.15
PAR PHARMACEUTICAL INC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
PAR PHARMACEUTICAL INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
PAR PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
PAR PHARMACEUTICAL INC,C01 Infections,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PAR PHARMACEUTICAL INC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C04 Neoplasms,FLUTAMIDE,276.21,3.27,1,3,1,3,72.24,,12.81
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,FLUTAMIDE,276.21,3.27,1,3,1,3,72.24,,12.81
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
PAR PHARMACEUTICAL INC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PAR PHARMACEUTICAL INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,MINOXIDIL,209.25,0,1,5,2,1,95.11,1.69,
PAR PHARMACEUTICAL INC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
PAR PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,CABERGOLINE,451.62,2.58,2,4,2,8,71.68,9.32,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
PAR PHARMACEUTICAL INC,C11 Eye Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C04 Neoplasms,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PAR PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C01 Infections,PRAZIQUANTEL,312.41,2.3,1,2,0,1,40.62,,
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PAR PHARMACEUTICAL INC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
PAR PHARMACEUTICAL INC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PAR PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PAR PHARMACEUTICAL INC,C04 Neoplasms,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
PAR PHARMACEUTICAL INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PAR PHARMACEUTICAL INC,C04 Neoplasms,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,ESTAZOLAM,294.75,2.9,3,4,0,1,43.07,4.9,
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
PAR PHARMACEUTICAL INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PAR PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
PAR PHARMACEUTICAL INC,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
PAR PHARMACEUTICAL INC,C04 Neoplasms,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PAR PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
PAR PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
PAR PHARMACEUTICAL INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PAR PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PAR PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PAR PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PAR PHARMACEUTICAL INC,C12 Male Urogenital Diseases,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
PAR PHARMACEUTICAL INC,C06 Digestive System Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
PAR PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,HYDROXYUREA,76.05,-1.37,0,2,3,0,75.35,,10.14
PAR PHARMACEUTICAL INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PAR PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PAR PHARMACEUTICAL INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PARKE DAVIS DIV WARNER LAMBERT CO,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C10 Nervous System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
PARKE DAVIS DIV WARNER LAMBERT CO,C20 Immune System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
PARKE DAVIS DIV WARNER LAMBERT CO,C15 Hemic and Lymphatic Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
PARKE DAVIS DIV WARNER LAMBERT CO,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C04 Neoplasms,PHENELZINE SULFATE,136.2,1.2,1,2,2,3,38.05,5.55,
PARKE DAVIS DIV WARNER LAMBERT CO,F01 Behavior and Behavior Mechanisms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
PARKE DAVIS DIV WARNER LAMBERT CO,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C10 Nervous System Diseases,METHSUXIMIDE,203.24,1.46,1,2,0,1,37.38,,
PARKE DAVIS DIV WARNER LAMBERT CO,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C06 Digestive System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
PARKE DAVIS DIV WARNER LAMBERT CO,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C10 Nervous System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
PARKE DAVIS DIV WARNER LAMBERT CO,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,C26 Wounds and Injuries,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
PARKE DAVIS DIV WARNER LAMBERT CO,C04 Neoplasms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
PARKE DAVIS DIV WARNER LAMBERT CO,C25 Chemically-Induced Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
PARKE DAVIS DIV WARNER LAMBERT CO,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PARKE DAVIS DIV WARNER LAMBERT CO,F03 Mental Disorders,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
PARKE DAVIS DIV WARNER LAMBERT CO,F03 Mental Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
PARKE DAVIS DIV WARNER LAMBERT CO,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PERRIGO PHARMA INTERNATIONAL DAC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE SULFATE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PERRIGO PHARMA INTERNATIONAL DAC,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
PERRIGO PHARMA INTERNATIONAL DAC,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
PERRIGO PHARMA INTERNATIONAL DAC,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
PERRIGO PHARMA INTERNATIONAL DAC,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DAC,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DAC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DAC,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
PERRIGO PHARMA INTERNATIONAL DAC,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DAC,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
PERRIGO PHARMA INTERNATIONAL DAC,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
PERRIGO PHARMA INTERNATIONAL DAC,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
PERRIGO PHARMA INTERNATIONAL DAC,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DAC,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DAC,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DAC,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DAC,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY CO,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY CO,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY CO,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY CO,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY CO,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY CO,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY CO,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PERRIGO PHARMACEUTICALS CO,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO PHARMACEUTICALS CO,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO PHARMACEUTICALS CO,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO PHARMACEUTICALS CO,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO PHARMACEUTICALS CO,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO PHARMACEUTICALS CO,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO PHARMACEUTICALS CO,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO PHARMACEUTICALS CO,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO PHARMACEUTICALS CO,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO PHARMACEUTICALS CO,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO PHARMACEUTICALS CO,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO PHARMACEUTICALS CO,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO PHARMACEUTICALS CO,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PERRIGO R AND D CO,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
PERRIGO R AND D CO,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
PERRIGO R AND D CO,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
PERRIGO R AND D CO,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PERRIGO R AND D CO,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO R AND D CO,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PERRIGO R AND D CO,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
PERRIGO R AND D CO,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
PERRIGO R AND D CO,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PERRIGO R AND D CO,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
PERRIGO R AND D CO,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PERRIGO R AND D CO,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO R AND D CO,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
PERRIGO R AND D CO,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C06 Digestive System Diseases,OMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO R AND D CO,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PERRIGO R AND D CO,C19 Endocrine System Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PERRIGO R AND D CO,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PERRIGO R AND D CO,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,C12 Male Urogenital Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C04 Neoplasms,CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
PERRIGO R AND D CO,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C05 Musculoskeletal Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN SODIUM,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO R AND D CO,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C06 Digestive System Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
PERRIGO R AND D CO,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PERRIGO R AND D CO,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
PERRIGO R AND D CO,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
PERRIGO R AND D CO,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
PERRIGO R AND D CO,C10 Nervous System Diseases,DIPHENHYDRAMINE CITRATE,255.36,3.65,2,2,0,6,12.47,8.87,
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PERRIGO R AND D CO,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO R AND D CO,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C01 Infections,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
PERRIGO R AND D CO,C01 Infections,CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO R AND D CO,C26 Wounds and Injuries,CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,C08 Respiratory Tract Diseases,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
PERRIGO R AND D CO,C18 Nutritional and Metabolic Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO R AND D CO,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
PERRIGO R AND D CO,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO R AND D CO,C11 Eye Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PERRIGO R AND D CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
PERRIGO R AND D CO,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
PERRIGO R AND D CO,C15 Hemic and Lymphatic Diseases,CALCIUM CARBONATE,100.09,,,,,,,,
PERRIGO R AND D CO,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
PERRIGO R AND D CO,C14 Cardiovascular Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PERRIGO R AND D CO,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PERRIGO R AND D CO,C01 Infections,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PERRIGO R AND D CO,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PERRIGO R AND D CO,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
PERRIGO R AND D CO,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
PERRIGO R AND D CO,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO R AND D CO,C20 Immune System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PERRIGO R AND D CO,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PERRIGO R AND D CO,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
PERRIGO R AND D CO,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C08 Respiratory Tract Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PERRIGO R AND D CO,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
PERRIGO R AND D CO,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C04 Neoplasms,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PERRIGO R AND D CO,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
PERRIGO R AND D CO,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C07 Stomatognathic Diseases,DIPHENHYDRAMINE CITRATE,255.36,3.65,2,2,0,6,12.47,8.87,
PERRIGO R AND D CO,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C10 Nervous System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PERRIGO R AND D CO,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
PERRIGO R AND D CO,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
PERRIGO R AND D CO,C04 Neoplasms,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PERRIGO R AND D CO,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C08 Respiratory Tract Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PERRIGO R AND D CO,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
PERRIGO R AND D CO,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERRIGO R AND D CO,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PERSION PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PERSION PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PERSION PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PERSION PHARMACEUTICALS LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PERSION PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PERSION PHARMACEUTICALS LLC,C01 Infections,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
PERSION PHARMACEUTICALS LLC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PERSION PHARMACEUTICALS LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PERSION PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PERSION PHARMACEUTICALS LLC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PERSION PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
PERSION PHARMACEUTICALS LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PERSION PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
PF PRISM CV,F01 Behavior and Behavior Mechanisms,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PF PRISM CV,"C23 Pathological Conditions, Signs and Symptoms",PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,G08 Reproductive and Urinary Physiological Phenomena,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,F03 Mental Disorders,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C25 Chemically-Induced Disorders,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C06 Digestive System Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C18 Nutritional and Metabolic Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C10 Nervous System Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C04 Neoplasms,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C08 Respiratory Tract Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C05 Musculoskeletal Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C11 Eye Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C08 Respiratory Tract Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C12 Male Urogenital Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,C15 Hemic and Lymphatic Diseases,AXITINIB,386.48,4.15,4,4,2,5,70.67,4.59,13.07
PF PRISM CV,F03 Mental Disorders,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,"C23 Pathological Conditions, Signs and Symptoms",SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PF PRISM CV,C04 Neoplasms,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C05 Musculoskeletal Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C17 Skin and Connective Tissue Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C07 Stomatognathic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C26 Wounds and Injuries,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
PF PRISM CV,G07 Physiological Phenomena,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C11 Eye Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C25 Chemically-Induced Disorders,VARENICLINE TARTRATE,211.27,1.01,2,3,1,0,37.81,9.73,
PF PRISM CV,F01 Behavior and Behavior Mechanisms,VARENICLINE TARTRATE,211.27,1.01,2,3,1,0,37.81,9.73,
PF PRISM CV,C04 Neoplasms,AXITINIB,386.48,4.15,4,4,2,5,70.67,4.59,13.07
PF PRISM CV,C18 Nutritional and Metabolic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PF PRISM CV,C12 Male Urogenital Diseases,BOSUTINIB,530.46,4.09,3,8,1,9,82.88,8.03,
PF PRISM CV,"C23 Pathological Conditions, Signs and Symptoms",AXITINIB,386.48,4.15,4,4,2,5,70.67,4.59,13.07
PF PRISM CV,C10 Nervous System Diseases,BOSUTINIB,530.46,4.09,3,8,1,9,82.88,8.03,
PF PRISM CV,C12 Male Urogenital Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C04 Neoplasms,BOSUTINIB,530.46,4.09,3,8,1,9,82.88,8.03,
PF PRISM CV,F03 Mental Disorders,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
PF PRISM CV,C25 Chemically-Induced Disorders,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C14 Cardiovascular Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PF PRISM CV,C20 Immune System Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PF PRISM CV,C15 Hemic and Lymphatic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C10 Nervous System Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
PF PRISM CV,C05 Musculoskeletal Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
PF PRISM CV,C13 Female Urogenital Diseases and Pregnancy Complications,AXITINIB,386.48,4.15,4,4,2,5,70.67,4.59,13.07
PF PRISM CV,G08 Reproductive and Urinary Physiological Phenomena,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
PF PRISM CV,C04 Neoplasms,CRIZOTINIB,450.35,3.57,3,6,2,5,77.99,10.12,
PF PRISM CV,C01 Infections,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PF PRISM CV,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PF PRISM CV,C10 Nervous System Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
PFIZER CENTRAL RESEARCH,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CENTRAL RESEARCH,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CENTRAL RESEARCH,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CENTRAL RESEARCH,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CENTRAL RESEARCH,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CENTRAL RESEARCH,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CENTRAL RESEARCH,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CENTRAL RESEARCH,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CENTRAL RESEARCH,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CENTRAL RESEARCH,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CENTRAL RESEARCH,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CHEMICALS DIV PFIZER INC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CHEMICALS DIV PFIZER INC,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CHEMICALS DIV PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CHEMICALS DIV PFIZER INC,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CHEMICALS DIV PFIZER INC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CHEMICALS DIV PFIZER INC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CHEMICALS DIV PFIZER INC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CHEMICALS DIV PFIZER INC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER CHEMICALS DIV PFIZER INC,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
PFIZER CHEMICALS DIV PFIZER INC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
PFIZER INC,C08 Respiratory Tract Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
PFIZER INC,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C17 Skin and Connective Tissue Diseases,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
PFIZER INC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C01 Infections,CHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
PFIZER INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C12 Male Urogenital Diseases,FESOTERODINE FUMARATE,411.59,5.7,2,4,1,10,49.77,10.64,
PFIZER INC,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,C20 Immune System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PFIZER INC,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PFIZER INC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PFIZER INC,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,F03 Mental Disorders,ZIPRASIDONE HYDROCHLORIDE,412.95,4.3,3,5,1,4,48.47,7.09,12.21
PFIZER INC,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
PFIZER INC,C10 Nervous System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PFIZER INC,C04 Neoplasms,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PFIZER INC,C08 Respiratory Tract Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PFIZER INC,C04 Neoplasms,GLASDEGIB MALEATE,374.45,2.28,3,4,3,3,96.84,6.67,11.39
PFIZER INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PFIZER INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PFIZER INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PFIZER INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,F01 Behavior and Behavior Mechanisms,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
PFIZER INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PFIZER INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
PFIZER INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER INC,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PFIZER INC,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PFIZER INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
PFIZER INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
PFIZER INC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER INC,C10 Nervous System Diseases,DIPHENHYDRAMINE CITRATE,255.36,3.65,2,2,0,6,12.47,8.87,
PFIZER INC,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PFIZER INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C04 Neoplasms,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PFIZER INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C08 Respiratory Tract Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PFIZER INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,F03 Mental Disorders,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
PFIZER INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PFIZER INC,C01 Infections,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PFIZER INC,C10 Nervous System Diseases,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
PFIZER INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C11 Eye Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PFIZER INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
PFIZER INC,C14 Cardiovascular Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
PFIZER INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PFIZER INC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER INC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PFIZER INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
PFIZER INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PFIZER INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C07 Stomatognathic Diseases,DIPHENHYDRAMINE CITRATE,255.36,3.65,2,2,0,6,12.47,8.87,
PFIZER INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PFIZER INC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PFIZER INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
PFIZER INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
PFIZER INC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
PFIZER INC,C06 Digestive System Diseases,NIZATIDINE,331.47,0.77,1,8,2,10,83.33,6.54,
PFIZER LABORATORIES DIV PFIZER INC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER LABORATORIES DIV PFIZER INC,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
PFIZER LABORATORIES DIV PFIZER INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
PFIZER LABORATORIES DIV PFIZER INC,C14 Cardiovascular Diseases,PRAZOSIN HYDROCHLORIDE,383.41,1.65,3,8,1,4,106.95,7.24,
PFIZER LABORATORIES DIV PFIZER INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
PFIZER LABORATORIES DIV PFIZER INC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER LABORATORIES DIV PFIZER INC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER LABORATORIES DIV PFIZER INC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER LABORATORIES DIV PFIZER INC,F03 Mental Disorders,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
PFIZER LABORATORIES DIV PFIZER INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C17 Skin and Connective Tissue Diseases,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
PFIZER LABORATORIES DIV PFIZER INC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER LABORATORIES DIV PFIZER INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER LABORATORIES DIV PFIZER INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C01 Infections,DOXYCYCLINE CALCIUM,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
PFIZER LABORATORIES DIV PFIZER INC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
PFIZER LABORATORIES DIV PFIZER INC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER LABORATORIES DIV PFIZER INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PFIZER PHARMACEUTICALS LTD,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
PFIZER PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,QUINAPRIL HYDROCHLORIDE,438.52,1.96,2,5,2,9,95.94,5.2,3.7
PFIZER PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PFIZER PHARMACEUTICALS LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PFIZER PHARMACEUTICALS LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
PFIZER PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
PFIZER PHARMACEUTICALS LTD,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
PFIZER PHARMACEUTICALS LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PFIZER PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
PFIZER PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PFIZER PHARMACEUTICALS LTD,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
PFIZER PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
PFIZER PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
PFIZER PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PFIZER PHARMACEUTICALS LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PFIZER PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PFIZER PHARMACEUTICALS LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PFIZER PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
PHARMACEUTICAL ASSOC INC,C01 Infections,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
PHARMACEUTICAL ASSOC INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
PHARMACEUTICAL ASSOC INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
PHARMACEUTICAL ASSOC INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOC INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOC INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOC INC,C11 Eye Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
PHARMACEUTICAL ASSOC INC,C08 Respiratory Tract Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
PHARMACEUTICAL ASSOC INC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
PHARMACEUTICAL ASSOC INC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
PHARMACEUTICAL ASSOC INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOC INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
PHARMACEUTICAL ASSOC INC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
PHARMACEUTICAL ASSOC INC,C10 Nervous System Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
PHARMACEUTICAL ASSOC INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
PHARMACEUTICAL ASSOC INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOC INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOC INC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
PHARMACEUTICAL ASSOC INC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
PHARMACEUTICAL ASSOC INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOC INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C20 Immune System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
PHARMACEUTICAL ASSOCIATES INC,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
PHARMACEUTICAL ASSOCIATES INC,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
PHARMACEUTICAL ASSOCIATES INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PHARMACEUTICAL ASSOCIATES INC,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOCIATES INC,C14 Cardiovascular Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
PHARMACEUTICAL ASSOCIATES INC,C06 Digestive System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C05 Musculoskeletal Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C20 Immune System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
PHARMACEUTICAL ASSOCIATES INC,C15 Hemic and Lymphatic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C08 Respiratory Tract Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C11 Eye Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C17 Skin and Connective Tissue Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C08 Respiratory Tract Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PHARMACEUTICAL ASSOCIATES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C12 Male Urogenital Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C19 Endocrine System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C13 Female Urogenital Diseases and Pregnancy Complications,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C18 Nutritional and Metabolic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PHARMACEUTICAL ASSOCIATES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOCIATES INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOCIATES INC,C07 Stomatognathic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,"C23 Pathological Conditions, Signs and Symptoms",DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
PHARMACEUTICAL ASSOCIATES INC,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
PHARMACEUTICAL ASSOCIATES INC,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
PHARMACEUTICAL ASSOCIATES INC,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
PHARMACEUTICAL ASSOCIATES INC,C07 Stomatognathic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
PHARMACEUTICAL ASSOCIATES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
PHARMACEUTICAL ASSOCIATES INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMACEUTICAL ASSOCIATES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
PHARMACEUTICAL ASSOCIATES INC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
PHARMACEUTICAL ASSOCIATES INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMACEUTICAL ASSOCIATES INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PHARMACEUTICAL ASSOCIATES INC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
PHARMACEUTICAL ASSOCIATES INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMACEUTICAL ASSOCIATES INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMACEUTICAL ASSOCIATES INC,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
PHARMACEUTICAL ASSOCIATES INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
PHARMACEUTICAL ASSOCIATES INC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
PHARMACEUTICAL ASSOCIATES INC,C06 Digestive System Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
PHARMACEUTICAL ASSOCIATES INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
PHARMACEUTICAL ASSOCIATES INC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
PHARMACEUTICAL ASSOCIATES INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,HALOPERIDOL LACTATE,375.87,3.66,2,3,1,6,40.54,8.05,13.96
PHARMACEUTICAL ASSOCIATES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
PHARMACEUTICAL ASSOCIATES INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C26 Wounds and Injuries,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
PHARMACEUTICAL ASSOCIATES INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOCIATES INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
PHARMACEUTICAL ASSOCIATES INC,C15 Hemic and Lymphatic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
PHARMACEUTICAL ASSOCIATES INC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
PHARMACEUTICAL ASSOCIATES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
PHARMACEUTICAL ASSOCIATES INC,F03 Mental Disorders,HALOPERIDOL LACTATE,375.87,3.66,2,3,1,6,40.54,8.05,13.96
PHARMACEUTICAL ASSOCIATES INC,C12 Male Urogenital Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,FLUPHENAZINE HYDROCHLORIDE,437.53,3.97,2,5,1,6,29.95,7.81,
PHARMACEUTICAL ASSOCIATES INC,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
PHARMACEUTICAL ASSOCIATES INC,C17 Skin and Connective Tissue Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
PHARMACEUTICAL ASSOCIATES INC,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
PHARMACEUTICAL ASSOCIATES INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
PHARMACEUTICAL ASSOCIATES INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
PHARMACEUTICAL ASSOCIATES INC,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
PHARMACEUTICAL ASSOCIATES INC,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
PHARMACEUTICAL ASSOCIATES INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
PHARMACEUTICAL ASSOCIATES INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOCIATES INC,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
PHARMACEUTICAL ASSOCIATES INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
PHARMACEUTICAL ASSOCIATES INC,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
PHARMACEUTICAL ASSOCIATES INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
PHARMACEUTICAL ASSOCIATES INC,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
PHARMACEUTICAL ASSOCIATES INC,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
PHARMACEUTICAL ASSOCIATES INC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
PHARMACEUTICAL ASSOCIATES INC,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
PHARMACEUTICAL ASSOCIATES INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PHARMACEUTICAL ASSOCIATES INC,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
PHARMACEUTICAL ASSOCIATES INC,F03 Mental Disorders,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
PHARMACEUTICAL ASSOCIATES INC,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
PHARMACEUTICAL ASSOCIATES INC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
PHARMACEUTICAL ASSOCIATES INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
PHARMACEUTICAL ASSOCIATES INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PHARMACEUTICAL ASSOCIATES INC,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
PHARMACEUTICAL ASSOCIATES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
PHARMACEUTICAL ASSOCIATES INC,C06 Digestive System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
PHARMACEUTICAL ASSOCIATES INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
PHARMACEUTICAL ASSOCIATES INC,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
PHARMACEUTICS INTERNATIONAL INC,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PHARMACEUTICS INTERNATIONAL INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C08 Respiratory Tract Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C17 Skin and Connective Tissue Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C14 Cardiovascular Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C25 Chemically-Induced Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,G07 Physiological Phenomena,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PHARMACEUTICS INTERNATIONAL INC,C07 Stomatognathic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PHARMACEUTICS INTERNATIONAL INC,C19 Endocrine System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C15 Hemic and Lymphatic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C09 Otorhinolaryngologic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C26 Wounds and Injuries,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PHARMACEUTICS INTERNATIONAL INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C10 Nervous System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PHARMACEUTICS INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C06 Digestive System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C01 Infections,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C18 Nutritional and Metabolic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PHARMACEUTICS INTERNATIONAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PHARMACEUTICS INTERNATIONAL INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
PHARMACEUTICS INTERNATIONAL INC,C04 Neoplasms,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C11 Eye Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C12 Male Urogenital Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C05 Musculoskeletal Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,F03 Mental Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACEUTICS INTERNATIONAL INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
PHARMACEUTICS INTERNATIONAL INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
PHARMACEUTICS INTERNATIONAL INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
PHARMACEUTICS INTERNATIONAL INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
PHARMACEUTICS INTERNATIONAL INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
PHARMACEUTICS INTERNATIONAL INC,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
PHARMACEUTICS INTERNATIONAL INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
PHARMACEUTICS INTERNATIONAL INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
PHARMACEUTICS INTERNATIONAL INC,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
PHARMACEUTICS INTERNATIONAL INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACEUTICS INTERNATIONAL INC,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
PHARMACEUTICS INTERNATIONAL INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
PHARMACEUTICS INTERNATIONAL INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
PHARMACEUTICS INTERNATIONAL INC,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
PHARMACEUTICS INTERNATIONAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PHARMACEUTICS INTERNATIONAL INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
PHARMACIA AND UPJOHN CO,C01 Infections,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C18 Nutritional and Metabolic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C05 Musculoskeletal Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,"C23 Pathological Conditions, Signs and Symptoms",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C06 Digestive System Diseases,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
PHARMACIA AND UPJOHN CO,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PHARMACIA AND UPJOHN CO,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PHARMACIA AND UPJOHN CO,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PHARMACIA AND UPJOHN CO,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PHARMACIA AND UPJOHN CO,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
PHARMACIA AND UPJOHN CO,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
PHARMACIA AND UPJOHN CO,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PHARMACIA AND UPJOHN CO,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
PHARMACIA AND UPJOHN CO,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PHARMACIA AND UPJOHN CO,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PHARMACIA AND UPJOHN CO,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PHARMACIA AND UPJOHN CO,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
PHARMACIA AND UPJOHN CO,C04 Neoplasms,ESTRAMUSTINE PHOSPHATE SODIUM,520.39,4.98,1,4,2,7,96.3,,1.86
PHARMACIA AND UPJOHN CO,C06 Digestive System Diseases,RIFABUTIN,847.02,3.88,1,14,5,4,205.55,7.87,6.88
PHARMACIA AND UPJOHN CO,C01 Infections,RIFABUTIN,847.02,3.88,1,14,5,4,205.55,7.87,6.88
PHARMACIA AND UPJOHN CO,C26 Wounds and Injuries,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C09 Otorhinolaryngologic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C18 Nutritional and Metabolic Diseases,MIGLITOL,207.23,-3.19,0,6,5,3,104.39,7.6,12.9
PHARMACIA AND UPJOHN CO,C07 Stomatognathic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C15 Hemic and Lymphatic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C04 Neoplasms,EXEMESTANE,296.41,3.87,0,2,0,0,34.14,,
PHARMACIA AND UPJOHN CO,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PHARMACIA AND UPJOHN CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C06 Digestive System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C01 Infections,CLINDAMYCIN PALMITATE HYDROCHLORIDE,663.41,7.96,0,8,3,22,108.33,7.55,12.59
PHARMACIA AND UPJOHN CO,C10 Nervous System Diseases,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C05 Musculoskeletal Diseases,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
PHARMACIA AND UPJOHN CO,C19 Endocrine System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,"C23 Pathological Conditions, Signs and Symptoms",SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
PHARMACIA AND UPJOHN CO,C14 Cardiovascular Diseases,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C04 Neoplasms,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C25 Chemically-Induced Disorders,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,F03 Mental Disorders,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C08 Respiratory Tract Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,F01 Behavior and Behavior Mechanisms,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C15 Hemic and Lymphatic Diseases,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,G07 Physiological Phenomena,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C12 Male Urogenital Diseases,TOLTERODINE TARTRATE,325.5,5.12,2,2,1,7,23.47,11.01,10.28
PHARMACIA AND UPJOHN CO,G08 Reproductive and Urinary Physiological Phenomena,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,C17 Skin and Connective Tissue Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,C01 Infections,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
PHARMACIA AND UPJOHN CO,C10 Nervous System Diseases,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
PHARMACIA AND UPJOHN CO,C12 Male Urogenital Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,C10 Nervous System Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,C04 Neoplasms,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
PHARMACIA AND UPJOHN CO,C14 Cardiovascular Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
PHARMACIA AND UPJOHN CO,C13 Female Urogenital Diseases and Pregnancy Complications,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,C05 Musculoskeletal Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,C01 Infections,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C10 Nervous System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,F03 Mental Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C01 Infections,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMACIA AND UPJOHN CO,C14 Cardiovascular Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C08 Respiratory Tract Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C17 Skin and Connective Tissue Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C26 Wounds and Injuries,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C25 Chemically-Induced Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,G07 Physiological Phenomena,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C12 Male Urogenital Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C08 Respiratory Tract Diseases,NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C04 Neoplasms,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
PHARMACIA AND UPJOHN CO,"C23 Pathological Conditions, Signs and Symptoms",NICOTINE,162.24,1.16,1,2,0,1,16.13,8.58,
PHARMACIA AND UPJOHN CO,C11 Eye Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
PHARMACIA AND UPJOHN CO,"C23 Pathological Conditions, Signs and Symptoms",MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
PHARMADAX INC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PHARMADAX INC,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
PHARMADAX INC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PHARMADAX INC,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
PHARMADAX INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMADAX INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
PHARMADAX INC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PHARMADAX INC,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
PHARMADAX INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMADAX INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMADAX INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMADAX INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMADAX INC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PHARMADAX INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PHARMADAX INC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
PIRAMAL HEALTHCARE UK LTD,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
PIRAMAL HEALTHCARE UK LTD,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
PIRAMAL HEALTHCARE UK LTD,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
PIRAMAL HEALTHCARE UK LTD,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
PIRAMAL HEALTHCARE UK LTD,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
PIRAMAL HEALTHCARE UK LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
PLIVA INC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
PLIVA INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
PLIVA INC,C08 Respiratory Tract Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
PLIVA INC,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PLIVA INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
PLIVA INC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PLIVA INC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
PLIVA INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PLIVA INC,"C23 Pathological Conditions, Signs and Symptoms",KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
PLIVA INC,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
PLIVA INC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C11 Eye Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
PLIVA INC,"C23 Pathological Conditions, Signs and Symptoms",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
PLIVA INC,C08 Respiratory Tract Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
PLIVA INC,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
PLIVA INC,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PLIVA INC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C10 Nervous System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
PLIVA INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
PLIVA INC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
PLIVA INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PLIVA INC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,C14 Cardiovascular Diseases,WARFARIN SODIUM,308.33,2.74,3,4,1,4,67.51,,5.56
PLIVA INC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PLIVA INC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
PLIVA INC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PLIVA INC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
PLIVA INC,C04 Neoplasms,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
PLIVA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PLIVA INC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
PLIVA INC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
PLIVA INC,C14 Cardiovascular Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
PLIVA INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
PLIVA INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PLIVA INC,C06 Digestive System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
PLIVA INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PLIVA INC,C10 Nervous System Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
PLIVA INC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
PLIVA INC,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PLIVA INC,C05 Musculoskeletal Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
PLIVA INC,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PLIVA INC,"C23 Pathological Conditions, Signs and Symptoms",BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
PLIVA INC,C12 Male Urogenital Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
PLIVA INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PLIVA INC,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
PLIVA INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
PLIVA INC,C10 Nervous System Diseases,BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
PLIVA INC,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
PLIVA INC,C07 Stomatognathic Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
PLIVA INC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLIVA INC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
PLX PHARMA INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
PLX PHARMA INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
POLYGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
POLYGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
PRINSTON PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PRINSTON PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
PRINSTON PHARMACEUTICAL INC,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
PRINSTON PHARMACEUTICAL INC,C11 Eye Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
PRINSTON PHARMACEUTICAL INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PRINSTON PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
PRINSTON PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
PRINSTON PHARMACEUTICAL INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PRINSTON PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
PRINSTON PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
PRINSTON PHARMACEUTICAL INC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,FOSINOPRIL SODIUM,563.67,5.62,1,6,1,14,110.21,,3.87
PRINSTON PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
PRINSTON PHARMACEUTICAL INC,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PRINSTON PHARMACEUTICAL INC,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PRINSTON PHARMACEUTICAL INC,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
PRINSTON PHARMACEUTICAL INC,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PRINSTON PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
PRINSTON PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
PRINSTON PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,QUINAPRIL HYDROCHLORIDE,438.52,1.96,2,5,2,9,95.94,5.2,3.7
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
PRINSTON PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
PRINSTON PHARMACEUTICAL INC,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PRINSTON PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
PRINSTON PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
PRINSTON PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PRINSTON PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
PRINSTON PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
PRINSTON PHARMACEUTICAL INC,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
PRINSTON PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
PRINSTON PHARMACEUTICAL INC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
PRINSTON PHARMACEUTICAL INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
PRINSTON PHARMACEUTICAL INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PRINSTON PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
PRINSTON PHARMACEUTICAL INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
PRINSTON PHARMACEUTICAL INC,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
PRINSTON PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
PRINSTON PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
PRINSTON PHARMACEUTICAL INC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
PRINSTON PHARMACEUTICAL INC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
PRINSTON PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
PRINSTON PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
PRINSTON PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
PRINSTON PHARMACEUTICAL INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PRINSTON PHARMACEUTICAL INC,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
PRINSTON PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
PRINSTON PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
PRINSTON PHARMACEUTICAL INC,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
PRINSTON PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
PRINSTON PHARMACEUTICAL INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
PRINSTON PHARMACEUTICAL INC,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
PRINSTON PHARMACEUTICAL INC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
PRINSTON PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
PRINSTON PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
PRINSTON PHARMACEUTICAL INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
PRINSTON PHARMACEUTICAL INC,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
PRINSTON PHARMACEUTICAL INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PRINSTON PHARMACEUTICAL INC,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
PRINSTON PHARMACEUTICAL INC,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
PRINSTON PHARMACEUTICAL INC,G08 Reproductive and Urinary Physiological Phenomena,PAROXETINE MESYLATE,329.37,3.15,2,4,1,4,39.72,9.77,
PRINSTON PHARMACEUTICAL INC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
PRINSTON PHARMACEUTICAL INC,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
PRINSTON PHARMACEUTICAL INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
PRINSTON PHARMACEUTICAL INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
PRINSTON PHARMACEUTICAL INC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
PRINSTON PHARMACEUTICAL INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
PURACAP PHARMACEUTICAL LLC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
PURACAP PHARMACEUTICAL LLC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
PURACAP PHARMACEUTICAL LLC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PURACAP PHARMACEUTICAL LLC,G08 Reproductive and Urinary Physiological Phenomena,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PURACAP PHARMACEUTICAL LLC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PURACAP PHARMACEUTICAL LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
PURACAP PHARMACEUTICAL LLC,F03 Mental Disorders,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
PURACAP PHARMACEUTICAL LLC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
PURACAP PHARMACEUTICAL LLC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PURACAP PHARMACEUTICAL LLC,C19 Endocrine System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PURACAP PHARMACEUTICAL LLC,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
PURACAP PHARMACEUTICAL LLC,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
PURACAP PHARMACEUTICAL LLC,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
PURACAP PHARMACEUTICAL LLC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
PURACAP PHARMACEUTICAL LLC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
PURACAP PHARMACEUTICAL LLC,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
PURACAP PHARMACEUTICAL LLC,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
PURACAP PHARMACEUTICAL LLC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
PURACAP PHARMACEUTICAL LLC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
PURACAP PHARMACEUTICAL LLC,C18 Nutritional and Metabolic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C01 Infections,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
PURACAP PHARMACEUTICAL LLC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
PURACAP PHARMACEUTICAL LLC,C06 Digestive System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C14 Cardiovascular Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C15 Hemic and Lymphatic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C10 Nervous System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C26 Wounds and Injuries,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C17 Skin and Connective Tissue Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C05 Musculoskeletal Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
PURACAP PHARMACEUTICAL LLC,C04 Neoplasms,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C08 Respiratory Tract Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURACAP PHARMACEUTICAL LLC,C12 Male Urogenital Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
PURDUE PHARMA LP,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
PURDUE PHARMA LP,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PURDUE PHARMA LP,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PURDUE PHARMA LP,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PURDUE PHARMA LP,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PURDUE PHARMA LP,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PURDUE PHARMA LP,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PURDUE PHARMA LP,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
PURDUE PHARMA LP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PURDUE PHARMA LP,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PURDUE PHARMA LP,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PURDUE PHARMA LP,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
PURDUE PHARMA LP,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PURDUE PHARMA LP,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PURDUE PHARMA LP,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PURDUE PHARMA LP,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
PURDUE PHARMA LP,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
PURDUE PHARMA LP,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
QILU PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
QILU PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
QILU PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
QILU PHARMACEUTICAL CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
QILU PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
QILU PHARMACEUTICAL CO LTD,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
QILU PHARMACEUTICAL CO LTD,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
QILU PHARMACEUTICAL CO LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
QILU PHARMACEUTICAL CO LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
QILU PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
QILU PHARMACEUTICAL CO LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
QILU PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
QILU PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
QILU PHARMACEUTICAL CO LTD,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
QINGDAO BAHEAL PHARMACEUTICAL CO LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
QUAGEN PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
QUAGEN PHARMACEUTICALS LLC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
QUAGEN PHARMACEUTICALS LLC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
QUAGEN PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
QUAGEN PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
RB HEALTH US LLC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
RB HEALTH US LLC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
RB HEALTH US LLC,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
RB HEALTH US LLC,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
RB HEALTH US LLC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
RB HEALTH US LLC,C08 Respiratory Tract Diseases,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
RB HEALTH US LLC,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
RB HEALTH US LLC,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
RB HEALTH US LLC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
RB HEALTH US LLC,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
RB HEALTH US LLC,C01 Infections,GUAIFENESIN,198.22,0.34,1,4,2,5,58.92,,13.62
RB HEALTH US LLC,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
RB HEALTH US LLC,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
RECIPHARM PHARMASERVICES PRIVATE LTD,C04 Neoplasms,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
RECIPHARM PHARMASERVICES PRIVATE LTD,C01 Infections,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
RECIPHARM PHARMASERVICES PRIVATE LTD,C10 Nervous System Diseases,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
RHODES PHARMACEUTICALS LP,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
RHODES PHARMACEUTICALS LP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RHODES PHARMACEUTICALS LP,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
RHODES PHARMACEUTICALS LP,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
RHODES PHARMACEUTICALS LP,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
RHODES PHARMACEUTICALS LP,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C06 Digestive System Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
RHODES PHARMACEUTICALS LP,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RHODES PHARMACEUTICALS LP,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
RHODES PHARMACEUTICALS LP,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
RHODES PHARMACEUTICALS LP,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
RHODES PHARMACEUTICALS LP,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
RHODES PHARMACEUTICALS LP,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
RHODES PHARMACEUTICALS LP,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
RHODES PHARMACEUTICALS LP,"C23 Pathological Conditions, Signs and Symptoms",HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
RHODES PHARMACEUTICALS LP,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RHODES PHARMACEUTICALS LP,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
RHODES PHARMACEUTICALS LP,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RHODES PHARMACEUTICALS LP,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
RHODES PHARMACEUTICALS LP,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
RHODES PHARMACEUTICALS LP,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
RHODES PHARMACEUTICALS LP,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
RHODES PHARMACEUTICALS LP,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
RHODES PHARMACEUTICALS LP,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
RHODES PHARMACEUTICALS LP,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
RHODES PHARMACEUTICALS LP,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
RHODES PHARMACEUTICALS LP,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RHODES PHARMACEUTICALS LP,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
RHODES PHARMACEUTICALS LP,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
RHODES PHARMACEUTICALS LP,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RHODES PHARMACEUTICALS LP,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
RHODES PHARMACEUTICALS LP,C25 Chemically-Induced Disorders,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
RHODES PHARMACEUTICALS LP,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RHODES PHARMACEUTICALS LP,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
RHODES PHARMACEUTICALS LP,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
RHODES PHARMACEUTICALS LP,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
RHODES PHARMACEUTICALS LP,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
RHODES PHARMACEUTICALS LP,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
RHODES PHARMACEUTICALS LP,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
RHODES PHARMACEUTICALS LP,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
RHODES PHARMACEUTICALS LP,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
RHODES PHARMACEUTICALS LP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
RHODES PHARMACEUTICALS LP,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RHODES PHARMACEUTICALS LP,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
RHODES PHARMACEUTICALS LP,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
RHODES PHARMACEUTICALS LP,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RHODES PHARMACEUTICALS LP,C05 Musculoskeletal Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
RHODES PHARMACEUTICALS LP,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
RHODES PHARMACEUTICALS LP,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
RICONPHARMA LLC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
RICONPHARMA LLC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
RICONPHARMA LLC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
RICONPHARMA LLC,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
RICONPHARMA LLC,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
RICONPHARMA LLC,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
RICONPHARMA LLC,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
RICONPHARMA LLC,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
RICONPHARMA LLC,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
RICONPHARMA LLC,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
RICONPHARMA LLC,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RICONPHARMA LLC,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
RISING PHARMA HOLDINGS INC,C04 Neoplasms,ZILEUTON,236.3,2.01,2,3,2,2,66.56,,8.84
RISING PHARMA HOLDINGS INC,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",ZILEUTON,236.3,2.01,2,3,2,2,66.56,,8.84
RISING PHARMA HOLDINGS INC,C17 Skin and Connective Tissue Diseases,DOXERCALCIFEROL,412.66,5.75,0,2,2,5,40.46,,
RISING PHARMA HOLDINGS INC,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
RISING PHARMA HOLDINGS INC,C06 Digestive System Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
RISING PHARMA HOLDINGS INC,C25 Chemically-Induced Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
RISING PHARMA HOLDINGS INC,C08 Respiratory Tract Diseases,ZILEUTON,236.3,2.01,2,3,2,2,66.56,,8.84
RISING PHARMA HOLDINGS INC,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,C17 Skin and Connective Tissue Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
RISING PHARMA HOLDINGS INC,C10 Nervous System Diseases,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
RISING PHARMA HOLDINGS INC,F03 Mental Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
RISING PHARMA HOLDINGS INC,C17 Skin and Connective Tissue Diseases,ZILEUTON,236.3,2.01,2,3,2,2,66.56,,8.84
RISING PHARMA HOLDINGS INC,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,C25 Chemically-Induced Disorders,ZILEUTON,236.3,2.01,2,3,2,2,66.56,,8.84
RISING PHARMA HOLDINGS INC,C15 Hemic and Lymphatic Diseases,ZILEUTON,236.3,2.01,2,3,2,2,66.56,,8.84
RISING PHARMA HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
RISING PHARMA HOLDINGS INC,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
RISING PHARMA HOLDINGS INC,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
RISING PHARMA HOLDINGS INC,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
RISING PHARMA HOLDINGS INC,C19 Endocrine System Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
RISING PHARMA HOLDINGS INC,C12 Male Urogenital Diseases,DOXERCALCIFEROL,412.66,5.75,0,2,2,5,40.46,,
RISING PHARMA HOLDINGS INC,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
RISING PHARMA HOLDINGS INC,C25 Chemically-Induced Disorders,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
RISING PHARMA HOLDINGS INC,C10 Nervous System Diseases,SELEGILINE HYDROCHLORIDE,187.29,2.85,1,1,0,4,3.24,8.67,
RISING PHARMA HOLDINGS INC,C06 Digestive System Diseases,ALOSETRON HYDROCHLORIDE,294.36,1.21,3,3,1,2,53.92,6.81,13.32
RISING PHARMA HOLDINGS INC,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
RISING PHARMA HOLDINGS INC,C01 Infections,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C14 Cardiovascular Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C18 Nutritional and Metabolic Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C19 Endocrine System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C10 Nervous System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C04 Neoplasms,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C12 Male Urogenital Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C15 Hemic and Lymphatic Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C06 Digestive System Diseases,LEVOCARNITINE,161.2,-4.89,0,3,1,4,60.36,,4.2
RISING PHARMA HOLDINGS INC,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
RISING PHARMA HOLDINGS INC,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
RISING PHARMA HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
RISING PHARMA HOLDINGS INC,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,C12 Male Urogenital Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
RISING PHARMA HOLDINGS INC,C04 Neoplasms,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
RISING PHARMA HOLDINGS INC,C18 Nutritional and Metabolic Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
RISING PHARMA HOLDINGS INC,C04 Neoplasms,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
RISING PHARMA HOLDINGS INC,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
RISING PHARMA HOLDINGS INC,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
RISING PHARMA HOLDINGS INC,F01 Behavior and Behavior Mechanisms,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
RISING PHARMA HOLDINGS INC,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
RISING PHARMA HOLDINGS INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
RISING PHARMA HOLDINGS INC,C05 Musculoskeletal Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
RISING PHARMA HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
RISING PHARMA HOLDINGS INC,C08 Respiratory Tract Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
RISING PHARMA HOLDINGS INC,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
RISING PHARMA HOLDINGS INC,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
RISING PHARMA HOLDINGS INC,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
RISING PHARMA HOLDINGS INC,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
RISING PHARMA HOLDINGS INC,C14 Cardiovascular Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
RISING PHARMA HOLDINGS INC,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
RISING PHARMA HOLDINGS INC,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
RISING PHARMA HOLDINGS INC,C11 Eye Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
RISING PHARMA HOLDINGS INC,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
RISING PHARMA HOLDINGS INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
RISING PHARMA HOLDINGS INC,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
RISING PHARMA HOLDINGS INC,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
RISING PHARMA HOLDINGS INC,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
RISING PHARMA HOLDINGS INC,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
RISING PHARMA HOLDINGS INC,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
RISING PHARMA HOLDINGS INC,C10 Nervous System Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
RISING PHARMA HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
RISING PHARMA HOLDINGS INC,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
RISING PHARMA HOLDINGS INC,C12 Male Urogenital Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
RISING PHARMA HOLDINGS INC,C04 Neoplasms,TOREMIFENE CITRATE,405.97,6.27,3,2,0,9,12.47,8.76,
RISING PHARMA HOLDINGS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
RISING PHARMA HOLDINGS INC,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
RISING PHARMA HOLDINGS INC,C04 Neoplasms,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
RISING PHARMA HOLDINGS INC,C12 Male Urogenital Diseases,CROMOLYN SODIUM,468.37,1.48,4,9,3,8,173.71,,1.55
RISING PHARMA HOLDINGS INC,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
RISING PHARMA HOLDINGS INC,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
RISING PHARMA HOLDINGS INC,C04 Neoplasms,DOXERCALCIFEROL,412.66,5.75,0,2,2,5,40.46,,
RISING PHARMA HOLDINGS INC,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
RISING PHARMA HOLDINGS INC,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
RISING PHARMA HOLDINGS INC,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ROCHE PALO ALTO LLC,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROCHE PALO ALTO LLC,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ROMEG THERAPEUTICS LLC,C12 Male Urogenital Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ROMEG THERAPEUTICS LLC,C06 Digestive System Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ROMEG THERAPEUTICS LLC,C01 Infections,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ROMEG THERAPEUTICS LLC,C05 Musculoskeletal Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ROMEG THERAPEUTICS LLC,C04 Neoplasms,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ROMEG THERAPEUTICS LLC,C07 Stomatognathic Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ROMEG THERAPEUTICS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ROMEG THERAPEUTICS LLC,C11 Eye Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ROMEG THERAPEUTICS LLC,C14 Cardiovascular Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
RUBICON RESEARCH PRIVATE LTD,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
RUBICON RESEARCH PRIVATE LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
RUBICON RESEARCH PRIVATE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
RUBICON RESEARCH PRIVATE LTD,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
RUBICON RESEARCH PRIVATE LTD,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
RUBICON RESEARCH PRIVATE LTD,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
RUBICON RESEARCH PRIVATE LTD,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
RUBICON RESEARCH PRIVATE LTD,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
RUBICON RESEARCH PRIVATE LTD,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
RUBICON RESEARCH PRIVATE LTD,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
RUBICON RESEARCH PRIVATE LTD,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
RUBICON RESEARCH PRIVATE LTD,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
RUBICON RESEARCH PRIVATE LTD,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
RUBICON RESEARCH PRIVATE LTD,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
RUBICON RESEARCH PRIVATE LTD,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
RUBICON RESEARCH PRIVATE LTD,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
RUBICON RESEARCH PRIVATE LTD,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
RUBICON RESEARCH PRIVATE LTD,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
RUBICON RESEARCH PRIVATE LTD,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
RUBICON RESEARCH PRIVATE LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
RUBICON RESEARCH PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
RUBICON RESEARCH PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
RUBICON RESEARCH PRIVATE LTD,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
RUBICON RESEARCH PRIVATE LTD,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
RUBICON RESEARCH PRIVATE LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
RUBICON RESEARCH PRIVATE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
RXMTM THERAPEUTICS LLC A WHOLLY OWNED SUB OF CUTISPHARMA INC,C06 Digestive System Diseases,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
RXMTM THERAPEUTICS LLC A WHOLLY OWNED SUB OF CUTISPHARMA INC,C01 Infections,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
SAI LIFE SCIENCES LTD,C10 Nervous System Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
SAI LIFE SCIENCES LTD,C17 Skin and Connective Tissue Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
SAI LIFE SCIENCES LTD,C15 Hemic and Lymphatic Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
SAI LIFE SCIENCES LTD,C08 Respiratory Tract Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
SAI LIFE SCIENCES LTD,C01 Infections,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
SAI LIFE SCIENCES LTD,C04 Neoplasms,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
SALIX PHARMACEUTICALS INC,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SALIX PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CHLOROTHIAZIDE,295.73,-0.31,1,5,2,1,118.69,,6.49
SALIX PHARMACEUTICALS INC,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SALIX PHARMACEUTICALS INC,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SALIX PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SALIX PHARMACEUTICALS INC,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SALIX PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SALIX PHARMACEUTICALS INC,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SALIX PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SALIX PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM PHOSPHATE,141.96,,,,,,,,
SALIX PHARMACEUTICALS INC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SALIX PHARMACEUTICALS INC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SALIX PHARMACEUTICALS INC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SALIX PHARMACEUTICALS INC,C12 Male Urogenital Diseases,CHLOROTHIAZIDE,295.73,-0.31,1,5,2,1,118.69,,6.49
SALIX PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SALIX PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C06 Digestive System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C01 Infections,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,SODIUM ASCORBATE,198.11,,,,,,,,
SALIX PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SALIX PHARMACEUTICALS INC,C14 Cardiovascular Diseases,RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C12 Male Urogenital Diseases,RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,C04 Neoplasms,RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,C01 Infections,RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,C06 Digestive System Diseases,RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,C10 Nervous System Diseases,RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C01 Infections,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C04 Neoplasms,METHYLNALTREXONE BROMIDE,356.44,-2.49,1,4,2,2,66.76,,9.9
SALIX PHARMACEUTICALS INC,C24 Occupational Diseases,RIFAXIMIN,785.89,4.59,4,13,5,2,198.38,5.88,6.42
SALIX PHARMACEUTICALS INC,C26 Wounds and Injuries,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,SODIUM ASCORBATE,198.11,,,,,,,,
SALIX PHARMACEUTICALS INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SALIX PHARMACEUTICALS INC,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SALIX PHARMACEUTICALS INC,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SALIX PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SALIX PHARMACEUTICALS INC,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SALIX PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SALIX PHARMACEUTICALS INC,C01 Infections,"SODIUM PHOSPHATE, MONOBASIC",119.98,,,,,,,,
SALIX PHARMACEUTICALS INC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C04 Neoplasms,SODIUM ASCORBATE,198.11,,,,,,,,
SALIX PHARMACEUTICALS INC,C07 Stomatognathic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SALIX PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SALIX PHARMACEUTICALS INC,C14 Cardiovascular Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SALIX PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SALIX PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,A10 Tissues,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C11 Eye Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C04 Neoplasms,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C06 Digestive System Diseases,METHYLNALTREXONE BROMIDE,356.44,-2.49,1,4,2,2,66.76,,9.9
SALIX PHARMACEUTICALS INC,C04 Neoplasms,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLNALTREXONE BROMIDE,356.44,-2.49,1,4,2,2,66.76,,9.9
SALIX PHARMACEUTICALS INC,C19 Endocrine System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,G07 Physiological Phenomena,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SALIX PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SALIX PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C10 Nervous System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SALIX PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,F03 Mental Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C20 Immune System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,F03 Mental Disorders,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C10 Nervous System Diseases,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C26 Wounds and Injuries,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,D01 Inorganic Chemicals,SODIUM CHLORIDE,58.44,,,,,,,,
SALIX PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ASCORBIC ACID,176.12,-1.91,0,6,4,2,107.22,,4.36
SALIX PHARMACEUTICALS INC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SALIX PHARMACEUTICALS INC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
SANDOZ INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANDOZ INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
SANDOZ INC,F03 Mental Disorders,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
SANDOZ INC,C17 Skin and Connective Tissue Diseases,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
SANDOZ INC,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C04 Neoplasms,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
SANDOZ INC,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANDOZ INC,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
SANDOZ INC,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SANDOZ INC,F03 Mental Disorders,HYDROXYZINE PAMOATE,374.91,3.41,2,4,1,8,35.94,7.45,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
SANDOZ INC,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C25 Chemically-Induced Disorders,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
SANDOZ INC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SANDOZ INC,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
SANDOZ INC,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
SANDOZ INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
SANDOZ INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
SANDOZ INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
SANDOZ INC,C10 Nervous System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
SANDOZ INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C19 Endocrine System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
SANDOZ INC,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
SANDOZ INC,C18 Nutritional and Metabolic Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
SANDOZ INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
SANDOZ INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C12 Male Urogenital Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
SANDOZ INC,C05 Musculoskeletal Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
SANDOZ INC,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
SANDOZ INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C06 Digestive System Diseases,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
SANDOZ INC,C01 Infections,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
SANDOZ INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
SANDOZ INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C01 Infections,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,C17 Skin and Connective Tissue Diseases,APREPITANT,534.43,5.22,3,5,2,6,83.24,3.63,6.59
SANDOZ INC,F03 Mental Disorders,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C14 Cardiovascular Diseases,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
SANDOZ INC,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SANDOZ INC,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SANDOZ INC,C12 Male Urogenital Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
SANDOZ INC,C10 Nervous System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
SANDOZ INC,C06 Digestive System Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
SANDOZ INC,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SANDOZ INC,C01 Infections,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
SANDOZ INC,C20 Immune System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
SANDOZ INC,C01 Infections,SULFADIAZINE,250.28,0.39,2,5,2,3,97.97,2.01,6.99
SANDOZ INC,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C26 Wounds and Injuries,SULFADIAZINE,250.28,0.39,2,5,2,3,97.97,2.01,6.99
SANDOZ INC,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SANDOZ INC,C05 Musculoskeletal Diseases,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
SANDOZ INC,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SANDOZ INC,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SANDOZ INC,C26 Wounds and Injuries,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
SANDOZ INC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANDOZ INC,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SANDOZ INC,C01 Infections,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
SANDOZ INC,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SANDOZ INC,C04 Neoplasms,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
SANDOZ INC,C04 Neoplasms,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
SANDOZ INC,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SANDOZ INC,C08 Respiratory Tract Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SANDOZ INC,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SANDOZ INC,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
SANDOZ INC,C04 Neoplasms,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
SANDOZ INC,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SANDOZ INC,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANDOZ INC,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SANDOZ INC,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
SANDOZ INC,C25 Chemically-Induced Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C06 Digestive System Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANDOZ INC,C01 Infections,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
SANDOZ INC,C26 Wounds and Injuries,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
SANDOZ INC,C14 Cardiovascular Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,G08 Reproductive and Urinary Physiological Phenomena,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANDOZ INC,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SANDOZ INC,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANDOZ INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
SANDOZ INC,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SANDOZ INC,C15 Hemic and Lymphatic Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
SANDOZ INC,F03 Mental Disorders,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SANDOZ INC,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SANDOZ INC,C05 Musculoskeletal Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
SANDOZ INC,C10 Nervous System Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
SANDOZ INC,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,F01 Behavior and Behavior Mechanisms,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SANDOZ INC,C18 Nutritional and Metabolic Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANDOZ INC,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
SANDOZ INC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,G08 Reproductive and Urinary Physiological Phenomena,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
SANDOZ INC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SANDOZ INC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
SANDOZ INC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANDOZ INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",ORPHENADRINE CITRATE,269.39,4.17,2,2,0,6,12.47,8.87,
SANDOZ INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANDOZ INC,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
SANDOZ INC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
SANDOZ INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SANDOZ INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANDOZ INC,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
SANDOZ INC,C14 Cardiovascular Diseases,METOLAZONE,365.84,2.94,2,4,2,2,92.5,,9.54
SANDOZ INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANDOZ INC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANDOZ INC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SANDOZ INC,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SANDOZ INC,C01 Infections,CEFPODOXIME PROXETIL,557.61,1.33,1,14,2,10,180.97,3.28,10.99
SANDOZ INC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
SANDOZ INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
SANDOZ INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
SANDOZ INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SANDOZ INC,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
SANDOZ INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
SANDOZ INC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
SANDOZ INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
SANDOZ INC,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
SANDOZ INC,C17 Skin and Connective Tissue Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
SANDOZ INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C18 Nutritional and Metabolic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C11 Eye Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C08 Respiratory Tract Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C04 Neoplasms,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C01 Infections,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C05 Musculoskeletal Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C15 Hemic and Lymphatic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C17 Skin and Connective Tissue Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANDOZ INC,C20 Immune System Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
SANDOZ INC,C12 Male Urogenital Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SANDOZ INC,C04 Neoplasms,FLUPHENAZINE HYDROCHLORIDE,437.53,3.97,2,5,1,6,29.95,7.81,
SANDOZ INC,C14 Cardiovascular Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SANDOZ INC,F03 Mental Disorders,ZIPRASIDONE HYDROCHLORIDE,412.95,4.3,3,5,1,4,48.47,7.09,12.21
SANDOZ INC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
SANDOZ INC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
SANDOZ INC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
SANDOZ INC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
SANDOZ INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C10 Nervous System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C26 Wounds and Injuries,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
SANDOZ INC,C07 Stomatognathic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C06 Digestive System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C14 Cardiovascular Diseases,BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
SANDOZ INC,C20 Immune System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
SANDOZ INC,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
SANDOZ INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C01 Infections,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
SANDOZ INC,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SANDOZ INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SANDOZ INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANDOZ INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANDOZ INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SANDOZ INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANDOZ INC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SANDOZ INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SANDOZ INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,F03 Mental Disorders,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
SANDOZ INC,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
SANDOZ INC,C10 Nervous System Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
SANDOZ INC,C17 Skin and Connective Tissue Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
SANDOZ INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SANDOZ INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
SANDOZ INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SANDOZ INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SANDOZ INC,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SANDOZ INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
SANDOZ INC,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SANDOZ INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SANDOZ INC,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SANDOZ INC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
SANDOZ INC,C09 Otorhinolaryngologic Diseases,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
SANDOZ INC,C10 Nervous System Diseases,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
SANDOZ INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANDOZ INC,C01 Infections,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
SANDOZ INC,C25 Chemically-Induced Disorders,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
SANDOZ INC,F03 Mental Disorders,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
SANDOZ INC,C10 Nervous System Diseases,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
SANDOZ INC,F01 Behavior and Behavior Mechanisms,OXAZEPAM,286.72,2.92,2,3,2,1,61.69,,10.61
SANDOZ INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C25 Chemically-Induced Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
SANDOZ INC,F03 Mental Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
SANDOZ INC,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SANDOZ INC,C10 Nervous System Diseases,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
SANDOZ INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,F01 Behavior and Behavior Mechanisms,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
SANDOZ INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANDOZ INC,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
SANDOZ INC,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
SANDOZ INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
SANDOZ INC,F03 Mental Disorders,QUINIDINE SULFATE,324.42,2.51,2,4,1,4,45.59,9.05,13.89
SANDOZ INC,F03 Mental Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
SANDOZ INC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C14 Cardiovascular Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SANDOZ INC,C25 Chemically-Induced Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
SANDOZ INC,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SANDOZ INC,C06 Digestive System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SANDOZ INC,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,C14 Cardiovascular Diseases,FOSINOPRIL SODIUM,563.67,5.62,1,6,1,14,110.21,,3.87
SANDOZ INC,C08 Respiratory Tract Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,C04 Neoplasms,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SANDOZ INC,C10 Nervous System Diseases,QUINIDINE SULFATE,324.42,2.51,2,4,1,4,45.59,9.05,13.89
SANDOZ INC,F03 Mental Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,F03 Mental Disorders,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
SANDOZ INC,C05 Musculoskeletal Diseases,OXAPROZIN,293.32,3.46,3,3,1,5,63.33,,4.95
SANDOZ INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
SANDOZ INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SANDOZ INC,C14 Cardiovascular Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
SANDOZ INC,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SANDOZ INC,F03 Mental Disorders,CLOMIPRAMINE HYDROCHLORIDE,314.86,4.88,2,2,0,4,6.48,9.2,
SANDOZ INC,F01 Behavior and Behavior Mechanisms,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
SANDOZ INC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SANDOZ INC,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SANDOZ INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SANDOZ INC,C10 Nervous System Diseases,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
SANDOZ INC,C01 Infections,DICLOXACILLIN SODIUM,470.33,2.91,2,6,2,4,112.74,,3.75
SANDOZ INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
SANDOZ INC,C01 Infections,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SANDOZ INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SANDOZ INC,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SANDOZ INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C05 Musculoskeletal Diseases,AMPICILLIN,349.41,-2,1,5,3,4,112.73,7.23,3.24
SANDOZ INC,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,C01 Infections,AMPICILLIN,349.41,-2,1,5,3,4,112.73,7.23,3.24
SANDOZ INC,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
SANDOZ INC,F03 Mental Disorders,IMIPRAMINE HYDROCHLORIDE,280.42,4.28,2,2,0,4,6.48,9.2,
SANDOZ INC,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
SANDOZ INC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
SANDOZ INC,C01 Infections,GRISEOFULVIN,352.77,2.17,1,6,0,3,71.06,,
SANDOZ INC,C10 Nervous System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C25 Chemically-Induced Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SANDOZ INC,C04 Neoplasms,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
SANDOZ INC,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SANDOZ INC,C05 Musculoskeletal Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
SANDOZ INC,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,F03 Mental Disorders,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
SANDOZ INC,C10 Nervous System Diseases,ERGOTAMINE TARTRATE,581.67,2.6,3,6,3,4,118.21,7.78,9.69
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
SANDOZ INC,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANDOZ INC,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SANDOZ INC,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C14 Cardiovascular Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SANDOZ INC,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
SANDOZ INC,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C01 Infections,CEFPROZIL,389.43,-1.92,1,6,4,5,132.96,7.22,3.3
SANDOZ INC,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SANDOZ INC,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
SANDOZ INC,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SANDOZ INC,C04 Neoplasms,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SANDOZ INC,C01 Infections,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SANDOZ INC,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C11 Eye Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SANDOZ INC,C17 Skin and Connective Tissue Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SANDOZ INC,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SANDOZ INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
SANDOZ INC,C14 Cardiovascular Diseases,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
SANDOZ INC,C04 Neoplasms,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
SANDOZ INC,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
SANDOZ INC,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
SANDOZ INC,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
SANDOZ INC,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
SANDOZ INC,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
SANDOZ INC,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SANDOZ INC,C01 Infections,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
SANDOZ INC,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SANDOZ INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SANDOZ INC,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SANDOZ INC,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SANDOZ INC,C05 Musculoskeletal Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
SANDOZ INC,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
SANDOZ INC,C10 Nervous System Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
SANDOZ INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SANDOZ INC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SANDOZ INC,C12 Male Urogenital Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
SANDOZ INC,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SANDOZ INC,C04 Neoplasms,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
SANDOZ INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
SANDOZ INC,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,C18 Nutritional and Metabolic Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
SANDOZ INC,F03 Mental Disorders,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
SANDOZ INC,C10 Nervous System Diseases,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
SANDOZ INC,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
SANDOZ INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
SANDOZ INC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
SANDOZ INC,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SANDOZ INC,C08 Respiratory Tract Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SANDOZ INC,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SANDOZ INC,C20 Immune System Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SANDOZ INC,C06 Digestive System Diseases,NIZATIDINE,331.47,0.77,1,8,2,10,83.33,6.54,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SANDOZ INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
SANDOZ INC,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
SANDOZ INC,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SANDOZ INC,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
SANDOZ INC,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
SANDOZ INC,C25 Chemically-Induced Disorders,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
SANDOZ INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
SANDOZ INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SANDOZ INC,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
SANDOZ INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SANDOZ INC,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
SANDOZ INC,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SANDOZ INC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SANDOZ INC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
SANDOZ INC,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANDOZ INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
SANDOZ INC,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
SANDOZ INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
SANDOZ INC,C01 Infections,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
SANDOZ INC,C11 Eye Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
SANDOZ INC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C05 Musculoskeletal Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
SANDOZ INC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
SANDOZ INC,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SANDOZ INC,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
SANDOZ INC,C19 Endocrine System Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
SANDOZ INC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
SANDOZ INC,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
SANDOZ INC,C10 Nervous System Diseases,RASAGILINE MESYLATE,171.24,2.3,1,1,1,2,12.03,8.4,
SANDOZ INC,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SANDOZ INC,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
SANDOZ INC,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
SANDOZ INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SANDOZ INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SANDOZ INC,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
SANDOZ INC,C15 Hemic and Lymphatic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,C12 Male Urogenital Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
SANDOZ INC,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
SANDOZ INC,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SANDOZ INC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
SANDOZ INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
SANDOZ INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANDOZ INC,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
SANDOZ INC,C04 Neoplasms,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
SANDOZ INC,C14 Cardiovascular Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,C08 Respiratory Tract Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,C18 Nutritional and Metabolic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,C01 Infections,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SANDOZ INC,C10 Nervous System Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,C10 Nervous System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,C05 Musculoskeletal Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SANDOZ INC,C06 Digestive System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,F03 Mental Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SANDOZ INC,C04 Neoplasms,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANDOZ INC,C09 Otorhinolaryngologic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
SANDOZ INC,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
SANDOZ INC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
SANDOZ INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SANDOZ INC,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
SANDOZ INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SANDOZ INC,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
SANDOZ INC,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SANDOZ INC,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
SANDOZ INC,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
SANDOZ INC,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
SANDOZ INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
SANDOZ INC,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
SANDOZ INC,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
SANDOZ INC,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
SANDOZ INC,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
SANDOZ INC,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SANDOZ INC,C04 Neoplasms,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SANDOZ INC,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
SANDOZ INC,C04 Neoplasms,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
SANDOZ INC,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
SANDOZ INC,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
SANDOZ INC,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
SANDOZ INC,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SANDOZ INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SANDOZ INC,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C12 Male Urogenital Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
SANDOZ INC,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
SANDOZ INC,C14 Cardiovascular Diseases,EPLERENONE,414.5,2.33,0,6,0,1,82.2,,
SANDOZ INC,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C07 Stomatognathic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
SANDOZ INC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SANDOZ INC,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
SANDOZ INC,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANDOZ INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SANDOZ INC,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SANDOZ INC,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
SANDOZ INC,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
SANDOZ INC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
SANDOZ INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SANDOZ INC,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
SANDOZ INC,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
SANDOZ INC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SANDOZ INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANDOZ INC,C04 Neoplasms,METHAZOLAMIDE,236.28,-0.59,1,6,1,1,107.41,,7.21
SANDOZ INC,C11 Eye Diseases,METHAZOLAMIDE,236.28,-0.59,1,6,1,1,107.41,,7.21
SANDOZ INC,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
SANDOZ INC,C12 Male Urogenital Diseases,SILODOSIN,495.54,3.05,2,6,3,13,97.05,9.66,
SANDOZ INC,C08 Respiratory Tract Diseases,METHAZOLAMIDE,236.28,-0.59,1,6,1,1,107.41,,7.21
SANDOZ INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SANOFI AVENTIS US LLC,C15 Hemic and Lymphatic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,C01 Infections,RIFAPENTINE,877.04,3.7,2,15,6,5,220.15,7.82,7
SANOFI AVENTIS US LLC,C01 Infections,PRIMAQUINE PHOSPHATE,259.35,1.64,2,4,2,6,60.17,10.2,
SANOFI AVENTIS US LLC,C14 Cardiovascular Diseases,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
SANOFI AVENTIS US LLC,C15 Hemic and Lymphatic Diseases,PRIMAQUINE PHOSPHATE,259.35,1.64,2,4,2,6,60.17,10.2,
SANOFI AVENTIS US LLC,C06 Digestive System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,C04 Neoplasms,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
SANOFI AVENTIS US LLC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
SANOFI AVENTIS US LLC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
SANOFI AVENTIS US LLC,C14 Cardiovascular Diseases,DRONEDARONE HYDROCHLORIDE,556.77,5.28,3,6,1,18,88.85,9.79,9.08
SANOFI AVENTIS US LLC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
SANOFI AVENTIS US LLC,C12 Male Urogenital Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
SANOFI AVENTIS US LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANOFI AVENTIS US LLC,C13 Female Urogenital Diseases and Pregnancy Complications,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
SANOFI AVENTIS US LLC,C08 Respiratory Tract Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
SANOFI AVENTIS US LLC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SANOFI AVENTIS US LLC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
SANOFI AVENTIS US LLC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SANOFI AVENTIS US LLC,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SANOFI AVENTIS US LLC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SANOFI AVENTIS US LLC,C01 Infections,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
SANOFI AVENTIS US LLC,C18 Nutritional and Metabolic Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANOFI AVENTIS US LLC,C17 Skin and Connective Tissue Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
SANOFI AVENTIS US LLC,C04 Neoplasms,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANOFI AVENTIS US LLC,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANOFI AVENTIS US LLC,C04 Neoplasms,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
SANOFI AVENTIS US LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANOFI AVENTIS US LLC,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANOFI AVENTIS US LLC,C01 Infections,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
SANOFI AVENTIS US LLC,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANOFI AVENTIS US LLC,C11 Eye Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
SANOFI AVENTIS US LLC,C05 Musculoskeletal Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
SANOFI AVENTIS US LLC,C01 Infections,PYRAZINAMIDE,123.11,-1.23,1,3,1,1,68.87,,13.06
SANOFI AVENTIS US LLC,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SANOFI AVENTIS US LLC,C20 Immune System Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
SANOFI AVENTIS US LLC,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SANOFI AVENTIS US LLC,C25 Chemically-Induced Disorders,ALUMINUM HYDROXIDE,78,,,,,,,,
SANOFI AVENTIS US LLC,C07 Stomatognathic Diseases,ALUMINUM HYDROXIDE,78,,,,,,,,
SANOFI AVENTIS US LLC,C04 Neoplasms,ALUMINUM HYDROXIDE,78,,,,,,,,
SANOFI AVENTIS US LLC,C01 Infections,ALUMINUM HYDROXIDE,78,,,,,,,,
SANOFI AVENTIS US LLC,C18 Nutritional and Metabolic Diseases,ALUMINUM HYDROXIDE,78,,,,,,,,
SANOFI AVENTIS US LLC,C14 Cardiovascular Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
SANOFI AVENTIS US LLC,C12 Male Urogenital Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
SANOFI AVENTIS US LLC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
SANOFI AVENTIS US LLC,"C23 Pathological Conditions, Signs and Symptoms",RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
SANOFI AVENTIS US LLC,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SANOFI AVENTIS US LLC,C05 Musculoskeletal Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
SANOFI AVENTIS US LLC,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
SANOFI AVENTIS US LLC,C10 Nervous System Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANOFI AVENTIS US LLC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
SANOFI AVENTIS US LLC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANOFI AVENTIS US LLC,C01 Infections,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SANOFI AVENTIS US LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANOFI AVENTIS US LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANOFI AVENTIS US LLC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SANOFI AVENTIS US LLC,C14 Cardiovascular Diseases,RIFAMPIN,822.95,2.95,2,15,6,4,220.15,7.37,6.8
SANOFI AVENTIS US LLC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANOFI AVENTIS US LLC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANOFI AVENTIS US LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANOFI AVENTIS US LLC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
SANOFI AVENTIS US LLC,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SANOFI AVENTIS US LLC,C10 Nervous System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
SANOFI AVENTIS US LLC,C20 Immune System Diseases,TERIFLUNOMIDE,270.21,2.14,1,3,2,2,73.12,,5.48
SANOFI AVENTIS US LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SANOFI AVENTIS US LLC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SANTARUS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANTARUS INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANTARUS INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANTARUS INC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANTARUS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANTARUS INC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANTARUS INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANTARUS INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SANTARUS INC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SANTARUS INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SANTARUS INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SAPTALIS PHARMACEUTICALS LLC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SAPTALIS PHARMACEUTICALS LLC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SAPTALIS PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SAPTALIS PHARMACEUTICALS LLC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SAPTALIS PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SAPTALIS PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SAPTALIS PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SAPTALIS PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SAPTALIS PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SAPTALIS PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SAPTALIS PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
SCIECURE PHARMA INC,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SCIEGEN PHARMACEUTICALS INC,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SCIEGEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
SCIEGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
SCIEGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
SCIEGEN PHARMACEUTICALS INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SCIEGEN PHARMACEUTICALS INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
SCIEGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
SCIEGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
SCIEGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SCIEGEN PHARMACEUTICALS INC,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SCIEGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SCIEGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SCIEGEN PHARMACEUTICALS INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
SCIEGEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SCIEGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SCIEGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SCIEGEN PHARMACEUTICALS INC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SCIEGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SCIEGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SCIEGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
SCIEGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SCIEGEN PHARMACEUTICALS INC,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SCIEGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SCIEGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SCIEGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,RALOXIFENE HYDROCHLORIDE,473.59,5.69,4,6,2,7,70,7.95,8.89
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
SCIEGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
SCIEGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
SCIEGEN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SCIEGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
SCIEGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SCIEGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SCIEGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SCIEGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SCIEGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SCIEGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
SCIEGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
SCIEGEN PHARMACEUTICALS INC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
SCIEGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SCIEGEN PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
SCIEGEN PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
SCIEGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
SCIEGEN PHARMACEUTICALS INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SCIEGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SCIEGEN PHARMACEUTICALS INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
SCIEGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SCIEGEN PHARMACEUTICALS INC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
SCIEGEN PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SCIEGEN PHARMACEUTICALS INC,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SCIEGEN PHARMACEUTICALS INC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SCIEGEN PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SCIEGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SCIEGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
SCIEGEN PHARMACEUTICALS INC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SCIEGEN PHARMACEUTICALS INC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SCIEGEN PHARMACEUTICALS INC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SCIEGEN PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SCIEGEN PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
SEBELA IRELAND LTD,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SEBELA IRELAND LTD,C05 Musculoskeletal Diseases,AURANOFIN,678.49,,,,,,,,
SEBELA IRELAND LTD,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SEBELA IRELAND LTD,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SEBELA IRELAND LTD,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SEBELA IRELAND LTD,C04 Neoplasms,AURANOFIN,678.49,,,,,,,,
SEBELA IRELAND LTD,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SEBELA IRELAND LTD,G08 Reproductive and Urinary Physiological Phenomena,PAROXETINE MESYLATE,329.37,3.15,2,4,1,4,39.72,9.77,
SEBELA IRELAND LTD,C08 Respiratory Tract Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
SEBELA IRELAND LTD,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SEBELA IRELAND LTD,C01 Infections,AURANOFIN,678.49,,,,,,,,
SEBELA IRELAND LTD,C11 Eye Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
SEBELA IRELAND LTD,"C23 Pathological Conditions, Signs and Symptoms",AURANOFIN,678.49,,,,,,,,
SEBELA IRELAND LTD,C06 Digestive System Diseases,ALOSETRON HYDROCHLORIDE,294.36,1.21,3,3,1,2,53.92,6.81,13.32
SEBELA IRELAND LTD,C06 Digestive System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,C17 Skin and Connective Tissue Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,"C23 Pathological Conditions, Signs and Symptoms",ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
SEBELA IRELAND LTD,C12 Male Urogenital Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,C04 Neoplasms,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,C20 Immune System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,C08 Respiratory Tract Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,C05 Musculoskeletal Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,C10 Nervous System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,C06 Digestive System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
SEBELA IRELAND LTD,C15 Hemic and Lymphatic Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SEBELA IRELAND LTD,C14 Cardiovascular Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
SEBELA IRELAND LTD,C10 Nervous System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
SEBELA IRELAND LTD,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
SHANDONG NEW TIME PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SHANDONG NEW TIME PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SHANDONG NEW TIME PHARMACEUTICAL CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANDONG XINHUA PHARMACEUTICAL CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
SHANGHAI DESANO BIO-PHARMACEUTICALS CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
SHILPA MEDICARE LTD,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
SHILPA MEDICARE LTD,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
SHILPA MEDICARE LTD,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SHILPA MEDICARE LTD,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SHILPA MEDICARE LTD,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SHILPA MEDICARE LTD,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SHILPA MEDICARE LTD,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SHILPA MEDICARE LTD,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SHILPA MEDICARE LTD,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SHILPA MEDICARE LTD,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SHILPA MEDICARE LTD,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
SHIRE DEVELOPMENT INC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT INC,C04 Neoplasms,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SHIRE DEVELOPMENT INC,F03 Mental Disorders,LISDEXAMFETAMINE DIMESYLATE,263.38,1.14,1,3,3,8,81.14,10.21,
SHIRE DEVELOPMENT INC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT INC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT INC,C18 Nutritional and Metabolic Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SHIRE DEVELOPMENT INC,C10 Nervous System Diseases,LISDEXAMFETAMINE DIMESYLATE,263.38,1.14,1,3,3,8,81.14,10.21,
SHIRE DEVELOPMENT INC,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
SHIRE DEVELOPMENT INC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT INC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT INC,C08 Respiratory Tract Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SHIRE DEVELOPMENT INC,C06 Digestive System Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SHIRE DEVELOPMENT INC,C01 Infections,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SHIRE DEVELOPMENT LLC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT LLC,C12 Male Urogenital Diseases,LANTHANUM CARBONATE,457.84,,,,,,,,
SHIRE DEVELOPMENT LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT LLC,C14 Cardiovascular Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
SHIRE DEVELOPMENT LLC,C15 Hemic and Lymphatic Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
SHIRE DEVELOPMENT LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT LLC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT LLC,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
SHIRE DEVELOPMENT LLC,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
SHIRE DEVELOPMENT LLC,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
SHIRE DEVELOPMENT LLC,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
SHIRE DEVELOPMENT LLC,F03 Mental Disorders,LISDEXAMFETAMINE DIMESYLATE,263.38,1.14,1,3,3,8,81.14,10.21,
SHIRE DEVELOPMENT LLC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT LLC,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
SHIRE DEVELOPMENT LLC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SHIRE DEVELOPMENT LLC,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
SHIRE DEVELOPMENT LLC,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
SHIRE DEVELOPMENT LLC,C10 Nervous System Diseases,LISDEXAMFETAMINE DIMESYLATE,263.38,1.14,1,3,3,8,81.14,10.21,
SIGMAPHARM LABORATORIES LLC,C10 Nervous System Diseases,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
SIGMAPHARM LABORATORIES LLC,C01 Infections,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
SIGMAPHARM LABORATORIES LLC,C19 Endocrine System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C04 Neoplasms,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
SIGMAPHARM LABORATORIES LLC,C06 Digestive System Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
SIGMAPHARM LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C01 Infections,GRISEOFULVIN,352.77,2.17,1,6,0,3,71.06,,
SIGMAPHARM LABORATORIES LLC,C14 Cardiovascular Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C01 Infections,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
SIGMAPHARM LABORATORIES LLC,C04 Neoplasms,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
SIGMAPHARM LABORATORIES LLC,C01 Infections,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C25 Chemically-Induced Disorders,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
SIGMAPHARM LABORATORIES LLC,C04 Neoplasms,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
SIGMAPHARM LABORATORIES LLC,C14 Cardiovascular Diseases,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
SIGMAPHARM LABORATORIES LLC,C12 Male Urogenital Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,F03 Mental Disorders,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C01 Infections,ADEFOVIR DIPIVOXIL,501.48,3.06,2,13,1,11,166.98,3.75,
SIGMAPHARM LABORATORIES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C14 Cardiovascular Diseases,AMILORIDE HYDROCHLORIDE,229.63,-0.5,1,6,5,1,156.79,7.35,11.43
SIGMAPHARM LABORATORIES LLC,G08 Reproductive and Urinary Physiological Phenomena,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C06 Digestive System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C06 Digestive System Diseases,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
SIGMAPHARM LABORATORIES LLC,C10 Nervous System Diseases,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
SIGMAPHARM LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
SIGMAPHARM LABORATORIES LLC,C14 Cardiovascular Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
SIGMAPHARM LABORATORIES LLC,C10 Nervous System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C10 Nervous System Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
SIGMAPHARM LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
SIGMAPHARM LABORATORIES LLC,C08 Respiratory Tract Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C08 Respiratory Tract Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
SIGMAPHARM LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
SIGMAPHARM LABORATORIES LLC,C10 Nervous System Diseases,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
SIGMAPHARM LABORATORIES LLC,C01 Infections,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
SIGMAPHARM LABORATORIES LLC,C05 Musculoskeletal Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C04 Neoplasms,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
SIGMAPHARM LABORATORIES LLC,C19 Endocrine System Diseases,LIOTHYRONINE SODIUM,650.98,2.8,2,4,3,5,92.78,9.48,0.3
SIGMAPHARM LABORATORIES LLC,C26 Wounds and Injuries,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SIGMAPHARM LABORATORIES LLC,C14 Cardiovascular Diseases,DOFETILIDE,441.58,0.24,2,6,2,11,104.81,8.99,10.15
SIGMAPHARM LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
SIGMAPHARM LABORATORIES LLC,C04 Neoplasms,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
SIGMAPHARM LABORATORIES LLC,C01 Infections,SODIUM PHENYLBUTYRATE,164.2,2.5,1,1,1,4,37.3,,4.81
SIGMAPHARM LABORATORIES LLC,C04 Neoplasms,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SINOTHERAPEUTICS INC,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
SMITHKLINE BEECHAM,C11 Eye Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C18 Nutritional and Metabolic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C04 Neoplasms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C06 Digestive System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C01 Infections,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,F03 Mental Disorders,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C17 Skin and Connective Tissue Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C12 Male Urogenital Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C13 Female Urogenital Diseases and Pregnancy Complications,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C14 Cardiovascular Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C10 Nervous System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C26 Wounds and Injuries,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C07 Stomatognathic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,F01 Behavior and Behavior Mechanisms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,"C23 Pathological Conditions, Signs and Symptoms",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM,C05 Musculoskeletal Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C04 Neoplasms,CARVEDILOL PHOSPHATE,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C14 Cardiovascular Diseases,CARVEDILOL PHOSPHATE,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SMITHKLINE BEECHAM (CORK) LTD IRELAND,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SOFGEN PHARMACEUTICALS LLC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C06 Digestive System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C10 Nervous System Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C01 Infections,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,F03 Mental Disorders,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C01 Infections,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C10 Nervous System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C26 Wounds and Injuries,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C11 Eye Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C04 Neoplasms,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,F03 Mental Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SOFGEN PHARMACEUTICALS LLC,C04 Neoplasms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SOFGEN PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
SOFGEN PHARMACEUTICALS LLC,C26 Wounds and Injuries,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
SPECGX LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SPECGX LLC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
SPECGX LLC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SPECGX LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,F03 Mental Disorders,IMIPRAMINE HYDROCHLORIDE,280.42,4.28,2,2,0,4,6.48,9.2,
SPECGX LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
SPECGX LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SPECGX LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SPECGX LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SPECGX LLC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
SPECGX LLC,C25 Chemically-Induced Disorders,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
SPECGX LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SPECGX LLC,F01 Behavior and Behavior Mechanisms,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SPECGX LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
SPECGX LLC,C10 Nervous System Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SPECGX LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SPECGX LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SPECGX LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SPECGX LLC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
SPECGX LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SPECGX LLC,F03 Mental Disorders,CLOMIPRAMINE HYDROCHLORIDE,314.86,4.88,2,2,0,4,6.48,9.2,
SPECGX LLC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SPECGX LLC,C06 Digestive System Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
SPECGX LLC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
SPECGX LLC,C05 Musculoskeletal Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
SPECGX LLC,C25 Chemically-Induced Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
SPECGX LLC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SPECGX LLC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
SPECGX LLC,C08 Respiratory Tract Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
SPECGX LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SPECGX LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,F03 Mental Disorders,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SPECGX LLC,F03 Mental Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
SPECGX LLC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SPECGX LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
SPECGX LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,C01 Infections,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
SPECGX LLC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SPECGX LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
SPECGX LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
SPECGX LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
SPECGX LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SPECGX LLC,C06 Digestive System Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
SPECGX LLC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SPECGX LLC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SPECGX LLC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SPECGX LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,C14 Cardiovascular Diseases,MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
SPECGX LLC,C05 Musculoskeletal Diseases,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
SPECGX LLC,C04 Neoplasms,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
SPECGX LLC,C17 Skin and Connective Tissue Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
SPECGX LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SPECGX LLC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SPECGX LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SPECGX LLC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SPECGX LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SPECGX LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
SQUARE PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
SQUARE PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
SQUARE PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
STI PHARMA LLC,C11 Eye Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C05 Musculoskeletal Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C14 Cardiovascular Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C17 Skin and Connective Tissue Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C10 Nervous System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C06 Digestive System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C08 Respiratory Tract Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,G08 Reproductive and Urinary Physiological Phenomena,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C12 Male Urogenital Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C11 Eye Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
STI PHARMA LLC,C10 Nervous System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C09 Otorhinolaryngologic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C15 Hemic and Lymphatic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C20 Immune System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C20 Immune System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
STI PHARMA LLC,C07 Stomatognathic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C08 Respiratory Tract Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C18 Nutritional and Metabolic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
STI PHARMA LLC,C14 Cardiovascular Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C15 Hemic and Lymphatic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C04 Neoplasms,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C01 Infections,ETHAMBUTOL HYDROCHLORIDE,204.31,-0.06,0,4,4,9,64.52,9.55,
STI PHARMA LLC,C19 Endocrine System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C12 Male Urogenital Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C05 Musculoskeletal Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C01 Infections,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
STI PHARMA LLC,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
STI PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
STI PHARMA LLC,C17 Skin and Connective Tissue Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C01 Infections,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C07 Stomatognathic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C18 Nutritional and Metabolic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C04 Neoplasms,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C06 Digestive System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
STI PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
STI PHARMA LLC,C26 Wounds and Injuries,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
STI PHARMA LLC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
STRIDES PHARMA GLOBAL PTE LTD,F01 Behavior and Behavior Mechanisms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
STRIDES PHARMA GLOBAL PTE LTD,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
STRIDES PHARMA GLOBAL PTE LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C26 Wounds and Injuries,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,G08 Reproductive and Urinary Physiological Phenomena,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
STRIDES PHARMA GLOBAL PTE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C20 Immune System Diseases,DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",DIPHENHYDRAMINE HYDROCHLORIDE,255.36,3.65,2,2,0,6,12.47,8.87,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,ETHOSUXIMIDE,141.17,0.55,0,2,1,1,46.17,,10.73
STRIDES PHARMA GLOBAL PTE LTD,C11 Eye Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
STRIDES PHARMA GLOBAL PTE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
STRIDES PHARMA GLOBAL PTE LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
STRIDES PHARMA GLOBAL PTE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
STRIDES PHARMA GLOBAL PTE LTD,C19 Endocrine System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
STRIDES PHARMA GLOBAL PTE LTD,C20 Immune System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C26 Wounds and Injuries,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
STRIDES PHARMA GLOBAL PTE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C07 Stomatognathic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
STRIDES PHARMA GLOBAL PTE LTD,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C19 Endocrine System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,G07 Physiological Phenomena,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
STRIDES PHARMA GLOBAL PTE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
STRIDES PHARMA GLOBAL PTE LTD,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
STRIDES PHARMA GLOBAL PTE LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
STRIDES PHARMA GLOBAL PTE LTD,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C19 Endocrine System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
STRIDES PHARMA GLOBAL PTE LTD,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
STRIDES PHARMA GLOBAL PTE LTD,F01 Behavior and Behavior Mechanisms,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
STRIDES PHARMA GLOBAL PTE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHOXSALEN,216.19,1.78,3,4,0,1,52.58,,
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C26 Wounds and Injuries,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
STRIDES PHARMA GLOBAL PTE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,METHOXSALEN,216.19,1.78,3,4,0,1,52.58,,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
STRIDES PHARMA GLOBAL PTE LTD,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C20 Immune System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C26 Wounds and Injuries,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C07 Stomatognathic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C25 Chemically-Induced Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
STRIDES PHARMA GLOBAL PTE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,NEVIRAPINE,266.3,2.49,2,4,1,1,58.12,3.28,
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C11 Eye Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
STRIDES PHARMA GLOBAL PTE LTD,D01 Inorganic Chemicals,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
STRIDES PHARMA GLOBAL PTE LTD,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
STRIDES PHARMA GLOBAL PTE LTD,A10 Tissues,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
STRIDES PHARMA GLOBAL PTE LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
STRIDES PHARMA GLOBAL PTE LTD,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
STRIDES PHARMA GLOBAL PTE LTD,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C20 Immune System Diseases,TACROLIMUS,804.03,5.59,0,12,3,7,178.36,,9.96
STRIDES PHARMA GLOBAL PTE LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,G07 Physiological Phenomena,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
STRIDES PHARMA GLOBAL PTE LTD,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
STRIDES PHARMA GLOBAL PTE LTD,C15 Hemic and Lymphatic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C09 Otorhinolaryngologic Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,EFAVIRENZ,315.68,4.46,1,2,1,0,38.33,,12.52
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
STRIDES PHARMA GLOBAL PTE LTD,C04 Neoplasms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
STRIDES PHARMA GLOBAL PTE LTD,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,METHOXSALEN,216.19,1.78,3,4,0,1,52.58,,
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C19 Endocrine System Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C20 Immune System Diseases,METHOXSALEN,216.19,1.78,3,4,0,1,52.58,,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C12 Male Urogenital Diseases,SODIUM CHLORIDE,58.44,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C05 Musculoskeletal Diseases,METHOXSALEN,216.19,1.78,3,4,0,1,52.58,,
STRIDES PHARMA GLOBAL PTE LTD,C15 Hemic and Lymphatic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
STRIDES PHARMA GLOBAL PTE LTD,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C15 Hemic and Lymphatic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
STRIDES PHARMA GLOBAL PTE LTD,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C13 Female Urogenital Diseases and Pregnancy Complications,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
STRIDES PHARMA GLOBAL PTE LTD,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
STRIDES PHARMA GLOBAL PTE LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
STRIDES PHARMA GLOBAL PTE LTD,C18 Nutritional and Metabolic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
STRIDES PHARMA GLOBAL PTE LTD,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
STRIDES VIVIMED PTE LTD,C01 Infections,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
STRIDES VIVIMED PTE LTD,C18 Nutritional and Metabolic Diseases,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
SUN PHARMA ADVANCED RESEARCH CO LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMA ADVANCED RESEARCH CO LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMA ADVANCED RESEARCH CO LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMA ADVANCED RESEARCH CO LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMA ADVANCED RESEARCH CO LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMA ADVANCED RESEARCH CO LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMA GLOBAL FZE,C12 Male Urogenital Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
SUN PHARMA GLOBAL FZE,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SUN PHARMA GLOBAL FZE,C04 Neoplasms,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
SUN PHARMA GLOBAL FZE,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SUN PHARMA GLOBAL FZE,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SUN PHARMA GLOBAL FZE,C06 Digestive System Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
SUN PHARMA GLOBAL FZE,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SUN PHARMA GLOBAL FZE,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SUN PHARMA GLOBAL FZE,C25 Chemically-Induced Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
SUN PHARMA GLOBAL FZE,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SUN PHARMA GLOBAL FZE,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SUN PHARMA GLOBAL FZE,F01 Behavior and Behavior Mechanisms,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
SUN PHARMA GLOBAL FZE,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SUN PHARMA GLOBAL FZE,F03 Mental Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
SUN PHARMA GLOBAL FZE,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SUN PHARMA GLOBAL FZE,C05 Musculoskeletal Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
SUN PHARMA GLOBAL FZE,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
SUN PHARMA GLOBAL FZE,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SUN PHARMA GLOBAL FZE,C10 Nervous System Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
SUN PHARMA INDUSTRIES LTD,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
SUN PHARMA INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
SUN PHARMA INDUSTRIES LTD,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
SUN PHARMA INDUSTRIES LTD,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
SUN PHARMA INDUSTRIES LTD,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
SUN PHARMA INDUSTRIES LTD,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
SUN PHARMA INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
SUN PHARMA INDUSTRIES LTD,C06 Digestive System Diseases,OMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMA INDUSTRIES LTD,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
SUN PHARMA INDUSTRIES LTD,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
SUN PHARMA INDUSTRIES LTD,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,SULINDAC,356.42,2.93,2,2,1,4,54.37,,4.09
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,SULINDAC,356.42,2.93,2,2,1,4,54.37,,4.09
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SUN PHARMACEUTICAL INDUSTRIES INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,PAROMOMYCIN SULFATE,615.63,-8.31,0,19,13,9,347.32,9.59,12.15
SUN PHARMACEUTICAL INDUSTRIES INC,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
SUN PHARMACEUTICAL INDUSTRIES INC,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES INC,C11 Eye Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
SUN PHARMACEUTICAL INDUSTRIES INC,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,OXAPROZIN,293.32,3.46,3,3,1,5,63.33,,4.95
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
SUN PHARMACEUTICAL INDUSTRIES INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
SUN PHARMACEUTICAL INDUSTRIES INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
SUN PHARMACEUTICAL INDUSTRIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES INC,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
SUN PHARMACEUTICAL INDUSTRIES INC,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,C19 Endocrine System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,PINDOLOL,248.33,1.69,2,3,3,6,57.28,9.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,ERGOLOID MESYLATES,2330.89,,,,,,,,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,ERGOLOID MESYLATES,2330.89,,,,,,,,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,ISOSORBIDE DINITRATE,236.14,-0.01,0,8,0,4,123.2,,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
SUN PHARMACEUTICAL INDUSTRIES INC,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
SUN PHARMACEUTICAL INDUSTRIES INC,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,REPAGLINIDE,452.6,3.95,2,4,2,10,78.87,4.82,3.68
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,QUINIDINE SULFATE,324.42,2.51,2,4,1,4,45.59,9.05,13.89
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,PINDOLOL,248.33,1.69,2,3,3,6,57.28,9.67,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,QUINIDINE SULFATE,324.42,2.51,2,4,1,4,45.59,9.05,13.89
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES INC,F01 Behavior and Behavior Mechanisms,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
SUN PHARMACEUTICAL INDUSTRIES INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
SUN PHARMACEUTICAL INDUSTRIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,CARVEDILOL PHOSPHATE,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
SUN PHARMACEUTICAL INDUSTRIES INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,MINOXIDIL,209.25,0,1,5,2,1,95.11,1.69,
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,TRIMETHOBENZAMIDE HYDROCHLORIDE,388.46,2.16,2,6,1,10,69.26,8.77,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",TRIMETHOBENZAMIDE HYDROCHLORIDE,388.46,2.16,2,6,1,10,69.26,8.77,
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,MINOXIDIL,209.25,0,1,5,2,1,95.11,1.69,
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
SUN PHARMACEUTICAL INDUSTRIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
SUN PHARMACEUTICAL INDUSTRIES INC,G08 Reproductive and Urinary Physiological Phenomena,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
SUN PHARMACEUTICAL INDUSTRIES INC,C19 Endocrine System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,IMIPRAMINE HYDROCHLORIDE,280.42,4.28,2,2,0,4,6.48,9.2,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,C07 Stomatognathic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES INC,F01 Behavior and Behavior Mechanisms,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
SUN PHARMACEUTICAL INDUSTRIES INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
SUN PHARMACEUTICAL INDUSTRIES INC,C26 Wounds and Injuries,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SUN PHARMACEUTICAL INDUSTRIES INC,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
SUN PHARMACEUTICAL INDUSTRIES INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,TEMAZEPAM,300.75,2.79,2,3,1,1,52.9,,10.68
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,DIGOXIN,780.95,2.37,0,14,6,7,203.06,,7.15
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SUN PHARMACEUTICAL INDUSTRIES INC,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
SUN PHARMACEUTICAL INDUSTRIES INC,F01 Behavior and Behavior Mechanisms,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C11 Eye Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES INC,C15 Hemic and Lymphatic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
SUN PHARMACEUTICAL INDUSTRIES INC,C11 Eye Diseases,METHIMAZOLE,114.17,0.75,1,2,1,0,20.72,,10.41
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SUN PHARMACEUTICAL INDUSTRIES INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES INC,C05 Musculoskeletal Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUN PHARMACEUTICAL INDUSTRIES INC,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
SUN PHARMACEUTICAL INDUSTRIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,CARVEDILOL PHOSPHATE,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES INC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES INC,C01 Infections,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
SUN PHARMACEUTICAL INDUSTRIES INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
SUN PHARMACEUTICAL INDUSTRIES INC,C14 Cardiovascular Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C18 Nutritional and Metabolic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C06 Digestive System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,"C23 Pathological Conditions, Signs and Symptoms",MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
SUN PHARMACEUTICAL INDUSTRIES INC,C26 Wounds and Injuries,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES INC,C07 Stomatognathic Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
SUN PHARMACEUTICAL INDUSTRIES INC,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
SUN PHARMACEUTICAL INDUSTRIES INC,C04 Neoplasms,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
SUN PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms","CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,"CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,RILUZOLE,234.2,3.4,2,4,1,1,48.14,4.57,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,TIAGABINE HYDROCHLORIDE,375.56,2.6,2,4,1,6,40.54,9.26,4.14
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,NALTREXONE HYDROCHLORIDE,341.41,1.36,1,5,2,2,70,8.88,10.11
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,"CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES LTD,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,"CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,TETRABENAZINE,317.43,3.4,1,4,0,4,38.77,7.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,DOFETILIDE,441.58,0.24,2,6,2,11,104.81,8.99,10.15
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
SUN PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,RANOLAZINE,427.55,2.83,2,6,2,9,74.27,6.77,13.6
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C09 Otorhinolaryngologic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,SUMATRIPTAN SUCCINATE,295.41,0.74,2,3,2,6,65.2,9.54,11.24
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,ALFUZOSIN HYDROCHLORIDE,389.46,1.19,2,8,2,8,111.83,7.3,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C19 Endocrine System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,PALIPERIDONE,426.49,1.76,3,7,1,4,84.39,8.76,13.74
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,LURASIDONE HYDROCHLORIDE,492.69,4.56,2,6,0,5,56.75,8.5,
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
SUN PHARMACEUTICAL INDUSTRIES LTD,C07 Stomatognathic Diseases,GLYCOPYRROLATE,318.44,-1.41,1,3,1,4,46.53,,11.53
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",NALOXONE HYDROCHLORIDE,327.38,1.62,1,5,2,2,70,7.84,10.07
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",PENTAZOCINE HYDROCHLORIDE,285.43,3.89,1,2,1,2,23.47,9.57,10.42
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE SULFATE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
SUN PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SUN PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
SUN PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
SUN PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,NALOXONE HYDROCHLORIDE,327.38,1.62,1,5,2,2,70,7.84,10.07
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
SUN PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
SUN PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
SUN PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,NALOXONE HYDROCHLORIDE,327.38,1.62,1,5,2,2,70,7.84,10.07
SUN PHARMACEUTICAL INDUSTRIES LTD,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
SUN PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
SUN PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
SUN PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
SUN PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
SUN PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
SUN PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
SUN PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
SUN PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
SUNGEN PHARMA LLC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUNGEN PHARMA LLC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUNGEN PHARMA LLC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUNGEN PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUNGEN PHARMA LLC,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUNGEN PHARMA LLC,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUNGEN PHARMA LLC,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUNGEN PHARMA LLC,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNGEN PHARMA LLC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
SUNGEN PHARMA LLC,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
SUNNY PHARMTECH INC,C14 Cardiovascular Diseases,AMINOCAPROIC ACID,131.18,-2,0,2,2,5,63.32,10.21,4.73
SUNNY PHARMTECH INC,C05 Musculoskeletal Diseases,AMINOCAPROIC ACID,131.18,-2,0,2,2,5,63.32,10.21,4.73
SUNNY PHARMTECH INC,C10 Nervous System Diseases,AMINOCAPROIC ACID,131.18,-2,0,2,2,5,63.32,10.21,4.73
SUNNY PHARMTECH INC,C17 Skin and Connective Tissue Diseases,AMINOCAPROIC ACID,131.18,-2,0,2,2,5,63.32,10.21,4.73
SUNNY PHARMTECH INC,"C23 Pathological Conditions, Signs and Symptoms",AMINOCAPROIC ACID,131.18,-2,0,2,2,5,63.32,10.21,4.73
SUNSHINE LAKE PHARMA CO LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SUNSHINE LAKE PHARMA CO LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SUNSHINE LAKE PHARMA CO LTD,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SUNSHINE LAKE PHARMA CO LTD,C18 Nutritional and Metabolic Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
SUNSHINE LAKE PHARMA CO LTD,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
SUNSHINE LAKE PHARMA CO LTD,C10 Nervous System Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
SUNSHINE LAKE PHARMA CO LTD,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SUNSHINE LAKE PHARMA CO LTD,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SUNSHINE LAKE PHARMA CO LTD,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
SUNSHINE LAKE PHARMA CO LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SUNSHINE LAKE PHARMA CO LTD,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SUNSHINE LAKE PHARMA CO LTD,C25 Chemically-Induced Disorders,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
SUNSHINE LAKE PHARMA CO LTD,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SUNSHINE LAKE PHARMA CO LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
SUNSHINE LAKE PHARMA CO LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUNSHINE LAKE PHARMA CO LTD,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
SUNSHINE LAKE PHARMA CO LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
SUPERNUS PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUPERNUS PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUPERNUS PHARMACEUTICALS INC,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUPERNUS PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUPERNUS PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
SUPERNUS PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUPERNUS PHARMACEUTICALS INC,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
SUPERNUS PHARMACEUTICALS INC,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
SUPERNUS PHARMACEUTICALS INC,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUPERNUS PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUPERNUS PHARMACEUTICALS INC,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
SUPERNUS PHARMACEUTICALS INC,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
TAKEDA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
TAKEDA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
TAKEDA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
TAKEDA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TAKEDA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
TAKEDA PHARMACEUTICALS USA INC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TAKEDA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
TAKEDA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TAKEDA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
TAKEDA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
TAKEDA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TAKEDA PHARMACEUTICALS USA INC,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TAKEDA PHARMACEUTICALS USA INC,C26 Wounds and Injuries,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
TAKEDA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TAKEDA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TAKEDA PHARMACEUTICALS USA INC,C11 Eye Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
TAKEDA PHARMACEUTICALS USA INC,C04 Neoplasms,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
TAKEDA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TAKEDA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TAKEDA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
TAKEDA PHARMACEUTICALS USA INC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TAKEDA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
TAKEDA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
TAKEDA PHARMACEUTICALS USA INC,F03 Mental Disorders,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
TAKEDA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TAKEDA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
TAKEDA PHARMACEUTICALS USA INC,C01 Infections,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
TAKEDA PHARMACEUTICALS USA INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TAKEDA PHARMACEUTICALS USA INC,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TAKEDA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TAKEDA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,DEXLANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TAKEDA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
TAKEDA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
TAKEDA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DEXLANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TAKEDA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TAKEDA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TAKEDA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TAKEDA PHARMACEUTICALS USA INC,C04 Neoplasms,DEXLANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TAKEDA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TAKEDA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,FEBUXOSTAT,316.38,3.52,2,5,1,5,83.21,0.39,3.08
TAKEDA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TAKEDA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,RAMELTEON,259.35,2.57,1,2,1,4,38.33,,
TAKEDA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TAKEDA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TARO PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
TARO PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TARO PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TARO PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
TARO PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TARO PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TARO PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TARO PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
TARO PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C19 Endocrine System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICAL INDUSTRIES LTD,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
TARO PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,CLOMIPRAMINE HYDROCHLORIDE,314.86,4.88,2,2,0,4,6.48,9.2,
TARO PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TARO PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
TARO PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
TARO PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TARO PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TARO PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TARO PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
TARO PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
TARO PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,KETOCONAZOLE,531.44,4.19,3,7,0,7,69.06,6.42,
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
TARO PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TARO PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
TARO PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TARO PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
TARO PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
TARO PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
TARO PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TARO PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TARO PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
TARO PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TARO PHARMACEUTICAL INDUSTRIES LTD,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TARO PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TARO PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
TARO PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TARO PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TARO PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TARO PHARMACEUTICAL INDUSTRIES LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TARO PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TARO PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TARO PHARMACEUTICAL INDUSTRIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
TARO PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
TARO PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TARO PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
TARO PHARMACEUTICAL INDUSTRIES LTD,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TARO PHARMACEUTICAL INDUSTRIES LTD,C07 Stomatognathic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TARO PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
TARO PHARMACEUTICAL INDUSTRIES LTD,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
TARO PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,WARFARIN SODIUM,308.33,2.74,3,4,1,4,67.51,,5.56
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
TARO PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TARO PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
TARO PHARMACEUTICAL INDUSTRIES LTD,C15 Hemic and Lymphatic Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICAL INDUSTRIES LTD,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
TARO PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICAL INDUSTRIES LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
TARO PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
TARO PHARMACEUTICAL INDUSTRIES LTD,C11 Eye Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICAL INDUSTRIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
TARO PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,DESLORATADINE,310.83,3.97,2,2,1,0,24.92,9.73,
TARO PHARMACEUTICAL INDUSTRIES LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
TARO PHARMACEUTICAL INDUSTRIES LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TARO PHARMACEUTICAL INDUSTRIES LTD,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TARO PHARMACEUTICAL INDUSTRIES LTD,C26 Wounds and Injuries,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TARO PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TARO PHARMACEUTICAL INDUSTRIES LTD,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TARO PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TARO PHARMACEUTICAL INDUSTRIES LTD,C17 Skin and Connective Tissue Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TARO PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TARO PHARMACEUTICAL INDUSTRIES LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TARO PHARMACEUTICAL INDUSTRIES LTD,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TARO PHARMACEUTICAL INDUSTRIES LTD,C04 Neoplasms,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
TARO PHARMACEUTICAL INDUSTRIES LTD,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
TARO PHARMACEUTICAL INDUSTRIES LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TARO PHARMACEUTICALS USA INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C26 Wounds and Injuries,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
TARO PHARMACEUTICALS USA INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
TARO PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
TARO PHARMACEUTICALS USA INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C04 Neoplasms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICALS USA INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TARO PHARMACEUTICALS USA INC,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICALS USA INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TARO PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICALS USA INC,C20 Immune System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
TARO PHARMACEUTICALS USA INC,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICALS USA INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TARO PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TARO PHARMACEUTICALS USA INC,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TARO PHARMACEUTICALS USA INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TARO PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICALS USA INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
TARO PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICALS USA INC,F03 Mental Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICALS USA INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
TARO PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
TARO PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TARO PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
TARO PHARMACEUTICALS USA INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TCG FLUENT PHARMA INVESTORS LP,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TCG FLUENT PHARMA INVESTORS LP,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
TERSERA THERAPEUTICS LLC,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TERSERA THERAPEUTICS LLC,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TERSERA THERAPEUTICS LLC,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TERSERA THERAPEUTICS LLC,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TERSERA THERAPEUTICS LLC,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TERSERA THERAPEUTICS LLC,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C14 Cardiovascular Diseases,BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,F03 Mental Disorders,DIAZOXIDE,230.68,1,1,3,1,0,58.53,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C18 Nutritional and Metabolic Diseases,DIAZOXIDE,230.68,1,1,3,1,0,58.53,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C14 Cardiovascular Diseases,DIAZOXIDE,230.68,1,1,3,1,0,58.53,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
TEVA PHARMACEUTICALS USA,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,C01 Infections,CEFPROZIL,389.43,-1.92,1,6,4,5,132.96,7.22,3.3
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
TEVA PHARMACEUTICALS USA,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TEVA PHARMACEUTICALS USA,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA,C04 Neoplasms,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TEVA PHARMACEUTICALS USA,C01 Infections,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TEVA PHARMACEUTICALS USA,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
TEVA PHARMACEUTICALS USA,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,CLOZAPINE,326.83,3.4,2,4,1,0,30.87,7.35,
TEVA PHARMACEUTICALS USA,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,MYCOPHENOLIC ACID,320.34,3.53,1,5,2,6,93.06,,3.57
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,C07 Stomatognathic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA,C26 Wounds and Injuries,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,C01 Infections,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
TEVA PHARMACEUTICALS USA,C09 Otorhinolaryngologic Diseases,CEFDINIR,395.42,-0.89,1,9,4,5,158.21,3.61,2.73
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
TEVA PHARMACEUTICALS USA,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,RALOXIFENE HYDROCHLORIDE,473.59,5.69,4,6,2,7,70,7.95,8.89
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C09 Otorhinolaryngologic Diseases,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
TEVA PHARMACEUTICALS USA,C04 Neoplasms,VIGABATRIN,129.16,-2.09,0,2,2,4,63.32,9.91,4.61
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
TEVA PHARMACEUTICALS USA,C04 Neoplasms,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
TEVA PHARMACEUTICALS USA,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
TEVA PHARMACEUTICALS USA,C01 Infections,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,C26 Wounds and Injuries,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,G08 Reproductive and Urinary Physiological Phenomena,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
TEVA PHARMACEUTICALS USA,C04 Neoplasms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
TEVA PHARMACEUTICALS USA,C01 Infections,ACITRETIN,326.44,5.59,1,2,1,6,46.53,,4.77
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
TEVA PHARMACEUTICALS USA,C01 Infections,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
TEVA PHARMACEUTICALS USA,C01 Infections,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TEVA PHARMACEUTICALS USA,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
TEVA PHARMACEUTICALS USA,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
TEVA PHARMACEUTICALS USA,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TEVA PHARMACEUTICALS USA,C01 Infections,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
TEVA PHARMACEUTICALS USA,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,TRANDOLAPRIL,430.55,1.95,1,5,2,9,95.94,5.21,3.8
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TEVA PHARMACEUTICALS USA,C01 Infections,ATAZANAVIR SULFATE,704.87,4.54,3,9,5,14,171.22,4.42,11.92
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
TEVA PHARMACEUTICALS USA,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
TEVA PHARMACEUTICALS USA,C01 Infections,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
TEVA PHARMACEUTICALS USA,C04 Neoplasms,ISOTRETINOIN,300.44,5.01,0,1,1,5,37.3,,4.76
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TEVA PHARMACEUTICALS USA,C19 Endocrine System Diseases,PARICALCITOL,416.65,4.26,0,3,3,5,60.69,,
TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA,C01 Infections,VORICONAZOLE,349.32,1.82,3,6,1,5,76.72,2.01,12.7
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TEVA PHARMACEUTICALS USA,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,ALMOTRIPTAN MALATE,335.47,1.52,2,3,1,6,56.41,9.55,
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TEVA PHARMACEUTICALS USA,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TEVA PHARMACEUTICALS USA,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TEVA PHARMACEUTICALS USA,C25 Chemically-Induced Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
TEVA PHARMACEUTICALS USA,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA,C07 Stomatognathic Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
TEVA PHARMACEUTICALS USA,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,TOLTERODINE TARTRATE,325.5,5.12,2,2,1,7,23.47,11.01,10.28
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
TEVA PHARMACEUTICALS USA,C04 Neoplasms,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
TEVA PHARMACEUTICALS USA,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,ULIPRISTAL ACETATE,475.63,4.62,1,5,0,4,63.68,4.89,
TEVA PHARMACEUTICALS USA,G08 Reproductive and Urinary Physiological Phenomena,ULIPRISTAL ACETATE,475.63,4.62,1,5,0,4,63.68,4.89,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
TEVA PHARMACEUTICALS USA,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",ULIPRISTAL ACETATE,475.63,4.62,1,5,0,4,63.68,4.89,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,ULIPRISTAL ACETATE,475.63,4.62,1,5,0,4,63.68,4.89,
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TEVA PHARMACEUTICALS USA,C04 Neoplasms,ULIPRISTAL ACETATE,475.63,4.62,1,5,0,4,63.68,4.89,
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
TEVA PHARMACEUTICALS USA,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
TEVA PHARMACEUTICALS USA,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C01 Infections,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TEVA PHARMACEUTICALS USA,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,PRAZOSIN HYDROCHLORIDE,383.41,1.65,3,8,1,4,106.95,7.24,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TEVA PHARMACEUTICALS USA,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TEVA PHARMACEUTICALS USA,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TEVA PHARMACEUTICALS USA,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,FLUVASTATIN SODIUM,411.47,3.83,3,4,3,8,82.69,,4.54
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
TEVA PHARMACEUTICALS USA,C05 Musculoskeletal Diseases,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
TEVA PHARMACEUTICALS USA,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TEVA PHARMACEUTICALS USA,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,FLUVASTATIN SODIUM,411.47,3.83,3,4,3,8,82.69,,4.54
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,VARDENAFIL HYDROCHLORIDE,488.61,1.43,3,8,1,8,112.9,6.21,11.75
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
TEVA PHARMACEUTICALS USA,C04 Neoplasms,RISEDRONATE SODIUM,283.11,-3.32,1,4,5,4,148.18,4.91,0.68
TEVA PHARMACEUTICALS USA,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
TEVA PHARMACEUTICALS USA,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
TEVA PHARMACEUTICALS USA,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
TEVA PHARMACEUTICALS USA,C14 Cardiovascular Diseases,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
TEVA PHARMACEUTICALS USA,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
TEVA PHARMACEUTICALS USA,C01 Infections,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
TEVA PHARMACEUTICALS USA,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TEVA PHARMACEUTICALS USA,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
TEVA PHARMACEUTICALS USA,C04 Neoplasms,ERLOTINIB HYDROCHLORIDE,393.44,3.2,3,7,1,10,74.73,4.62,
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
TEVA PHARMACEUTICALS USA,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
TEVA PHARMACEUTICALS USA,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TEVA PHARMACEUTICALS USA,C01 Infections,LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TEVA PHARMACEUTICALS USA,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
TEVA PHARMACEUTICALS USA,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA,C01 Infections,CEFADROXIL,363.39,-2.45,1,6,4,4,132.96,7.22,3.25
TEVA PHARMACEUTICALS USA,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TEVA PHARMACEUTICALS USA,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LEVOCETIRIZINE DIHYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA INC,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
TEVA PHARMACEUTICALS USA INC,C01 Infections,TENOFOVIR DISOPROXIL FUMARATE,519.45,2.65,2,15,1,13,185.44,3.74,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
TEVA PHARMACEUTICALS USA INC,C01 Infections,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,LURASIDONE HYDROCHLORIDE,492.69,4.56,2,6,0,5,56.75,8.5,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TEVA PHARMACEUTICALS USA INC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
TEVA PHARMACEUTICALS USA INC,C01 Infections,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
TEVA PHARMACEUTICALS USA INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
TEVA PHARMACEUTICALS USA INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,GLIMEPIRIDE,490.63,3.12,1,5,3,7,124.68,,4.32
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C20 Immune System Diseases,CLEMASTINE FUMARATE,343.9,4.92,2,2,0,6,12.47,9.55,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,MOEXIPRIL HYDROCHLORIDE,498.58,1.5,2,7,2,11,114.4,5.2,3.46
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
TEVA PHARMACEUTICALS USA INC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,C01 Infections,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLERGONOVINE MALEATE,339.44,1.59,2,3,3,4,68.36,7.93,
TEVA PHARMACEUTICALS USA INC,C01 Infections,FLURBIPROFEN,244.26,3.94,2,1,1,3,37.3,,4.42
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
TEVA PHARMACEUTICALS USA INC,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TEVA PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TEVA PHARMACEUTICALS USA INC,C01 Infections,OSELTAMIVIR PHOSPHATE,312.41,1.16,0,5,2,7,90.65,9.31,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
TEVA PHARMACEUTICALS USA INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
TEVA PHARMACEUTICALS USA INC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA INC,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TEVA PHARMACEUTICALS USA INC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
TEVA PHARMACEUTICALS USA INC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TEVA PHARMACEUTICALS USA INC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,AMPHETAMINE ASPARTATE,135.21,1.8,1,1,1,2,26.02,10.01,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
TEVA PHARMACEUTICALS USA INC,C01 Infections,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
TEVA PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,SOTALOL HYDROCHLORIDE,272.37,-0.4,1,4,3,6,78.43,9.43,10.07
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
TEVA PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,DICLOFENAC POTASSIUM,296.15,4.26,2,2,2,4,49.33,,4
TEVA PHARMACEUTICALS USA INC,C26 Wounds and Injuries,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,NORTRIPTYLINE HYDROCHLORIDE,263.38,4.43,2,1,1,3,12.03,10.47,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
TEVA PHARMACEUTICALS USA INC,C01 Infections,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
TEVA PHARMACEUTICALS USA INC,C01 Infections,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TEVA PHARMACEUTICALS USA INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TEVA PHARMACEUTICALS USA INC,C26 Wounds and Injuries,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
TEVA PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,NAPROXEN SODIUM,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
TEVA PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,OFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,CIMETIDINE,252.35,-0.11,1,4,3,5,88.89,6.91,13.38
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,KETOPROFEN,254.29,3.61,2,2,1,4,54.37,,3.88
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
TEVA PHARMACEUTICALS USA INC,C01 Infections,ONDANSETRON,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,FLUVOXAMINE MALEATE,318.34,2.8,1,4,1,9,56.84,8.86,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PIMOZIDE,461.56,5.83,4,3,1,7,41.03,8.38,12.9
TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,PIMOZIDE,461.56,5.83,4,3,1,7,41.03,8.38,12.9
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,PIMOZIDE,461.56,5.83,4,3,1,7,41.03,8.38,12.9
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,C01 Infections,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,C01 Infections,CEFPROZIL,389.43,-1.92,1,6,4,5,132.96,7.22,3.3
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C01 Infections,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SACCHARATE,135.21,1.8,1,1,1,2,26.02,10.01,
TEVA PHARMACEUTICALS USA INC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,MEXILETINE HYDROCHLORIDE,179.26,2.46,1,2,1,3,35.25,9.52,
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
TEVA PHARMACEUTICALS USA INC,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,LOVASTATIN,404.55,3.9,0,5,1,6,72.83,,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
TEVA PHARMACEUTICALS USA INC,C01 Infections,EMTRICITABINE,247.25,-0.9,1,7,2,2,90.37,,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,FOSINOPRIL SODIUM,563.67,5.62,1,6,1,14,110.21,,3.87
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,CLOMIPRAMINE HYDROCHLORIDE,314.86,4.88,2,2,0,4,6.48,9.2,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C01 Infections,DARUNAVIR ETHANOLATE,547.67,2.82,2,8,3,11,140.42,2.39,13.59
TEVA PHARMACEUTICALS USA INC,C01 Infections,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
TEVA PHARMACEUTICALS USA INC,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
TEVA PHARMACEUTICALS USA INC,C01 Infections,DICLOXACILLIN SODIUM,470.33,2.91,2,6,2,4,112.74,,3.75
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
TEVA PHARMACEUTICALS USA INC,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C20 Immune System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,AMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TEVA PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",KETOROLAC TROMETHAMINE,255.27,2.28,2,3,1,3,59.3,,3.84
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
TEVA PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
TEVA PHARMACEUTICALS USA INC,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TEVA PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA INC,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
TEVA PHARMACEUTICALS USA INC,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,DISOPYRAMIDE PHOSPHATE,339.48,3.47,2,3,1,8,59.22,10.42,
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,CEFACLOR,367.81,-2.31,1,5,3,4,112.73,7.23,2.83
TEVA PHARMACEUTICALS USA INC,C01 Infections,CEFACLOR,367.81,-2.31,1,5,3,4,112.73,7.23,2.83
TEVA PHARMACEUTICALS USA INC,C26 Wounds and Injuries,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,DIFLUNISAL,250.2,3.91,2,2,2,2,57.53,,2.69
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TEVA PHARMACEUTICALS USA INC,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
TEVA PHARMACEUTICALS USA INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,OXAPROZIN,293.32,3.46,3,3,1,5,63.33,,4.95
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DIFLUNISAL,250.2,3.91,2,2,2,2,57.53,,2.69
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,SUCRALFATE,2072.71,,,,,,,,
TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DIFLUNISAL,250.2,3.91,2,2,2,2,57.53,,2.69
TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
THEPHARMANETWORK LLC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C14 Cardiovascular Diseases,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
THEPHARMANETWORK LLC,C12 Male Urogenital Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
THEPHARMANETWORK LLC,C10 Nervous System Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
THEPHARMANETWORK LLC,C01 Infections,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
THEPHARMANETWORK LLC,C04 Neoplasms,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
THEPHARMANETWORK LLC,F03 Mental Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
THEPHARMANETWORK LLC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
THEPHARMANETWORK LLC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C01 Infections,ISONIAZID,137.14,-0.69,1,3,2,1,68.01,3.35,13.61
THEPHARMANETWORK LLC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C25 Chemically-Induced Disorders,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
THEPHARMANETWORK LLC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C05 Musculoskeletal Diseases,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
THEPHARMANETWORK LLC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,"C23 Pathological Conditions, Signs and Symptoms",METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
THEPHARMANETWORK LLC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THEPHARMANETWORK LLC,C14 Cardiovascular Diseases,NIMODIPINE,418.45,2.54,1,8,1,8,117,,
THEPHARMANETWORK LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
THERAPEUTICSMD INC,C26 Wounds and Injuries,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,C18 Nutritional and Metabolic Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,C01 Infections,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,C10 Nervous System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,"C23 Pathological Conditions, Signs and Symptoms",PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,C19 Endocrine System Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,C25 Chemically-Induced Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,C04 Neoplasms,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,F03 Mental Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,C18 Nutritional and Metabolic Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,C12 Male Urogenital Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,C10 Nervous System Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,F03 Mental Disorders,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,C12 Male Urogenital Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,C14 Cardiovascular Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,C01 Infections,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,C14 Cardiovascular Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,G07 Physiological Phenomena,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,C11 Eye Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,C05 Musculoskeletal Diseases,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
THERAPEUTICSMD INC,G08 Reproductive and Urinary Physiological Phenomena,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
THERAPEUTICSMD INC,C04 Neoplasms,ESTRADIOL,272.39,3.75,1,2,2,0,40.46,,10.33
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TIANJIN TIANYAO PHARMACEUTICALS CO LTD,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
TORRENT PHARMA INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TORRENT PHARMA INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMA INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
TORRENT PHARMA INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMA INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
TORRENT PHARMA INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMA INC,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
TORRENT PHARMA INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TORRENT PHARMA INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
TORRENT PHARMA INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TORRENT PHARMA INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
TORRENT PHARMA INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMA INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TORRENT PHARMA INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TORRENT PHARMA INC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
TORRENT PHARMA INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TORRENT PHARMA INC,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
TORRENT PHARMA INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TORRENT PHARMA INC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
TORRENT PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
TORRENT PHARMA INC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMA INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TORRENT PHARMA INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TORRENT PHARMA INC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMA INC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMA INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TORRENT PHARMACEUTICALS LIMITED,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LIMITED,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
TORRENT PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TORRENT PHARMACEUTICALS LLC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TORRENT PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TORRENT PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TORRENT PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TORRENT PHARMACEUTICALS LLC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TORRENT PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TORRENT PHARMACEUTICALS LLC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TORRENT PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TORRENT PHARMACEUTICALS LLC,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TORRENT PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LLC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
TORRENT PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LLC,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TORRENT PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
TORRENT PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,ANAGRELIDE HYDROCHLORIDE,256.09,1.94,1,3,1,0,44.7,3.62,11.25
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TORRENT PHARMACEUTICALS LTD,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
TORRENT PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
TORRENT PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
TORRENT PHARMACEUTICALS LTD,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
TORRENT PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TORRENT PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TORRENT PHARMACEUTICALS LTD,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TORRENT PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TORRENT PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
TORRENT PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,RABEPRAZOLE SODIUM,359.45,2.09,3,5,1,8,77.1,4.24,9.35
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TORRENT PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TORRENT PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
TORRENT PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,ESCITALOPRAM OXALATE,324.4,3.76,2,3,0,5,36.26,9.78,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
TORRENT PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
TORRENT PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
TORRENT PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
TORRENT PHARMACEUTICALS LTD,C01 Infections,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
TORRENT PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
TORRENT PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
TORRENT PHARMACEUTICALS LTD,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMACEUTICALS LTD,C11 Eye Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
TORRENT PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
TORRENT PHARMACEUTICALS LTD,C01 Infections,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TORRENT PHARMACEUTICALS LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
TORRENT PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
TORRENT PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TORRENT PHARMACEUTICALS LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
TORRENT PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
TORRENT PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
TORRENT PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,FLUVOXAMINE MALEATE,318.34,2.8,1,4,1,9,56.84,8.86,
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TOLTERODINE TARTRATE,325.5,5.12,2,2,1,7,23.47,11.01,10.28
TORRENT PHARMACEUTICALS LTD,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
TORRENT PHARMACEUTICALS LTD,C06 Digestive System Diseases,MOXIFLOXACIN HYDROCHLORIDE,401.44,-0.5,2,6,2,4,83.8,9.42,5.49
TORRENT PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,ROFLUMILAST,403.21,4.45,2,4,1,7,60.45,2.4,13.3
TORRENT PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
TORRENT PHARMACEUTICALS LTD,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TORRENT PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
TORRENT PHARMACEUTICALS LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TORRENT PHARMACEUTICALS LTD,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
TORRENT PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
TORRENT PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
TORRENT PHARMACEUTICALS LTD,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
TORRENT PHARMACEUTICALS LTD,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
TORRENT PHARMACEUTICALS LTD,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
TRIS PHARMA INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TRIS PHARMA INC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,F03 Mental Disorders,DEXMETHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TRIS PHARMA INC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TRIS PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TRIS PHARMA INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
TRIS PHARMA INC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
TRIS PHARMA INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TRIS PHARMA INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TRIS PHARMA INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TRIS PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TRIS PHARMA INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TRIS PHARMA INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TRIS PHARMA INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
TRIS PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TRIS PHARMA INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TRIS PHARMA INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TRIS PHARMA INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TRIS PHARMA INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TRIS PHARMA INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TRIS PHARMA INC,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TRIS PHARMA INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TRIS PHARMA INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TRIS PHARMA INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
TRIS PHARMA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TRIS PHARMA INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TRIS PHARMA INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TRIS PHARMA INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
TRIS PHARMA INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TRIS PHARMA INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TRIS PHARMA INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
TRIS PHARMA INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
TRIS PHARMA INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C12 Male Urogenital Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
TRIS PHARMA INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
TRIS PHARMA INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
TRIS PHARMA INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TRIS PHARMA INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
TRIS PHARMA INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TRIS PHARMA INC,C25 Chemically-Induced Disorders,AMPHETAMINE,135.21,1.8,1,1,1,2,26.02,10.01,
TRIS PHARMA INC,F03 Mental Disorders,AMPHETAMINE,135.21,1.8,1,1,1,2,26.02,10.01,
TRIS PHARMA INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TRIS PHARMA INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TRIS PHARMA INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
TRIS PHARMA INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
TRIS PHARMA INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
TRIS PHARMA INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
TRIS PHARMA INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
TRIS PHARMA INC,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
TRIS PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
TRIS PHARMA INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
TRIS PHARMA INC,C08 Respiratory Tract Diseases,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
TRIS PHARMA INC,C04 Neoplasms,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
TRIS PHARMA INC,F03 Mental Disorders,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
TRIS PHARMA INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TRIS PHARMA INC,C01 Infections,THEOPHYLLINE,180.17,-0.81,2,5,1,0,72.68,2.44,8.44
TRIS PHARMA INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
TRIS PHARMA INC,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
TULEX PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
TWI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TWI PHARMACEUTICALS INC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TWI PHARMACEUTICALS INC,C10 Nervous System Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
TWI PHARMACEUTICALS INC,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
TWI PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TWI PHARMACEUTICALS INC,C01 Infections,SEVELAMER CARBONATE,149.62,,,,,,,,
TWI PHARMACEUTICALS INC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TWI PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SEVELAMER CARBONATE,149.62,,,,,,,,
TWI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
TWI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
TWI PHARMACEUTICALS INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TWI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TWI PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TWI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
TWI PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TWI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CHOLINE FENOFIBRATE,318.76,4.36,2,3,1,5,63.6,,3.1
TWI PHARMACEUTICALS INC,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
TWI PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
TWI PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
TWI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
TWI PHARMACEUTICALS INC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
TWI PHARMACEUTICALS INC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
TWI PHARMACEUTICALS INC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
TWI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
TWI PHARMACEUTICALS INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
TWI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TWI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,CYCLOBENZAPRINE HYDROCHLORIDE,275.4,4.61,2,1,0,3,3.24,9.76,
TWI PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TWI PHARMACEUTICALS INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
TWI PHARMACEUTICALS INC,C10 Nervous System Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TWI PHARMACEUTICALS INC,C04 Neoplasms,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TWI PHARMACEUTICALS INC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
TWI PHARMACEUTICALS INC,C01 Infections,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TWI PHARMACEUTICALS INC,C10 Nervous System Diseases,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
TWI PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
TWI PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
TWI PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
TWI PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
TWI PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
TWI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
TWI PHARMACEUTICALS INC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
TWI PHARMACEUTICALS INC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
TWI PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
TWI PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
UCB INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
UCB INC,F01 Behavior and Behavior Mechanisms,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
UCB INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
UCB INC,C05 Musculoskeletal Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
UCB INC,C25 Chemically-Induced Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
UCB INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
UCB INC,F03 Mental Disorders,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
UCB INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
UCB INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
UCB INC,C10 Nervous System Diseases,ERLOSAMIDE,250.3,-0.02,1,3,2,6,67.43,,12.46
UCB INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
UMEDICA LABORATORIES PRIVATE LTD,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
UMEDICA LABORATORIES PRIVATE LTD,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
UMEDICA LABORATORIES PRIVATE LTD,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
UMEDICA LABORATORIES PRIVATE LTD,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
UMEDICA LABORATORIES PRIVATE LTD,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
UMEDICA LABORATORIES PRIVATE LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
UMEDICA LABORATORIES PRIVATE LTD,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
UNICHEM LABORATORIES LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
UNICHEM LABORATORIES LTD,C14 Cardiovascular Diseases,BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
UNICHEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BISOPROLOL FUMARATE,325.45,2.2,1,5,2,12,59.95,9.67,
UNICHEM LABORATORIES LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
UNICHEM LABORATORIES LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
UNICHEM LABORATORIES LTD,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UNICHEM LABORATORIES LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UNICHEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UNICHEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UNICHEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UNICHEM LABORATORIES LTD,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
UNICHEM LABORATORIES LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UNICHEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
UNICHEM LABORATORIES LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
UNICHEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UNICHEM LABORATORIES LTD,C05 Musculoskeletal Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
UNICHEM LABORATORIES LTD,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UNICHEM LABORATORIES LTD,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
UNICHEM LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
UNICHEM LABORATORIES LTD,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
UNICHEM LABORATORIES LTD,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C11 Eye Diseases,PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
UNICHEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
UNICHEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UNICHEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
UNICHEM LABORATORIES LTD,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",PIROXICAM,331.35,0.6,2,5,2,2,99.6,3.79,4.76
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
UNICHEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
UNICHEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
UNICHEM LABORATORIES LTD,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
UNICHEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
UNICHEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
UNICHEM LABORATORIES LTD,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
UNICHEM LABORATORIES LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
UNICHEM LABORATORIES LTD,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
UNICHEM LABORATORIES LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UNICHEM LABORATORIES LTD,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,ALFUZOSIN HYDROCHLORIDE,389.46,1.19,2,8,2,8,111.83,7.3,
UNICHEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
UNICHEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
UNICHEM LABORATORIES LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
UNICHEM LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
UNICHEM LABORATORIES LTD,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
UNICHEM LABORATORIES LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
UNICHEM LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UNICHEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
UNICHEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UNICHEM LABORATORIES LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UNICHEM LABORATORIES LTD,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
UNICHEM LABORATORIES LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UNICHEM LABORATORIES LTD,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
UNICHEM LABORATORIES LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UNICHEM LABORATORIES LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
UNICHEM LABORATORIES LTD,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
UNICHEM LABORATORIES LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
UNICHEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
UNICHEM LABORATORIES LTD,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
UNICHEM LABORATORIES LTD,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
UNICHEM LABORATORIES LTD,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,F03 Mental Disorders,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
UNICHEM LABORATORIES LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
UNICHEM LABORATORIES LTD,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
UNICHEM LABORATORIES LTD,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
UNICHEM LABORATORIES LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UNICHEM LABORATORIES LTD,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UNICHEM LABORATORIES LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
UNICHEM LABORATORIES LTD,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UNICHEM LABORATORIES LTD,C10 Nervous System Diseases,RIZATRIPTAN BENZOATE,269.35,1.77,3,4,1,5,49.74,9.56,
UNICHEM LABORATORIES LTD,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UNICHEM LABORATORIES LTD,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
UNICHEM LABORATORIES LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UNICHEM LABORATORIES LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
UNICHEM LABORATORIES LTD,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
UNICHEM LABORATORIES LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
UNICHEM LABORATORIES LTD,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UNICHEM LABORATORIES LTD,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
UNICHEM LABORATORIES LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C01 Infections,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C04 Neoplasms,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C04 Neoplasms,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C17 Skin and Connective Tissue Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C26 Wounds and Injuries,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C10 Nervous System Diseases,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C01 Infections,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C09 Otorhinolaryngologic Diseases,DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,"C23 Pathological Conditions, Signs and Symptoms",DICLOFENAC SODIUM,296.15,4.26,2,2,2,4,49.33,,4
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
UNIQUE PHARMACEUTICAL LABORATORIES A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICALS LTD,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
UPSHER SMITH LABORATORIES INC,C10 Nervous System Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
UPSHER SMITH LABORATORIES INC,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
UPSHER SMITH LABORATORIES INC,C14 Cardiovascular Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
UPSHER SMITH LABORATORIES INC,C11 Eye Diseases,HYDRALAZINE HYDROCHLORIDE,160.18,0.75,2,4,2,1,63.83,8.88,
UPSHER SMITH LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UPSHER SMITH LABORATORIES LLC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
UPSHER SMITH LABORATORIES LLC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
UPSHER SMITH LABORATORIES LLC,C04 Neoplasms,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
UPSHER SMITH LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
UPSHER SMITH LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UPSHER SMITH LABORATORIES LLC,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UPSHER SMITH LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UPSHER SMITH LABORATORIES LLC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UPSHER SMITH LABORATORIES LLC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
UPSHER SMITH LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
UPSHER SMITH LABORATORIES LLC,F03 Mental Disorders,BEXAROTENE,348.49,6.94,2,1,1,3,37.3,,4.07
UPSHER SMITH LABORATORIES LLC,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UPSHER SMITH LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
UPSHER SMITH LABORATORIES LLC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UPSHER SMITH LABORATORIES LLC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
UPSHER SMITH LABORATORIES LLC,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UPSHER SMITH LABORATORIES LLC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UPSHER SMITH LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UPSHER SMITH LABORATORIES LLC,C14 Cardiovascular Diseases,SOTALOL HYDROCHLORIDE,272.37,-0.4,1,4,3,6,78.43,9.43,10.07
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UPSHER SMITH LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UPSHER SMITH LABORATORIES LLC,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UPSHER SMITH LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
UPSHER SMITH LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
UPSHER SMITH LABORATORIES LLC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
UPSHER SMITH LABORATORIES LLC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UPSHER SMITH LABORATORIES LLC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
UPSHER SMITH LABORATORIES LLC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
UPSHER SMITH LABORATORIES LLC,C08 Respiratory Tract Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
UPSHER SMITH LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
UPSHER SMITH LABORATORIES LLC,C05 Musculoskeletal Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
UPSHER SMITH LABORATORIES LLC,C14 Cardiovascular Diseases,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
UPSHER SMITH LABORATORIES LLC,C01 Infections,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
UPSHER SMITH LABORATORIES LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
UPSHER SMITH LABORATORIES LLC,F03 Mental Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
UPSHER SMITH LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
UPSHER SMITH LABORATORIES LLC,F01 Behavior and Behavior Mechanisms,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
UPSHER SMITH LABORATORIES LLC,C25 Chemically-Induced Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
UPSHER SMITH LABORATORIES LLC,C14 Cardiovascular Diseases,FOSINOPRIL SODIUM,563.67,5.62,1,6,1,14,110.21,,3.87
UPSHER SMITH LABORATORIES LLC,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UPSHER SMITH LABORATORIES LLC,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
UPSHER SMITH LABORATORIES LLC,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UPSHER SMITH LABORATORIES LLC,C06 Digestive System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
UPSHER SMITH LABORATORIES LLC,C11 Eye Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
UPSHER SMITH LABORATORIES LLC,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UPSHER SMITH LABORATORIES LLC,C08 Respiratory Tract Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
UPSHER SMITH LABORATORIES LLC,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UPSHER SMITH LABORATORIES LLC,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
UPSHER SMITH LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
UPSHER SMITH LABORATORIES LLC,C04 Neoplasms,EXEMESTANE,296.41,3.87,0,2,0,0,34.14,,
UPSHER SMITH LABORATORIES LLC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
UPSHER SMITH LABORATORIES LLC,F03 Mental Disorders,FLUVOXAMINE MALEATE,318.34,2.8,1,4,1,9,56.84,8.86,
UPSHER SMITH LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
UPSHER SMITH LABORATORIES LLC,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
UPSHER SMITH LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
UPSHER SMITH LABORATORIES LLC,C05 Musculoskeletal Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
UPSHER SMITH LABORATORIES LLC,C08 Respiratory Tract Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,F03 Mental Disorders,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C14 Cardiovascular Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C04 Neoplasms,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C06 Digestive System Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
UPSHER SMITH LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C05 Musculoskeletal Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
UPSHER SMITH LABORATORIES LLC,C12 Male Urogenital Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
UPSHER SMITH LABORATORIES LLC,C04 Neoplasms,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
UPSHER SMITH LABORATORIES LLC,C12 Male Urogenital Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C26 Wounds and Injuries,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
UPSHER SMITH LABORATORIES LLC,C15 Hemic and Lymphatic Diseases,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
UPSHER SMITH LABORATORIES LLC,C18 Nutritional and Metabolic Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
UPSHER SMITH LABORATORIES LLC,C12 Male Urogenital Diseases,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
UPSHER SMITH LABORATORIES LLC,C04 Neoplasms,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
UPSHER SMITH LABORATORIES LLC,C14 Cardiovascular Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
UPSHER SMITH LABORATORIES LLC,F03 Mental Disorders,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
UPSHER SMITH LABORATORIES LLC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
UPSHER SMITH LABORATORIES LLC,C01 Infections,MIDODRINE HYDROCHLORIDE,254.29,-0.95,1,5,3,6,93.81,8.14,13.77
UPSHER SMITH LABORATORIES LLC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
UPSHER SMITH LABORATORIES LLC,C17 Skin and Connective Tissue Diseases,OXANDROLONE,306.45,2.95,0,3,1,0,46.53,,
UPSHER SMITH LABORATORIES LLC,C13 Female Urogenital Diseases and Pregnancy Complications,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C10 Nervous System Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
UPSHER SMITH LABORATORIES LLC,C01 Infections,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,C26 Wounds and Injuries,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
UPSHER SMITH LABORATORIES LLC,"C23 Pathological Conditions, Signs and Symptoms",PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
US PHARMACEUTICAL HOLDINGS II LLC,F03 Mental Disorders,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
US PHARMACEUTICAL HOLDINGS II LLC,C17 Skin and Connective Tissue Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C01 Infections,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,"C23 Pathological Conditions, Signs and Symptoms",MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
US PHARMACEUTICAL HOLDINGS II LLC,C14 Cardiovascular Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C18 Nutritional and Metabolic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
US PHARMACEUTICAL HOLDINGS II LLC,C06 Digestive System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C26 Wounds and Injuries,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C04 Neoplasms,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,"C23 Pathological Conditions, Signs and Symptoms",DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
US PHARMACEUTICAL HOLDINGS II LLC,C05 Musculoskeletal Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
US PHARMACEUTICAL HOLDINGS II LLC,C08 Respiratory Tract Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C14 Cardiovascular Diseases,MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
US PHARMACEUTICAL HOLDINGS II LLC,C15 Hemic and Lymphatic Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C12 Male Urogenital Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C10 Nervous System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,G08 Reproductive and Urinary Physiological Phenomena,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
US PHARMACEUTICAL HOLDINGS II LLC,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
US PHARMACEUTICAL HOLDINGS II LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
US PHARMACEUTICAL HOLDINGS II LLC,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
US PHARMACEUTICAL HOLDINGS II LLC,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
US PHARMACEUTICAL HOLDINGS II LLC,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
US PHARMACEUTICAL HOLDINGS II LLC,C19 Endocrine System Diseases,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C01 Infections,METHENAMINE HIPPURATE,140.19,0.39,0,4,0,0,12.96,5.88,
US PHARMACEUTICAL HOLDINGS II LLC,F03 Mental Disorders,ERGOCALCIFEROL,396.66,7.05,0,1,1,5,20.23,,
US PHARMACEUTICAL HOLDINGS II LLC,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
US PHARMACEUTICAL HOLDINGS II LLC,C04 Neoplasms,DESIPRAMINE HYDROCHLORIDE,266.39,3.9,2,2,1,4,15.27,10.02,
US PHARMACEUTICALS HOLDINGS I LLC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
US PHARMACEUTICALS HOLDINGS I LLC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
US PHARMACEUTICALS HOLDINGS I LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
US PHARMACEUTICALS HOLDINGS I LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
US PHARMACEUTICALS HOLDINGS I LLC,C05 Musculoskeletal Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
US PHARMACEUTICALS HOLDINGS I LLC,C18 Nutritional and Metabolic Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
US PHARMACEUTICALS HOLDINGS I LLC,C10 Nervous System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
US PHARMACEUTICALS HOLDINGS I LLC,C19 Endocrine System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
US PHARMACEUTICALS HOLDINGS I LLC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
US PHARMACEUTICALS HOLDINGS I LLC,C12 Male Urogenital Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
US PHARMACEUTICALS HOLDINGS I LLC,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
US PHARMACEUTICALS HOLDINGS I LLC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
US PHARMACEUTICALS HOLDINGS I LLC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
US PHARMACEUTICALS HOLDINGS I LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
US PHARMACEUTICALS HOLDINGS I LLC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
USL PHARMA LLC,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
USL PHARMA LLC,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
USL PHARMA LLC,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
USL PHARMA LLC,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
USL PHARMA LLC,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
USL PHARMA LLC,C14 Cardiovascular Diseases,WARFARIN SODIUM,308.33,2.74,3,4,1,4,67.51,,5.56
USL PHARMA LLC,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
USL PHARMA LLC,C04 Neoplasms,FLUOXYMESTERONE,336.45,2.38,0,3,2,0,57.53,,13.6
USL PHARMA LLC,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
USL PHARMA LLC,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
USL PHARMA LLC,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
USL PHARMA LLC,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
USL PHARMA LLC,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
USL PHARMA LLC,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C14 Cardiovascular Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C14 Cardiovascular Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C26 Wounds and Injuries,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C11 Eye Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C12 Male Urogenital Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,F03 Mental Disorders,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C10 Nervous System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C05 Musculoskeletal Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C18 Nutritional and Metabolic Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,"C23 Pathological Conditions, Signs and Symptoms",PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C10 Nervous System Diseases,TETRABENAZINE,317.43,3.4,1,4,0,4,38.77,7.33,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C04 Neoplasms,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C06 Digestive System Diseases,CLIDINIUM BROMIDE,352.45,-1.08,2,3,1,4,46.53,,11.05
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C15 Hemic and Lymphatic Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C06 Digestive System Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C06 Digestive System Diseases,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C10 Nervous System Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C01 Infections,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C01 Infections,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,F03 Mental Disorders,BUPROPION HYDROBROMIDE,239.75,3.27,1,2,1,3,29.1,8.22,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C25 Chemically-Induced Disorders,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C26 Wounds and Injuries,FENOFIBRATE,360.84,5.28,2,4,0,6,52.6,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C08 Respiratory Tract Diseases,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C04 Neoplasms,PENTOXIFYLLINE,278.31,0.23,2,7,0,5,78.89,,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
VALIDUS PHARMACEUTICALS LLC,C01 Infections,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
VALIDUS PHARMACEUTICALS LLC,C10 Nervous System Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
VALIDUS PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
VALIDUS PHARMACEUTICALS LLC,C04 Neoplasms,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
VALIDUS PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
VALIDUS PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
VALIDUS PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
VALIDUS PHARMACEUTICALS LLC,F03 Mental Disorders,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
VALIDUS PHARMACEUTICALS LLC,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
VALIDUS PHARMACEUTICALS LLC,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
VALIDUS PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
VALIDUS PHARMACEUTICALS LLC,C19 Endocrine System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,F03 Mental Disorders,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
VALIDUS PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
VALIDUS PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,C04 Neoplasms,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
VALIDUS PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VALIDUS PHARMACEUTICALS LLC,C06 Digestive System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
VERTEX PHARMACEUTICALS INC,C06 Digestive System Diseases,IVACAFTOR,392.5,5.76,3,3,3,2,82.19,,9.66
VERTEX PHARMACEUTICALS INC,C01 Infections,IVACAFTOR,392.5,5.76,3,3,3,2,82.19,,9.66
VERTEX PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,IVACAFTOR,392.5,5.76,3,3,3,2,82.19,,9.66
VIIV HEALTHCARE CO,C01 Infections,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
VIIV HEALTHCARE CO,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
VIIV HEALTHCARE CO,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
VIIV HEALTHCARE CO,"C23 Pathological Conditions, Signs and Symptoms",LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
VIIV HEALTHCARE CO,C20 Immune System Diseases,MARAVIROC,513.68,3.63,2,5,1,8,63.05,9.35,13.98
VIIV HEALTHCARE CO,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
VIIV HEALTHCARE CO,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
VIIV HEALTHCARE CO,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
VIIV HEALTHCARE CO,C17 Skin and Connective Tissue Diseases,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
VIIV HEALTHCARE CO,C01 Infections,ABACAVIR SULFATE,286.34,0.39,2,7,3,4,101.88,5.8,
VIIV HEALTHCARE CO,C01 Infections,FOSAMPRENAVIR CALCIUM,585.62,1.92,2,8,4,13,177.72,2.45,1.22
VIIV HEALTHCARE CO,C01 Infections,DELAVIRDINE MESYLATE,456.57,1.02,3,6,3,6,110.43,6.82,9.39
VIIV HEALTHCARE CO,C10 Nervous System Diseases,MARAVIROC,513.68,3.63,2,5,1,8,63.05,9.35,13.98
VIIV HEALTHCARE CO,C18 Nutritional and Metabolic Diseases,MARAVIROC,513.68,3.63,2,5,1,8,63.05,9.35,13.98
VIIV HEALTHCARE CO,C15 Hemic and Lymphatic Diseases,MARAVIROC,513.68,3.63,2,5,1,8,63.05,9.35,13.98
VIIV HEALTHCARE CO,C01 Infections,MARAVIROC,513.68,3.63,2,5,1,8,63.05,9.35,13.98
VIIV HEALTHCARE CO,C05 Musculoskeletal Diseases,MARAVIROC,513.68,3.63,2,5,1,8,63.05,9.35,13.98
VIIV HEALTHCARE CO,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
VIIV HEALTHCARE CO,C04 Neoplasms,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
VIIV HEALTHCARE CO,C04 Neoplasms,MARAVIROC,513.68,3.63,2,5,1,8,63.05,9.35,13.98
VIIV HEALTHCARE CO,C06 Digestive System Diseases,LAMIVUDINE,229.26,-1.1,1,7,2,2,90.37,,
VIIV HEALTHCARE CO,C01 Infections,RILPIVIRINE HYDROCHLORIDE,366.43,5.47,3,6,2,5,97.42,4.44,11.43
VINTAGE PHARMACEUTICALS,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
VINTAGE PHARMACEUTICALS,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
VINTAGE PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
VINTAGE PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
VINTAGE PHARMACEUTICALS,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
VINTAGE PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
VINTAGE PHARMACEUTICALS,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
VINTAGE PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
VINTAGE PHARMACEUTICALS,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
VINTAGE PHARMACEUTICALS,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
VINTAGE PHARMACEUTICALS,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
VINTAGE PHARMACEUTICALS,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
VINTAGE PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,C01 Infections,GRISEOFULVIN,352.77,2.17,1,6,0,3,71.06,,
VINTAGE PHARMACEUTICALS,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
VINTAGE PHARMACEUTICALS,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
VINTAGE PHARMACEUTICALS,C10 Nervous System Diseases,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
VINTAGE PHARMACEUTICALS,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
VINTAGE PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
VINTAGE PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
VINTAGE PHARMACEUTICALS,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
VINTAGE PHARMACEUTICALS,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
VINTAGE PHARMACEUTICALS,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
VINTAGE PHARMACEUTICALS,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
VINTAGE PHARMACEUTICALS,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
VINTAGE PHARMACEUTICALS,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
VINTAGE PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
VINTAGE PHARMACEUTICALS,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C08 Respiratory Tract Diseases,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
VINTAGE PHARMACEUTICALS,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
VINTAGE PHARMACEUTICALS,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
VINTAGE PHARMACEUTICALS,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
VINTAGE PHARMACEUTICALS,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS,F03 Mental Disorders,DEXTROAMPHETAMINE SULFATE,135.21,1.8,1,1,1,2,26.02,10.01,
VINTAGE PHARMACEUTICALS,C01 Infections,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
VINTAGE PHARMACEUTICALS,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
VINTAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
VINTAGE PHARMACEUTICALS INC,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
VINTAGE PHARMACEUTICALS INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C11 Eye Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C04 Neoplasms,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
VINTAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
VINTAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C01 Infections,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
VINTAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
VINTAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C01 Infections,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
VINTAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
VINTAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
VINTAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
VINTAGE PHARMACEUTICALS INC,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
VINTAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
VINTAGE PHARMACEUTICALS INC,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
VINTAGE PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
VINTAGE PHARMACEUTICALS INC,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
VINTAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
VINTAGE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
VINTAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,IBUPROFEN,206.28,3.84,1,1,1,4,37.3,,4.85
VINTAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
VINTAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
VINTAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
VINTAGE PHARMACEUTICALS INC,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
VINTAGE PHARMACEUTICALS INC,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
VINTAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
VINTAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
VINTAGE PHARMACEUTICALS INC,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
VINTAGE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
VINTAGE PHARMACEUTICALS INC,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
VINTAGE PHARMACEUTICALS INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
VINTAGE PHARMACEUTICALS INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
VINTAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
VINTAGE PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
VINTAGE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
VINTAGE PHARMACEUTICALS INC,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
VINTAGE PHARMACEUTICALS INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
VINTAGE PHARMACEUTICALS INC,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
VINTAGE PHARMACEUTICALS INC,C10 Nervous System Diseases,ISOSORBIDE MONONITRATE,191.14,-0.71,0,6,1,2,91.06,,13.34
VINTAGE PHARMACEUTICALS INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
VINTAGE PHARMACEUTICALS LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
VINTAGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
VINTAGE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
VINTAGE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
VINTAGE PHARMACEUTICALS LLC,C19 Endocrine System Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
VINTAGE PHARMACEUTICALS LLC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
VINTAGE PHARMACEUTICALS LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C06 Digestive System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
VINTAGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
VINTAGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
VINTAGE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,C01 Infections,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
VINTAGE PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
VINTAGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
VINTAGE PHARMACEUTICALS LLC,C11 Eye Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
VINTAGE PHARMACEUTICALS LLC,C01 Infections,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
VINTAGE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,PHENYLEPHRINE HYDROCHLORIDE,167.21,-0.07,1,3,3,3,52.49,9.69,9.07
VINTAGE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
VINTAGE PHARMACEUTICALS LLC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
VINTAGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
VINTAGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS LLC,C01 Infections,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
VINTAGE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,NORGESTIMATE,369.51,4.11,0,4,1,2,58.89,3.11,11.47
VINTAGE PHARMACEUTICALS LLC,C11 Eye Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS LLC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
VINTAGE PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
VINTAGE PHARMACEUTICALS LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,NORETHINDRONE ACETATE,340.46,3.66,0,3,0,1,43.37,,
VINTAGE PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,BENZTROPINE MESYLATE,307.44,4.19,2,2,0,4,12.47,9.54,
VINTAGE PHARMACEUTICALS LLC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
VINTAGE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
VINTAGE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,G07 Physiological Phenomena,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,F03 Mental Disorders,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C06 Digestive System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C11 Eye Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VINTAGE PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
VINTAGE PHARMACEUTICALS LLC,C01 Infections,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C09 Otorhinolaryngologic Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
VINTAGE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
VINTAGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
VINTAGE PHARMACEUTICALS LLC,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
VINTAGE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
VINTAGE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C19 Endocrine System Diseases,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VINTAGE PHARMACEUTICALS LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
VINTAGE PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
VINTAGE PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VINTAGE PHARMACEUTICALS LLC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
VINTAGE PHARMACEUTICALS LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
VINTAGE PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
VINTAGE PHARMACEUTICALS LLC,C26 Wounds and Injuries,HYDROCORTISONE,362.47,1.28,0,5,3,2,94.83,,12.59
VINTAGE PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VINTAGE PHARMACEUTICALS LLC,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS LLC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
VINTAGE PHARMACEUTICALS LLC,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VINTAGE PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VINTAGE PHARMACEUTICALS LLC,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
VIRTUS PHARMACEUTICAL INC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
VIRTUS PHARMACEUTICAL INC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
VIRTUS PHARMACEUTICAL INC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
VIRTUS PHARMACEUTICALS LLC,C04 Neoplasms,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
VIRTUS PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
VIRTUS PHARMACEUTICALS LLC,C10 Nervous System Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,C01 Infections,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
VIRTUS PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
VIRTUS PHARMACEUTICALS LLC,C04 Neoplasms,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,C10 Nervous System Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
VIRTUS PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,DAPSONE,248.31,1.27,2,4,2,2,86.18,2.39,
VIRTUS PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,F03 Mental Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,C26 Wounds and Injuries,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,C01 Infections,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VIRTUS PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,PROGESTERONE,314.47,4.15,0,2,0,1,34.14,,
VISTA PHARMACEUTICALS INC,C06 Digestive System Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
VISTA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
VISTA PHARMACEUTICALS INC,C01 Infections,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
VISTA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
VISTA PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
VISTA PHARMACEUTICALS INC,C17 Skin and Connective Tissue Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
VISTA PHARMACEUTICALS INC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
VISTA PHARMACEUTICALS INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
VISTA PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
VISTA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
VISTA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
VISTA PHARMACEUTICALS INC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
VISTA PHARMACEUTICALS INC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
VISTA PHARMACEUTICALS INC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
VISTA PHARMACEUTICALS INC,C04 Neoplasms,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
VISTA PHARMACEUTICALS INC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
VISTA PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SULFAMETHOXAZOLE,253.28,0.79,2,5,2,3,98.22,1.97,6.16
VISTAPHARM INC,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
VISTAPHARM INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,"C23 Pathological Conditions, Signs and Symptoms",ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
VISTAPHARM INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
VISTAPHARM INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
VISTAPHARM INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VISTAPHARM INC,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
VISTAPHARM INC,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
VISTAPHARM INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
VISTAPHARM INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VISTAPHARM INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C14 Cardiovascular Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
VISTAPHARM INC,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
VISTAPHARM INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
VISTAPHARM INC,C01 Infections,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
VISTAPHARM INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VISTAPHARM INC,C26 Wounds and Injuries,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
VISTAPHARM INC,C12 Male Urogenital Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
VISTAPHARM INC,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
VISTAPHARM INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VISTAPHARM INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VISTAPHARM INC,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
VISTAPHARM INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C04 Neoplasms,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
VISTAPHARM INC,C15 Hemic and Lymphatic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
VISTAPHARM INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
VISTAPHARM INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
VISTAPHARM INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
VISTAPHARM INC,C07 Stomatognathic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
VISTAPHARM INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
VISTAPHARM INC,C08 Respiratory Tract Diseases,ALBUTEROL SULFATE,239.31,0.34,1,4,4,4,72.72,9.4,10.12
VISTAPHARM INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
VISTAPHARM INC,C04 Neoplasms,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C12 Male Urogenital Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C08 Respiratory Tract Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C15 Hemic and Lymphatic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C05 Musculoskeletal Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,F03 Mental Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
VISTAPHARM INC,C01 Infections,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C06 Digestive System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C20 Immune System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
VISTAPHARM INC,C11 Eye Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C17 Skin and Connective Tissue Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C18 Nutritional and Metabolic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C20 Immune System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C14 Cardiovascular Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C10 Nervous System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C07 Stomatognathic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C01 Infections,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
VISTAPHARM INC,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
VISTAPHARM INC,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VISTAPHARM INC,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
VISTAPHARM INC,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VISTAPHARM INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VISTAPHARM INC,F01 Behavior and Behavior Mechanisms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
VISTAPHARM INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
VISTAPHARM INC,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VISTAPHARM INC,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
VISTAPHARM INC,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VISTAPHARM INC,C10 Nervous System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
VISTAPHARM INC,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
VISTAPHARM INC,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VISTAPHARM INC,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C05 Musculoskeletal Diseases,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
VISTAPHARM INC,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VISTAPHARM INC,C19 Endocrine System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
VISTAPHARM INC,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
VISTAPHARM INC,"C23 Pathological Conditions, Signs and Symptoms",METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
VISTAPHARM INC,C13 Female Urogenital Diseases and Pregnancy Complications,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
VISTAPHARM INC,C04 Neoplasms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
VISTAPHARM INC,C15 Hemic and Lymphatic Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
VISTAPHARM INC,C26 Wounds and Injuries,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
VISTAPHARM INC,C10 Nervous System Diseases,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
VISTAPHARM INC,C25 Chemically-Induced Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
VISTAPHARM INC,F03 Mental Disorders,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
VKT PHARMA PRIVATE LTD,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
WATSON LABORATORIES,C18 Nutritional and Metabolic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C07 Stomatognathic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C11 Eye Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C04 Neoplasms,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C06 Digestive System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,F03 Mental Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C12 Male Urogenital Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C05 Musculoskeletal Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C15 Hemic and Lymphatic Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
WATSON LABORATORIES,C14 Cardiovascular Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C01 Infections,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C13 Female Urogenital Diseases and Pregnancy Complications,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C25 Chemically-Induced Disorders,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C17 Skin and Connective Tissue Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,"C23 Pathological Conditions, Signs and Symptoms",FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES,C10 Nervous System Diseases,FOLIC ACID,441.4,-0.69,3,9,6,9,213.28,2.09,3.32
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
WATSON LABORATORIES INC,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
WATSON LABORATORIES INC,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
WATSON LABORATORIES INC,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C10 Nervous System Diseases,RIVASTIGMINE TARTRATE,250.34,2.41,1,3,0,4,32.78,8.8,
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,F03 Mental Disorders,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
WATSON LABORATORIES INC,C01 Infections,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WATSON LABORATORIES INC,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C06 Digestive System Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DIENOGEST,311.42,2.31,0,3,1,1,61.09,,13.78
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WATSON LABORATORIES INC,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,DIENOGEST,311.42,2.31,0,3,1,1,61.09,,13.78
WATSON LABORATORIES INC,C04 Neoplasms,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C11 Eye Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
WATSON LABORATORIES INC,C19 Endocrine System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C06 Digestive System Diseases,NIZATIDINE,331.47,0.77,1,8,2,10,83.33,6.54,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C04 Neoplasms,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C10 Nervous System Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C20 Immune System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
WATSON LABORATORIES INC,C01 Infections,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
WATSON LABORATORIES INC,C09 Otorhinolaryngologic Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
WATSON LABORATORIES INC,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
WATSON LABORATORIES INC,C01 Infections,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
WATSON LABORATORIES INC,C10 Nervous System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C07 Stomatognathic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WATSON LABORATORIES INC,C09 Otorhinolaryngologic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,LEVONORGESTREL,312.45,3.66,0,2,1,1,37.3,,
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WATSON LABORATORIES INC,C11 Eye Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C04 Neoplasms,NORGESTREL,312.45,3.66,0,2,1,1,37.3,,
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
WATSON LABORATORIES INC,C10 Nervous System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
WATSON LABORATORIES INC,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,F03 Mental Disorders,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
WATSON LABORATORIES INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C04 Neoplasms,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WATSON LABORATORIES INC,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
WATSON LABORATORIES INC,C06 Digestive System Diseases,MODAFINIL,273.36,1.53,2,2,1,5,60.16,,8.84
WATSON LABORATORIES INC,C15 Hemic and Lymphatic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C01 Infections,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WATSON LABORATORIES INC,C06 Digestive System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,VERAPAMIL HYDROCHLORIDE,454.61,5.04,2,6,0,13,63.95,9.68,
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
WATSON LABORATORIES INC,C04 Neoplasms,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
WATSON LABORATORIES INC,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
WATSON LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
WATSON LABORATORIES INC,F03 Mental Disorders,AMOXAPINE,313.79,3.08,2,4,1,0,36.86,8.83,
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
WATSON LABORATORIES INC,C19 Endocrine System Diseases,ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",ESTRADIOL VALERATE,356.51,5.78,1,3,1,4,46.53,,10.33
WATSON LABORATORIES INC,C01 Infections,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
WATSON LABORATORIES INC,C04 Neoplasms,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
WATSON LABORATORIES INC,C15 Hemic and Lymphatic Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
WATSON LABORATORIES INC,C04 Neoplasms,RALOXIFENE HYDROCHLORIDE,473.59,5.69,4,6,2,7,70,7.95,8.89
WATSON LABORATORIES INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
WATSON LABORATORIES INC,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
WATSON LABORATORIES INC,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C04 Neoplasms,DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
WATSON LABORATORIES INC,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DESOGESTREL,310.48,4.42,0,1,1,1,20.23,,
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
WATSON LABORATORIES INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WATSON LABORATORIES INC,C04 Neoplasms,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
WATSON LABORATORIES INC,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WATSON LABORATORIES INC,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
WATSON LABORATORIES INC,C15 Hemic and Lymphatic Diseases,LEVOMEFOLATE CALCIUM,459.46,-2.98,2,9,7,9,202.77,5.3,2.56
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,LEVOMEFOLATE CALCIUM,459.46,-2.98,2,9,7,9,202.77,5.3,2.56
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
WATSON LABORATORIES INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,SULINDAC,356.42,2.93,2,2,1,4,54.37,,4.09
WATSON LABORATORIES INC,C04 Neoplasms,SULINDAC,356.42,2.93,2,2,1,4,54.37,,4.09
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,NABUMETONE,228.29,3.22,2,2,0,4,26.3,,
WATSON LABORATORIES INC,F03 Mental Disorders,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
WATSON LABORATORIES INC,C10 Nervous System Diseases,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,PERPHENAZINE,403.98,3.69,2,5,1,6,29.95,7.81,
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
WATSON LABORATORIES INC,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WATSON LABORATORIES INC,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
WATSON LABORATORIES INC,F03 Mental Disorders,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,DROSPIRENONE,366.5,3.37,0,3,0,0,43.37,,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
WATSON LABORATORIES INC,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WATSON LABORATORIES INC,C01 Infections,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
WATSON LABORATORIES INC,C10 Nervous System Diseases,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
WATSON LABORATORIES INC,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WATSON LABORATORIES INC,C06 Digestive System Diseases,SULFASALAZINE,398.4,4.25,3,7,3,6,141.31,0.55,3.23
WATSON LABORATORIES INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,G07 Physiological Phenomena,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WATSON LABORATORIES INC,C04 Neoplasms,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WATSON LABORATORIES INC,C11 Eye Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C04 Neoplasms,PENICILLAMINE,149.22,-2.15,0,3,3,2,63.32,9.09,2.56
WATSON LABORATORIES INC,C06 Digestive System Diseases,PENICILLAMINE,149.22,-2.15,0,3,3,2,63.32,9.09,2.56
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WATSON LABORATORIES INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C01 Infections,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,C10 Nervous System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WATSON LABORATORIES INC,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
WATSON LABORATORIES INC,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
WATSON LABORATORIES INC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
WATSON LABORATORIES INC,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
WATSON LABORATORIES INC,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
WATSON LABORATORIES INC,C06 Digestive System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WATSON LABORATORIES INC,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C15 Hemic and Lymphatic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,METOPROLOL TARTRATE,267.37,1.76,1,4,2,9,50.72,9.67,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",PENTAZOCINE HYDROCHLORIDE,285.43,3.89,1,2,1,2,23.47,9.57,10.42
WATSON LABORATORIES INC,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,F03 Mental Disorders,QUINIDINE SULFATE,324.42,2.51,2,4,1,4,45.59,9.05,13.89
WATSON LABORATORIES INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C10 Nervous System Diseases,QUINIDINE SULFATE,324.42,2.51,2,4,1,4,45.59,9.05,13.89
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WATSON LABORATORIES INC,C07 Stomatognathic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC,C06 Digestive System Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
WATSON LABORATORIES INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,METRONIDAZOLE,171.16,-0.46,1,5,1,3,81.19,3.03,
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
WATSON LABORATORIES INC,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,TRIMETHOPRIM,290.32,1.28,2,7,2,5,105.51,7.16,
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
WATSON LABORATORIES INC,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
WATSON LABORATORIES INC,C04 Neoplasms,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WATSON LABORATORIES INC,C10 Nervous System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,SOLIFENACIN SUCCINATE,362.47,3.96,2,3,0,2,32.78,8.88,
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WATSON LABORATORIES INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WATSON LABORATORIES INC,C06 Digestive System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,F03 Mental Disorders,GUANFACINE HYDROCHLORIDE,246.1,1.74,1,2,3,2,78.97,8.65,11.64
WATSON LABORATORIES INC,C11 Eye Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WATSON LABORATORIES INC,C06 Digestive System Diseases,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
WATSON LABORATORIES INC,C10 Nervous System Diseases,RASAGILINE MESYLATE,171.24,2.3,1,1,1,2,12.03,8.4,
WATSON LABORATORIES INC,C01 Infections,VANCOMYCIN HYDROCHLORIDE,1449.27,,,,,,,,
WATSON LABORATORIES INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WATSON LABORATORIES INC,F03 Mental Disorders,DIENOGEST,311.42,2.31,0,3,1,1,61.09,,13.78
WATSON LABORATORIES INC,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,NALOXONE HYDROCHLORIDE,327.38,1.62,1,5,2,2,70,7.84,10.07
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
WATSON LABORATORIES INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,MEPROBAMATE,218.25,0.93,0,4,2,6,104.64,,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
WATSON LABORATORIES INC,C10 Nervous System Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
WATSON LABORATORIES INC,C11 Eye Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WATSON LABORATORIES INC,C01 Infections,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C04 Neoplasms,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",NALOXONE HYDROCHLORIDE,327.38,1.62,1,5,2,2,70,7.84,10.07
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,NALOXONE HYDROCHLORIDE,327.38,1.62,1,5,2,2,70,7.84,10.07
WATSON LABORATORIES INC,C07 Stomatognathic Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,SILDENAFIL CITRATE,474.59,1.23,3,8,1,7,113.42,5.98,7.63
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
WATSON LABORATORIES INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
WATSON LABORATORIES INC,F03 Mental Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
WATSON LABORATORIES INC,C10 Nervous System Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WATSON LABORATORIES INC,C07 Stomatognathic Diseases,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,CLONAZEPAM,315.72,3.15,2,4,1,2,84.6,1.89,11.65
WATSON LABORATORIES INC,C10 Nervous System Diseases,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
WATSON LABORATORIES INC,C10 Nervous System Diseases,SUMATRIPTAN SUCCINATE,295.41,0.74,2,3,2,6,65.2,9.54,11.24
WATSON LABORATORIES INC,C01 Infections,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
WATSON LABORATORIES INC,C11 Eye Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
WATSON LABORATORIES INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
WATSON LABORATORIES INC,C04 Neoplasms,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
WATSON LABORATORIES INC,C06 Digestive System Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WATSON LABORATORIES INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WATSON LABORATORIES INC,C06 Digestive System Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
WATSON LABORATORIES INC,G08 Reproductive and Urinary Physiological Phenomena,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,MINOXIDIL,209.25,0,1,5,2,1,95.11,1.69,
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WATSON LABORATORIES INC,C10 Nervous System Diseases,PRIMIDONE,218.26,1.12,1,2,2,2,58.2,,11.5
WATSON LABORATORIES INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLDOPA,211.22,-1.36,1,4,4,3,103.78,9.85,1.73
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C10 Nervous System Diseases,ESTAZOLAM,294.75,2.9,3,4,0,1,43.07,4.9,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,NATEGLINIDE,317.43,4.03,1,2,2,6,66.4,,4
WATSON LABORATORIES INC,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,MINOXIDIL,209.25,0,1,5,2,1,95.11,1.69,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
WATSON LABORATORIES INC,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC,C04 Neoplasms,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC,C26 Wounds and Injuries,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
WATSON LABORATORIES INC,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC,C01 Infections,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
WATSON LABORATORIES INC,C26 Wounds and Injuries,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
WATSON LABORATORIES INC,C06 Digestive System Diseases,METHOCARBAMOL,241.24,0.45,1,5,2,6,91.01,,13.6
WATSON LABORATORIES INC,C11 Eye Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WATSON LABORATORIES INC,C10 Nervous System Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WATSON LABORATORIES INC,C04 Neoplasms,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,F03 Mental Disorders,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WATSON LABORATORIES INC,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WATSON LABORATORIES INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WATSON LABORATORIES INC,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,C08 Respiratory Tract Diseases,PREGABALIN,159.23,-1.35,0,2,2,5,63.32,10.23,4.8
WATSON LABORATORIES INC,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WATSON LABORATORIES INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WATSON LABORATORIES INC,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C26 Wounds and Injuries,PROBENECID,285.36,2.44,1,3,1,7,74.68,,3.53
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C11 Eye Diseases,TRIENTINE HYDROCHLORIDE,146.24,-2.15,0,4,4,7,76.1,9.77,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,G08 Reproductive and Urinary Physiological Phenomena,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,NORETHINDRONE,298.43,3.22,0,2,1,0,37.3,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,ISRADIPINE,371.39,2,2,8,1,4,103.55,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ISRADIPINE,371.39,2,2,8,1,4,103.55,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,ISRADIPINE,371.39,2,2,8,1,4,103.55,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,VARDENAFIL HYDROCHLORIDE,488.61,1.43,3,8,1,8,112.9,6.21,11.75
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ISRADIPINE,371.39,2,2,8,1,4,103.55,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,IBANDRONATE SODIUM,319.23,-2.48,0,4,5,9,138.53,9.93,0.66
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,G08 Reproductive and Urinary Physiological Phenomena,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ETHINYL ESTRADIOL,296.41,3.9,1,2,2,0,40.46,,10.33
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
WES PHARMA INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WES PHARMA INC,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WES PHARMA INC,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
WES PHARMA INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WES PHARMA INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
WES PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
WES PHARMA INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WES PHARMA INC,C10 Nervous System Diseases,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
WES PHARMA INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WES PHARMA INC,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
WES PHARMA INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,F03 Mental Disorders,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
WES PHARMA INC,C04 Neoplasms,METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
WES PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WES PHARMA INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WES PHARMA INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPHENIDATE HYDROCHLORIDE,233.31,2.25,1,3,1,3,38.33,9.09,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C20 Immune System Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F01 Behavior and Behavior Mechanisms,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C09 Otorhinolaryngologic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C20 Immune System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C09 Otorhinolaryngologic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C20 Immune System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",SODIUM OXYBATE,104.11,-0.51,0,2,2,3,57.53,,4.44
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,SODIUM OXYBATE,104.11,-0.51,0,2,2,3,57.53,,4.44
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,SODIUM OXYBATE,104.11,-0.51,0,2,2,3,57.53,,4.44
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,SODIUM OXYBATE,104.11,-0.51,0,2,2,3,57.53,,4.44
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,MONTELUKAST SODIUM,586.2,8.49,4,4,2,12,70.42,3.12,4.4
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,TORSEMIDE,348.43,1.86,2,5,3,5,100.19,4.2,5.92
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,"CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,"CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms","CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,"CAFFEINE, CITRATED",194.19,-0.55,2,6,0,0,61.82,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,G08 Reproductive and Urinary Physiological Phenomena,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C09 Otorhinolaryngologic Diseases,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,ALENDRONATE SODIUM,249.1,-4.19,0,4,6,5,161.31,9.91,0.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,EVEROLIMUS,958.24,7.4,0,14,3,9,204.66,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C07 Stomatognathic Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F01 Behavior and Behavior Mechanisms,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,MIDAZOLAM HYDROCHLORIDE,325.77,3.97,3,3,0,1,30.18,6.19,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,GRANISETRON HYDROCHLORIDE,312.42,1.88,2,4,1,2,50.16,9,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",NARATRIPTAN HYDROCHLORIDE,335.47,1.44,2,3,2,5,65.2,9.18,11.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C07 Stomatognathic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,MERCAPTOPURINE,152.18,0.35,2,4,2,0,54.46,2.19,7.51
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,MERCAPTOPURINE,152.18,0.35,2,4,2,0,54.46,2.19,7.51
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,MERCAPTOPURINE,152.18,0.35,2,4,2,0,54.46,2.19,7.51
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,G08 Reproductive and Urinary Physiological Phenomena,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,BALSALAZIDE DISODIUM,357.32,3.17,2,6,4,7,148.65,,3.06
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,CILOSTAZOL,369.47,3.31,2,6,1,7,81.93,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C19 Endocrine System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,DALFAMPRIDINE,94.12,-0.07,1,2,1,0,38.91,8.95,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,LETROZOLE,285.31,2.94,3,5,0,3,78.29,1.89,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C19 Endocrine System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,HYDROMORPHONE HYDROCHLORIDE,285.34,1.62,1,4,1,0,49.77,8.59,10.11
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C20 Immune System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,LEUCOVORIN CALCIUM,473.45,-3.76,2,9,7,10,219.84,4.67,2.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,LEUCOVORIN CALCIUM,473.45,-3.76,2,9,7,10,219.84,4.67,2.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,LEUCOVORIN CALCIUM,473.45,-3.76,2,9,7,10,219.84,4.67,2.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,CITALOPRAM HYDROBROMIDE,324.4,3.76,2,3,0,5,36.26,9.78,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",OXYMORPHONE HYDROCHLORIDE,301.34,0.78,1,5,2,0,70,8.21,10.07
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,FLUCYTOSINE,129.09,-0.95,1,3,2,0,71.77,,8.16
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,LEUCOVORIN CALCIUM,473.45,-3.76,2,9,7,10,219.84,4.67,2.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,LEUCOVORIN CALCIUM,473.45,-3.76,2,9,7,10,219.84,4.67,2.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,LEUCOVORIN CALCIUM,473.45,-3.76,2,9,7,10,219.84,4.67,2.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,G08 Reproductive and Urinary Physiological Phenomena,RITONAVIR,720.96,5.22,4,9,4,17,145.78,2.84,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,RUFINAMIDE,238.2,1.27,2,4,1,3,73.8,,12.64
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,ONDANSETRON HYDROCHLORIDE,293.37,2.35,3,4,0,2,39.82,7.34,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,LEUCOVORIN CALCIUM,473.45,-3.76,2,9,7,10,219.84,4.67,2.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,LEUCOVORIN CALCIUM,473.45,-3.76,2,9,7,10,219.84,4.67,2.55
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,DIAZEPAM,284.75,3.08,2,2,0,1,32.67,2.92,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,LORAZEPAM,321.16,3.53,2,3,2,1,61.69,,10.61
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,CAPECITABINE,359.35,0.77,1,8,3,6,122.91,,8.63
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,METHADONE HYDROCHLORIDE,309.45,5.01,2,2,0,7,20.31,9.12,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F01 Behavior and Behavior Mechanisms,LITHIUM CARBONATE,73.89,,,,,,,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,LITHIUM CARBONATE,73.89,,,,,,,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,LITHIUM CARBONATE,73.89,,,,,,,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,LITHIUM CARBONATE,73.89,,,,,,,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,ESZOPICLONE,388.82,0.52,2,7,0,2,91.76,6.86,8.04
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F01 Behavior and Behavior Mechanisms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,DOXERCALCIFEROL,412.66,5.75,0,2,2,5,40.46,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,DOXERCALCIFEROL,412.66,5.75,0,2,2,5,40.46,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,DOXERCALCIFEROL,412.66,5.75,0,2,2,5,40.46,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F01 Behavior and Behavior Mechanisms,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F01 Behavior and Behavior Mechanisms,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,FLECAINIDE ACETATE,414.35,3.19,1,4,2,7,59.59,9.62,13.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,ZALEPLON,305.34,1.53,3,5,0,3,74.29,0.28,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,ALOSETRON HYDROCHLORIDE,294.36,1.21,3,3,1,2,53.92,6.81,13.32
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,G07 Physiological Phenomena,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,ACARBOSE,645.61,-7.61,0,19,14,9,321.17,7.03,11.23
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,LITHIUM CARBONATE,73.89,,,,,,,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,TINIDAZOLE,247.28,-0.58,1,6,0,5,95.1,3.28,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,PROPANTHELINE BROMIDE,368.5,0.36,2,3,0,6,35.53,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,CLOTRIMAZOLE,344.85,5.84,4,2,0,4,17.82,6.26,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C19 Endocrine System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,CALCIUM ACETATE,158.17,,,,,,,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,ZIDOVUDINE,267.25,-0.3,1,6,2,3,133.08,,9.96
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",MEPERIDINE HYDROCHLORIDE,247.34,2.46,1,3,0,3,29.54,8.16,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,ATROPINE SULFATE,289.37,1.57,1,4,1,4,49.77,9.39,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,TETRABENAZINE,317.43,3.4,1,4,0,4,38.77,7.33,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,ALPRAZOLAM,308.77,3.02,3,4,0,1,43.07,5.01,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C23 Pathological Conditions, Signs and Symptoms",LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,G08 Reproductive and Urinary Physiological Phenomena,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,MORPHINE SULFATE,285.34,0.9,1,4,2,0,52.93,9.12,10.26
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,QUETIAPINE FUMARATE,383.52,2.81,2,6,1,5,48.3,7.06,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C15 Hemic and Lymphatic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,G08 Reproductive and Urinary Physiological Phenomena,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,CYCLOPHOSPHAMIDE,261.09,0.1,0,2,1,5,41.57,0.02,13.48
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C05 Musculoskeletal Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C12 Male Urogenital Diseases,CALCIUM ACETATE,158.17,,,,,,,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C26 Wounds and Injuries,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,E03 Anesthesia and Analgesia,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C09 Otorhinolaryngologic Diseases,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C07 Stomatognathic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,EXEMESTANE,296.41,3.87,0,2,0,0,34.14,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C18 Nutritional and Metabolic Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,PERINDOPRIL ERBUMINE,368.47,0.63,0,5,2,8,95.94,5.48,3.79
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C11 Eye Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C04 Neoplasms,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,ETHACRYNIC ACID,303.14,3.66,1,3,1,6,63.6,,2.8
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C14 Cardiovascular Diseases,PREDNISONE,358.43,1.66,0,5,2,2,91.67,,12.58
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,OXCARBAZEPINE,252.27,1.82,2,2,1,0,63.4,,13.18
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C25 Chemically-Induced Disorders,DISULFIRAM,296.55,4.16,0,4,0,4,6.48,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C06 Digestive System Diseases,CALCITRIOL,416.65,4.35,0,3,3,6,60.69,,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,F03 Mental Disorders,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C01 Infections,FAMCICLOVIR,321.34,-0.48,2,9,1,7,122.22,3.65,
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD,C10 Nervous System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
WILSHIRE PHARMACEUTICALS INC,C01 Infections,SEVELAMER CARBONATE,149.62,,,,,,,,
WILSHIRE PHARMACEUTICALS INC,C14 Cardiovascular Diseases,PROPAFENONE HYDROCHLORIDE,341.45,3.54,2,4,2,11,58.56,9.63,
WILSHIRE PHARMACEUTICALS INC,C12 Male Urogenital Diseases,SEVELAMER CARBONATE,149.62,,,,,,,,
WILSHIRE PHARMACEUTICALS INC,C18 Nutritional and Metabolic Diseases,NATEGLINIDE,317.43,4.03,1,2,2,6,66.4,,4
WOCKHARDT BIO AG,C06 Digestive System Diseases,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
WOCKHARDT BIO AG,C20 Immune System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C01 Infections,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,DEXCHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
WOCKHARDT BIO AG,F01 Behavior and Behavior Mechanisms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
WOCKHARDT BIO AG,C04 Neoplasms,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C20 Immune System Diseases,DEXCHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
WOCKHARDT BIO AG,C09 Otorhinolaryngologic Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
WOCKHARDT BIO AG,C07 Stomatognathic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C11 Eye Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
WOCKHARDT BIO AG,C10 Nervous System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
WOCKHARDT BIO AG,C20 Immune System Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
WOCKHARDT BIO AG,C06 Digestive System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C25 Chemically-Induced Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
WOCKHARDT BIO AG,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT BIO AG,C01 Infections,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT BIO AG,C26 Wounds and Injuries,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
WOCKHARDT BIO AG,F03 Mental Disorders,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WOCKHARDT BIO AG,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C14 Cardiovascular Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
WOCKHARDT BIO AG,C09 Otorhinolaryngologic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C17 Skin and Connective Tissue Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C12 Male Urogenital Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
WOCKHARDT BIO AG,C05 Musculoskeletal Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C14 Cardiovascular Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C04 Neoplasms,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C13 Female Urogenital Diseases and Pregnancy Complications,LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
WOCKHARDT BIO AG,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
WOCKHARDT BIO AG,C15 Hemic and Lymphatic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C13 Female Urogenital Diseases and Pregnancy Complications,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WOCKHARDT BIO AG,C01 Infections,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C11 Eye Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C17 Skin and Connective Tissue Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WOCKHARDT BIO AG,C10 Nervous System Diseases,DEXCHLORPHENIRAMINE MALEATE,274.8,3.58,2,2,0,5,16.13,9.47,
WOCKHARDT BIO AG,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
WOCKHARDT BIO AG,C04 Neoplasms,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C10 Nervous System Diseases,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
WOCKHARDT BIO AG,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT BIO AG,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT BIO AG,C15 Hemic and Lymphatic Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C04 Neoplasms,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",METOCLOPRAMIDE HYDROCHLORIDE,299.8,1.4,1,4,2,7,67.59,9.04,
WOCKHARDT BIO AG,C10 Nervous System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
WOCKHARDT BIO AG,C11 Eye Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT BIO AG,C13 Female Urogenital Diseases and Pregnancy Complications,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
WOCKHARDT BIO AG,C13 Female Urogenital Diseases and Pregnancy Complications,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C12 Male Urogenital Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C09 Otorhinolaryngologic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C11 Eye Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C01 Infections,BROMPHENIRAMINE MALEATE,319.25,3.75,2,2,0,5,16.13,9.48,
WOCKHARDT BIO AG,C19 Endocrine System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C10 Nervous System Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
WOCKHARDT BIO AG,C26 Wounds and Injuries,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
WOCKHARDT BIO AG,C01 Infections,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C26 Wounds and Injuries,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C07 Stomatognathic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C17 Skin and Connective Tissue Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C06 Digestive System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C12 Male Urogenital Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WOCKHARDT BIO AG,C14 Cardiovascular Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C12 Male Urogenital Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C04 Neoplasms,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",LACTULOSE,342.3,-4.53,0,11,8,5,189.53,,10.28
WOCKHARDT BIO AG,C05 Musculoskeletal Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C19 Endocrine System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C10 Nervous System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C20 Immune System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WOCKHARDT BIO AG,C15 Hemic and Lymphatic Diseases,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",CODEINE PHOSPHATE,299.37,1.34,1,4,1,1,41.93,9.19,13.78
WOCKHARDT BIO AG,C01 Infections,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,F03 Mental Disorders,PHENYTOIN,252.27,2.63,2,2,2,2,61.69,,5.86
WOCKHARDT BIO AG,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT BIO AG,C01 Infections,PREDNISOLONE SODIUM PHOSPHATE,440.43,1.15,0,6,4,4,141.36,,1.18
WOCKHARDT BIO AG,C10 Nervous System Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,F03 Mental Disorders,FLUOXETINE HYDROCHLORIDE,309.33,4.17,2,2,1,6,21.26,9.8,
WOCKHARDT BIO AG,C14 Cardiovascular Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WOCKHARDT BIO AG,C05 Musculoskeletal Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C07 Stomatognathic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,FUROSEMIDE,330.75,1.75,2,5,3,5,122.63,,4.25
WOCKHARDT BIO AG,C06 Digestive System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
WOCKHARDT BIO AG,C15 Hemic and Lymphatic Diseases,PREDNISOLONE,360.45,1.27,0,5,3,2,94.83,,12.59
WOCKHARDT BIO AG,C20 Immune System Diseases,CYCLOSPORINE,1202.63,,,,,,,,
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
WOCKHARDT BIO AG,C17 Skin and Connective Tissue Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WOCKHARDT BIO AG,C06 Digestive System Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
WOCKHARDT BIO AG,C06 Digestive System Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WOCKHARDT BIO AG,C07 Stomatognathic Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
WOCKHARDT BIO AG,C14 Cardiovascular Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,C04 Neoplasms,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,C06 Digestive System Diseases,DOXEPIN HYDROCHLORIDE,279.38,3.84,2,2,0,3,12.47,9.76,
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,C09 Otorhinolaryngologic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,C07 Stomatognathic Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
WOCKHARDT BIO AG,C05 Musculoskeletal Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WOCKHARDT BIO AG,C11 Eye Diseases,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
WOCKHARDT BIO AG,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
WOCKHARDT BIO AG,C06 Digestive System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WOCKHARDT BIO AG,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
WOCKHARDT BIO AG,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
WOCKHARDT BIO AG,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WOCKHARDT BIO AG,C17 Skin and Connective Tissue Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT BIO AG,C01 Infections,AMOXICILLIN,365.41,-2.31,1,6,4,4,132.96,7.22,3.23
WOCKHARDT BIO AG,C07 Stomatognathic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
WOCKHARDT BIO AG,G08 Reproductive and Urinary Physiological Phenomena,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WOCKHARDT BIO AG,C04 Neoplasms,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WOCKHARDT BIO AG,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C05 Musculoskeletal Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
WOCKHARDT BIO AG,C01 Infections,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
WOCKHARDT BIO AG,C25 Chemically-Induced Disorders,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WOCKHARDT BIO AG,C04 Neoplasms,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WOCKHARDT BIO AG,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
WOCKHARDT BIO AG,C20 Immune System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
WOCKHARDT BIO AG,C10 Nervous System Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
WOCKHARDT BIO AG,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
WOCKHARDT BIO AG,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
WOCKHARDT BIO AG,C26 Wounds and Injuries,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WOCKHARDT BIO AG,E03 Anesthesia and Analgesia,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WOCKHARDT BIO AG,C17 Skin and Connective Tissue Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
WOCKHARDT BIO AG,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",LOPERAMIDE HYDROCHLORIDE,477.05,4.77,3,3,1,7,43.78,9.41,13.96
WOCKHARDT BIO AG,C04 Neoplasms,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WOCKHARDT BIO AG,C01 Infections,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WOCKHARDT BIO AG,C09 Otorhinolaryngologic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
WOCKHARDT BIO AG,C07 Stomatognathic Diseases,CLAVULANATE POTASSIUM,199.16,-1.52,0,4,2,2,87.07,,3.32
WOCKHARDT BIO AG,C10 Nervous System Diseases,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WOCKHARDT BIO AG,C14 Cardiovascular Diseases,LIDOCAINE HYDROCHLORIDE,234.34,2.84,1,2,1,5,32.34,7.75,13.78
WOCKHARDT BIO AG,C10 Nervous System Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
WOCKHARDT BIO AG,C10 Nervous System Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT BIO AG,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
WOCKHARDT BIO AG,F01 Behavior and Behavior Mechanisms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT BIO AG,C01 Infections,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WOCKHARDT BIO AG,C12 Male Urogenital Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
WOCKHARDT BIO AG,C26 Wounds and Injuries,HYDROCODONE BITARTRATE,299.37,1.96,1,4,0,1,38.77,8.61,
WOCKHARDT BIO AG,C01 Infections,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
WOCKHARDT BIO AG,C01 Infections,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WOCKHARDT BIO AG,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C26 Wounds and Injuries,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
WOCKHARDT BIO AG,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C01 Infections,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
WOCKHARDT BIO AG,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C04 Neoplasms,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
WOCKHARDT BIO AG,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C10 Nervous System Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
WOCKHARDT BIO AG,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
WOCKHARDT BIO AG,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C06 Digestive System Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
WOCKHARDT BIO AG,C04 Neoplasms,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
WOCKHARDT BIO AG,C12 Male Urogenital Diseases,ABIRATERONE ACETATE,391.56,4.41,1,3,0,2,39.19,4.81,
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,PSEUDOEPHEDRINE HYDROCHLORIDE,165.24,1.32,1,2,2,3,32.26,9.52,13.89
WOCKHARDT BIO AG,C15 Hemic and Lymphatic Diseases,NYSTATIN,926.11,-1.94,0,17,12,3,319.61,9.11,3.72
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,LORATADINE,382.89,4.55,2,3,0,1,42.43,4.33,
WOCKHARDT BIO AG,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,F03 Mental Disorders,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
WOCKHARDT BIO AG,C04 Neoplasms,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT BIO AG,F03 Mental Disorders,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WOCKHARDT BIO AG,C01 Infections,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT BIO AG,C15 Hemic and Lymphatic Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT BIO AG,C10 Nervous System Diseases,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WOCKHARDT BIO AG,C11 Eye Diseases,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT BIO AG,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WOCKHARDT BIO AG,F03 Mental Disorders,LITHIUM CITRATE,209.92,,,,,,,,
WOCKHARDT BIO AG,C15 Hemic and Lymphatic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WOCKHARDT BIO AG,"C23 Pathological Conditions, Signs and Symptoms",MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WOCKHARDT BIO AG,C26 Wounds and Injuries,VALPROIC ACID,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT BIO AG,C20 Immune System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WOCKHARDT BIO AG,C08 Respiratory Tract Diseases,DEXTROMETHORPHAN HYDROBROMIDE,271.4,3.49,1,2,0,1,12.47,9.85,
WOCKHARDT BIO AG,C04 Neoplasms,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WOCKHARDT BIO AG,C18 Nutritional and Metabolic Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WOCKHARDT BIO AG,C17 Skin and Connective Tissue Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WOCKHARDT BIO AG,C04 Neoplasms,MEGESTROL ACETATE,384.52,3.72,0,4,0,2,60.44,,
WOCKHARDT BIO AG,C10 Nervous System Diseases,IMATINIB MESYLATE,493.62,4.38,4,7,2,7,86.28,7.84,12.69
WOCKHARDT LTD,F03 Mental Disorders,ZIPRASIDONE HYDROCHLORIDE,412.95,4.3,3,5,1,4,48.47,7.09,12.21
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WOCKHARDT LTD,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT LTD,C04 Neoplasms,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WOCKHARDT LTD,C14 Cardiovascular Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WOCKHARDT LTD,C14 Cardiovascular Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
WOCKHARDT LTD,C01 Infections,RANITIDINE HYDROCHLORIDE,314.41,0.99,1,7,2,10,83.58,7.8,
WOCKHARDT LTD,C08 Respiratory Tract Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WOCKHARDT LTD,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C06 Digestive System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WOCKHARDT LTD,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
WOCKHARDT LTD,C12 Male Urogenital Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WOCKHARDT LTD,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
WOCKHARDT LTD,C11 Eye Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WOCKHARDT LTD,C18 Nutritional and Metabolic Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WOCKHARDT LTD,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C04 Neoplasms,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WOCKHARDT LTD,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,F03 Mental Disorders,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WOCKHARDT LTD,C08 Respiratory Tract Diseases,CAPTOPRIL,217.29,0.73,0,3,2,3,57.61,,4.02
WOCKHARDT LTD,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
WOCKHARDT LTD,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
WOCKHARDT LTD,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
WOCKHARDT LTD,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WOCKHARDT LTD,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WOCKHARDT LTD,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WOCKHARDT LTD,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WOCKHARDT LTD,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
WOCKHARDT LTD,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
WOCKHARDT LTD,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
WOCKHARDT LTD,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
WOCKHARDT LTD,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WOCKHARDT LTD,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WOCKHARDT LTD,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
WOCKHARDT LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
WOCKHARDT LTD,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WOCKHARDT LTD,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WOCKHARDT LTD,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WOCKHARDT LTD,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
WOCKHARDT LTD,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
WOCKHARDT LTD,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
WOCKHARDT LTD,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT LTD,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
WOCKHARDT LTD,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
WOCKHARDT LTD,C10 Nervous System Diseases,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
WOCKHARDT LTD,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
WOCKHARDT LTD,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT LTD,F03 Mental Disorders,SERTRALINE HYDROCHLORIDE,306.24,5.15,2,1,1,2,12.03,9.56,
WOCKHARDT LTD,C10 Nervous System Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
WOCKHARDT LTD,C08 Respiratory Tract Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
WOCKHARDT LTD,F03 Mental Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
WOCKHARDT LTD,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
WOCKHARDT LTD,C10 Nervous System Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WOCKHARDT LTD,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
WOCKHARDT LTD,C25 Chemically-Induced Disorders,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
WOCKHARDT LTD,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT LTD,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WOCKHARDT LTD,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
WOCKHARDT LTD,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WOCKHARDT LTD,C11 Eye Diseases,LEVODOPA,197.19,-1.79,1,4,4,3,103.78,9.06,1.65
WOCKHARDT LTD,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT LTD,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WOCKHARDT LTD,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WOCKHARDT LTD,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WOCKHARDT LTD,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WOCKHARDT LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WOCKHARDT LTD,C12 Male Urogenital Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
WOCKHARDT LTD,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WOCKHARDT LTD,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WOCKHARDT LTD,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WOCKHARDT LTD,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WOCKHARDT LTD,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WOCKHARDT LTD,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WOCKHARDT LTD,C13 Female Urogenital Diseases and Pregnancy Complications,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
WOCKHARDT LTD,C14 Cardiovascular Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
WOCKHARDT LTD,C10 Nervous System Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
WOCKHARDT LTD,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,C01 Infections,CEFPROZIL,389.43,-1.92,1,6,4,5,132.96,7.22,3.3
WOCKHARDT LTD,C01 Infections,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WOCKHARDT LTD,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,C10 Nervous System Diseases,ROPINIROLE HYDROCHLORIDE,260.38,3.06,1,2,1,7,32.34,10.17,12.27
WOCKHARDT LTD,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,C25 Chemically-Induced Disorders,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
WOCKHARDT LTD,C18 Nutritional and Metabolic Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
WOCKHARDT LTD,C10 Nervous System Diseases,ENTACAPONE,305.29,1.63,1,6,2,5,127.7,,6.09
WOCKHARDT LTD,C08 Respiratory Tract Diseases,FEXOFENADINE HYDROCHLORIDE,501.67,2.94,3,4,3,10,81,9.01,4.04
WOCKHARDT LTD,C05 Musculoskeletal Diseases,ENALAPRIL MALEATE,376.45,0.59,1,5,2,9,95.94,5.2,3.67
WOCKHARDT LTD,C25 Chemically-Induced Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
WOCKHARDT LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,F03 Mental Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
WOCKHARDT LTD,C09 Otorhinolaryngologic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
WOCKHARDT LTD,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
WOCKHARDT LTD,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,C04 Neoplasms,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
WOCKHARDT LTD,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
WOCKHARDT LTD,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
WOCKHARDT LTD,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
WOCKHARDT LTD,C05 Musculoskeletal Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
WOCKHARDT LTD,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
WOCKHARDT LTD,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
WOCKHARDT LTD,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
WOCKHARDT LTD,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
WOCKHARDT LTD,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
WOCKHARDT LTD,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
WOCKHARDT LTD,C06 Digestive System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
WOCKHARDT LTD,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
WOCKHARDT LTD,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
WOCKHARDT LTD,C18 Nutritional and Metabolic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
WOCKHARDT LTD,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
WOCKHARDT LTD,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
WOCKHARDT LTD,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
WOCKHARDT LTD,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
WOCKHARDT LTD,C01 Infections,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
WOCKHARDT LTD,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
WOCKHARDT LTD,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
WOCKHARDT LTD,F03 Mental Disorders,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
WOCKHARDT LTD,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
WOCKHARDT LTD,C10 Nervous System Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
WOCKHARDT LTD,C17 Skin and Connective Tissue Diseases,FAMOTIDINE,337.46,-1.95,1,6,4,7,175.83,8.38,9.29
WOCKHARDT LTD,C10 Nervous System Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
WOCKHARDT LTD,C14 Cardiovascular Diseases,LISINOPRIL,405.5,-3.1,1,5,4,12,132.96,10.21,3.17
WOCKHARDT LTD,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,C20 Immune System Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
WOCKHARDT LTD,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C17 Skin and Connective Tissue Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
WOCKHARDT LTD,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT LTD,C10 Nervous System Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
WOCKHARDT LTD,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
WOCKHARDT LTD,C04 Neoplasms,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
WOCKHARDT LTD,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C14 Cardiovascular Diseases,CLOPIDOGREL BISULFATE,321.83,4.03,2,4,0,3,29.54,4.77,
WOCKHARDT LTD,C08 Respiratory Tract Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
WOCKHARDT LTD,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C01 Infections,CEFUROXIME AXETIL,510.48,-0.43,1,12,2,9,189.06,,10.92
WOCKHARDT LTD,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
WOCKHARDT LTD,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,C07 Stomatognathic Diseases,CLARITHROMYCIN,747.96,3.24,0,14,4,8,182.91,8.38,12.46
WOCKHARDT LTD,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
WOCKHARDT LTD,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
WOCKHARDT LTD,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WOCKHARDT LTD,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,C12 Male Urogenital Diseases,CETIRIZINE HYDROCHLORIDE,388.9,0.87,2,4,1,8,53.01,7.42,3.59
WOCKHARDT LTD,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
WOCKHARDT LTD,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WOCKHARDT LTD,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT LTD,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WOCKHARDT LTD,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
WOCKHARDT LTD,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
WOCKHARDT LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WOCKHARDT LTD,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
WRASER PHARMACEUTICALS LLC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",DIHYDROCODEINE BITARTRATE,301.39,1.55,1,4,1,1,41.93,9.33,
WRASER PHARMACEUTICALS LLC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C01 Infections,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C10 Nervous System Diseases,BUTALBITAL,224.26,1.59,0,3,2,4,75.27,,7.48
WRASER PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C15 Hemic and Lymphatic Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C06 Digestive System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,F03 Mental Disorders,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C10 Nervous System Diseases,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C04 Neoplasms,CAFFEINE,194.19,-0.55,2,6,0,0,61.82,,
WRASER PHARMACEUTICALS LLC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WRASER PHARMACEUTICALS LLC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
WYETH PHARMACEUTICALS LLC,C14 Cardiovascular Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,C10 Nervous System Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,C04 Neoplasms,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,C12 Male Urogenital Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,C13 Female Urogenital Diseases and Pregnancy Complications,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,C08 Respiratory Tract Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,C06 Digestive System Diseases,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
WYETH PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,C17 Skin and Connective Tissue Diseases,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
WYETH PHARMACEUTICALS LLC,C04 Neoplasms,PANTOPRAZOLE SODIUM,383.38,2.18,3,6,1,7,86.33,3.55,9.54
WYETH PHARMACEUTICALS LLC,C01 Infections,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,G08 Reproductive and Urinary Physiological Phenomena,MEDROXYPROGESTERONE ACETATE,386.53,4.13,0,4,0,2,60.44,,
WYETH PHARMACEUTICALS LLC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WYETH PHARMACEUTICALS LLC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WYETH PHARMACEUTICALS LLC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WYETH PHARMACEUTICALS LLC,C01 Infections,ETHIONAMIDE,166.25,1.33,1,2,1,2,38.91,5,11.89
WYETH PHARMACEUTICALS LLC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WYETH PHARMACEUTICALS LLC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WYETH PHARMACEUTICALS LLC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
WYETH PHARMACEUTICALS LLC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
XSPIRE PHARMA LLC,C11 Eye Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C05 Musculoskeletal Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C04 Neoplasms,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C17 Skin and Connective Tissue Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C19 Endocrine System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C12 Male Urogenital Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C18 Nutritional and Metabolic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C15 Hemic and Lymphatic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C08 Respiratory Tract Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C20 Immune System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C09 Otorhinolaryngologic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C26 Wounds and Injuries,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C06 Digestive System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C14 Cardiovascular Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C10 Nervous System Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,"C23 Pathological Conditions, Signs and Symptoms",DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C07 Stomatognathic Diseases,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
XSPIRE PHARMA LLC,C01 Infections,DEXAMETHASONE,392.47,1.68,0,5,3,2,94.83,,12.42
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,F03 Mental Disorders,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C04 Neoplasms,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C11 Eye Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C01 Infections,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YICHANG HUMANWELL PHARMACEUTICAL CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NIACIN,123.11,-0.17,1,2,1,1,50.19,4.19,2.79
YILING PHARMACEUTICAL LTD,C01 Infections,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
YILING PHARMACEUTICAL LTD,C12 Male Urogenital Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
YILING PHARMACEUTICAL LTD,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
YILING PHARMACEUTICAL LTD,C09 Otorhinolaryngologic Diseases,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
YILING PHARMACEUTICAL LTD,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
YILING PHARMACEUTICAL LTD,C04 Neoplasms,CIPROFLOXACIN HYDROCHLORIDE,331.35,-0.85,2,5,2,3,74.57,8.68,5.56
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C10 Nervous System Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C18 Nutritional and Metabolic Diseases,ZOLPIDEM TARTRATE,307.4,3.02,3,3,0,3,37.61,5.39,
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C14 Cardiovascular Diseases,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C14 Cardiovascular Diseases,FELODIPINE,384.26,3.44,1,5,1,4,64.63,,
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C12 Male Urogenital Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C17 Skin and Connective Tissue Diseases,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C04 Neoplasms,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C01 Infections,CEPHALEXIN,347.4,-2.14,1,5,3,4,112.73,7.23,3.26
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,F03 Mental Disorders,CLONIDINE HYDROCHLORIDE,230.1,2.04,1,1,2,1,36.42,9.34,
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C09 Otorhinolaryngologic Diseases,CEFACLOR,367.81,-2.31,1,5,3,4,112.73,7.23,2.83
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD,C01 Infections,CEFACLOR,367.81,-2.31,1,5,3,4,112.73,7.23,2.83
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C20 Immune System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C14 Cardiovascular Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C04 Neoplasms,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C01 Infections,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C05 Musculoskeletal Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C15 Hemic and Lymphatic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C10 Nervous System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C12 Male Urogenital Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C08 Respiratory Tract Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C17 Skin and Connective Tissue Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C11 Eye Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C18 Nutritional and Metabolic Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZHEJIANG HISUN PHARMACEUTICAL CO LTD,C06 Digestive System Diseases,MYCOPHENOLATE MOFETIL,433.5,3.47,1,8,1,9,94.53,6.19,9.76
ZYDUS HEALTHCARE USA LLC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS HEALTHCARE USA LLC,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS HEALTHCARE USA LLC,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS HEALTHCARE USA LLC,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS HEALTHCARE USA LLC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS HEALTHCARE USA LLC,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS HEALTHCARE USA LLC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS HEALTHCARE USA LLC,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS HEALTHCARE USA LLC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS HEALTHCARE USA LLC,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS HEALTHCARE USA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS HEALTHCARE USA LLC,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS HEALTHCARE USA LLC,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS HEALTHCARE USA LLC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS HEALTHCARE USA LLC,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS HEALTHCARE USA LLC,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS HEALTHCARE USA LLC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS HEALTHCARE USA LLC,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS HEALTHCARE USA LLC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS HEALTHCARE USA LLC,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS HEALTHCARE USA LLC,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS HEALTHCARE USA LLC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ATOMOXETINE HYDROCHLORIDE,255.36,3.81,2,2,1,6,21.26,9.8,
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,AMLODIPINE BESYLATE,408.88,1.64,1,7,2,8,99.88,9.45,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,TIZANIDINE HYDROCHLORIDE,253.72,2.02,2,6,2,1,62.2,7.49,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,EXEMESTANE,296.41,3.87,0,2,0,0,34.14,,
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,BROMOCRIPTINE MESYLATE,654.61,3.89,2,6,3,5,118.21,6.71,9.69
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,MESALAMINE,153.14,-0.29,1,3,3,1,83.55,5.87,2.02
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",BUSPIRONE HYDROCHLORIDE,385.51,1.78,1,6,0,6,69.64,7.62,
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,PAROXETINE HYDROCHLORIDE,329.37,3.15,2,4,1,4,39.72,9.77,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,METFORMIN HYDROCHLORIDE,129.17,-0.92,0,2,4,0,88.99,12.33,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,COLCHICINE,399.44,1.46,2,6,1,5,83.09,,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CLOBAZAM,300.75,2.55,2,2,0,1,40.62,,5.82
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,PIOGLITAZONE HYDROCHLORIDE,356.45,3.33,2,5,1,7,68.29,5.6,6.66
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",OLANZAPINE,312.44,3.39,2,5,1,0,30.87,7.24,13.17
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,LOSARTAN POTASSIUM,422.92,4.06,4,6,2,8,92.51,3.82,4.26
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AMIODARONE HYDROCHLORIDE,645.32,7.64,3,4,0,11,42.68,8.47,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ITRACONAZOLE,705.65,7.31,5,12,0,11,104.7,3.91,
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,DULOXETINE HYDROCHLORIDE,297.42,4.2,3,3,1,6,21.26,9.7,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,CARVEDILOL,406.48,3.42,4,5,3,10,75.74,8.74,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,LABETALOL HYDROCHLORIDE,328.41,1.89,2,4,4,8,95.58,9.8,8.05
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CARBAMAZEPINE,236.27,2.77,2,1,1,0,46.33,,
ZYDUS PHARMACEUTICALS USA INC,G08 Reproductive and Urinary Physiological Phenomena,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CANDESARTAN CILEXETIL,610.67,8.17,5,11,1,10,143.34,1.45,5.85
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,CYPROHEPTADINE HYDROCHLORIDE,287.41,4.38,2,1,0,0,3.24,8.05,
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ZYDUS PHARMACEUTICALS USA INC,C20 Immune System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ENTECAVIR,277.28,-1.96,2,7,4,2,130.05,0.74,10.17
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ZYDUS PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,FINASTERIDE,372.55,3.07,0,2,2,1,58.2,0.33,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,TELMISARTAN,514.63,6.13,6,5,1,7,72.94,5.86,3.62
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,FLUCONAZOLE,306.28,0.56,3,7,1,5,81.65,2.3,12.68
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
ZYDUS PHARMACEUTICALS USA INC,C20 Immune System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",PROMETHAZINE HYDROCHLORIDE,284.43,4.29,2,3,0,3,6.48,9.05,
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,HALOPERIDOL,375.87,3.66,2,3,1,6,40.54,8.05,13.96
ZYDUS PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,CINACALCET HYDROCHLORIDE,357.42,6.27,3,1,1,6,12.03,10.01,
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,TRAZODONE HYDROCHLORIDE,371.87,3.13,3,6,0,5,45.78,7.09,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,VALACYCLOVIR HYDROCHLORIDE,324.34,-0.06,2,9,3,7,151.14,7.48,11.99
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DIFLUNISAL,250.2,3.91,2,2,2,2,57.53,,2.69
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DIFLUNISAL,250.2,3.91,2,2,2,2,57.53,,2.69
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,DIFLUNISAL,250.2,3.91,2,2,2,2,57.53,,2.69
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,CARBIDOPA,226.23,-1.21,1,5,5,4,115.81,5.66,2.35
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,GLYBURIDE,494.01,3.79,2,5,3,8,113.6,,4.32
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ZYDUS PHARMACEUTICALS USA INC,G07 Physiological Phenomena,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ZYDUS PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DUTASTERIDE,528.54,5.79,1,2,2,2,58.2,,12.56
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PITAVASTATIN MAGNESIUM,421.47,2.92,3,4,3,8,90.65,4.86,4.13
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,AMITRIPTYLINE HYDROCHLORIDE,277.41,4.81,2,1,0,3,3.24,9.76,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,NAPROXEN,230.26,2.99,2,2,1,3,46.53,,4.19
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,WARFARIN SODIUM,308.33,2.74,3,4,1,4,67.51,,5.56
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,GEMFIBROZIL,250.34,4.39,1,2,1,6,46.53,,4.42
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,TEMOZOLOMIDE,194.15,-0.28,2,7,1,1,108.17,,10.46
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PHENTERMINE HYDROCHLORIDE,149.24,2.08,1,1,1,2,26.02,10.25,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,HYDROCHLOROTHIAZIDE,297.75,-0.58,1,5,3,1,118.36,,9.09
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,TAMSULOSIN HYDROCHLORIDE,408.52,2.04,2,6,2,11,99.88,9.28,9.93
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PYRIDOSTIGMINE BROMIDE,181.22,-3.47,1,2,0,1,33.42,,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ZYDUS PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,BOSENTAN,551.63,4.94,4,10,2,10,145.65,0.57,5.8
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,DOXAZOSIN MESYLATE,451.48,2.14,3,9,1,4,112.27,7.24,12.67
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,CLINDAMYCIN HYDROCHLORIDE,424.99,1.04,0,7,4,7,102.26,7.55,12.41
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,LEVOFLOXACIN,361.37,0.51,2,6,1,2,75.01,6.16,5.29
ZYDUS PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",RISPERIDONE,410.49,2.63,3,6,0,4,64.16,8.76,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,OLMESARTAN MEDOXOMIL,558.6,4.54,5,11,2,10,162.16,3.63,4.25
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",LAMOTRIGINE,256.1,1.93,2,5,2,1,90.71,5.89,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,NATEGLINIDE,317.43,4.03,1,2,2,6,66.4,,4
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,TRIENTINE HYDROCHLORIDE,146.24,-2.15,0,4,4,7,76.1,9.77,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,DIPYRIDAMOLE,504.64,1.81,2,12,4,12,145.44,3.54,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,TAMOXIFEN CITRATE,371.52,6.35,3,2,0,8,12.47,8.76,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,CLOMIPRAMINE HYDROCHLORIDE,314.86,4.88,2,2,0,4,6.48,9.2,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ZONISAMIDE,212.23,-0.03,2,4,2,2,87.18,2.46,1.82
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,DOXYCYCLINE HYCLATE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,GABAPENTIN,171.24,-1.27,0,2,2,3,63.32,9.91,4.63
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,DOXYCYCLINE,444.44,-3.29,1,9,6,2,181.62,7.46,2.92
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,LANSOPRAZOLE,369.37,3.03,3,4,1,5,67.87,4.16,9.35
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,TADALAFIL,389.41,1.64,3,4,1,1,74.87,,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,LINEZOLID,337.35,0.64,1,5,1,4,71.11,,
ZYDUS PHARMACEUTICALS USA INC,G08 Reproductive and Urinary Physiological Phenomena,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,ACAMPROSATE CALCIUM,181.21,-2.75,0,3,2,4,83.47,,-0.88
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,MISOPROSTOL,382.54,3.86,0,5,2,13,83.83,,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,ETODOLAC,287.36,3.44,2,2,2,4,62.32,,4.73
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ACYCLOVIR,225.21,-0.56,2,8,3,4,119.31,1.01,11.58
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,TOPIRAMATE,339.37,0.13,0,8,1,3,115.54,,11.09
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,RAMIPRIL,416.52,1.47,1,5,2,9,95.94,5.2,3.75
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,AMBRISENTAN,378.43,2.97,3,5,1,7,81.54,4,3.08
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C20 Immune System Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ARIPIPRAZOLE,448.39,4.9,2,4,1,7,44.81,7.46,13.51
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ZYDUS PHARMACEUTICALS USA INC,E01 Diagnosis,ALLOPURINOL,136.11,-1.76,0,3,2,0,74.43,0.09,7.83
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,MELOXICAM,351.41,1.6,2,6,2,2,99.6,0.47,4.47
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,EZETIMIBE,409.43,4.56,3,3,2,6,60.77,,9.48
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,VENLAFAXINE HYDROCHLORIDE,277.41,2.74,1,3,1,5,32.7,8.91,
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",ROSUVASTATIN CALCIUM,481.55,1.92,2,7,3,10,140.92,,4
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,OXYBUTYNIN CHLORIDE,357.49,4.44,1,4,1,7,49.77,8.77,11.53
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ALBENDAZOLE,265.34,3.2,2,4,2,4,67.01,4.27,9.51
ZYDUS PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,TRIAMTERENE,253.27,1.11,3,7,3,1,129.62,1.86,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ZOLMITRIPTAN,287.36,2.04,2,3,2,5,57.36,9.55,13
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ZYDUS PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,VARDENAFIL HYDROCHLORIDE,488.61,1.43,3,8,1,8,112.9,6.21,11.75
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C20 Immune System Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ZYDUS PHARMACEUTICALS USA INC,C20 Immune System Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,G07 Physiological Phenomena,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C20 Immune System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METOPROLOL SUCCINATE,267.37,1.76,1,4,2,9,50.72,9.67,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C09 Otorhinolaryngologic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,D01 Inorganic Chemicals,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,BUDESONIDE,430.54,2.73,0,6,2,4,93.06,,13.75
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PRAMIPEXOLE DIHYDROCHLORIDE,211.33,1.76,1,4,2,3,50.94,10.31,
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ZYDUS PHARMACEUTICALS USA INC,G07 Physiological Phenomena,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,DIVALPROEX SODIUM,144.21,2.8,0,1,1,5,37.3,,5.14
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAZOLAMIDE,222.25,-1.04,1,6,2,2,115.04,,6.55
ZYDUS PHARMACEUTICALS USA INC,C19 Endocrine System Diseases,SPIRONOLACTONE,416.58,3.64,0,5,0,1,60.44,,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,G07 Physiological Phenomena,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,METHYLPREDNISOLONE,374.48,1.56,0,5,3,2,94.83,,12.59
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,MIRTAZAPINE,265.36,3.21,2,3,0,0,19.37,6.67,
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,NADOLOL,309.41,0.87,1,5,4,5,81.95,9.76,13.59
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,LEVETIRACETAM,170.21,-0.59,0,2,1,3,63.4,,
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,SIROLIMUS,914.19,7.45,0,13,3,6,195.43,,9.96
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ESOMEPRAZOLE MAGNESIUM,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ANASTROZOLE,293.37,3.03,2,5,0,4,78.29,2,
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,FELBAMATE,238.24,0.68,1,4,2,5,104.64,,
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,RIBAVIRIN,244.21,-2.77,1,8,4,3,143.72,,11.88
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",TRAMADOL HYDROCHLORIDE,263.38,2.45,1,3,1,4,32.7,9.23,13.8
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,GALANTAMINE HYDROBROMIDE,287.36,1.16,1,4,1,1,41.93,8.58,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C20 Immune System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,AMANTADINE HYDROCHLORIDE,151.25,1.47,0,1,1,0,26.02,10.71,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,BENZONATATE,603.75,2.35,1,12,1,32,121.4,3.47,
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,PROPRANOLOL HYDROCHLORIDE,259.35,2.58,2,3,2,6,41.49,9.67,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,FESOTERODINE FUMARATE,411.59,5.7,2,4,1,10,49.77,10.64,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,BUPROPION HYDROCHLORIDE,239.75,3.27,1,2,1,3,29.1,8.22,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,G08 Reproductive and Urinary Physiological Phenomena,DESVENLAFAXINE SUCCINATE,263.38,2.29,1,3,2,4,43.7,8.87,10.11
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,SODIUM BICARBONATE,84.01,,,,,,,,
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,MEMANTINE HYDROCHLORIDE,179.31,2.07,0,1,1,0,26.02,10.7,
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ATORVASTATIN CALCIUM,558.65,5.39,4,5,4,12,111.79,,4.31
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,DONEPEZIL HYDROCHLORIDE,379.5,4.21,2,4,0,6,38.77,8.54,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,HYDROXYCHLOROQUINE SULFATE,335.88,2.89,2,4,2,9,48.39,9.76,
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,INDOMETHACIN,357.79,3.53,3,4,1,4,68.53,,3.79
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",DILTIAZEM HYDROCHLORIDE,414.53,2.73,2,6,0,6,59.08,8.18,12.86
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,BENAZEPRIL HYDROCHLORIDE,424.5,1.54,2,5,2,9,95.94,5.36,3.53
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,CHLORTHALIDONE,338.77,1.6,2,4,3,2,109.49,,8.76
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C20 Immune System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,ASPIRIN,180.16,1.24,1,3,1,2,63.6,,3.41
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ZYDUS PHARMACEUTICALS USA INC,C07 Stomatognathic Diseases,ACETAMINOPHEN,151.16,0.91,1,2,2,1,49.33,,9.46
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,VALSARTAN,435.53,4.59,3,5,2,10,112.07,,4
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C11 Eye Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C17 Skin and Connective Tissue Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C26 Wounds and Injuries,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,ATENOLOL,266.34,0.43,1,4,3,8,84.58,9.67,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ZYDUS PHARMACEUTICALS USA INC,F01 Behavior and Behavior Mechanisms,SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,IRBESARTAN,428.54,5.39,3,5,1,7,87.13,4.12,5.85
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,AZATHIOPRINE,277.27,1.17,3,8,1,3,115.42,2.16,8.62
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,"C23 Pathological Conditions, Signs and Symptoms",SIMVASTATIN,418.57,4.46,0,5,1,6,72.83,,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
ZYDUS PHARMACEUTICALS USA INC,C13 Female Urogenital Diseases and Pregnancy Complications,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ZYDUS PHARMACEUTICALS USA INC,C08 Respiratory Tract Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,GLIPIZIDE,445.55,1.43,2,6,3,7,130.15,0.06,4.32
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
ZYDUS PHARMACEUTICALS USA INC,C06 Digestive System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ZYDUS PHARMACEUTICALS USA INC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,LURASIDONE HYDROCHLORIDE,492.69,4.56,2,6,0,5,56.75,8.5,
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,PRAVASTATIN SODIUM,424.53,1.65,0,6,4,10,124.29,,4.21
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,BICALUTAMIDE,430.38,2.71,2,5,2,5,107.26,,11.78
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C25 Chemically-Induced Disorders,NIFEDIPINE,346.34,1.82,1,7,1,4,107.77,,
ZYDUS PHARMACEUTICALS USA INC,C18 Nutritional and Metabolic Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C15 Hemic and Lymphatic Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,F03 Mental Disorders,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
ZYDUS PHARMACEUTICALS USA INC,C01 Infections,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
ZYDUS PHARMACEUTICALS USA INC,C10 Nervous System Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
ZYDUS PHARMACEUTICALS USA INC,C05 Musculoskeletal Diseases,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS PHARMACEUTICALS USA INC,C14 Cardiovascular Diseases,BUMETANIDE,364.42,2.42,2,5,3,8,118.72,2.7,4.69
ZYDUS PHARMACEUTICALS USA INC,C12 Male Urogenital Diseases,NITROFURANTOIN,238.16,-0.22,1,6,1,3,118.05,,8.23
ZYDUS PHARMACEUTICALS USA INC,C04 Neoplasms,OMEPRAZOLE,345.42,2.43,3,5,1,5,77.1,4.77,9.68
ZYDUS WORLDWIDE DMCC,C06 Digestive System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
ZYDUS WORLDWIDE DMCC,C01 Infections,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
ZYDUS WORLDWIDE DMCC,C04 Neoplasms,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
ZYDUS WORLDWIDE DMCC,C25 Chemically-Induced Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
ZYDUS WORLDWIDE DMCC,C10 Nervous System Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
ZYDUS WORLDWIDE DMCC,C04 Neoplasms,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
ZYDUS WORLDWIDE DMCC,G11 Musculoskeletal and Neural Physiological Phenomena,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
ZYDUS WORLDWIDE DMCC,C05 Musculoskeletal Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
ZYDUS WORLDWIDE DMCC,C07 Stomatognathic Diseases,MINOCYCLINE HYDROCHLORIDE,457.48,-2.54,1,9,5,3,164.63,7.9,2.9
ZYDUS WORLDWIDE DMCC,C18 Nutritional and Metabolic Diseases,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
ZYDUS WORLDWIDE DMCC,F03 Mental Disorders,BACLOFEN,213.66,-0.78,1,2,2,4,63.32,9.79,3.89
ZYDUS WORLDWIDE DMCC,C04 Neoplasms,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ZYDUS WORLDWIDE DMCC,C06 Digestive System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C20 Immune System Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ZYDUS WORLDWIDE DMCC,C05 Musculoskeletal Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C10 Nervous System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ZYDUS WORLDWIDE DMCC,"C23 Pathological Conditions, Signs and Symptoms",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C11 Eye Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,"C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities",OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C12 Male Urogenital Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C06 Digestive System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C18 Nutritional and Metabolic Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ZYDUS WORLDWIDE DMCC,C06 Digestive System Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ZYDUS WORLDWIDE DMCC,C13 Female Urogenital Diseases and Pregnancy Complications,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C07 Stomatognathic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C12 Male Urogenital Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C07 Stomatognathic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C05 Musculoskeletal Diseases,PHYTONADIONE,450.71,9.7,1,2,0,14,34.14,,
ZYDUS WORLDWIDE DMCC,C09 Otorhinolaryngologic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,F03 Mental Disorders,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C18 Nutritional and Metabolic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C10 Nervous System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C12 Male Urogenital Diseases,PHYTONADIONE,450.71,9.7,1,2,0,14,34.14,,
ZYDUS WORLDWIDE DMCC,C10 Nervous System Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C20 Immune System Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,"C23 Pathological Conditions, Signs and Symptoms",AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,G08 Reproductive and Urinary Physiological Phenomena,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C05 Musculoskeletal Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ZYDUS WORLDWIDE DMCC,C08 Respiratory Tract Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C11 Eye Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C17 Skin and Connective Tissue Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ZYDUS WORLDWIDE DMCC,C12 Male Urogenital Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ZYDUS WORLDWIDE DMCC,C14 Cardiovascular Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ZYDUS WORLDWIDE DMCC,C11 Eye Diseases,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ZYDUS WORLDWIDE DMCC,C01 Infections,LEFLUNOMIDE,270.21,2.51,2,3,1,2,55.13,,13.72
ZYDUS WORLDWIDE DMCC,C10 Nervous System Diseases,PHYTONADIONE,450.71,9.7,1,2,0,14,34.14,,
ZYDUS WORLDWIDE DMCC,C17 Skin and Connective Tissue Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C01 Infections,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,F01 Behavior and Behavior Mechanisms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C14 Cardiovascular Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C26 Wounds and Injuries,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C17 Skin and Connective Tissue Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,C04 Neoplasms,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C01 Infections,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C18 Nutritional and Metabolic Diseases,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C01 Infections,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ZYDUS WORLDWIDE DMCC,G08 Reproductive and Urinary Physiological Phenomena,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ZYDUS WORLDWIDE DMCC,C04 Neoplasms,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ZYDUS WORLDWIDE DMCC,C14 Cardiovascular Diseases,PHYTONADIONE,450.71,9.7,1,2,0,14,34.14,,
ZYDUS WORLDWIDE DMCC,C13 Female Urogenital Diseases and Pregnancy Complications,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,"C23 Pathological Conditions, Signs and Symptoms",URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6
ZYDUS WORLDWIDE DMCC,C15 Hemic and Lymphatic Diseases,AZITHROMYCIN,749,2.44,0,14,5,7,180.08,9.57,12.43
ZYDUS WORLDWIDE DMCC,F03 Mental Disorders,OMEGA-3-ACID ETHYL ESTERS,687.06,,,,,,,,
ZYDUS WORLDWIDE DMCC,C14 Cardiovascular Diseases,URSODIOL,392.58,3.71,0,3,3,4,77.76,,4.6